<SEC-DOCUMENT>0000914121-23-000147.txt : 20230313
<SEC-HEADER>0000914121-23-000147.hdr.sgml : 20230313
<ACCEPTANCE-DATETIME>20230313063206
ACCESSION NUMBER:		0000914121-23-000147
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		7
FILED AS OF DATE:		20230313
DATE AS OF CHANGE:		20230313
GROUP MEMBERS:		POLITAN CAPITAL MANAGEMENT GP LLC
GROUP MEMBERS:		POLITAN CAPITAL PARTNERS GP LLC
GROUP MEMBERS:		QUENTIN KOFFEY

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MASIMO CORP
		CENTRAL INDEX KEY:			0000937556
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				330368882
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-83497
		FILM NUMBER:		23725631

	BUSINESS ADDRESS:	
		STREET 1:		52 DISCOVERY
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92618
		BUSINESS PHONE:		949-297-7000

	MAIL ADDRESS:	
		STREET 1:		52 DISCOVERY
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92618

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Politan Capital Management LP
		CENTRAL INDEX KEY:			0001885245
		IRS NUMBER:				871666292
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		C/O SCHULTE ROTH & ZABEL LLP
		STREET 2:		919 THIRD AVENUE, SUITE 2300
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		(212) 756-2000

	MAIL ADDRESS:	
		STREET 1:		C/O SCHULTE ROTH & ZABEL LLP
		STREET 2:		919 THIRD AVENUE, SUITE 2300
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>po58913627-sc13da4.htm
<DESCRIPTION>AMENDMENT NO. 4
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Cadwalader, Wickersham & Taft LLP
         Document created using Broadridge PROfile 23.1.1.5115
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; text-align: left; color: #000000;">
  <div><br>
  </div>
  <div>
    <div>
      <div>
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
    <div style="text-align: center; margin-top: 12pt; color: #000000; font-size: 14pt; font-weight: bold;">UNITED STATES</div>
    <div style="text-align: center; color: #000000; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; margin-bottom: 12pt; color: #000000; font-weight: bold;">Washington, D.C. 20549</div>
    <div style="text-align: center; font-size: 12pt;"><u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u></div>
    <div style="text-align: center; margin-top: 12pt; color: #000000; font-size: 18pt; font-weight: bold;">SCHEDULE 13D</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">(Rule 13d-101)</div>
    <div style="text-align: center; margin-top: 12pt; color: #000000; font-weight: bold;">INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">PURSUANT TO RULE 13d-2(a)</div>
    <div style="text-align: center; margin-top: 6pt; color: #000000; font-weight: bold;">Under the Securities Exchange Act of 1934</div>
    <div style="text-align: center; margin-top: 6pt; color: #000000; font-weight: bold;">(Amendment No. 4)*</div>
    <div style="text-align: center; margin-top: 9pt; color: #000000; font-size: 18pt; font-weight: bold;">Masimo Corporation</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">(Name of Issuer)</div>
    <div style="text-align: center; margin-top: 12pt; color: #000000; font-weight: bold;">Common Stock, par value $0.001 per share</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">(Title of Class of Securities)</div>
    <div style="text-align: center; margin-top: 12pt; color: #000000; font-weight: bold;">574795100</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">(CUSIP Number)</div>
    <div style="text-align: center; margin-top: 6pt; color: #000000; font-weight: bold;">Quentin Koffey</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">Politan Capital Management LP</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">c/o Schulte Roth &amp; Zabel LLP</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">919 Third Avenue, Suite 2300</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">New York, New York 10022</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">646-690-2830</div>
    <div style="text-align: center; margin-top: 6pt; color: #000000; font-style: italic; font-weight: bold;">With a copy to:</div>
    <div style="text-align: center; margin-top: 6pt; color: #000000; font-weight: bold;">Richard M. Brand</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">Cadwalader, Wickersham &amp; Taft LLP</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">200 Liberty Street</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">New York, NY 10281</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">212-504-6000</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)</div>
    <div style="text-align: center; margin-top: 9pt; color: #000000; font-weight: bold;">March 10, 2023</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">(Date of Event Which Requires Filing of This Statement)</div>
    <div style="text-align: center; font-size: 12pt;"><u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u></div>
    <div style="text-align: center; margin-top: 6pt; margin-bottom: 6pt; color: #000000;">If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule
      because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. &#9744;</div>
    <div>
      <div style="margin: 2pt 0px 1pt; color: #000000;">
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 1px; color: #000000; text-align: center;"></div>
      <div style="margin: 0px 0px; color: #000000;"><font style="font-weight: bold;">Note:</font> Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to
        whom copies are to be sent.</div>
      <div style="color: #000000;">
        <hr noshade="noshade" align="left" style="height: 1px; width: 100%; color: #000000; background-color: #000000; margin-left: 0px; margin-right: auto; border: none;"> </div>
    </div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="ze394071f8ffa453591f9f2d654e68837" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="color: #000000;">&#160;*</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="color: #000000;">The remainder of this cover page shall be filled out for a reporting person&#8217;s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information
              which would alter disclosures provided in a prior cover page.</div>
          </td>
        </tr>

    </table>
    <div style="text-indent: 17.3pt; margin-top: 6pt; color: #000000;">The information required on the remainder of this cover page shall not be deemed to be &#8220;filed&#8221; for the purpose of section 18 of the Securities Exchange Act of 1934 (&#8220;Act&#8221;) or otherwise
      subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).</div>
    <div style="text-indent: 17.3pt; margin-top: 6pt; color: #000000;"> <br>
    </div>
    <div>
      <div style="margin-bottom: 2pt;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      <div><br>
      </div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z580c8370fda441f9a61e916cddd2ff9a" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="color: #000000;">CUSIP No. 574795100</div>
          </td>
          <td style="width: 1%; vertical-align: bottom;">
            <div style="color: #000000;">&#160;</div>
          </td>
          <td style="width: 49%; vertical-align: bottom;">
            <div style="text-align: right; color: #000000;">Page 2</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="2" border="0" id="zde07e3068dae498e878286d41568d351" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">1</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">NAME OF REPORTING PERSON</div>
            <div style="color: #000000;">Politan Capital Management LP</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">2</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP</div>
            <div style="color: #000000;">(a) &#9746;&#160; (b) &#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">3</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">SEC USE ONLY</div>
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">4</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">SOURCE OF FUNDS</div>
            <div>&#160;</div>
            <div style="color: #000000;">OO (See Item 3)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">5</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)</div>
            <div>&#160;</div>
            <div style="color: #000000;">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">6</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">CITIZENSHIP OR PLACE OF ORGANIZATION</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">Delaware</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="2" border="0" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);" rowspan="4">
            <div style="text-align: center; color: #000000;">Number of<br>
              shares<br>
              beneficially<br>
              owned by<br>
              each<br>
              reporting<br>
              person<br>
              with</div>
          </td>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="text-align: right; color: #000000;">7</div>
          </td>
          <td style="width: 84%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">SOLE VOTING POWER</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">0</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="text-align: right; color: #000000;">8</div>
          </td>
          <td style="width: 84%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">SHARED VOTING POWER</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">4,739,963</div>
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="text-align: right; color: #000000;">9</div>
          </td>
          <td style="width: 84%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">SOLE DISPOSITIVE POWER</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">0</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="text-align: right; color: #000000;">10</div>
          </td>
          <td style="width: 84%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">SHARED DISPOSITIVE POWER</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">4,739,963</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="2" border="0" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">11</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">4,739,963</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">12</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">13</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">9.0%<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">*</sup></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">14</div>
          </td>
          <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="color: #000000;">TYPE OF REPORTING PERSON</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">IA</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; margin-top: 6pt; color: #000000; font-size: 8pt;">* All percentage calculations set forth herein are based upon the aggregate of 52,601,943 shares of Common Stock outstanding as of January 28, 2023, as reported in the
      Issuer&#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission (the &#8220;<u>SEC</u>&#8221;) on March 1, 2023.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="za68e7764622b4110b3fb57e49b836dcf" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="color: #000000;">CUSIP No. 574795100</div>
          </td>
          <td style="width: 1%; vertical-align: bottom;">
            <div style="color: #000000;">&#160;</div>
          </td>
          <td style="width: 49%; vertical-align: bottom;">
            <div style="text-align: right; color: #000000;">Page 3</div>
          </td>
        </tr>

    </table>
    <div style="margin-bottom: 8pt;"><br>
    </div>
    <table cellspacing="0" cellpadding="2" border="0" id="z3e7344fce61f404293a47a9e19b07e81" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">1</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">NAME OF REPORTING PERSON</div>
            <div style="color: #000000;">Politan Capital Management GP LLC</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">2</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP</div>
            <div style="color: #000000;">(a) &#9746;&#160; (b) &#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">3</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">SEC USE ONLY</div>
            <div style="color: #000000;">&#160;</div>
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">4</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">SOURCE OF FUNDS</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">OO (See Item 3)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">5</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)</div>
            <div>&#160;</div>
            <div style="color: #000000;">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">6</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">CITIZENSHIP OR PLACE OF ORGANIZATION</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">Delaware</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="2" border="0" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);" rowspan="4">
            <div style="text-align: center; color: #000000;">Number of<br>
              shares<br>
              beneficially<br>
              owned by<br>
              each<br>
              reporting<br>
              person<br>
              with</div>
          </td>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="text-align: right; color: #000000;">7</div>
          </td>
          <td style="width: 84%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">SOLE VOTING POWER</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">0</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="text-align: right; color: #000000;">8</div>
          </td>
          <td style="width: 84%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">SHARED VOTING POWER</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">4,739,963</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="text-align: right; color: #000000;">9</div>
          </td>
          <td style="width: 84%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">SOLE DISPOSITIVE POWER</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">0</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="text-align: right; color: #000000;">10</div>
          </td>
          <td style="width: 84%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">SHARED DISPOSITIVE POWER</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">4,739,963</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="2" border="0" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">11</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">4,739,963</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">12</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">13</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">9.0%<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">*</sup></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">14</div>
          </td>
          <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="color: #000000;">TYPE OF REPORTING PERSON</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">IA</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; color: #000000; font-size: 8pt;">* All percentage calculations set forth herein are based upon the aggregate of 52,601,943 shares of Common Stock outstanding as of January 28, 2023, as reported in the Issuer&#8217;s Annual
      Report on Form 10-K filed with the SEC on March 1, 2023.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z3f004e28a8054a1facfa5be99fc4798c" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="color: #000000;">CUSIP No. 574795100</div>
          </td>
          <td style="width: 1%; vertical-align: bottom;">
            <div style="color: #000000;">&#160;</div>
          </td>
          <td style="width: 49%; vertical-align: bottom;">
            <div style="text-align: right; color: #000000;">Page 4</div>
          </td>
        </tr>

    </table>
    <div style="margin-bottom: 8pt;"><br>
    </div>
    <table cellspacing="0" cellpadding="2" border="0" id="zd1878f0703414a2996fb65cb9625dbf6" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">1</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">NAME OF REPORTING PERSON</div>
            <div style="color: #000000;">Politan Capital Partners GP LLC</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">2</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP</div>
            <div style="color: #000000;">(a) &#9746;&#160; (b) &#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">3</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">SEC USE ONLY</div>
            <div style="color: #000000;">&#160;</div>
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">4</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">SOURCE OF FUNDS</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">OO (See Item 3)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">5</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)</div>
            <div>&#160;</div>
            <div style="color: #000000;">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">6</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">CITIZENSHIP OR PLACE OF ORGANIZATION</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">Delaware</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="2" border="0" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);" rowspan="4">
            <div style="text-align: center; color: #000000;">Number of<br>
              shares<br>
              beneficially<br>
              owned by<br>
              each<br>
              reporting<br>
              person<br>
              with</div>
          </td>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="text-align: right; color: #000000;">7</div>
          </td>
          <td style="width: 84%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">SOLE VOTING POWER</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">0</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="text-align: right; color: #000000;">8</div>
          </td>
          <td style="width: 84%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">SHARED VOTING POWER</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">4,739,963</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="text-align: right; color: #000000;">9</div>
          </td>
          <td style="width: 84%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">SOLE DISPOSITIVE POWER</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">0</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="text-align: right; color: #000000;">10</div>
          </td>
          <td style="width: 84%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">SHARED DISPOSITIVE POWER</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">4,739,963</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="2" border="0" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">11</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">4,739,963</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">12</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">13</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">9.0%<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">*</sup></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">14</div>
          </td>
          <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="color: #000000;">TYPE OF REPORTING PERSON</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">IA</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; color: #000000; font-size: 8pt;">* All percentage calculations set forth herein are based upon the aggregate of 52,601,943 shares of Common Stock outstanding as of January 28, 2023, as reported in the Issuer&#8217;s Annual
      Report on Form 10-K filed with the SEC on March 1, 2023.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z2d1a01163fe14391abdf3dbebe1a6d64" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="color: #000000;">CUSIP No. 574795100</div>
          </td>
          <td style="width: 1%; vertical-align: bottom;">
            <div style="color: #000000;">&#160;</div>
          </td>
          <td style="width: 49%; vertical-align: bottom;">
            <div style="text-align: right; color: #000000;">Page 5</div>
          </td>
        </tr>

    </table>
    <div style="margin-bottom: 8pt;"><br>
    </div>
    <table cellspacing="0" cellpadding="2" border="0" id="z664f50e3a0364fef948893492553ed52" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">1</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">NAME OF REPORTING PERSON</div>
            <div style="color: #000000;">Quentin Koffey</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">2</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP</div>
            <div style="color: #000000;">(a) &#9746;&#160; (b) &#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">3</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">SEC USE ONLY</div>
            <div style="color: #000000;">&#160;</div>
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">4</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">SOURCE OF FUNDS</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">OO (See Item 3)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">5</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)</div>
            <div>&#160;</div>
            <div style="color: #000000;">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">6</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">CITIZENSHIP OR PLACE OF ORGANIZATION</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">United States</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="2" border="0" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);" rowspan="4">
            <div style="text-align: center; color: #000000;">Number of<br>
              shares<br>
              beneficially<br>
              owned by<br>
              each<br>
              reporting<br>
              person<br>
              with</div>
          </td>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="text-align: right; color: #000000;">7</div>
          </td>
          <td style="width: 84%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">SOLE VOTING POWER</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">0</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="text-align: right; color: #000000;">8</div>
          </td>
          <td style="width: 84%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">SHARED VOTING POWER</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">4,739,963</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="text-align: right; color: #000000;">9</div>
          </td>
          <td style="width: 84%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">SOLE DISPOSITIVE POWER</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">0</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="text-align: right; color: #000000;">10</div>
          </td>
          <td style="width: 84%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">SHARED DISPOSITIVE POWER</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">4,739,963</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="2" border="0" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">11</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">4,739,963</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">12</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">13</div>
          </td>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">9.0%<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">*</sup></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="color: #000000;">14</div>
          </td>
          <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="color: #000000;">TYPE OF REPORTING PERSON</div>
            <div style="color: #000000;">&#160;</div>
            <div style="color: #000000;">IN</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; color: #000000; font-size: 8pt;">* All percentage calculations set forth herein are based upon the aggregate of 52,601,943 shares of Common Stock outstanding as of January 28, 2023, as reported in the Issuer&#8217;s Annual
      Report on Form 10-K filed with the SEC on March 1, 2023.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="zbe23a1de9e6a4e5891358101f75afe8b" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="color: #000000;">CUSIP No. 574795100</div>
          </td>
          <td style="width: 1%; vertical-align: bottom;">
            <div style="color: #000000;">&#160;</div>
          </td>
          <td style="width: 49%; vertical-align: bottom;">
            <div style="text-align: right; color: #000000;">Page 6</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; text-indent: 36pt; margin-top: 12pt; color: #000000;">This Amendment No. 4 to Schedule 13D (this &#8220;<u>Amendment No. 4</u>&#8221;) amends and supplements the Schedule 13D filed on August 16, 2022 (as amended and supplemented
      through the date of this Amendment No. 4, collectively, the &#8220;<u>Schedule 13D</u>&#8221;) by the Reporting Persons, relating to the common stock, par value $0.001 per share, of Masimo Corporation, a Delaware corporation (the &#8220;<u>Issuer</u>&#8221;). Capitalized
      terms not defined in this Amendment No. 4 shall have the meaning ascribed to them in the Schedule 13D.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-top: 12pt; margin-bottom: 12pt; color: #000000;">The information set forth in response to Item 4 below shall be deemed to be a response to all Items where such information is relevant.</div>
    <div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 10pt; color: #000000; width: 100%;" id="z37d9d32d8da446f3b41cbc46c7a3f0ce">

              <tr>
                <td style="width: 8%;">
                  <div style="font-weight: bold;"><font style="text-align: left;">ITEM 4.</font></div>
                </td>
                <td style="width: 92%;">
                  <div style="font-weight: bold;">PURPOSE OF TRANSACTION</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
    </div>
    <div>
      <div><br>
      </div>
      <div>
        <div style="font-family: Arial,Helvetica,sans-serif; text-indent: 36pt;">Item 4 of the Schedule 13D is hereby amended and supplemented with the following information:</div>
      </div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; margin-top: 12pt;">On March 10, 2023, Politan filed a public version of a motion for leave to file the Second Amended and Supplemented Complaint.</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-top: 12pt;">A copy of the form of Second Amended and Supplemented Complaint, which was filed as an exhibit to the motion for leave to amend, is attached hereto as Exhibit 99.5 and is
        incorporated herein by reference.</div>
    </div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z98147afdef4c43b7956d21ec1e326795" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 8.2%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">ITEM 7.</div>
          </td>
          <td style="width: 91.8%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">MATERIAL TO BE FILED AS AN EXHIBIT</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zf18c62bd66f143ba9d2a7c084c913754" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 14.28%; vertical-align: top;">
            <div style="color: #000000;">Exhibit 99.1</div>
          </td>
          <td style="width: 85.72%; vertical-align: top;">
            <div style="color: #000000;">Joint Filing Agreement among Politan Capital Management LP, Politan Capital Management GP LLC, Politan Capital Partners GP LLC, and Quentin Koffey*</div>
          </td>
        </tr>
        <tr>
          <td style="width: 14.28%; vertical-align: top;">
            <div style="color: #000000;">&#160;</div>
          </td>
          <td style="width: 85.72%; vertical-align: top;">
            <div style="color: #000000;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 14.28%; vertical-align: top;">
            <div style="color: #000000;">Exhibit 99.2</div>
          </td>
          <td style="width: 85.72%; vertical-align: top;">
            <div style="color: #000000;">Trading Data*</div>
          </td>
        </tr>
        <tr>
          <td style="width: 14.28%; vertical-align: top;">&#160;</td>
          <td style="width: 85.72%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 14.28%; vertical-align: top;">
            <div style="color: #000000;">Exhibit 99.3</div>
          </td>
          <td style="width: 85.72%; vertical-align: top;">
            <div style="color: #000000;">Trading Data*</div>
          </td>
        </tr>
        <tr>
          <td style="width: 14.28%; vertical-align: top;">&#160;</td>
          <td style="width: 85.72%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 14.28%; vertical-align: top;">
            <div style="color: #000000;">Exhibit 99.4</div>
          </td>
          <td style="width: 85.72%; vertical-align: top;">
            <div style="color: #000000;">Form of Verified Complaint, filed with the Delaware Court of Chancery on October 21, 2022*</div>
          </td>
        </tr>
        <tr>
          <td style="width: 14.28%; vertical-align: top;">&#160;</td>
          <td style="width: 85.72%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 14.28%; vertical-align: top;">
            <div style="color: #000000;"><a href="po58913627-ex99_5.htm">Exhibit 99.5</a></div>
          </td>
          <td style="width: 85.72%; vertical-align: top;">
            <div style="color: #000000;">Form of Second Amended and Supplemented Complaint, filed as an Exhibit to the Motion for Leave to Amend with the Delaware Court of Chancery on March 10, 2023</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="color: #000000;">*Previously filed.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="zdda8deaad56a48639920257764550a14" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="color: #000000;">CUSIP No. 574795100</div>
          </td>
          <td style="width: 1%; vertical-align: bottom;">
            <div style="color: #000000;">&#160;</div>
          </td>
          <td style="width: 49%; vertical-align: bottom;">
            <div style="text-align: right; color: #000000;">Page 7</div>
          </td>
        </tr>

    </table>
    <div style="text-align: center; margin-top: 24pt; color: #000000;">SIGNATURES</div>
    <div style="text-indent: 36pt; margin-top: 12pt; color: #000000;">After reasonable inquiry and to the best of each of the undersigned&#8217;s knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true,
      complete and correct.</div>
    <div style="margin-top: 12pt; color: #000000;">Date: March 13, 2023</div>
    <div style="margin-top: 12pt; color: #000000;">
      <div style="margin-top: 12pt; color: #000000;">
        <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: Arial, Helvetica, sans-serif; font-size: 10pt;">

            <tr>
              <td valign="top" style="width: 50%;">&#160;</td>
              <td valign="top" style="width: 38%;" colspan="2">POLITAN CAPITAL MANAGEMENT LP</td>
              <td valign="top" style="width: 12%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;">&#160;</td>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="top" style="width: 35%;">&#160;</td>
              <td valign="top" style="width: 12%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;" rowspan="1">&#160;</td>
              <td valign="top" style="width: 3%;" rowspan="1">By:<br>
              </td>
              <td valign="top" style="width: 35%;" rowspan="1">Politan Capital Management GP LLC,<br>
                its general partner</td>
              <td valign="top" style="width: 12%;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;" rowspan="1">&#160;</td>
              <td valign="top" style="width: 3%;" rowspan="1">&#160;</td>
              <td valign="top" style="width: 35%;" rowspan="1">&#160;</td>
              <td valign="top" style="width: 12%;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;">
                <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt"><br>
                </div>
              </td>
              <td valign="top" style="width: 3%; padding-bottom: 2px;">
                <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
              </td>
              <td valign="top" nowrap="nowrap" align="left" style="width: 35%; border-bottom: #000000 2px solid">/s/&#160; Quentin Koffey<br>
              </td>
              <td valign="top" style="width: 12%; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;">&#160;</td>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" align="left" style="width: 35%;">Name:&#160; Quentin Koffey<br>
              </td>
              <td valign="top" style="width: 12%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;">&#160;</td>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="top" style="width: 35%;">Title:&#160;&#160;&#160;&#160; Managing Member<br>
              </td>
              <td valign="top" style="width: 12%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;">&#160;</td>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="top" style="width: 35%;">&#160;</td>
              <td valign="top" style="width: 12%;">&#160;</td>
            </tr>

        </table>
      </div>
    </div>
    <div style="margin-top: 12pt; color: rgb(0, 0, 0); font-family: Arial,Helvetica,sans-serif;">
      <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: Arial, Helvetica, sans-serif; font-size: 10pt;">

          <tr>
            <td valign="top" style="width: 50%;">&#160;</td>
            <td valign="top" style="width: 38%;" colspan="2">POLITAN CAPITAL MANAGEMENT GP LLC</td>
            <td valign="top" style="width: 12%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 50%;" rowspan="1">&#160;</td>
            <td valign="top" style="width: 3%;" rowspan="1">&#160;</td>
            <td valign="top" style="width: 35%;" rowspan="1">&#160;</td>
            <td valign="top" style="width: 12%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;">
              <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt"><br>
              </div>
            </td>
            <td valign="top" style="width: 3%; padding-bottom: 2px;">
              <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
            </td>
            <td valign="top" nowrap="nowrap" align="left" style="width: 35%; border-bottom: #000000 2px solid">/s/&#160; Quentin Koffey<br>
            </td>
            <td valign="top" style="width: 12%; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 50%;">&#160;</td>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" align="left" style="width: 35%;">Name:&#160; Quentin Koffey<br>
            </td>
            <td valign="top" style="width: 12%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 50%;">&#160;</td>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="top" style="width: 35%;">Title:&#160;&#160;&#160;&#160; Managing Member<br>
            </td>
            <td valign="top" style="width: 12%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 50%;">&#160;</td>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="top" style="width: 35%;">&#160;</td>
            <td valign="top" style="width: 12%;">&#160;</td>
          </tr>

      </table>
    </div>
    <div style="margin-top: 12pt; color: rgb(0, 0, 0); font-family: Arial,Helvetica,sans-serif;">
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: Arial, Helvetica, sans-serif; font-size: 10pt;">

            <tr>
              <td valign="top" style="width: 50%;">&#160;</td>
              <td valign="top" style="width: 38%;" colspan="2">POLITAN CAPITAL PARTNERS GP LLC</td>
              <td valign="top" style="width: 12%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;" rowspan="1">&#160;</td>
              <td valign="top" style="width: 3%;" rowspan="1">&#160;</td>
              <td valign="top" style="width: 35%;" rowspan="1">&#160;</td>
              <td valign="top" style="width: 12%;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;">
                <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt"><br>
                </div>
              </td>
              <td valign="top" style="width: 3%; padding-bottom: 2px;">
                <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
              </td>
              <td valign="top" nowrap="nowrap" align="left" style="width: 35%; border-bottom: #000000 2px solid">/s/&#160; Quentin Koffey<br>
              </td>
              <td valign="top" style="width: 12%; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;">&#160;</td>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" align="left" style="width: 35%;">Name:&#160; Quentin Koffey<br>
              </td>
              <td valign="top" style="width: 12%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;">&#160;</td>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="top" style="width: 35%;">Title:&#160;&#160;&#160;&#160; Managing Member<br>
              </td>
              <td valign="top" style="width: 12%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;">&#160;</td>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="top" style="width: 35%;">&#160;</td>
              <td valign="top" style="width: 12%;">&#160;</td>
            </tr>

        </table>
      </div>
    </div>
    <div style="margin-top: 12pt; color: rgb(0, 0, 0); font-family: Arial,Helvetica,sans-serif;">
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: Arial, Helvetica, sans-serif; font-size: 10pt;">

            <tr>
              <td valign="top" style="width: 50%;">&#160;</td>
              <td valign="top" style="width: 38%;" colspan="2">QUENTIN KOFFEY<br>
              </td>
              <td valign="top" style="width: 12%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;" rowspan="1">&#160;</td>
              <td valign="top" style="width: 3%;" rowspan="1">&#160;</td>
              <td valign="top" style="width: 35%;" rowspan="1">&#160;</td>
              <td valign="top" style="width: 12%;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;">
                <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt"><br>
                </div>
              </td>
              <td valign="top" style="width: 3%; padding-bottom: 2px;">
                <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
              </td>
              <td valign="top" nowrap="nowrap" align="left" style="width: 35%; border-bottom: #000000 2px solid">/s/&#160; Quentin Koffey<br>
              </td>
              <td valign="top" style="width: 12%; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;">&#160;</td>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" align="left" style="width: 35%;">Name:&#160; Quentin Koffey<br>
              </td>
              <td valign="top" style="width: 12%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;">&#160;</td>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="top" style="width: 35%;"><br>
              </td>
              <td valign="top" style="width: 12%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;">&#160;</td>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="top" style="width: 35%;">&#160;</td>
              <td valign="top" style="width: 12%;">&#160;</td>
            </tr>

        </table>
      </div>
    </div>
    <br>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z7d5336a7b42a45fd9a481dc9c4daaf9d" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="color: #000000;">CUSIP No. 574795100</div>
          </td>
          <td style="width: 1%; vertical-align: bottom;">
            <div style="color: #000000;">&#160;</div>
          </td>
          <td style="width: 49%; vertical-align: bottom;">
            <div style="text-align: right; color: #000000;">Page 8</div>
          </td>
        </tr>

    </table>
    <div style="text-align: center; margin-top: 12pt; margin-bottom: 12pt; color: #000000; font-weight: bold;">INDEX TO EXHIBITS</div>
    <table cellspacing="0" cellpadding="0" border="0" id="z3ddcb66936f847829bd6c0c75a56e227" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 13.7%; vertical-align: top; border-bottom: 2px solid black;">
            <div>
              <div>&#160;</div>
              <div>Exhibit</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td style="width: 85%; vertical-align: top; border-bottom: 2px solid black;">
            <div>
              <div>&#160;</div>
              <div style="text-align: center;">Description</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 13.7%; vertical-align: top;">
            <div style="color: #000000;">Exhibit 99.1</div>
          </td>
          <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
          <td style="width: 85%; vertical-align: top;">
            <div style="color: #000000;">Joint Filing Agreement among Politan Capital Management LP, Politan Capital Management GP LLC, Politan Capital Partners GP LLC, and Quentin Koffey*</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13.7%; vertical-align: top;">
            <div style="color: #000000;">&#160;</div>
          </td>
          <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
          <td style="width: 85%; vertical-align: top;">
            <div style="color: #000000;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13.7%; vertical-align: top;">
            <div style="color: #000000;">Exhibit 99.2</div>
          </td>
          <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
          <td style="width: 85%; vertical-align: top;">
            <div style="color: #000000;">Trading Data*</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13.7%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
          <td style="width: 85%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 13.7%; vertical-align: top;">
            <div style="color: #000000;">Exhibit 99.3</div>
          </td>
          <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
          <td style="width: 85%; vertical-align: top;">
            <div style="color: #000000;">Trading Data*</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13.7%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
          <td style="width: 85%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 13.7%; vertical-align: top;">
            <div style="color: #000000;">Exhibit 99.4</div>
          </td>
          <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
          <td style="width: 85%; vertical-align: top;">
            <div style="color: #000000;">Form of Verified Complaint, filed with the Delaware Court of Chancery on October 21, 2022*</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13.7%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
          <td style="width: 85%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 13.7%; vertical-align: top;">
            <div style="color: #000000;"><a href="po58913627-ex99_5.htm">Exhibit 99.5</a></div>
          </td>
          <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
          <td style="width: 85%; vertical-align: top;">
            <div style="color: #000000;">Form of Second Amended and Supplemented Complaint, filed as an Exhibit to the Motion for Leave to Amend with the Delaware Court of Chancery on March 10, 2023</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="color: #000000;">*Previously filed.</div>
    <div><br>
    </div>
    <div><br>
    </div>
  </div>
  <div><br>
  </div>
  <div>
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  <div><br>
  </div>
  <div><br>
  </div>
  <div><br>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.5
<SEQUENCE>2
<FILENAME>po58913627-ex99_5.htm
<DESCRIPTION>FORM OF SECOND AMENDED AND SUPPLEMENTED COMPLAINT, FILED AS AN EXHIBIT TO THE MOTION FOR LEAVE TO AMEND WITH THE DELAWARE COURT OF CHANCERY ON MARCH 10, 2023
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Cadwalader, Wickersham & Taft LLP
         Document created using Broadridge PROfile 23.1.1.5115
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; text-align: left; color: #000000;">
  <div><br>
  </div>
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 99.5</font><br>
  </div>
  <div><br>
  </div>
  <div><br>
  </div>
  <div>
    <div><br>
    </div>
    <div style="text-align: center; margin-right: 30.9pt; margin-left: 31.8pt; margin-top: 3pt; font-size: 14pt;">IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE</div>
    <div style="text-align: center; margin-right: 30.9pt; margin-left: 31.8pt; margin-top: 3pt; font-size: 14pt;"> <br>
    </div>
    <div style="margin-top: 0.5pt; margin-bottom: 0.05pt;"><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="z5fcebec377d640b0afb7d62bc4cce90d" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div style="margin-right: 11.5pt; margin-left: 10pt; font-size: 14pt;">POLITAN CAPITAL MANAGEMENT</div>
            <div style="margin-right: 11.5pt; margin-left: 10pt; font-size: 14pt;">LP and POLITAN CAPITAL NY LLC,</div>
            <div>&#160;</div>
            <div style="margin-right: 48.55pt; margin-left: 63.95pt; font-size: 14pt;">Plaintiffs/Counterclaim-</div>
            <div style="margin-right: 48.55pt; margin-left: 63.95pt; font-size: 14pt;">Defendants,</div>
            <div style="margin-left: 81.05pt; font-size: 14pt;"> <br>
            </div>
            <div style="margin-left: 81.05pt; font-size: 14pt;">v.</div>
            <div>&#160;</div>
            <div style="margin-left: 10pt; font-size: 14pt;">MASIMO CORPORATION,</div>
            <div style="margin-right: 41.55pt; margin-left: 63.95pt; font-size: 14pt;"> <br>
            </div>
            <div style="margin-right: 41.55pt; margin-left: 63.95pt; font-size: 14pt;">Defendant/Counterclaim-</div>
            <div style="margin-right: 41.55pt; margin-left: 63.95pt; font-size: 14pt;">Plaintiff,</div>
            <div style="margin-left: 81.25pt; font-size: 14pt;"> <br>
            </div>
            <div style="margin-left: 81.25pt; font-size: 14pt;">and</div>
            <div style="margin-right: 12.65pt; margin-left: 10pt; font-size: 14pt;"> <br>
            </div>
            <div style="margin-right: 12.65pt; margin-left: 10pt; font-size: 14pt;">JOE E. KIANI, H. MICHAEL COHEN, </div>
            <div style="margin-right: 12.65pt; margin-left: 10pt; font-size: 14pt;">ADAM P. MIKKELSON, CRAIG B. </div>
            <div style="margin-right: 12.65pt; margin-left: 10pt; font-size: 14pt;">REYNOLDS, and JULIE A. SHIMER, </div>
            <div style="margin-right: 12.65pt; margin-left: 10pt; font-size: 14pt;">Ph.D.,</div>
            <div style="margin-right: 12.65pt; margin-left: 10pt; font-size: 14pt;"> <br>
            </div>
            <div style="margin-left: 68.55pt; font-size: 14pt;">Defendants.</div>
            <div style="margin-left: 68.55pt; font-size: 14pt;"> <br>
            </div>
          </td>
          <td style="width: 2%; vertical-align: top;">
            <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 12.4pt; font-size: 14pt;">) </div>
            <div style="margin-left: 12.4pt; font-size: 14pt;">) </div>
            <div style="margin-left: 12.4pt; font-size: 14pt;">) </div>
          </td>
          <td style="width: 49%; vertical-align: top;">
            <div style="margin: 100pt 0px 0px 5.4pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt;">C.A. No. 2022-0948-NAC</div>
            <div>&#160;</div>
            <div style="margin: 6pt 0px 0px 6.25pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt; font-weight: bold;">PUBLIC VERSION</div>
            <div style="margin-left: 6.25pt; font-size: 14pt; font-weight: bold;">Filed March 10, 2023</div>
          </td>
        </tr>

    </table>
    <div style="text-align: center; margin-top: 5.95pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt; font-weight: bold; text-indent: -9pt; margin-left: 9pt;">EXHIBIT A TO PLAINTIFFS&#8217; MOTION FOR LEAVE TO FILE SECOND</div>
    <div style="font-family: Arial,Helvetica,'sans-serif'; font-size: 14pt; font-weight: bold; text-align: center;"><font style="font-family: Arial,Helvetica,sans-serif;"><u>AMENDED AND SUPPLEMENTED VERIFIED COMPLAINT</u></font></div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="margin-top: 0.3pt;"><br>
    </div>
    <div style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt;">John P. DiTomo, Esq.</div>
    <div style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt;">Alexandra M. Cumings, Esq.</div>
    <div style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt;">MORRIS, NICHOLS, ARSHT &amp; TUNNELL LLP</div>
    <div style="font-family: Arial,Helvetica,sans-serif; font-size: 14pt;">1201 N. Market Street</div>
    <div style="font-family: Arial,Helvetica,sans-serif; font-size: 14pt;">Wilmington, DE 19899-1347</div>
    <div style="font-family: Arial,Helvetica,sans-serif; font-size: 14pt;">(302) 658-9200</div>
    <div style="font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="font-family: Arial,Helvetica,'sans-serif'; font-size: 24pt; font-weight: bold; text-align: center;">EXHIBIT A</div>
    <div style="margin-top: 11.8pt; font-family: Arial,Helvetica,sans-serif; font-size: 24pt; font-weight: bold;"><font style="font-size: 10pt;"> <br>
      </font></div>
    <div style="margin-top: 11.8pt; font-family: Arial,Helvetica,sans-serif; font-size: 24pt; font-weight: bold;"><font style="font-size: 10pt;"><br>
      </font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; margin-right: 30.9pt; margin-left: 31.9pt; margin-top: 3pt; font-size: 14pt; font-weight: bold;">IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE</div>
    <div style="margin-top: 0.45pt; margin-bottom: 0.05pt;"><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="zb76c5177a9374e168e1739816d94813a" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div style="margin-left: 10pt; font-size: 14pt;">POLITAN CAPITAL</div>
            <div style="margin-right: 15.2pt; margin-left: 10pt; font-size: 14pt;">MANAGEMENT LP, a Delaware</div>
            <div style="margin-right: 15.2pt; margin-left: 10pt; font-size: 14pt;">limited partnership, POLITAN</div>
            <div style="margin-right: 15.2pt; margin-left: 10pt; font-size: 14pt;">CAPITAL NY LLC, and</div>
            <div style="margin-right: 15.2pt; margin-left: 10pt; font-size: 14pt;">CALIFORNIA STATE TEACHERS&#8217; </div>
            <div style="margin-right: 15.2pt; margin-left: 10pt; font-size: 14pt;">RETIREMENT SYSTEM,</div>
            <div style="margin-right: 15.2pt; margin-left: 10pt; font-size: 14pt;"> <br>
            </div>
            <div>&#160;</div>
            <div style="margin-left: 118pt; font-size: 14pt;">Plaintiffs,</div>
            <div>&#160;</div>
            <div style="margin-left: 46pt; font-size: 14pt;">v.</div>
            <div style="font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"> <br>
            </div>
            <div>&#160;</div>
            <div style="margin-right: 1.6pt; margin-left: 10pt; font-size: 14pt;">JOE E. KIANI, H. MICHAEL COHEN, </div>
            <div style="margin-right: 1.6pt; margin-left: 10pt; font-size: 14pt;">ADAM P. MIKKELSON, CRAIG B. </div>
            <div style="margin-right: 1.6pt; margin-left: 10pt; font-size: 14pt;">REYNOLDS, JULIE A. SHIMER, </div>
            <div style="margin-right: 1.6pt; margin-left: 10pt; font-size: 14pt;">PH.D., STEVEN J. BARKER, M.D., </div>
            <div style="margin-right: 1.6pt; margin-left: 10pt; font-size: 14pt;">PH.D., SANFORD FITCH, JACK </div>
            <div style="margin-right: 1.6pt; margin-left: 10pt; font-size: 14pt;">LASERSOHN, THOMAS HARKIN, </div>
            <div style="margin-right: 1.6pt; margin-left: 10pt; font-size: 14pt;">and MASIMO CORPORATION, a</div>
            <div style="margin-left: 10pt; font-size: 14pt;">Delaware corporation,</div>
            <div style="margin-left: 10pt; font-size: 14pt;"> <br>
            </div>
            <div>&#160;</div>
            <div style="margin-left: 118pt; font-size: 14pt;">Defendants.</div>
            <div style="font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"> <br>
            </div>
          </td>
          <td style="width: 2%; vertical-align: top;">
            <div style="margin-left: 2.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 2.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 2.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 2.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 2.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 2.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 2.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 2.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 2.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 2.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 2.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 2.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 2.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 2.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 2.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 2.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 2.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 2.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 2.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 2.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 2.4pt; font-size: 14pt;">)</div>
            <div style="margin-left: 2.4pt; font-size: 14pt;">) </div>
            <div style="margin-left: 2.4pt; font-size: 14pt;">) </div>
          </td>
          <td style="width: 49%; vertical-align: top;">
            <div>&#160;</div>
            <div>&#160;</div>
            <div>&#160;</div>
            <div>&#160;</div>
            <div>&#160;</div>
            <div>&#160;</div>
            <div>&#160;</div>
            <div>&#160;</div>
            <div>&#160;</div>
            <div style="margin-left: 8.05pt; font-size: 14pt;"> <br>
            </div>
            <div style="margin-left: 8.05pt; font-size: 14pt;"> <br>
            </div>
            <div style="margin-left: 8.05pt; font-size: 14pt;">C.A. No. 2022-0948-NAC</div>
            <div>&#160;</div>
            <div style="margin-left: 8.05pt; font-size: 14pt; font-weight: bold;">CONFIDENTIAL</div>
          </td>
        </tr>

    </table>
    <div style="text-align: center; margin-right: 30.9pt; margin-left: 31.95pt; margin-top: 11.95pt; font-size: 14pt; font-weight: bold;"><u>VERIFIED SECOND AMENDED AND SUPPLEMENTED COMPLAINT</u></div>
    <br>
    <div style="margin-top: 4.4pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"><br>
      <div style="line-height: 0pt;"><br style="line-height: 0pt;">
      </div>
      <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;">Plaintiffs Politan Capital Management LP, Politan Capital NY LLC (collectively, &#8220;<u>Politan</u>&#8221;) and California State<font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 12pt;">&#160;</font>Teachers&#8217; Retirement System (&#8220;<u>CalSTRS</u>&#8221; and, together with Politan, &#8220;<u>Plaintiffs</u>&#8221;), by and through their undersigned counsel, bring this Verified Second Amended and Supplemented
        Complaint against Defendants Joe E. Kiani, Steven J. Barker, M.D., Ph.D., H. Michael Cohen, Sanford Fitch, Thomas Harkin, Jack Lasersohn, Adam P. Mikkelson, Craig B. Reynolds, Julie A. Shimer Ph.D. (collectively, the &#8220;<u>Director</u></div>
    </div>
    <div style="margin-top: 4.4pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"><u> <br>
      </u></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div><br>
    </div>
    <div>
      <div style="line-height: 0pt;"><br style="line-height: 0pt;">
      </div>
      <div style="line-height: 31.9pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt;"><u>Defendants</u>&#8221;) and Masimo Corporation (&#8220;<u>Masimo</u>&#8221; or the &#8220;<u>Company</u>&#8221; and, together with the Director Defendants, the &#8220;<u>Defendants</u>&#8221;).</div>
      <div style="line-height: 11.4pt; margin-top: 0.25pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="text-align: center; margin-right: 30.9pt; margin-left: 31.95pt; line-height: 15.95pt; margin-top: 4.45pt; font-size: 14pt; font-weight: bold;"><u>NATURE OF THE ACTION</u></div>
    </div>
    <div><br>
    </div>
    <div>
      <div style="line-height: 31.9pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt; text-align: justify; text-indent: 72pt;"><font style="font-family: Arial, Helvetica, sans-serif;">1.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-family: Arial, Helvetica, sans-serif;">This action&#8212;commenced by Politan and joined by CalSTRS&#8212; challenges the invalid and illegal employment agreement (as
          amended, the &#8220;<u>Employment Agreement</u>&#8221;) of Masimo&#8217;s Chairman and Chief Executive Officer</font> (&#8220;<font style="font-family: Arial, Helvetica, sans-serif;"><u>CEO</u></font>&#8221;) Joe Kiani, which is unmatched in its overreach. As a recognized
        expert in executive compensation put it, the Employment Agreement is &#8220;the most egregious and problematic that I have ever seen or believe exists in the United States.&#8221;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">2.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">The Employment Agreement is the product of Masimo&#8217;s dismissive view of corporate governance. According to Director Defendant Michael Cohen, &#8220;better governance doesn&#8217;t drive better stock price&#8221;&#8212;a proposition with which Mr.
          Kiani concurs.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup><font style="font-size: 10pt;">&#160;</font>That attitude resulted in Masimo&#8217;s directors abdicating their fiduciary duties by agreeing to an Employment Agreement that erects enormous obstacles to the free exercise of the
          stockholder franchise and, if left in place, prevents future Masimo boards of directors from exercising independent judgment and fulfilling their fiduciary obligations.</font></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="margin: 0px 0px 3pt;">________________________<br>
    </div>
    <div>
      <div style="line-height: 0pt;"><br style="line-height: 0pt;">
      </div>
      <div style="text-align: justify; line-height: 15.95pt; margin-top: 4.05pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">1</font></sup> &#8220;Q:&#160; Do you believe that good corporate governance
        leads to enhanced shareholder returns? [Kiani]: Defined by who? Q: By the standards of ISS. [Kiani]: No.&#8221;&#160; (Kiani Tr. at 168:1&#8211;5.)</div>
    </div>
    <br>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div>
      <div style="line-height: 0pt;"><br style="line-height: 0pt;">
      </div>
      <div style="line-height: 31.9pt;"><br>
        <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">3.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Numerous aspects of the Employment Agreement, alone or in combination, violate Delaware statutory law and public policy by stripping Masimo&#8217;s Board of Directors (the &#8220;<u>Board</u>&#8221;) of its authority and disenfranchising
            Masimo stockholders. The Employment Agreement, among other things:</font></div>
      </div>
      <div style="line-height: 15.95pt; margin-top: 0.05pt;"><br style="line-height: 15.95pt;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z649e619e7e524f49a4ddc3955636feaa" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 132pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-size: 14pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 14pt;">Obligates Masimo to make massive payments to Mr. Kiani, including&#8212;in addition to accelerated salary, bonus, unvested stock options, and equity awards&#8212;restricted stock units (&#8220;<u>RSUs</u>&#8221;) equal to <font style="font-weight: bold; font-style: italic;">5% of the Company&#8217;s outstanding shares </font>and <font style="font-weight: bold; font-style: italic;">$35 million </font>in cash (together, the &#8220;<u>Special Payment</u>&#8221;) upon the
                occurrence of certain events;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z742a39594e904fd2aa6ae8045b429507" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 11.9pt;">

          <tr>
            <td style="width: 132pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-size: 14pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 14pt;">Entitles Mr. Kiani to receive the Special Payment if more than <font style="font-weight: bold; font-style: italic;">one-third </font>of the Board is voted out of office over a <font style="font-weight: bold; font-style: italic;">24-month period (which can span three election cycles)</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup>, even if there is <font style="font-weight: bold; font-style: italic;">no change </font>to his title, responsibilities, duties or authority
                (the &#8220;<u>Director Change in Control Provision</u>&#8221; or &#8220;<u>DCCP</u>&#8221;);</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="zca552f36da3f4bcc93acf5260ecf3bd7" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 11.6pt;">

          <tr>
            <td style="width: 132pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-size: 14pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 14pt;">Contains a <font style="font-weight: bold; font-style: italic;">strict single trigger </font>for the Special Payment triggered by the DCCP pursuant to which Mr. Kiani is immediately unconditionally entitled to
                the payment irrespective of whether he chooses to leave or stay (the &#8220;<u>Single Trigger</u>&#8221;);</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z942a5778567e4dde88d8193d60762f00" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12.05pt;">

          <tr>
            <td style="width: 132pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-size: 14pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 14pt;">Includes a <font style="font-weight: bold; font-style: italic;">dead hand </font>provision (the &#8220;<u>Dead Hand Provision</u>&#8221;) that <font style="font-weight: bold; font-style: italic;">irrevocably eliminates </font>the












                Board&#8217;s</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 9.7pt; margin-top: 0.25pt;"><br style="line-height: 9.7pt;">
      </div>
      <div style="line-height: 9.7pt; margin-top: 0.25pt;"><br style="line-height: 9.7pt;">
      </div>
      <div style="line-height: 9.7pt; margin-top: 0.25pt;"><br style="line-height: 9.7pt;">
      </div>
      <div style="line-height: 9.7pt; margin-top: 0.25pt;"><br style="line-height: 9.7pt;">
      </div>
      <div style="line-height: 9.7pt; margin-top: 0.25pt;"><br style="line-height: 9.7pt;">
      </div>
      <div style="line-height: 9.7pt; margin-top: 0.25pt;">
        <div><br>
        </div>
        <div style="margin: 0px 0px 3pt;">________________________<br>
        </div>
        <div>
          <div style="line-height: 0pt;"><br style="line-height: 0pt;">
          </div>
          <div style="text-align: justify; line-height: 15.95pt; margin-top: 4.05pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2</font></sup> In 2023, Masimo&#8217;s annual meeting will
            be held on June 26<font style="font-size: 10pt;">th</font>. Should the 2025 meeting be held earlier than June 26<font style="font-size: 10pt;">th</font>&#8212;a distinct possibility given that Masimo commonly holds its annual meeting in May&#8212;then
            three elections will occur within 24 months. Moreover, given that stockholders generally do not know the annual meeting date when they must decide whether to nominate, any stockholder wishing to nominate candidates in 2025 must simply roll the
            dice and hope that the nomination does not risk triggering a half billion dollar payment to Mr. Kiani.</div>
        </div>
      </div>
      <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="line-height: 0pt;"><br style="line-height: 0pt;">
      </div>
      <div style="text-align: justify; line-height: 15.95pt; margin-top: 3pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"> <br>
      </div>
      <div style="text-align: justify; line-height: 15.95pt; margin-top: 3pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;">
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12.05pt;">

            <tr>
              <td style="width: 132pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top; font-size: 14pt;"><br>
              </td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-size: 14pt;">authority to disable the DCCP for any new director whose &#8220;initial assumption of office is in connection with an actual or threatened election contest&#8221;;</div>
              </td>
            </tr>

        </table>
      </div>
      <table cellspacing="0" cellpadding="0" id="zf5bbe4f0694e4aa9ae3477e056c0f840" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

          <tr>
            <td style="width: 132pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-size: 14pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 14pt;">Allows Mr. Kiani to terminate his employment and receive the Special Payment if he <font style="font-weight: bold; font-style: italic;">ceases to serve as <u>both</u> Masimo&#8217;s Chairman and CEO </font>(the &#8220;<u>Chairman












                  Provision</u>&#8221;). Given that Mr. Kiani is the only director up for election at the 2024 annual meeting, stockholders cannot vote for anyone but Mr. Kiani in order to avoid triggering the Special Payment, despite the vote not impacting Mr.
                Kiani&#8217;s ability to remain CEO;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="zd6bce4a00ca84fdf9f6a47a6fd2abf34" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

          <tr>
            <td style="width: 132pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-size: 14pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 14pt;">Entitles Mr. Kiani to terminate his employment and receive the Special Payment if the Board <font style="font-weight: bold; font-style: italic;">appoints a lead independent director </font>(the &#8220;<u>Lead
                  Independent Director Provision</u>&#8221;);</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="za299f57d31b1427ca02efda53090d782" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 11.95pt;">

          <tr>
            <td style="width: 132pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-size: 14pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 14pt;"><font style="font-weight: bold; font-style: italic;">Automatically renews </font>every year, has <font style="font-weight: bold; font-style: italic;">no expiration date</font>, and nonrenewal by the Board
                entitles Mr. Kiani to terminate his employment and receive the Special Payment (the &#8220;<u>Automatic Renewal Provision</u>&#8221;), thereby effectively eliminating the Board&#8217;s control over the CEO; and</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z5f6c990e9ae54110845786a382e7a340" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 11.95pt;">

          <tr>
            <td style="width: 132pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-size: 14pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 14pt;">Requires a vote of 75% of the entire membership of the Board to terminate Mr. Kiani for cause, meaning that, excluding Mr. Kiani, any such vote must be <font style="font-weight: bold; font-style: italic;">unanimous












                </font>(the &#8220;<u>Unanimous Termination Provision</u>&#8221;).</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 31.9pt;">
        <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">4.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">At the outset, the sheer size of the Special Payment is shocking&#8212;on an absolute basis, as of year-end 2021, Mr. Kiani&#8217;s qualifying termination severance entitlement was 40.8 times Masimo&#8217;s peer group median and 5.2
            times its second highest peer. In fact, it amounted to approximately 400% of Masimo&#8217;s earnings and was in the 99.9th percentile of all US public companies.</font></div>
        <font style="font-size: 14pt; font-family: Arial,Helvetica,sans-serif;"></font></div>
      <div style="line-height: 27.05pt;"><br style="line-height: 27.05pt;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="line-height: 0pt;"><br style="line-height: 0pt;">
      </div>
      <br>
    </div>
    <div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">5.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Based on a comparison across all 2022 proxy statements, only one other company has a larger special qualifying termination severance entitlement, and that entitlement has a double trigger and is dependent upon a sale of
          the company. Even after adjusting down the size of the Special Payment for Masimo&#8217;s decline in stock price following the poorly-received acquisition of Sound United, LLC (&#8220;<u>Sound United</u>&#8221;) and not adjusting down any other company, the
          Special Payment remains in the 99.8<font style="font-size: 10pt;">th </font>percentile.</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">6.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Certain of the egregious provisions contained in the Employment Agreement are unique to Masimo. For instance, it appears that <font style="font-weight: bold; font-style: italic;">no other public company </font>in the
          United States has a Lead Independent Director Provision. And, as a recognized expert in executive compensation observed, while certain individual aspects of Mr. Kiani&#8217;s Employment Agreement may exist in certain employment agreements at other
          companies, &#8220;the combined effect of these provisions coexisting in one agreement is stunning.&#8221;</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">7.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Even more troubling, the Board implemented many of the offensive provisions in Mr. Kiani&#8217;s Employment Agreement only months after the Company had entered into a May 2015 settlement of a derivative suit brought by a Masimo
          stockholder challenging certain aspects of Mr. Kiani&#8217;s compensation and Masimo&#8217;s compensation practices. <font style="font-style: italic;">Ausikaitis v. Kiani, et al.</font>, No. 1:12-cv-01175-</font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">SLR (D. Del.). The terms of that settlement required Masimo to implement governance changes to the Board and the Compensation Committee and adhere to its compensation policies.
        It did no such thing.</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">8.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Less than six months later, the Board breached its fiduciary duties by approving the 2015 Employment Agreement,<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">3</sup></font>&#160;<font style="font-size: 14pt;">which, in effect, gave Mr. Kiani control over the Company,
          while at the same time entrenching the incumbent directors in office. Mr. Kiani himself admitted that he requested certain provisions in the 2015 Employment Agreement to prevent a situation where &#8220;one or two&#8221; new Board members could be
          &#8220;disruptive&#8221; to his agenda.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">4</sup></font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">9.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">In the event the DCCP was triggered (or the Chairman, Lead Independent Director, or Automatic Renewal Provisions were triggered and Mr. Kiani elected to terminate his employment), Mr. Kiani would be entitled to the
          Special Payment, <font style="font-weight: bold; font-style: italic;">regardless of Masimo&#8217;s market capitalization</font>; the 2015</font></div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 10.25pt; margin-top: 0.3pt;"><br style="line-height: 10.25pt;">
      </div>
      <div style="line-height: 10.25pt; margin-top: 0.3pt;"><br style="line-height: 10.25pt;">
      </div>
      <div style="line-height: 10.25pt; margin-top: 0.3pt;">
        <div style="margin: 0px 0px 3pt;">________________________<br>
        </div>
        <div>
          <div style="line-height: 0pt;"><br style="line-height: 0pt;">
          </div>
          <div style="line-height: 15.95pt; margin-top: 4.05pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">3</font></sup> &#8220;<u>2015 Employment Agreement</u>&#8221; refers to the
            Employment Agreement as originally adopted on November 4, 2015.</div>
        </div>
      </div>
      <div style="line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">4</font></sup> &#8220;Q: Why change the standard for board composition in connection with your employment
        agreement discussions? [Kiani]: Well, I had a board that I had known .&#8230; But at one point, when they were pushing me hard to change my agreement, it was done by&#8212;really by one person &#8230;. So I realized that even one or two board members, when they go
        kind of on their own issues and become&#8212;it becomes disruptive, and I didn&#8217;t want to be in an environment where I felt hostility or disruption if that was the case.&#8221; (Kiani Tr. at 17:8-18:8.)</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; line-height: 31.9pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;">Employment Agreement contained no collar, cap or other mechanism by which the Special Payment would be limited.</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">10.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">While nothing can excuse the 2015 Board&#8217;s breach of fiduciary duty and wasteful assent to the 2015 Employment Agreement&#8217;s terms, it at least provided that, starting in January 2018, ten percent of the Special Payment
          amount would burn off each year (the &#8220;<u>Burn-Off Provision</u>&#8221;), such that after January 2027 there would be no Special Payment upon an applicable triggering event. But even that minimal protection was short-lived, as the Board eliminated it
          before it ever came into effect.</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">11.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">In July 2017, just six months before the first ten-percent reduction pursuant to the Burn-Off Provision, the Board again breached its fiduciary duties by amending the 2015 Employment Agreement to remove the Burn-Off
          Provision and failing to replace it with a collar, cap, or any other limitation on the monetary value of the RSU award. Thereafter, the Special Payment would remain at 5% of the Company&#8217;s outstanding stock <font style="font-weight: bold; font-style: italic;">indefinitely</font>.</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">12.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">The First Amendment further transferred control of the Company to Mr. Kiani and entrenched the Board in office by (i) doubling the DCCP&#8217;s look- back period from 12 months (in the 2015 Employment Agreement) to 24 months,
          and (ii) creating the strict single trigger by eliminating the requirement that Mr. Kiani</font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">terminate his employment to receive the Special Payment after the DCCP was triggered, thereby allowing him to stay as Chairman &amp; CEO and still be unconditionally entitled to
        the Special Payment.</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">13.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Then, in January 2022, the Board again breached its fiduciary duties by further amending the 2015 Employment Agreement to provide, in exchange for <font style="font-weight: bold; font-style: italic;">no consideration </font>from











          Mr. Kiani, that the RSU award would immediately vest upon Mr. Kiani&#8217;s death or disability and by failing to take any action to amend or renegotiate the terms of the 2015 Employment Agreement, even though the value of the Special Payment at that
          time was nearly <font style="font-weight: bold; font-style: italic;">one billion dollars </font>(the &#8220;<u>Second Amendment</u>&#8221;).</font></div>
      <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">14.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">As further evidence of the Board&#8217;s abdication of its oversight role, Mr. Cohen, a member of the Compensation Committee for nearly two years at the time of his deposition&#8212;and for over nine months at the time of the Second
          Amendment&#8212;testified that he has still </font><font style="font-size: 14pt; font-weight: bold; font-style: italic;">not ever even reviewed </font><font style="font-size: 14pt;">Mr. Kiani&#8217;s compensation agreement.</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;">5</font></sup></div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;">
        <div style="margin: 0px 0px 3pt;">________________________<br>
        </div>
        <div>
          <div style="line-height: 0pt;"><br style="line-height: 0pt;">
          </div>
          <div style="text-align: justify; line-height: 15.95pt; margin-top: 4.05pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">5</font></sup> &#8220;Q: &#8230; Have you ever reviewed this
            provision in Mr. Kiani&#8217;s employment agreement before? [Cohen]: No. Nor was I part of the committee or the board at this time. Q: And since&#8212;but in any capacity on the board, you have not reviewed Mr. Kiani&#8217;s employment agreement? [Cohen]:
            Correct.&#8221; (Cohen Tr. at 313:13-22.)</div>
        </div>
      </div>
      <div style="text-align: right; line-height: 15.95pt; margin-top: 5.95pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;">(Continued . . .)</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">8</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">15.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">The preclusive and entrenching nature of the Employment Agreement is obvious. Indeed, one of Masimo&#8217;s current directors, Director Defendant Adam Mikkelson, testified under oath that the risk of triggering the Special
          Payment was a &#8220;<font style="font-weight: bold; font-style: italic;">very scary prospect </font>for me in that it&#8217;s a lot of shares and a lot of dollars.&#8221; (Mikkelson Tr. at 368:11-14 (emphasis added).) The consequences of triggering the Special
          Payment were so severe that Mr. Mikkelson viewed the Employment Agreement, standing alone, as &#8220;a <font style="font-weight: bold; font-style: italic;">sufficient poison pill</font>.&#8221; (<font style="font-style: italic;">Id. </font>at 62:19- 24
          (emphasis added).)</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt; font-family: Arial,Helvetica,sans-serif; font-weight: normal; font-style: italic;">16.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt; font-weight: normal;">&#160;</font><font style="font-size: 14pt;">Nevertheless, when faced with the prospect that the DCCP might actually be triggered by a stockholder&#8217;s potential nomination
          of two candidates for election to the Board, the Board opted to abdicate its fiduciary duties and instead rushed to adopt both a poison pill and preclusive advance notice bylaws to further thwart the free exercise of the stockholder franchise. As
          Mr. Mikkelson <font style="font-style: italic;">admitted</font>, it was Politan expressing a desire for &#8220;two board seats,&#8221; which would potentially trigger the DCCP, that was &#8220;<font style="font-weight: bold; font-style: italic;">one of the
            biggest pieces why that risk-reward balance for me was finally tipped in favor of adopting those bylaws, despite me believing</font></font></div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 10.85pt; margin-top: 0.2pt;"><br style="line-height: 10.85pt;">
      </div>
      <div style="line-height: 10.85pt; margin-top: 0.2pt;">
        <div style="margin: 0px 0px 3pt;">________________________<br>
        </div>
        <div>
          <div style="line-height: 0pt;"><br style="line-height: 0pt;">
          </div>
          <div style="text-align: justify; line-height: 15.95pt; margin-top: 4.4pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;">In fact, despite having joined the Compensation Committee nearly two years earlier (on April 1, 2021), Mr. Cohen
            believed he had only &#8220;recently&#8221; joined at some point &#8220;in the last year.&#8221; (Cohen Tr. at 311: 9-15.)</div>
        </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">9</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;"><font style="font-weight: bold; font-style: italic;">there was&#8212;that they were difficult to comply with, but not impossible.</font>&#8221; (Mikkelson Tr. at 62:19-63:6 (emphasis
        added).)</div>
      <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">17.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Specifically, in September 2022, Politan expressed an interest in obtaining representation on Masimo&#8217;s Board. Just one week later, in an effort to prevent Politan from engaging in a proxy contest&#8212;which the Board believed
          it would lose<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">6</sup>&#8212;the Board brazenly adopted what were perhaps the most preclusive advance notice bylaws in Delaware history (the &#8220;<u>Third Amended Bylaws</u>&#8221;). The Third Amended Bylaws were designed to make it extremely difficult and
          burdensome&#8212;if not outright impossible&#8212;for Politan, or any other investment fund stockholder, to nominate directors for election to the Board, thereby disenfranchising them.</font></div>
      <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">18.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Following the Board&#8217;s adoption of the preclusive Third Amended Bylaws, Politan&#8217;s counsel requested that&#8212;in addition to repealing the Third Amended Bylaws&#8212;the Board take action to disable, amend, or waive the DCCP. The
          Board refused to do so, instead responding that the directors other than</font></div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 6.25pt; margin-top: 0.15pt;"><br style="line-height: 6.25pt;">
      </div>
      <div style="line-height: 6.25pt; margin-top: 0.15pt;"><br style="line-height: 6.25pt;">
      </div>
      <div>
        <div style="margin-top: 0px; margin-bottom: 3pt;">____________________<br>
        </div>
        <div>
          <div style="line-height: 0pt;"><br style="line-height: 0pt;">
          </div>
          <div style="text-align: justify; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">6</font></sup> Mr. Kiani: &#8220;We&#8217;re likely to lose the proxy fight [with
            Politan], I thought.&#8221; (Kiani Tr. at 172:7-10.) Mr. Mikkelson: &#8220;Q: You also said that you assume that Politan might win a proxy contest. [Mikkelson]: Yeah, I did say that at some point.&#8221; (Mikkelson Tr. at 499:14-16.) Dr. Shimer: &#8220;[T]here would
            likely be a proxy contest &#8230;. Oh, and we&#8217;d likely lose, but there would be a proxy contest.&#8221; (Shimer Tr. at 141:14-16.)</div>
        </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">10</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="line-height: 31.9pt; font-size: 14pt;">Mr. Kiani (the &#8220;<u>Outside Directors</u>&#8221;) could not unilaterally waive, terminate, or amend the DCCP.</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">19.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Further demonstrating Mr. Kiani&#8217;s grip on the Board, neither the Company nor the Outside Directors engaged independent counsel to advise them as to their rights and obligations in connection with responding to Politan&#8217;s
          request. Instead, the Board&#8217;s four Outside Directors chose to continue to be advised by the <font style="font-weight: bold; font-style: italic;">same hopelessly-conflicted legal counsel advising Mr. Kiani</font>, even though Mr. Kiani stood to
          reap a <font style="font-weight: bold; font-style: italic;">half billion dollar windfall </font>from the Company if the DCCP were triggered, thereby pitting Mr. Kiani&#8217;s self-interest against Masimo&#8217;s best interests.</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">20.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Emblematic of the Masimo directors&#8217; misplaced loyalties, the Board did not: (i) meet to discuss Politan&#8217;s request, either at the time Politan made it or during the four months thereafter, (ii) consider creating an
          independent special committee to evaluate the request, (iii) consider whether it could avoid triggering the DCCP by expanding the Board and appointing two Politan nominees when Politan first requested representation at the September 2, 2022
          meeting, (iv) explore the possibility of amending the Employment Agreement, (v) treat the DCCP as the void provision that it is, or even (vi) request that Mr. Kiani waive the DCCP.</font></div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">11</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">21.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">After Politan commenced this action and Masimo further amended its bylaws, the Current Directors<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">7</sup><font style="font-size: 10pt;">&#160;</font>moved to dismiss Politan&#8217;s claim challenging the Employment Agreement and
          pressed for a decision before trial was scheduled to commence on Tuesday, February 14, 2023.</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">22.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">On Friday, February 3, 2023, the Court denied the Current Directors&#8217; motion. In doing so, the Court held that it was &#8220;reasonably conceivable that the [DCCP], and the termination rights it triggers, preclude the board from
          exercising its statutory and fiduciary duties to manage the corporation in the best interests of the corporation and its stockholders, and thus amounts to abdication, <font style="font-style: italic;">ultra vires</font>, and/or some form of
          waste.&#8221; (Feb. 3, 2023 Hearing Tr. at 180:23-181:6.) The Court further examined the DCCP and the other problematic provisions of the Employment Agreement and concluded that there was a &#8220;lack of clarity of what the purpose of all this would be
          absent an intent to impact the stockholder franchise for the nomination of directors in connection with an election contest.&#8221; (<font style="font-style: italic;">Id. </font>at 182:14- 17.)</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">23.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Indeed, the Court noted that while the Employment Agreement&#8217;s terms are &#8220;at least in some ways reminiscent of the type of extraordinary measures</font></div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;">
        <div style="margin-top: 0px; margin-bottom: 3pt;">____________________<br>
        </div>
        <div>
          <div style="line-height: 0pt;"><br style="line-height: 0pt;">
          </div>
          <div style="line-height: 15.95pt; margin-top: 4.05pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">7</font></sup> The &#8220;Current Directors&#8221; are Joe E. Kiani, H. Michael
            Cohen, Adam P. Mikkelson, Julie A. Shimer, Ph.D., and Craig B. Reynolds.</div>
        </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">12</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">that corporations considered potentially resorting to in the early &#8216;80s before the creation and wide-spread adoption of the shareholder rights plan. &#8230; I&#8217;m not sure that for a lot
        of these provisions, and certainly for them together, &#8230; there really is a parallel.&#8221; (<font style="font-style: italic;">Id. </font>at 184:9-185:7.)</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">24.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Following the Court&#8217;s Friday afternoon decision, Masimo and the Current Directors scrambled during the weekend to find a way to salvage Mr. Kiani&#8217;s Employment Agreement. Within approximately 48 hours of the Court&#8217;s
          ruling, the Current Directors showed their true colors by repealing the Bylaw Amendments (the &#8220;<u>Fifth Amended Bylaws</u>&#8221;), despite having spent the previous several months vociferously defending them to the Court. In addition, Mr. Kiani agreed
          to waive the DCCP as to all stockholders for the 2023 annual meeting (the &#8220;<u>Limited DCCP Waiver</u>&#8221;), conditioned upon an adjournment of trial until September 2023.</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">25.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">The reason for seeking to adjourn the trial was plain: As Defendants&#8217; counsel acknowledged, if the issue of the DCCP&#8217;s facial invalidity were submitted to the Court for resolution as a matter of law, Defendants likely
          would</font></div>
      <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">13</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">lose.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">8</sup><font style="font-size: 10pt;">&#160;</font>Thus, Defendants sought more time to try to build a more favorable factual record.</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">26.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Notably, when seeking to buy himself more time to defend his Employment Agreement, Mr. Kiani structured the Limited DCCP Waiver to ensure that he and the other incumbent directors would maintain their grip on power.
          Notwithstanding that Politan requested that the waiver be unconditional, the Limited DCCP Waiver expressly provides that any two directors who are elected in lieu of two of the Company&#8217;s current directors (the &#8220;<u>Exception Directors</u>&#8221;) will <font style="font-weight: bold; font-style: italic;">not </font>be considered continuing directors going forward for purposes of the Employment Agreement. Thus, the Exception Directors will not be permitted to vote to approve any additional
          directors who might join the Board during the next 24 months (a period that can span three election cycles), thereby creating an entirely new class of directors not authorized by the Company&#8217;s certificate of incorporation in violation of Delaware
          law.</font></div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 15.4pt; margin-top: 0.1pt;">
        <div style="margin-top: 0px; margin-bottom: 3pt;">____________________<br>
        </div>
        <div>
          <div style="line-height: 0pt;"><br style="line-height: 0pt;">
          </div>
          <div style="text-align: justify; line-height: 15.95pt; margin-top: 4.15pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">8</font></sup> &#8220;What we proposed was that the issue
            of the question of void or voidness be submitted to Your Honor for a decision based upon facial validity or invalidity as a matter of law. &#8230; It could be done so immediately for a resolution as a matter of law, and then the loser&#8212;<font style="font-weight: bold; font-style: italic;">I suspect it may be us</font>&#8212;will be in a position of taking that on an expedited appeal to the Supreme Court&#8230;&#8221; (Feb. 6, 2023 Hearing Tr. at 4:18-5:4 (emphasis added).)</div>
        </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">14</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">27.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">If the Limited DCCP Waiver is valid as structured and Politan (or another stockholder) succeeds in electing one or more candidates to the Board in 2023, then a defeat of Mr. Kiani in 2024 or a defeat of incumbent
          directors in 2025 (if the 2025 annual meeting is held before the second anniversary of the 2023 annual meeting) would trigger the DCCP and permit Mr. Kiani to remain as CEO and be unconditionally entitled to the Special Payment.</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">28.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Separate and apart from the DCCP, the Chairman Provision also effectively halts the free exercise of the stockholder franchise at next year&#8217;s annual meeting. Mr. Kiani is the only director up for re-election in 2024. If
          he is not re- elected, then he would no longer be Chairman (even though he would remain CEO) and could elect to terminate his employment and receive the Special Payment under the Chairman Provision.</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">29.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">As such, regardless of whether Politan (or any other stockholder) succeeds in electing candidates to Masimo&#8217;s Board in 2023, stockholders will be forced to vote on Mr. Kiani&#8217;s re-election with the Sword of Damocles&#8212;in the
          form of a potential half billion dollar payment to Mr. Kiani if the stockholder vote triggers the DCCP or the Chairman Provision&#8212;hanging over their heads.</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">30.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">In sum, the Employment Agreement is either void or voidable as against Delaware statutory law and public policy and constitutes waste. The Board&#8217;s</font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">15</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">desire to retain Mr. Kiani did not justify adopting the panoply of provisions contained in the Employment Agreement, which impose an uncapped tax on the stockholder franchise and
        exert dead hand control over the actions of <font style="font-style: italic;">all </font>future Boards. The right to nominate and elect directors who may oppose Mr. Kiani&#8217;s wishes is a fundamental right that belongs exclusively to Masimo&#8217;s
        stockholders. The Board breached its fiduciary duties by bartering away those rights (which do not belong to it) based on a thinly-veiled excuse that it was necessary to do so in order to retain Mr. Kiani as Masimo&#8217;s CEO and Chairman.</div>
      <div style="text-align: center; line-height: 31.9pt; font-size: 14pt; font-weight: bold;"><u>JURISDICTION AND VENUE</u></div>
      <div style="text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">31.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">This
          Court has jurisdiction over this action pursuant to 8 <font style="font-style: italic;">Del. C. </font>&#167; 111 and 10 <font style="font-style: italic;">Del. C. </font>&#167; 341.</font></div>
      <div style="text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">32.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">As
          directors of a Delaware corporation, the Director Defendants have consented to the jurisdiction of this Court pursuant to 10 <font style="font-style: italic;">Del. C. </font>&#167; 3114.</font></div>
      <div style="text-align: center; line-height: 31.9pt; font-size: 14pt; font-weight: bold;"><u>THE PARTIES</u></div>
      <div style="margin-left: 63pt; line-height: 31.9pt; font-size: 14pt; font-weight: bold;">Politan Capital Management</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">33.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Plaintiff Politan Capital Management LP is a Delaware limited partnership and an investment advisor to the funds it manages. Politan, together with certain affiliates, beneficially owns 4,739,963 shares of Masimo common
          stock, representing approximately 9.02% of Masimo&#8217;s outstanding common shares.</font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">16</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">34.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Plaintiff Politan Capital NY LLC is a New York limited liability company and the record owner of 1,000 shares of Masimo common stock.</font></div>
      <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">35.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Politan was founded in 2021 by Quentin Koffey. Mr. Koffey has been described as a &#8220;veteran activist&#8221; who seeks &#8220;high quality but underperforming businesses where there is a clear fix and a clear pathway to implement that
          fix&#8221; and &#8220;prefers to work privately with management before releasing public letters critiquing companies or pursing proxy fights&#8221; in presentations prepared for Masimo&#8217;s management by Morgan Stanley, Goldman Sachs, and others in August 2022.
          (MASI_0000004332; </font><font style="font-size: 14pt; font-style: italic;">see also </font><font style="font-size: 14pt;">MASI_0000003161; MASI_0000003604.) That approach has &#8220;creat[ed] significant value for shareholders.&#8221;<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">9</sup></font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">36.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Politan has relayed to Masimo, both in a meeting and in correspondence, that Politan is &#8220;focused on long-term value creation and open- minded to the strategic initiatives [Masimo] announced.&#8221; (MASI_0000002821.) Politan
          also made clear that it is focused on the appropriate functioning of a board of directors to provide oversight and accountability.</font></div>
      <div style="line-height: 15.95pt; margin-top: 0.2pt;"><br style="line-height: 15.95pt;">
      </div>
      <div style="line-height: 15.95pt; margin-top: 0.2pt;"><br style="line-height: 15.95pt;">
      </div>
      <div style="line-height: 15.95pt; margin-top: 0.2pt;"><br style="line-height: 15.95pt;">
      </div>
      <div style="line-height: 15.95pt; margin-top: 0.2pt;"><br style="line-height: 15.95pt;">
      </div>
      <div style="line-height: 15.95pt; margin-top: 0.2pt;">
        <div style="margin-top: 0px; margin-bottom: 3pt;">____________________<br>
        </div>
        <div>
          <div style="line-height: 0pt;"><br style="line-height: 0pt;">
          </div>
          <div style="line-height: 15.95pt; margin-top: 4.05pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">9</font></sup> Kenneth Squire, How activist investor Politan Capital can
            raise profitability and bring<font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 12pt;">&#160;</font>fresh<font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 12pt;">&#160;</font>perspectives<font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 12pt;">&#160;</font>to<font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 12pt;">&#160;</font>Centene,<font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 12pt;">&#160;</font>https://www.cnbc.com/2021/11/13/how- activist-investor-politan-capital-can-raise-profitability-at- centene.html#:~:text=Politan&#8217;s%20style%20is%20to%20amicably,do%20not%20s
            eek%20proxy%20fights.</div>
        </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">17</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-left: 63pt; line-height: 31.9pt; font-size: 14pt; font-weight: bold;">California State Teachers&#8217; Retirement System</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">37.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">CalSTRS is the largest teachers&#8217; retirement system and second largest state public pension fund in the nation. As a fiduciary for its members and beneficiaries, CalSTRS has a responsibility to create long-term value and a
          secure retirement for more than one million public educators. CalSTRS has a proven track record of successfully using proxy voting and engagement to mitigate risk and enhance the long-term value of the companies in which it invests. CalSTRS uses
          its influence to promote long-term sustainable business practices and public policies, and engages with publicly traded companies in order to support long-term value creation as well as mitigate risk to its portfolio and the financial market as a
          whole.</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">38.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">CalSTRS believes an essential part of managing its portfolio is an attention to good corporate governance. It sees good corporate governance practices as a way to both add value and mitigate risk in its portfolio.</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">39.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">As of January 31, 2023, the market value of CalSTRS&#8217; investment portfolio was approximately $311.5 billion. CalSTRS has been a continuous Masimo stockholder since well before the November 4, 2015 adoption of Mr. Kiani&#8217;s
          Employment Agreement.</font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">18</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-left: 63pt; line-height: 31.9pt; font-size: 14pt; font-weight: bold;">Masimo Corporation</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">40.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Founded in 1989, Defendant Masimo Corporation is a Delaware corporation with its headquarters and principal place of business in Irvine, California. Masimo is a supplier of various medical technologies, including
          pulse-oximetry monitoring technologies to hospitals&#8212;accounting for more than 90% of its revenues prior to the acquisition of Sound United.</font></div>
      <div style="margin-left: 63pt; line-height: 34.8pt; font-size: 14pt; font-weight: bold;">The Director Defendants</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">41.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Defendant Joe E. Kiani is Masimo&#8217;s founder. Mr. Kiani has served as a director of Masimo and as Masimo&#8217;s CEO and Chairman of the Board since the Company&#8217;s formation in 1989.</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">42.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Defendant Steven J. Barker, M.D., Ph.D., served as a director of Masimo from October 2005 to May 2020.</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">43.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Defendant H. Michael Cohen has served as a director of Masimo since 2018.</font></div>
      <div style="text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">44.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Defendant
          Sanford Fitch served as a director of Masimo from November 2006 to May 2020.</font></div>
      <div style="text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">45.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Defendant
          Thomas Harkin served as a director of Masimo from December 2015 to February 2021.</font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">19</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">46.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Defendant Jack Lasersohn served as a director of Masimo from January 1995 to April 2016.</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">47.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Defendant Adam P. Mikkelson has served as a director of Masimo since 2016. Mr. Mikkelson is an investment manager at Camber Capital Management, LLC, a healthcare-focused investment fund.</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 25.1pt;"><font style="font-size: 14pt;">48.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Defendant Craig B. Reynolds has served as a director of Masimo </font>since 2014.</div>
      <div style="text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">49.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Defendant
          Julie A. Shimer, Ph.D. has served as a director of Masimo since 2019.</font></div>
      <div style="text-indent: 72pt; line-height: 27.35pt;"><font style="font-size: 14pt;">50.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 14pt; width: 36pt;">&#160;</font><font style="font-size: 14pt;">Joe E.
          Kiani, Steven J. Barker, M.D., Ph.D, Sanford Fitch, Jack Lasersohn, and Craig B. Reynolds are referred to collectively herein as the &#8220;<u>2015 </u><u>Directors</u>.&#8221;</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">51.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Joe E. Kiani, Steven J. Barker, M.D., Ph.D, Sanford Fitch, Thomas Harkin, and Adam P. Mikkelson, and Craig B. Reynolds are referred to collectively herein as the &#8220;<u>2017 Directors</u>.&#8221;</font></div>
      <div style="text-align: center; line-height: 31.9pt; font-size: 14pt; font-weight: bold;"><u>FACTUAL BACKGROUND</u></div>
      <div style="line-height: 31.9pt;"><font style="font-size: 14pt; font-weight: bold;">A.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt; font-weight: bold;">Masimo&#8217;s Disregard for Good Corporate Governance</font></div>
      <div style="text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">52.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Masimo is
          well-known for its poor corporate governance, which stems from, among other things, Masimo&#8217;s (i) unusual and problematic Board</font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">20</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">structure, (ii) dismal executive compensation record, and (iii) improper payments that benefit Mr. Kiani personally.</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">53.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">That reputation is not surprising, given the Board&#8217;s strikingly dismissive approach to the very idea of good corporate governance. For instance, Mr. Cohen insisted that &#8220;better governance doesn&#8217;t drive better stock
          price.&#8221; (Cohen Tr. at 240:22-23.)</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">54.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Mr. Kiani agreed with Mr. Cohen that &#8220;good corporate governance&#8221; does not lead to &#8220;enhanced shareholder returns.&#8221; In addition, Mr. Kiani admitted that Masimo does not have a good reputation for corporate governance and
          suggested that the very idea of good corporate governance is a scheme concocted by Institutional Shareholder Services (&#8220;<u>ISS</u>&#8221;) to generate consulting fees.</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">55.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Specifically, in response to a question about whether he thinks Masimo has a good corporate governance reputation, Mr. Kiani testified:</font></div>
      <div style="text-align: justify; margin-right: 94.7pt; margin-left: 132pt; line-height: 15.95pt; font-size: 14pt;">No, we don&#8217;t because ISS and the way people want to put everyone on that mediocre slot. I mean, a lot of the things ISS says this or
        that about, I disagree with. I think&#8212;I think they are a problem. They&#8217;re part of a problem in our society.</div>
      <div style="text-align: justify; margin-right: 94.7pt; margin-left: 132pt; line-height: 15.95pt; margin-top: 11.95pt; font-size: 14pt;">And when they began &#8230; what do they say? We&#8217;re going to go set this thing up, but the real money isn&#8217;t going to
        come from the Fidelitys of the world. It&#8217;s going to come from Masimos of the world that&#8217;ll pay us consulting fees to get the votes they need.</div>
      <div style="line-height: 27.35pt; margin-top: 12pt; font-size: 14pt;">(Kiani Tr. at 165:3-14.)</div>
      <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">21</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">56.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Indeed, Masimo&#8217;s Board, under Mr. Kiani&#8217;s leadership, actively and aggressively rejects input from stockholders. For example, Mr. Kiani rarely, if ever, meets with stockholders and testified that he &#8220;declined&#8221; previous
          stockholder requests for meetings. (<font style="font-style: italic;">Id. </font>at 224:14-19.)</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">57.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Similarly, Mr. Cohen testified that, prior to November 2022, he had <font style="font-style: italic;">never </font>met with any stockholder in his capacity as a director, even though he joined the Board in 2018. (Cohen
          Tr. at 21:6-9.) In fact, the Board refused to meet with Politan because it &#8220;never meet[s] with shareholders&#8221; and did not see a reason to &#8220;make an exception.&#8221; (Kiani Tr. at 148:17-21.)</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">58.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Even when stockholder feedback made its way back to Mr. Kiani, he dismissed concerns raised by large stockholders, claiming that those institutions had a short term focus.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">10</sup>&#160;In fact, Mr. Kiani appears to
          believe that Masimo&#8217;s largest stockholders are involved in a vast, hidden conspiracy to undermine the company:&#160;&#160; &#8220;I don&#8217;t know&#160; what&#160; they&#8217;re doing.&#160;&#160; Maybe BlackRock</font></div>
      <div style="line-height: 13.1pt; margin-top: 0.55pt;"><br style="line-height: 13.1pt;">
      </div>
      <div style="line-height: 13.1pt; margin-top: 0.55pt;"><br style="line-height: 13.1pt;">
      </div>
      <div style="line-height: 13.1pt; margin-top: 0.55pt;"><br style="line-height: 13.1pt;">
      </div>
      <div style="line-height: 13.1pt; margin-top: 0.55pt;"><br style="line-height: 13.1pt;">
      </div>
      <div style="line-height: 13.1pt; margin-top: 0.55pt;">
        <div style="margin-top: 0px; margin-bottom: 3pt;">____________________<br>
        </div>
        <div>
          <div style="line-height: 0pt;"><br style="line-height: 0pt;">
          </div>
          <div style="text-align: justify; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">10</font></sup> Mr. Kiani testified: &#8220;[BlackRock&#8217;s] long-term is three to
            four years, and its valued year to year. &#8230; I started trying to understand why are these people reacting like this? ... So even a BlackRock that might be in a stock for 10, 20 years, it&#8217;s a year-to-year evaluation, whether they&#8217;re going to stay
            in it or not. That&#8217;s my understanding&#8212; Black Rock, Fidelity, every investor. No one looks at it the way I do&#8230;.&#8221; (Kiani Tr. at 160:1-22.) As well, Mr. Kiani testified that Politan only cared about cutting costs: &#8220;[Koffey] thinks that all that we
            should be doing is pulse oximetry, and with it, he would get great operating margins and EPS. He&#8217;s right. He would, instantly.&#8221; (<font style="font-style: italic;">Id. </font>at 193:3-6.)</div>
        </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">22</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; line-height: 20.5pt;"><font style="font-size: 14pt;">purposely sank our stock just to purchase it and make more money that way. I don&#8217;t know.&#8221;<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">11</sup></font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">59.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Mr. Kiani and the Board&#8217;s dismissive, critical, and even at times hostile view of stockholders is exemplified in how they perceived Politan. Despite multiple experienced financial advisors, such as Morgan Stanley and
          Goldman Sachs, describing Mr. Koffey as a &#8220;veteran activist&#8221; with whom they had extensive experience, the Board hired a private investigator to go beyond public records searches and to investigate Mr. Koffey as well as other Politan employees
          personally, including their family members. The investigator&#8217;s report found Mr. Koffey had a &#8220;reputation of engaging constructively with public companies,&#8221; a &#8220;reputation as a &#8216;behind the scenes&#8217; activist,&#8221; and that the last time Mr. Koffey
          nominated directors &#8220;86 percent of shareholders voted to support&#8221; his nominees. (MASI_0000009830.) Yet, these findings did not stop Mr. Kiani and the Board from repeatedly, publicly insisting&#160; Mr. Koffey might have&#160; ill&#160; intentions&#160; at&#160; odds&#160;
          with</font></div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;">
        <div style="margin-top: 0px; margin-bottom: 3pt;">____________________<br>
        </div>
        <div>
          <div style="line-height: 0pt;"><br style="line-height: 0pt;">
          </div>
          <div style="text-align: justify; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">11</font></sup> In context, Mr. Kiani testified: &#8220;We&#8217;re likely to lose
            the proxy fight, I thought. &#8230; Q: Why did you think you were likely to lose a proxy fight? [Kiani]: Because I think [Koffey is] right. I think he&#8217;s got the shareholders. &#8230; BlackRock and Fidelity who owned the biggest chunks of our company. The
            investment funds that are being run by employees [institutional investors], they view things differently &#8230; I think they&#8217;re just trying to make a point. I don&#8217;t know what they&#8217;re doing. But maybe Black Rock purposely sank our stock just to
            repurchase it again and make more money that way. I don&#8217;t know.&#8221; (Kiani Tr. at 172:9-173:8.)</div>
        </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">23</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="line-height: 31.9pt; font-family: Arial, Helvetica, 'sans-serif'; text-align: justify;"><font style="font-size: 14pt; font-family: Arial,Helvetica,sans-serif;">Masimo&#8217;s interests and that Politan was a &#8220;Trojan Horse&#8221; funded by Chinese
          entities seeking to steal Masimo&#8217;s intellectual property or by Apple to gain an advantage in its ongoing litigation with Masimo.</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-size: 14pt;">12</font></sup></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">60.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Although Mr. Kiani and the Board dismiss the concept that good corporate governance leads to better stock performance, it is not as though their stewardship has proven the concept false. Masimo&#8217;s total stockholder return
          has significantly underperformed both its peers and the S&amp;P 500 on a trailing one-, three-, and five-year basis&#8212;the standard time-frames and metric used by ISS to evaluate a company&#8217;s (and therefore its board&#8217;s) performance.</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 20.5pt;"><font style="font-size: 14pt;">61.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">The following chart reflects Masimo&#8217;s historical stock price performance as of the date of Politan&#8217;s Schedule 13D filing on August 16, 2022 compared to its peer companies and relevant indices.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">13</sup></font></div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;">
        <div style="margin-top: 0px; margin-bottom: 3pt;">____________________<br>
        </div>
        <div>
          <div style="line-height: 0pt;"><br style="line-height: 0pt;">
          </div>
          <div style="line-height: normal; text-align: justify;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">12</font></sup> <font style="font-size: 14pt;">Examples of Defendants&#8217; accusations of Politan&#8217;s alleged ill intentions include:</font><font style="font-size: 14pt; font-family: Arial,Helvetica,sans-serif;"> (i) the allegation in Masimo&#8217;s Counterclaim that &#8220;the fact that Politan has &#8216;sovereign entities&#8217; as investors is particularly concerning, given that there are a number of
              sovereign entities that do not respect&#8212;and have attempted to steal&#8212;intellectual property belonging to U.S. companies&#8221; (Counterclaim &#182; 12); and (ii) Mr. Kiani&#8217;s testimony that &#8220;what the board was worried about is that if Politan was working at
              the behest of Apple or Foxconn&#8221; (Kiani Tr. at 78:5-9).</font></div>
        </div>
      </div>
      <div style="text-align: justify; line-height: 15.95pt; margin-top: 11.65pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">13</font></sup> Peer companies are those selected by Masimo in its
        proxy statement for this year&#8217;s annual meeting, as well as those selected as peers by Bloomberg. &#8220;Proxy Peers with Same Growth Profile&#8221; are those proxy peers with a three-year forward revenue compound annual growth rate (CAGR) greater than 10%.</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">24</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
      </div>
      <div style="border: 1px solid rgb(0, 0, 0); padding: 5px; width: 99%;">
        <table cellspacing="0" cellpadding="3" border="0" id="z92cf8578c5c14335b80e6e903a055d23" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 17.17%; vertical-align: bottom; border-right: 2px double rgb(0, 0, 0); font-size: 12pt; padding-bottom: 2px;">&#160;</td>
              <td style="width: 45.31%; vertical-align: bottom; border-left: 2px double rgb(0, 0, 0); font-size: 12pt; padding-bottom: 2px;">&#160;</td>
              <td style="width: 12.5%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; line-height: 11.4pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">1 Year</div>
              </td>
              <td style="width: 1%; vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
              <td style="width: 12.5%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; line-height: 11.4pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">3 Years</div>
              </td>
              <td style="width: 1%; vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
              <td style="width: 12.5%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; line-height: 11.4pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">5 Years</div>
              </td>
            </tr>
            <tr>
              <td style="width: 17.17%; vertical-align: top; border-right: 2px double rgb(0, 0, 0);" rowspan="6">
                <div style="line-height: 11.4pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt; font-weight: bold;">Masimo<br>
                  stock<br>
                  performance<br>
                  vs:</div>
              </td>
              <td style="width: 45.31%; vertical-align: bottom; border-left: #000000 2px double;">
                <div style="line-height: 11.4pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">US Medical Device ETF</div>
              </td>
              <td style="width: 12.5%; vertical-align: bottom;">
                <div style="text-align: right; margin-right: 8.15pt; line-height: 11.4pt; color: rgb(255, 0, 0); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">(27%)</div>
              </td>
              <td style="width: 1%; vertical-align: bottom;" colspan="1">&#160;</td>
              <td style="width: 12.5%; vertical-align: bottom;">
                <div style="text-align: right; margin-right: 8.15pt; line-height: 11.4pt; color: rgb(255, 0, 0); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">(32%)</div>
              </td>
              <td style="width: 1%; vertical-align: bottom;" colspan="1">&#160;</td>
              <td style="width: 12.5%; vertical-align: bottom;">
                <div style="text-align: right; margin-right: 8.15pt; line-height: 11.4pt; color: rgb(255, 0, 0); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">(19%)</div>
              </td>
            </tr>
            <tr>
              <td style="width: 45.31%; vertical-align: bottom; border-left: #000000 2px double;">
                <div style="line-height: 11.4pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">NASDAQ</div>
              </td>
              <td style="width: 12.5%; vertical-align: bottom;">
                <div style="text-align: right; margin-right: 8.15pt; line-height: 11.4pt; color: rgb(255, 0, 0); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">(29%)</div>
              </td>
              <td style="width: 1%; vertical-align: bottom;" colspan="1">&#160;</td>
              <td style="width: 12.5%; vertical-align: bottom;">
                <div style="text-align: right; margin-right: 8.15pt; line-height: 11.4pt; color: rgb(255, 0, 0); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">(66%)</div>
              </td>
              <td style="width: 1%; vertical-align: bottom;" colspan="1">&#160;</td>
              <td style="width: 12.5%; vertical-align: bottom;">
                <div style="text-align: right; margin-right: 8.15pt; line-height: 11.4pt; color: rgb(255, 0, 0); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">(30%)</div>
              </td>
            </tr>
            <tr>
              <td style="width: 45.31%; vertical-align: bottom; border-left: #000000 2px double;">
                <div style="line-height: 11.4pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">S&amp;P 500 INDEX</div>
              </td>
              <td style="width: 12.5%; vertical-align: bottom;">
                <div style="text-align: right; margin-right: 8.15pt; line-height: 11.4pt; color: rgb(255, 0, 0); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">(37%)</div>
              </td>
              <td style="width: 1%; vertical-align: bottom;" colspan="1">&#160;</td>
              <td style="width: 12.5%; vertical-align: bottom;">
                <div style="text-align: right; margin-right: 8.15pt; line-height: 11.4pt; color: rgb(255, 0, 0); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">(51%)</div>
              </td>
              <td style="width: 1%; vertical-align: bottom;" colspan="1">&#160;</td>
              <td style="width: 12.5%; vertical-align: bottom;">
                <div style="text-align: right; margin-right: 8.15pt; line-height: 11.4pt; color: rgb(255, 0, 0); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">(3%)</div>
              </td>
            </tr>
            <tr>
              <td style="width: 45.31%; vertical-align: bottom; border-left: #000000 2px double;">
                <div style="line-height: 11.4pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Proxy Peers</div>
              </td>
              <td style="width: 12.5%; vertical-align: bottom;">
                <div style="text-align: right; margin-right: 8.15pt; line-height: 11.4pt; color: rgb(255, 0, 0); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">(21%)</div>
              </td>
              <td style="width: 1%; vertical-align: bottom;" colspan="1">&#160;</td>
              <td style="width: 12.5%; vertical-align: bottom;">
                <div style="text-align: right; margin-right: 8.15pt; line-height: 11.4pt; color: rgb(255, 0, 0); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">(19%)</div>
              </td>
              <td style="width: 1%; vertical-align: bottom;" colspan="1">&#160;</td>
              <td style="width: 12.5%; vertical-align: bottom;">
                <div style="text-align: right; margin-right: 8.15pt; line-height: 11.4pt; color: rgb(255, 0, 0); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">(19%)</div>
              </td>
            </tr>
            <tr>
              <td style="width: 45.31%; vertical-align: bottom; border-left: #000000 2px double;">
                <div style="line-height: 11.4pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Proxy Peers with Same Growth Profile Bloomberg Peers</div>
              </td>
              <td style="width: 12.5%; vertical-align: bottom;">
                <div style="text-align: right; margin-right: 8.15pt; line-height: 11.4pt; color: rgb(255, 0, 0); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">(26%)</div>
              </td>
              <td style="width: 1%; vertical-align: bottom;" colspan="1">&#160;</td>
              <td style="width: 12.5%; vertical-align: bottom;">
                <div style="text-align: right; margin-right: 8.15pt; line-height: 11.4pt; color: rgb(255, 0, 0); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">(41%)</div>
              </td>
              <td style="width: 1%; vertical-align: bottom;" colspan="1">&#160;</td>
              <td style="width: 12.5%; vertical-align: bottom;">
                <div style="text-align: right; margin-right: 8.15pt; line-height: 11.4pt; color: rgb(255, 0, 0); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">(69%)</div>
              </td>
            </tr>
            <tr>
              <td style="width: 45.31%; vertical-align: bottom; border-left: #000000 2px double;">
                <div style="line-height: 11.4pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Bloomberg Peers</div>
              </td>
              <td style="width: 12.5%; vertical-align: bottom;">
                <div style="text-align: right; margin-right: 8.15pt; line-height: 11.4pt; color: rgb(255, 0, 0); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">(66%)</div>
              </td>
              <td style="width: 1%; vertical-align: bottom;" colspan="1">&#160;</td>
              <td style="width: 12.5%; vertical-align: bottom;">
                <div style="text-align: right; margin-right: 8.15pt; line-height: 11.4pt; color: rgb(255, 0, 0); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">(123%)</div>
              </td>
              <td style="width: 1%; vertical-align: bottom;" colspan="1">&#160;</td>
              <td style="width: 12.5%; vertical-align: bottom;">
                <div style="text-align: right; margin-right: 8.15pt; line-height: 11.4pt; color: rgb(255, 0, 0); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">(14%)</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 11.4pt; margin-top: 0.35pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="margin-left: 36pt; line-height: 31.9pt;"><font style="font-size: 14pt; font-weight: bold; font-style: italic;">1.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt; font-weight: bold; font-style: italic;">Masimo&#8217;s Problematic Board Structure</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">62.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Masimo&#8217;s Board is small&#8212;only </font><font style="font-size: 14pt; font-weight: bold; font-style: italic;">five </font><font style="font-size: 14pt;">members&#8212;and staggered, and Mr. Kiani serves as both the Chairman and
          CEO. The Board lacks even a lead independent director&#8212;and it cannot appoint a lead independent director or independent chair without potentially triggering massive payments to Mr. Kiani. Indeed, Director Defendant Reynolds testified that the
          prospect of appointing a lead independent director came up only once, and any further discussion was quashed when Mr. Kiani responded by raising the prospect of renegotiating his Employment Agreement.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">14</sup></font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">63.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Masimo touts that structure in its &#8220;corporate governance guidelines,&#8221; which provide that &#8220;except in unusual circumstances, the positions of</font></div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;">
        <div style="margin-top: 0px; margin-bottom: 3pt;">____________________<br>
        </div>
        <div>
          <div style="line-height: 0pt;"><br style="line-height: 0pt;">
          </div>
          <div style="text-align: justify; line-height: 15.95pt; margin-top: 4.05pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">14</font></sup> Mr. Reynolds testified that
            appointing a lead independent director &#8220;came up once, and Joe said&#8230;That&#8217;s fine, but we would have to look at other areas of my contract. We listened to that, and that was the end of the discussion.&#8221; (Reynolds Tr. at 143:6- 12.)</div>
        </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">25</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">Chairman of our Board and CEO will be held by the same person.&#8221;<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">15</sup><font style="font-size: 10pt;">&#160;</font>Indeed, Mr. Kiani testified that he believes: &#8220;Everyone should
        know who to follow, who to listen to. So while I am CEO of the Company ... I need to be Chairman. I don&#8217;t want to have a lead director because I think it gets in the way .&#8230; Some people may disagree with me. But if anyone does, they can fire me.&#8221;<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">16</sup><font style="font-size: 10pt;">&#160;</font>(Kiani Tr. at 42:13-17.)</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">64.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">The combination of a staggered board and no independent chair <font style="font-style: italic;">or </font>lead independent director is highly unusual&#8212;only 3% of the companies in the Russell 3000 Index (the &#8220;<u>Russell
            3000</u>&#8221;) share all three features.</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">65.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Numerous large, long-term stockholders have raised concerns with Masimo about the size and structure of its Board. For instance, one of Masimo&#8217;s largest stockholders expressed its view to members of Masimo&#8217;s Board and
          management team that Masimo&#8217;s board size was &#8220;unusually small&#8221; and &#8220;a board size of seven people would have been better.&#8221; (Kammerman HC Tr. at 174:11- 175:2.) Another one of Masimo&#8217;s largest stockholders similarly criticized Masimo&#8217;s &#8220;governance
          practices including board size [and] board composition.&#8221; (<font style="font-style: italic;">Id. </font>at</font></div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;">
        <div style="margin-top: 0px; margin-bottom: 3pt;">____________________<br>
        </div>
        <div>
          <div style="line-height: 0pt;"><br style="line-height: 0pt;">
          </div>
          <div style="text-align: justify; line-height: 15.95pt; margin-top: 4.05pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">15</font></sup> Masimo, Proxy Statement (Form 14A)
            (Apr. 4, 2022), at 26.</div>
        </div>
      </div>
      <div style="text-align: justify; line-height: 15.95pt; margin-top: 5.65pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">16</font></sup> Mr. Kiani also testified that he believes
        &#8220;meddling [in] every little thing in a company, isn&#8217;t a board&#8217;s job. Their job is to hire a great CEO.&#8221; (Kiani Tr. at 43:20- 22.)</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">26</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; line-height: 20.5pt;"><font style="font-size: 14pt;">180:19-24.) And, independent directors acknowledged widespread stockholder concern on these issues.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">17</sup></font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">66.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Yet another of Masimo&#8217;s largest stockholders wrote to Director Defendant Julie Shimer, the Chair of Masimo&#8217;s Nominating, Compliance and Corporate Governance Committee, to express its &#8220;concerns regarding a lack of
          independent board leadership.&#8221; (MASI_0000008192.) The stockholder explained that &#8220;an independent chair would be better able to oversee management and set an agenda aligned with shareholder interests without conflicts of interest that an executive
          or insider director might encounter&#8221; and that, where the chair is not independent, &#8220;it is best practice to appoint a lead independent director.&#8221; That stockholder also expressed concern with Masimo&#8217;s staggered Board. (<font style="font-style: italic;">Id.</font>)</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">67.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Stockholders have shown their dissatisfaction with the Board at the ballot box as well&#8212;a significant contingent has refused to support the re-election of incumbent Board members, even though such withhold votes are little
          more than protest votes given that the Board members were unopposed.</font></div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;">
        <div style="margin-top: 0px; margin-bottom: 3pt;">____________________<br>
        </div>
        <div>
          <div style="line-height: 0pt;"><br style="line-height: 0pt;">
          </div>
          <div style="text-align: justify; line-height: 15.95pt; margin-top: 4.05pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">17</font></sup> Specifically, Mr. Cohen agreed that
            &#8220;[t]here had been criticisms of Masimo&#8217;s corporate governance in terms of its failed say on pay votes, in terms of its director withhold votes, in terms of its market performance&#8221; (Cohen Tr. at 133:8-17), and Dr. Shimer testified that &#8220;[s]ome
            investors have felt that Masimo might benefit from having a larger board, from having a lead director&#8221; (Shimer Tr. at 38:7-10).</div>
        </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">27</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">68.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">From 2011 through 2022, Masimo&#8217;s directors ranked in the bottom quartile of all Russell 3000 companies in terms of votes protesting their election (&#8220;withhold votes&#8221;). At the last annual meeting in 2022, Masimo&#8217;s two
          directors received withhold votes from <font style="font-weight: bold; font-style: italic;">20</font>% and <font style="font-weight: bold; font-style: italic;">30% </font>of the voting stock, respectively, placing them in the bottom <font style="font-weight: bold; font-style: italic;">6</font><font style="font-size: 10pt; font-weight: bold; font-style: italic;">th </font>and <font style="font-weight: bold; font-style: italic;">3</font><font style="font-size: 10pt; font-weight: bold; font-style: italic;">rd </font>percentile of all Russell 3000 directors. Indeed, only twice in the past decade has even a single Masimo independent director done better than the bottom 33<font style="font-size: 10pt;">rd </font>percentile.











          Mr. Kiani has, on average, been in the bottom 25<font style="font-size: 10pt;">th </font>percentile during the last decade.</font></div>
      <div style="margin-left: 36pt; line-height: 31.9pt;"><font style="font-size: 14pt; font-weight: bold; font-style: italic;">2.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt; font-weight: bold; font-style: italic;">Masimo&#8217;s Excessive Executive Compensation and Perks</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">69.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Masimo has <font style="font-weight: bold; font-style: italic;">ranked in the bottom 0.1% of the entire Russell 3000 </font>for &#8220;Say-on-Pay&#8221; since 2011 (when US companies were first required to hold advisory,
          non-binding votes at their annual meetings to approve the compensation of their named executive officers). In <font style="font-weight: bold; font-style: italic;">six of the last twelve years</font>, Masimo failed this vote. Remarkably, only <font style="font-weight: bold; font-style: italic;">three </font>other companies in the Russell 3000 had as many failures in their Say-on-Pay votes during that period.</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">70.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Even in the years that Masimo did not fail Say-on-Pay (2017 through 2021), stockholder support was anemic relative to the Russell 3000, never exceeding the <font style="font-weight: bold; font-style: italic;">20</font><font style="font-size: 10pt; font-weight: bold; font-style: italic;">th </font>percentile and averaging the bottom <font style="font-weight: bold; font-style: italic;">14</font><font style="font-size: 10pt; font-weight: bold; font-style: italic;">th











          </font>percentile. Such poor performance even in the years when Masimo&#8217;s Say-on-Pay passed is all the more</font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">28</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">stunning given that Mr. Kiani owned, on average, approximately 10% of Masimo&#8217;s stock in each of those years and presumably voted in favor of his own compensation.</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">71.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Excluding Mr. Kiani&#8217;s ownership, Masimo was in the bottom <font style="font-weight: bold; font-style: italic;">11</font><font style="font-size: 10pt; font-weight: bold; font-style: italic;">th </font>percentile of all
          Russell 3000 companies in the years it passed Say-on-Pay. Rather than taking note of the low approval ratings and listening to stockholders, Masimo&#8217;s directors and management refer to these years as &#8220;winning&#8221; Say-on-Pay and as evidence that
          nothing needed to change. (<font style="font-style: italic;">See </font>Shimer Tr. at 60:8-13; Young Tr. at 90:22-25.)</font></div>
      <div style="text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">72.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Masimo
          failed its Say-on-Pay vote again in 2022, with nearly <font style="font-weight: bold; font-style: italic;">58% </font>of stockholders, excluding Mr. Kiani, voting against.</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">73.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Part of the reason Masimo&#8217;s stockholders have expressed such strong disapproval of its executive compensation is the sheer excess of the compensation Masimo pays to Mr. Kiani. In 2020 and 2021, for example, Mr. Kiani&#8217;s
          total compensation&#8212;excluding any value attributable to potential Special Payments&#8212;was approximately <font style="font-weight: bold; font-style: italic;">three to nearly four times </font>median Russell 3000 CEO compensation, as calculated by
          ISS. Mr. Kiani&#8217;s total compensation as a percentage of Masimo&#8217;s sales was approximately <font style="font-weight: bold; font-style: italic;">four times </font>the median for Russell 3000 companies during that same time period.</font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">29</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">74.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Yet despite stockholder criticism, weak Say-on-Pay results, and compensation wildly in excess of peers, Mr. Kiani wanted more. Around January 2022, when the Board was considering the Second Amendment, Mr. Kiani requested
          he &#8220;get large sums of stock upon certain stock prices, kind of like the Elon Musk deal with Tesla.&#8221; (Kiani Tr. at 138:18-22.)</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">75.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Over the years, the Board also has approved excessive perks for Mr. Kiani, including nearly a million dollars for private security services for him and his family at his personal residence or other non-Masimo facilities
          that were unrelated to Masimo&#8217;s business. Those payments drew scrutiny by ISS, which noted: &#8220;The company provided a large security-related perquisite to CEO Kiani. The amount of compensation related to this perquisite, which in 2021 was provided
          by only 2 percent of companies in the Russell 3000 Index, significantly exceeded the index median.&#8221;</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">76.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Indeed, in September 2012, a Masimo stockholder filed a derivative action in federal court challenging the Board&#8217;s award of stock options to Mr. Kiani and other directors and officers in violation of the Company&#8217;s
          compensation policies. <font style="font-style: italic;">Ausikaitis</font>, No. 1:12-cv-01175-SLR. The plaintiff in <font style="font-style: italic;">Ausikaitis </font>alleged that, even though Masimo&#8217;s Executive Officer Compensation Policy
          (the &#8220;<u>Policy</u>&#8221;) provided for annual grants to Mr. Kiani of 100,000 stock</font></div>
      <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">30</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">options, Masimo issued Mr. Kiani <font style="font-weight: bold; font-style: italic;">1.5 million </font>stock options over the four-year period from 2008 through 2011&#8212;more
        than <font style="font-weight: bold; font-style: italic;">three times </font>the amount permitted under the Policy. <font style="font-style: italic;">See Ausikaitis</font>, First Am. Verified Stockholder Complaint, &#182;&#182; 12, 40-42 (filed July 1,
        2014).</div>
      <div style="text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">77.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Much of
          the record in the <font style="font-style: italic;">Ausikaitis </font>action remains under seal.&#160; However, the parties resolved the <font style="font-style: italic;">Ausikaitis </font>action in May 2015 pursuant to a settlement agreement that
          required &#8220;Masimo, the Board, and the committees thereof (as appropriate)&#8221; to implement certain corporate governance measures. (Exhibit A, <font style="font-style: italic;">Ausikaitis </font>Settlement Agreement, &#167; 2.1.) Among other things,
          Masimo was required to (i) increase the size of its Board to seven members for at least five years, (ii) engage a third party to review the process by which &#8220;stock option and other equity award grants are made and delivered,&#8221; and (iii) &#8220;comply at
          all times with any applicable Masimo compensation plan.&#8221; (<font style="font-style: italic;">Id. </font>at Ex. A, &#182;&#182; g, h, l.)</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">78.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Masimo&#8217;s Board did not comply with the terms of the <font style="font-style: italic;">Ausikaitis </font>settlement&#8212;the Board had six or fewer members until Mr. Cohen joined in August 2018. And almost immediately after
          the five-year period elapsed, Masimo again decreased the size of its Board to only five members.</font></div>
      <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">31</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-left: 36pt; line-height: 31.9pt;"><font style="font-size: 14pt; font-weight: bold; font-style: italic;">3.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt; font-weight: bold; font-style: italic;">Improper Payments That Benefit Mr. Kiani Personally</font></div>
      <div style="text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">79.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">In
          addition, the Company makes millions of dollars in payments to entities associated with Mr. Kiani, which serve no legitimate corporate purpose.</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">80.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Masimo makes cash contributions to the Masimo Foundation for Ethics, Innovation, and Competition in Healthcare (the &#8220;<u>Masimo Foundation</u>&#8221;), a non-profit organization at which Mr. Kiani is the Chairman, his wife is a
          director, and his sister was a director until recently (and for at least five years)&#8212;collectively the three family members comprised a majority of the board. Masimo has contributed over $30 million to the Masimo Foundation since its inception in
          2010, and the Masimo Foundation regularly uses a substantial portion of those funds to make contributions to politicians and their foundations at the direction of Mr. Kiani and his family members, which, upon information and belief, provides
          personal benefits to Mr. Kiani to present himself as a benefactor for causes he personally believes in but are unrelated to Masimo.</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">81.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">For instance, in its last four annual public tax returns, the Masimo Foundation reported making nearly $6.4 million in contributions to organizations associated with Presidents Carter, Clinton, Obama, and Biden for
          &#8220;general support&#8221;&#8212;approximately 50% of the grants and contributions the Masimo</font></div>
      <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">32</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="line-height: 31.9pt; font-size: 14pt;">Foundation made during that period. The Masimo Foundation has donated nearly $8.5 million to those organizations since its founding.</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">82.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">The Masimo Foundation also has donated millions of dollars to Chapman University (where Mr. Kiani has been a Trustee and where he is a member of the President&#8217;s Cabinet) and to a number of personal foundations that have
          no relationship to patient safety or the mission statement of the Masimo Foundation (but are likely connected to Mr. Kiani). Those payments are merely a further example of additional compensation to Mr. Kiani from Masimo that has not been
          reported as such in Masimo&#8217;s executive compensation SEC disclosures.</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">83.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Masimo also makes payments to Cercacor Laboratories, Inc. (&#8220;<u>Cercacor</u>&#8221;), a separate entity that was spun off from Masimo in 1998. Mr. Kiani is the Chairman and CEO of Cercacor and receives an undisclosed salary and
          equity compensation in connection with those roles. Mr. Kiani&#8217;s ownership of Cercacor is also undisclosed.</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">84.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Multiple Masimo directors testified that, at least prior to this litigation, they did not know how much of Cercacor Mr. Kiani owned. Mr. Mikkelson testified that Mr. Kiani has since told him that he owns 51% of Cercacor.
          As well, not a single Masimo director could testify to understanding the financial relationship between Cercacor and Masimo or what payments may be due from</font></div>
      <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">33</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="line-height: 31.9pt; font-size: 14pt;">Masimo&#160; under a variety of scenarios. (Cohen Tr. at 330:20-335:21; Shimer Tr. 297:17-298:23; Mikkelson Tr. 560:16-563:14.)</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">85.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Pursuant to a cross-licensing agreement between Masimo and Cercacor related to certain intellectual property (the &#8220;<u>CLA</u>&#8221;), Masimo is obligated to make minimum royalty payments of $5 million per year to Cercacor.
          Masimo&#8217;s aggregate royalty payment liabilities to Cercacor were approximately $13.5 million, $13.3 million, and $12.1 million, for the years ended January 1, 2022, January 2, 2021, and December 28, 2019, respectively.</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">86.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">In addition, the CLA includes change in control provisions that are triggered if Mr. Kiani ceases to be the CEO of Masimo or if non-affiliates directly or indirectly gain 50% or more of Masimo&#8217;s voting shares. (CLA &#167;
          1.4.)</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">87.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Upon such a change in control, Masimo is obligated to, among other things, pay Cercacor substantially increased aggregate minimum royalties, as well as specified minimum royalty fees per product. (<font style="font-style: italic;">Id. </font>&#167;&#167; 5.4(g), 5.6.) Instead of the current $5 million annual minimum, Masimo would be obligated to pay an aggregate minimum royalty of <font style="font-weight: bold; font-style: italic;">$17 million per year</font>,
          regardless of the amount of underlying sales of the licensed products, as well as a one-time $2.5 million payment. (<font style="font-style: italic;">See id.</font>)</font></div>
      <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">34</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">88.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">The
          change in control provision in the CLA serves no legitimate corporate purpose and is solely intended to entrench Mr. Kiani in office.</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">89.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Masimo also makes payments to a company founded by Mr. Kiani called Like Minded Media Ventures (&#8220;<u>LMMV</u>&#8221;), at which Mr. Kiani continues to serve as a director. Masimo describes LMMV in SEC filings as a &#8220;team of
          storytellers that create content focused in the areas of true stories, social causes and science.&#8221; Masimo pays LMMV and certain of its subsidiaries hundreds of thousands of dollars for &#8220;audiovisual production services promoting brand awareness,&#8221;
          software development, and certain patents.</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">90.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Additionally, Mr. Kiani appears to invest Masimo&#8217;s cash balances as though they were his personal assets. For example, Masimo invests an undisclosed amount of cash in Cota Capital based on a personal friendship between
          Mr. Kiani and Cota Capital&#8217;s founder, Bobby Yazdani. (Kiani Tr. at 188:15-22.)</font></div>
      <div style="margin: 12pt 0px 12pt 54pt; text-indent: -27pt;"><font style="font-size: 14pt; font-weight: bold; font-style: italic;">4.&#160;&#160;&#160; The Sound United Transaction Demonstrates That the Market Has Lost Confidence in the Board&#8217;s Stewardship of
          Masimo&#160;</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">91.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Long-simmering stockholder discontent with the Board&#8217;s inaction in the face of serious corporate governance failures finally boiled over when Masimo announced that it was acquiring Sound United&#8212;a consumer audio company
          that sells speakers and headphones under brands such as Bowers &amp; Wilkins, Denon,</font></div>
      <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">35</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">and Polk Audio&#8212;for approximately $1.025 billion. The Sound United acquisition, which represented a departure by Masimo from its core pulse oximetry business into unrelated
        consumer audio products, was the final straw for many of Masimo&#8217;s stockholders.</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">92.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">On February 15, 2022, the day on which Masimo announced the Sound United acquisition, the Company&#8217;s stock closed at $228 per share. The following day, the stock fell <font style="font-weight: bold; font-style: italic;">37%</font>,
          to $144 per share. Thus, the market responded to news of a $1.025 billion acquisition by erasing <font style="font-weight: bold; font-style: italic;">five times </font>that amount&#8212; approximately <font style="font-weight: bold; font-style: italic;">$5.1 billion</font>&#8212;from Masimo&#8217;s market cap. Masimo&#8217;s stock price remains around that same depressed level to this day and restoration of $5.1 billion in market capitalization equates to a <font style="font-weight: bold; font-style: italic;">58% increase </font>in Masimo&#8217;s current stock price.</font></div>
      <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">36</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="line-height: 11.4pt;"><br>
      </div>
      <div style="line-height: 11.4pt;">
        <div style="text-align: center; line-height: 11.4pt;"><img width="390" height="376" src="image0.jpg"></div>
      </div>
      <div style="line-height: 10.25pt; margin-top: 0.2pt;"><br style="line-height: 10.25pt;">
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">93.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Such a drop in value is extremely rare, if not unprecedented. To Politan&#8217;s knowledge, based on extensive research, never before in the history of United States publicly traded companies has an acquiring company&#8217;s market
          cap declined by more than <font style="font-weight: bold; font-style: italic;">two </font>times, let alone <font style="font-weight: bold; font-style: italic;">five </font>times, the purchase price of the acquisition where the acquisition was
          material (<font style="font-style: italic;">i.e.</font>, 5% or more of the acquiring company&#8217;s market cap).</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">94.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">What otherwise might have been limited to a negative reaction to one transaction instead broke out into a fear that such capital allocation decisions would repeat because the market had lost confidence in proper corporate
          governance</font></div>
      <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">37</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">at Masimo and was not confident that Masimo&#8217;s Board would adequately restrain management or steward stockholder resources.</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">95.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Masimo stockholders expressed alarm about Masimo&#8217;s governance to Eli Kammerman, Masimo&#8217;s Vice President of Investor Relations, who testified: &#8220;Because once something happens once, people believe that it has a higher than
          previous chance of happening. Once there&#8217;s a precedent, people believe that&#8230;the thing may repeat.&#8230; There were investors who expressed serious concern over the capital allocation decision and wondered how it could be justified.&#8221; (Kammerman HC Tr.
          at 194:12-195:13.)</font></div>
      <div>
        <div style="line-height: 31.9pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt; font-weight: bold;">B.&#160; Mr. Kiani&#8217;s Employment Agreement</div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">96.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">The Board abdicated its statutory and fiduciary duties and improperly bartered away the stockholder franchise (which does not belong to the Board) when it approved Mr. Kiani&#8217;s 2015 Employment Agreement and the amendments
          thereto, which entrenches the Board in office and vests virtually unchecked control over the Company in Mr. Kiani&#8217;s hands.</font></div>
      <div style="margin-left: 36pt; line-height: 31.9pt;"><font style="font-size: 14pt; font-weight: bold; font-style: italic;">1.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt; font-weight: bold; font-style: italic;">The Prior Employment Agreement</font></div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">97.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Prior to the Board&#8217;s approval of the 2015 Employment Agreement, Mr. Kiani&#8217;s employment was governed by an Amended and Restated Employment Agreement, dated February 7, 2012 (the &#8220;<u>2012 Agreement</u>&#8221;). (Exhibit B.)</font></div>
      <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">38</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">98.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">The 2012 Agreement lacked many of the egregious and problematic provisions of the current employment agreement, including the Special Payment, the DCCP, the Single Trigger, the Dead Hand Provision, the Chairman Provision,
          the Lead Independent Director Provision, and the Automatic Renewal Provision,<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">18</sup><font style="font-size: 10pt;">&#160;</font>all of which were inserted into the 2015 Employment Agreement and subsequent amendments.</font></div>
      <div style="text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">99.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">The 2012
          Agreement defined a &#8220;Change in Control&#8221; to include:</font></div>
      <div style="line-height: 34.8pt;">
        <div style="text-align: justify; margin-right: 72pt; margin-left: 72pt; line-height: 15.95pt; font-size: 14pt;">a change in the Board of Directors of the Company in which the individuals who constituted the Board of Directors of the Company at the
          beginning of the 12-month period immediately preceding such change (together with any other director whose election by the Board &#8230; or whose nomination for election by the stockholders of the Company was approved by a vote of at least a majority
          of the directors then in office either who were directors at the beginning of such period or whose election or nomination for election was previously so approved) cease for any reason to constitute a majority of the directors then in office</div>
      </div>
    </div>
    <div><font style="font-size: 14pt;"><br>
      </font>
      <div>
        <div><font style="font-size: 14pt;">(<font style="font-family: Arial,Helvetica,sans-serif; font-style: italic;">Id.</font>&#167; 9(iii).) <br>
          </font></div>
        <div><br>
          <div style="line-height: 31.9pt; text-indent: 72pt;"><font style="font-size: 14pt;">100.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 14pt; width: 36pt;"> </font><font style="font-size: 14pt;">Upon











              a Change in Control, Mr. Kiani's stock options and equity awards would vest, the Company would pay the exercise price of accelerated options, and Mr. Kiani would be entitled to receive a cash severance benefit &#8220;equal</font></div>
        </div>
        <div><font style="font-size: 14pt;"> <br>
          </font></div>
      </div>
      <div><font style="font-size: 14pt;"> <br>
        </font></div>
      <div><font style="font-size: 14pt;"> <br>
        </font></div>
      <div><font style="font-size: 14pt;"> </font><br>
        <div style="margin-top: 0px; margin-bottom: 3pt;">____________________<br>
        </div>
        <div>
          <div style="line-height: 0pt;"><br style="line-height: 0pt;">
          </div>
          <div style="text-align: justify; line-height: 15.95pt; margin-top: 4.05pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">18</font></sup> While the 2012 Agreement contained an
            automatic renewal provision, nonrenewal did not result in a Change in Control payment to Mr. Kiani.</div>
        </div>
        <div>
          <div>
            <div style="line-height: 15.95pt; font-size: 14pt;"><br>
            </div>
          </div>
          <div style="line-height: 0pt;"><br style="line-height: 0pt;">
          </div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageFooter"></div>
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">39</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            <div class="BRPFPageHeader"></div>
          </div>
          <div style="line-height: 0pt;"><br style="line-height: 0pt;">
          </div>
          <div style="line-height: 11.4pt; margin-top: 0.25pt;"><br style="line-height: 11.4pt;">
          </div>
          <div style="line-height: 12.55pt;">
            <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">to two times the sum of (i) [his] Base Salary at the rate then in effect, and (ii) the average annual bonus paid to [him] during the immediately prior three (3) years.&#8221; (<font style="font-style: italic;">Id. </font>&#167; 8.4.) Mr. Kiani also would receive tax gross-ups for withholding and excise taxes.</div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">101.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Thus, under the 2012 Agreement, a Change in Control would only occur if a <font style="font-weight: bold; font-style: italic;">majority </font>of the Board changed over a <font style="font-weight: bold; font-style: italic;">12-month </font>period, and even if there was such a change, the <font style="font-weight: bold; font-style: italic;">Board retained the authority to approve the new directors (i.e., no dead hand) </font>by a
                majority vote and thereby disable the provision.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">102.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Moreover<font style="font-style: italic;">, </font>the 2012 Agreement provided that Mr. Kiani had &#8220;Good Reason&#8221; to terminate his employment if there was any change in his duties or authority or any reduction in his
                compensation or fringe benefits. (<font style="font-style: italic;">Id. </font>&#167; 7.4.) A termination for Good Reason <font style="font-weight: bold; font-style: italic;">did not include </font>appointing a lead independent director, Mr.
                Kiani ceasing to be Chairman, a Change in Control, or non-renewal of Mr. Kiani&#8217;s employment contract.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">103.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Several of the Change in Control benefits provided to Mr. Kiani under the 2012 Agreement were subject to significant stockholder opposition and had become indefensible in a changing executive compensation landscape.
                In particular, upon a Change in Control, Mr. Kiani was due to receive golden parachute and tax expense reimbursement gross ups and payment by the Company of the taxes</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">40</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="line-height: 31.9pt; text-align: justify;"><font style="font-size: 14pt;">on accelerated option income&#8212;payouts that had been staunchly criticized by stockholders and proxy advisers for years and were fast becoming extinct as many
                companies eliminated them. Not surprisingly, Masimo failed Say-on-Pay in each of 2012, 2013, 2014 and 2015 (with votes of 37.7%, 48.2%, 30.1% and 43.5%).<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">19</sup></font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">104.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">As a practical matter, like many other public companies at the time, Masimo had no choice but to amend or terminate the 2012 Agreement. Yet, unlike other public companies at the time, Masimo amended its agreement to
                the unprecedented form it has today by bartering away the stockholder franchise.</font></div>
            <div style="text-align: justify; line-height: 31.9pt;">
              <div style="margin: 12pt 0px 12pt 54pt; line-height: normal; text-indent: -27pt;"><font style="font-size: 14pt; font-weight: bold; font-style: italic;">2.</font>&#160;&#160;&#160;&#160; <font style="font-size: 14pt; font-weight: bold; font-style: italic;">The
                  Undisclosed Circumstances Under Which Mr. Kiani Forced the 2015 Employment Agreement Through the Board&#160;</font></div>
              <font style="font-size: 14pt; font-family: Arial,Helvetica,sans-serif;"> </font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">105.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">In or around 2013, Mr. Kiani proposed his terms for a new employment agreement. The Board found the proposal egregious and rejected it.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">106.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Thereafter, Mr. Kiani and the Compensation Committee engaged in protracted negotiations regarding the terms of a new employment agreement, which eventually led to a standstill.</font></div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;">
              <div style="margin-top: 0px; margin-bottom: 3pt;">____________________<br>
              </div>
              <div>
                <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                </div>
                <div style="text-align: justify; line-height: 15.95pt; margin-top: 4.05pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">19</font></sup> Indeed, Mr. Kiani testified
                  that, in considering changes to his employment agreement, the Compensation Committee of Masimo&#8217;s Board (the &#8220;<u>Compensation&#160;Committee</u>&#8221; or the &#8220;<u>Committee</u>&#8221;) was &#8220;concerned with ISS not voting, say yes on pay&#8221; and &#8220;concerned with
                  the tax law changes that had occurred.&#8221; (Kiani Tr. at 16:13-17.)</div>
              </div>
            </div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">41</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">107.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">In October 2014, with the negotiations at an impasse, the Board considered a presentation by the Compensation Committee&#8217;s executive compensation consultant, Frederic W. Cook &amp; Co., Inc. (&#8220;<u>FW Cook</u>&#8221;), which
                stated that FW Cook &#8220;fully support[ed]&#8221; the Compensation Committee&#8217;s recommendation to deliver a notice of non-renewal of Mr. Kiani&#8217;s Employment Agreement. That notice would have terminated Mr. Kiani&#8217;s Employment Agreement following the
                expiration of his employment period unless he negotiated a new agreement on terms acceptable to the Board.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">108.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Soon after the Board presentation, Mr. Kiani indicated a desire to further negotiate and a willingness to make concessions.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">109.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">On March 18, 2015, following Mr. Kiani&#8217;s continued refusal to agree to terms acceptable to the Board, the then-Chair of the Compensation Committee, Robert Coleman, sent Mr. Kiani a letter on behalf of the Committee
                stating that the Committee intended to once again discuss delivering a notice of non-renewal to Mr. Kiani with the full Board at a meeting scheduled for March 20, 2015. The Compensation Committee attached a form notice of non-renewal to
                that letter.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">110.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">As set forth in the letter, if a notice of non-renewal had been delivered to Mr. Kiani, Masimo would have had to file a &#8220;Form 8-K with respect to this decision.&#8221; (MASI_0000006694.)</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">42</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">111.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Mr. Kiani retaliated against Compensation Committee Chair Coleman by effectively forcing him off the Board. Mr. Kiani testified that at the March 20, 2015 Board meeting&#8212;</font><font style="font-size: 14pt; font-style: italic;">i.e.</font><font style="font-size: 14pt;">, the meeting at which the Board was planning to discuss whether to deliver a notice of non-renewal to Mr. Kiani&#8212;he shamed Mr. Coleman by openly calling into question Mr.
                Coleman&#8217;s integrity and alleged conflict of interest. (Kiani Tr. at 46:10.)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">20</sup></font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">112.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">The purported conflict of interest was, in fact, Mr. Coleman exercising his fiduciary duties by choosing to act in the best interests of Masimo&#8217;s stockholders instead of in Mr. Kiani&#8217;s best interests. According to
                Mr. Kiani, Mr. Coleman was &#8220;afraid&#8221; to support Mr. Kiani&#8217;s demands because doing so might jeopardize Mr. Coleman&#8217;s board seat. (<font style="font-style: italic;">Id. </font>at 46:2-8.) In other words, Mr. Kiani believed that Mr. Coleman
                had a conflict of interest because Mr. Coleman was concerned that, if he supported Mr. Kiani&#8217;s demands, dissatisfied stockholders would vote him out of an office that he did not want to lose.</font></div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="text-align: justify; line-height: 15.95pt; margin-top: 4.05pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"><br>
              <div style="margin-top: 0px; margin-bottom: 3pt;">____________________<br>
              </div>
              <div>
                <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                </div>
                <div style="line-height: 15.95pt; margin-top: 4.05pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">20</font></sup> &#8220;I felt that Mr. Coleman had a conflict of interest and the board needed to know about it .&#8230; He just said
                  he&#8217;s afraid of doing what he thinks should be done with my agreement because he would lose his board seat &#8230; Bob had been the godfather of my son. I was his best man at his wedding. We had a really good relationship &#8230; [A]fter I told the
                  full board what he told me one-on-one, after the board meeting, he said to me, &#8216;I cannot be here anymore because of all the things you said I told you in our one-on-one conversation.&#8217; He was embarrassed about it.&#8221; (Kiani Tr. at 58:2-3;
                  57:5-7; 61:2-6; 57:13-17.)</div>
              </div>
            </div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">43</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">113.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Rather than risk Mr. Coleman acting in the stockholders&#8217; best interests, Mr. Kiani caused Mr. Coleman to leave the Board less than three months later, on June 2, 2015. Only by pressuring Mr. Coleman into leaving the
                Board and replacing him with a more favorable Board composition was Mr. Kiani ultimately able to force the Employment Agreement through the Board in November 2015.</font></div>
            <div style="margin: 12pt 0px 12pt 36pt;"><font style="font-size: 14pt; font-weight: bold; font-style: italic;">3.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt; font-weight: bold; font-style: italic;">The 2015 Employment Agreement</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">114.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">On November 4, 2015, Mr. Kiani entered into the 2015 Employment Agreement with Masimo. (Exhibit C.) The 2015 Employment Agreement made substantial changes to the terms of Mr. Kiani&#8217;s employment, virtually all of
                which were more favorable to Mr. Kiani and worse for Masimo&#8217;s stockholders.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">115.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;"><font style="font-style: italic;">First</font>, the 2015 Employment Agreement expanded the definition of Good Reason for Mr. Kiani to terminate his employment to include, among other things (i) a Change in Control;
                (ii) Mr. Kiani <font style="font-weight: bold; font-style: italic;">ceasing to be both Chairman and CEO </font>of Masimo, and (iii) the appointment of a <font style="font-weight: bold; font-style: italic;">lead independent director</font>.
                (<font style="font-style: italic;">Id. </font>&#167; 7.4.)</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt; font-weight: bold; font-style: italic;">116.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;"><font style="font-style: italic;">Second</font>, the 2015 Employment Agreement altered the definition of Change in Control such that a change in <font style="font-weight: bold; font-style: italic;">more than one-third </font>of the Board over a <font style="font-weight: bold; font-style: italic;">12-month period </font>would trigger the DCCP and the Board <font style="font-weight: bold; font-style: italic;">could
                  not vote to disable</font></font></div>
            <div style="line-height: 34.8pt;"><br style="line-height: 34.8pt;">
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">44</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;"><font style="font-weight: bold; font-style: italic;">it </font>where the new directors assumed office &#8220;in connection with an actual or threatened election contest.&#8221; (<font style="font-style: italic;">Id. </font>&#167; 9(iii).)</div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">117.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Specifically, Section 9(iii) provides, in relevant part, that a Change in Control takes place if:</font></div>
            <div style="text-align: justify; margin-right: 94.65pt; margin-left: 132pt; line-height: 15.95pt; font-size: 14pt;">there shall occur a change in the Board in which the <font style="font-weight: bold; font-style: italic;">individuals who
                constituted the Board at the beginning of the twelve (12) month period immediately preceding such change cease for any reason to constitute two-thirds or more of the directors then in office</font><font style="font-style: italic;">. </font>For











              purposes of this Section 9(iii), a director (<font style="font-weight: bold; font-style: italic;">other than a director whose initial assumption of office is in connection with an actual or threatened election contest, including but not
                limited to, a consent solicitation, relating to the election of directors of the Company</font>) whose election by the Board or whose nomination for election by the stockholders of the Company was approved by a vote of at least a majority
              of the directors then in office either who were directors at the beginning of such period or whose election or nomination for election was previously so approved will be treated as a member of the Board at the beginning of the twelve (12)
              month period.</div>
            <div style="line-height: 31.9pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt; text-align: justify;">(<font style="font-family: Arial,Helvetica,sans-serif; font-style: italic;">Id. </font>(emphasis added).)</div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">118.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Mr. Kiani testified that he requested the change in the threshold for a Change in Control (<font style="font-style: italic;">i.e. </font>from a majority of the Board to more than one-third) because &#8220;one person,&#8221;
                Director Defendant Jack Lasersohn, had been &#8220;pushing [him] hard&#8221; on his employment agreement, which made him realize that he wanted to prevent a situation in which &#8220;even one or two board members&#8221; created a &#8220;disruptive&#8221;</font></div>
            <div style="line-height: 34.8pt;"><br style="line-height: 34.8pt;">
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">45</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: justify; line-height: 31.9pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;">environment for him in the boardroom.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">21</sup><font style="font-size: 10pt;">&#160;</font>In other words, Mr. Kiani wanted the
              ability to prevent new directors from joining the Board who might push back against his agenda.</div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">119.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Remarkably, there was &#8220;no pushback&#8221; from the Board or even &#8220;much discussion&#8221; about Mr. Kiani&#8217;s requested change. (Kiani Tr. at 18:16-19.) The Board simply gave him what he wanted.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">120.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;"><font style="font-style: italic;">Third</font>, upon a &#8220;Qualifying Termination,&#8221; Mr. Kiani would be entitled to receive not just severance and stock options, but also the Special Payment, consisting of (i) 2.7
                million RSUs (equivalent to a stunning <font style="font-weight: bold; font-style: italic;">5% of the Company</font>) and (ii) a single lump-sum cash payment of <font style="font-weight: bold; font-style: italic;">$35 million</font>. (Ex.
                C, &#167; 8.4.)</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">121.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Notably, the Board did not impose a cap, collar or similar limitation on the monetary value of the Special Payment&#8212;that is, Mr. Kiani would receive nearly 6% of the Company (including stock options) <font style="font-weight: bold; font-style: italic;">regardless of Masimo&#8217;s market capitalization</font>.</font></div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;">
              <div style="margin-top: 0px; margin-bottom: 3pt;">____________________<br>
              </div>
              <div>
                <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                </div>
                <div style="text-align: justify; line-height: 15.95pt; margin-top: 4.05pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">21</font></sup> &#8220;Q: Why that particular change?
                  Why change the standard for board composition in connection with your employment agreement discussions? [Kiani]: Well, I had&#160; a board that I had known .&#8230; But at one point, when they were pushing me hard to change my agreement, it was done
                  by&#8212;really by one person .&#8230; So I realized that even one or two board members, when they go kind of on their own issues and become&#8212;it becomes disruptive, and I didn&#8217;t want to be in an environment where I felt hostility or disruption if that
                  was the case.&#8221; (Kiani Tr. at 17:12-18:2.)</div>
              </div>
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">46</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">122.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">The 2015 Employment Agreement did, however, include the Burn-Off Provision, pursuant to which &#8220;270,000 RSUs &#8230; shall terminate without the payment of any consideration to [Mr. Kiani], to the extent then unvested, on
                January 1 of each year, beginning on January 1, 2018&#8221; and that &#8220;the Cash Payment shall be reduced by three million five-hundred thousand dollars ($3,500,000) on January 1 of each year, beginning on January 1, 2018.&#8221; (<font style="font-style: italic;">Id. </font>&#167; 8.4(iii).)</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">123.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;"><font style="font-style: italic;">Fourth</font>, the 2015 Employment Agreement continued indefinitely; it automatically renewed each year, unless either Mr. Kiani or Masimo provided a notice of non-renewal. (<font style="font-style: italic;">Id. </font>&#167; 3.) Delivery of a notice of non-renewal, however, constituted Good Reason for Mr. Kiani to terminate his employment and receive the Special Payment. (<font style="font-style: italic;">Id. </font>&#167;
                7.4.)</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">124.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;"><font style="font-style: italic;">Finally</font>, notwithstanding that Article II, Section 8 the Company&#8217;s Bylaws requires that &#8220;all matters shall be determined by a vote of a majority of the directors present&#8221; at a
                meeting, the 2015 Employment Agreement provided that the Board could only terminate Mr. Kiani for cause if &#8220;not less than three-quarters of the <font style="font-weight: bold; font-style: italic;">entire membership </font>of the Board&#8221;
                voted to do so. (<font style="font-style: italic;">Id. </font>&#167; 7.3 (emphasis added).) That requirement not only exceeds the majority threshold in the Bylaws but measures the vote based on the entire Board, regardless of whether all such
                members are present at a meeting or vote. Therefore, assuming that Mr. Kiani will not vote</font></div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">47</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: justify; line-height: 31.9pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;">to terminate himself for cause or recuses himself from such a vote, the vote of the remaining four directors must be <font style="font-weight: bold; font-style: italic;">unanimous </font>in order to meet or exceed the 75% threshold of the entire Board. The 2015 Employment Agreement is a poison pill, and under Delaware law a poison pill with such a
              supermajority vote plainly violates both Article II, Section 8 of Masimo&#8217;s Bylaws and Section 141(b) of the DGCL.</div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">125.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">The 2015 Employment Agreement delivered Mr. Kiani a massive increase in his Change in Control benefit. Between 2011 and 2021, Masimo&#8217;s Change in Control benefit increased from a starting point of approximately $28
                million to approximately <font style="font-weight: bold; font-style: italic;">$913 million </font>(if he terminated his employment) or approximately <font style="font-weight: bold; font-style: italic;">$825 million </font>(if he
                remained Chairman and CEO). Granting Mr. Kiani RSUs equivalent to 5% of the company guaranteed Mr. Kiani excessive golden parachute payments in the event of a Change in Control.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">126.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">As well, the 2012 Agreement had been extremely tax inefficient, as only 21&#8208;23% of the after-tax value of the Change in Control payments actually accrued to Mr. Kiani, with 77&#8208;79% of it instead flowing to tax
                authorities. (MASI_0000005697.)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">22</sup><font style="font-size: 10pt;">&#160;</font>The 2015 changes reduced that tax inefficiency but delivered nearly all of the potential savings directly to Mr. Kiani, allowing him to</font></div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br>
              <div style="margin-top: 0px; margin-bottom: 3pt;">____________________<br>
              </div>
              <div>
                <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                </div>
                <div style="line-height: 15.95pt; margin-top: 4.05pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">22</font></sup> <font style="font-size: 14pt; font-family: Arial,Helvetica,sans-serif;">Mr. Kiani testified that &#8220;[f]or
                    every dollar I would get out of that change of control, the company would have to pay $9 in taxes.&#8221; (Kiani Tr. at 16:18-19.)</font></div>
              </div>
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">48</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: justify; line-height: 31.9pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;">capture money that, under the 2012 Agreement, was never going to end up in his pocket. As a result, upon signing the 2015
              Employment Agreement, the net payment due to Mr. Kiani upon a Change in Control increased from $81.5 million under the 2012 employment agreement to $160.0 million, a <font style="font-weight: bold; font-style: italic;">$78.5 million (96%)
                increase</font>.</div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">127.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Not only did the 2015 Employment Agreement deliver an additional $78.5 million in Change in Control compensation to Mr. Kiani, but, despite Masimo&#8217;s assertions to the contrary, it also failed to deliver material
                savings to the Company. In fact, in the most likely scenarios, it actually <font style="font-weight: bold; font-style: italic;">increased </font>the cost to the Company of a Change in Control by a significant amount. For example, under a
                Termination for Good Reason&#8212;now considerably more likely given the expanded definition&#8212;the potential cost to the Company under the 2015 Employment Agreement exceeded that under the 2012 Agreement by $29.0 million.</font></div>
            <div style="text-align: justify;"><br>
              <div>
                <table cellspacing="0" cellpadding="6" border="0" style="border-collapse: collapse; width: 98%; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; text-align: left;">

                    <tr>
                      <td style="width: 40%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                        <div style="font-size: 14pt; font-weight: bold;">Termination for Good Reason</div>
                      </td>
                      <td style="width: 20.33%; vertical-align: middle; text-align: center; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                        <div style="margin-right: 4.85pt; margin-left: 5pt; line-height: 16.1pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt; font-weight: bold;">2012</div>
                        <div style="margin-right: 4.75pt; margin-left: 5.25pt; line-height: 16.1pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt; font-weight: bold;">Agreement</div>
                      </td>
                      <td style="width: 20.31%; vertical-align: middle; text-align: center; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                        <div style="margin-right: 4.75pt; margin-left: 5pt; line-height: 16.1pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt; font-weight: bold;">2015</div>
                        <div style="margin-right: 4.7pt; margin-left: 5.25pt; line-height: 16.1pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt; font-weight: bold;">Agreement</div>
                      </td>
                      <td style="width: 20%; vertical-align: middle; text-align: center; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                        <div style="text-indent: 6.25pt; margin-right: 23pt; margin-left: 24.15pt; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt; font-weight: bold;">Increase </div>
                        <div style="text-indent: 6.25pt; margin-right: 23pt; margin-left: 24.15pt; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt; font-weight: bold;">(Decrease)</div>
                      </td>
                    </tr>
                    <tr>
                      <td style="width: 40%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                        <div style="margin-left: 5.35pt; line-height: 15.95pt; font-family: Arial, Helvetica, sans-serif; font-size: 14pt;">Payments to Mr. Kiani</div>
                      </td>
                      <td style="width: 20.33%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                        <div style="text-align: center; margin-right: 4.85pt; margin-left: 5.25pt; line-height: 15.95pt; font-family: Arial, Helvetica, sans-serif; font-size: 14pt;">$81.5 million</div>
                      </td>
                      <td style="width: 20.31%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                        <div style="text-align: center; margin-right: 4.75pt; margin-left: 5.25pt; line-height: 15.95pt; font-family: Arial, Helvetica, sans-serif; font-size: 14pt;">$160.0 million</div>
                      </td>
                      <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                        <div style="text-align: center; margin-right: 11.9pt; margin-left: 12.35pt; line-height: 15.95pt; font-family: Arial, Helvetica, sans-serif; font-size: 14pt; font-weight: bold;">$78.5 million</div>
                      </td>
                    </tr>
                    <tr>
                      <td style="width: 40%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                        <div style="margin-left: 5.35pt; line-height: 15.95pt; font-family: Arial, Helvetica, sans-serif; font-size: 14pt;">Taxes to Government</div>
                      </td>
                      <td style="width: 20.33%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                        <div style="text-align: center; margin-right: 4.85pt; margin-left: 5.25pt; line-height: 15.95pt; font-family: Arial, Helvetica, sans-serif; font-size: 14pt;">$49.5 million</div>
                      </td>
                      <td style="width: 20.31%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                        <div style="text-align: center; margin-left: 0.35pt; line-height: 15.95pt; font-family: Arial, Helvetica, sans-serif; font-size: 14pt;">0</div>
                      </td>
                      <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                        <div style="text-align: center; margin-right: 11.95pt; margin-left: 12.35pt; line-height: 15.95pt; font-family: Arial, Helvetica, sans-serif; font-size: 14pt;">($49.5) million</div>
                      </td>
                    </tr>
                    <tr>
                      <td style="width: 40%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
                        <div style="margin-left: 5.35pt; line-height: 15.95pt; font-family: Arial, Helvetica, sans-serif; font-size: 14pt;">Total Payments</div>
                      </td>
                      <td style="width: 20.33%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
                        <div style="text-align: center; margin-right: 4.85pt; margin-left: 5.25pt; line-height: 15.95pt; font-family: Arial, Helvetica, sans-serif; font-size: 14pt;">$131.0 million</div>
                      </td>
                      <td style="width: 20.31%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
                        <div style="text-align: center; margin-right: 4.75pt; margin-left: 5.25pt; line-height: 15.95pt; font-family: Arial, Helvetica, sans-serif; font-size: 14pt;">$160.0 million</div>
                      </td>
                      <td style="width: 20%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
                        <div style="text-align: center; margin-right: 11.9pt; margin-left: 12.35pt; line-height: 15.95pt; font-family: Arial, Helvetica, sans-serif; font-size: 14pt; font-weight: bold;">$29.0 million</div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
            <div style="text-align: justify; line-height: 31.9pt;"><font style="font-size: 14pt; font-family: Arial,Helvetica,sans-serif;"> <br>
              </font></div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">49</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="margin-left: 36pt; line-height: 15.95pt; margin-bottom: 12pt;"><font style="font-size: 14pt; font-weight: bold; font-style: italic;">4.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt; font-weight: bold; font-style: italic;">The First Amendment</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">128.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">In July 2017, the Board approved the First Amendment, which made the already-draconian and one-sided 2015 Employment Agreement materially worse, in three respects. (Exhibit D.)</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">129.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;"><font style="font-style: italic;">First</font>, it locked in the Special Payment forever. Less than <font style="font-weight: bold; font-style: italic;">six months </font>before the burn off was scheduled to
                begin, the First Amendment <font style="font-weight: bold; font-style: italic;">eliminated </font>the Burn-Off Provision entirely. Given that the Employment Agreement automatically extends each year, that change guaranteed that Mr. Kiani
                would receive the full amount of the Special Payment if <font style="font-style: italic;">either </font>a Change in Control or a termination by Mr. Kiani of his employment for Good Reason <font style="font-weight: bold; font-style: italic;">ever </font>were to occur. (<font style="font-style: italic;">Id. </font>&#182; 3.)</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">130.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;"><font style="font-style: italic;">Second</font>, it doubled the look-back period for a Change in Control, from 12 to <font style="font-weight: bold; font-style: italic;">24 months</font>, meaning that a change in <font style="font-weight: bold; font-style: italic;">two of five </font>members of Masimo&#8217;s Board over <font style="font-weight: bold; font-style: italic;">at least two, and easily three, </font>annual meetings would trigger a Change in
                Control. (<font style="font-style: italic;">Id. </font>&#182; 6.)</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">131.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;"><font style="font-style: italic;">Third</font>, it gave the DCCP a <font style="font-weight: bold; font-style: italic;">strict single-trigger</font>&#8212;that is, no further triggering event other than a change in more
                than one-third of the Board composition is required for Mr. Kiani to become <font style="font-weight: bold; font-style: italic;">unconditionally entitled </font>to receive the Special Payment.</font></div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">50</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">132.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">More specifically, the 2015 Employment Agreement had a modified single trigger for any Change in Control&#8212;Mr. Kiani either had to be terminated or choose to leave following a Change in Control in order to receive the
                Special Payment. The First Amendment created a strict single-trigger <font style="font-weight: bold; font-style: italic;">only </font>for the DCCP.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">23</sup><font style="font-size: 10pt;">&#160;</font>No other aspect of the Change in
                Control provision has a similar trigger.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">133.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">The 2017 Directors did not even attempt to mitigate against the worst aspects of the First Amendment, which made the DCCP both substantially more preclusive and coercive to stockholders and substantially more
                favorable to Mr. Kiani. For example, the 2017 Directors removed the Burn-Off Provision but did not negotiate a collar or some other mechanism to limit the amount Mr. Kiani would receive upon a Change in Control.</font></div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;">
              <div style="margin-top: 0px; margin-bottom: 3pt;">____________________<br>
              </div>
              <div>
                <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                </div>
                <div style="text-align: justify; line-height: 15.95pt; margin-top: 4.05pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">23</font></sup> The First Amendment achieved
                  this strict single trigger for the DCCP by separating the DCCP from other types of Change in Control in the definition of Good Reason, while also including new language in Section 8.4(iii)(3) that allowed Mr. Kiani to stay on at the
                  Company following any Change in Control (including a change in the composition of directors) and become unconditionally entitled to the Special Payment. Therefore, when it comes to payment under the DCCP, Mr. Kiani can stay or leave, and
                  there is no time limit on when he must decide.</div>
              </div>
            </div>
            <div style="text-align: justify; line-height: 15.95pt; margin-top: 6pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;">In order for Mr. Kiani to achieve favorable tax treatment for himself, the Frist Amendment provides that the
              payments will only transfer to Mr. Kiani when he actually departs the Company (whenever that might be), but his unconditional entitlement to them vests immediately upon the change in the Board composition.</div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">51</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="margin-left: 36pt; line-height: 15.95pt; margin-bottom: 12pt;"><font style="font-size: 14pt; font-weight: bold; font-style: italic;">5.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt; font-weight: bold; font-style: italic;">The Second Amendment</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">134.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">On January 14, 2022, the Current Directors approved the Second Amendment, which modified the Employment Agreement to provide that, among other things, the 2.7 million RSUs would vest upon Mr. Kiani&#8217;s death or
                disability. (Exhibit E, &#182; 1.)</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">135.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">At that time, the Board was actively evaluating a possible acquisition of Sound United, and the Current Directors were fully aware that a negative market reaction to the acquisition could render Masimo vulnerable to
                stockholder activism. Indeed, Mr. Cohen testified that while the Board was considering the Sound United acquisition, which was announced in February 2022, &#8220;[i]t was raised at the board meeting that if there&#8217;s an adverse negative impact on
                the share price, you may find that activists and/or strategics who want to take advantage of our depressed stock price show up.&#8221; (Cohen Tr. at 167:5-24.)</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">136.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Moreover, the sheer size of the Special Payment at the time of the Second Amendment was astronomical. For instance, if a Change in Control had occurred on December 31, 2021, Mr. Kiani would have been entitled to
                total payments worth approximately <font style="font-weight: bold; font-style: italic;">$913 million </font>(if he terminated his employment) or approximately <font style="font-weight: bold; font-style: italic;">$825 million </font>(if
                he remained Chairman and CEO).</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">52</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">137.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">By comparison, on December 31, 2021, Masimo&#8217;s market capitalization was approximately $16.2 billion and the Company&#8217;s revenue was approximately $1.2 billion. Thus, Mr. Kiani&#8217;s Good Reason termination payments, as of
                that date, equated to approximately <font style="font-weight: bold; font-style: italic;">5.65% </font>of Masimo&#8217;s market capitalization and approximately <font style="font-weight: bold; font-style: italic;">400% </font>of Masimo&#8217;s net
                income.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">138.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Those payments dwarf change in control payments at Masimo&#8217;s peer companies. As of December 31, 2021, relative to Masimo&#8217;s self-selected proxy peer group, the value of Mr. Kiani&#8217;s Good Reason termination payments are
                <font style="font-weight: bold; font-style: italic;">40.8 times </font>the peer group median and <font style="font-weight: bold; font-style: italic;">5.2 times </font>the second highest amount. Expressed as a percentage of company market
                capitalization, the payments are <font style="font-weight: bold; font-style: italic;">29.8 times </font>the peer group median and <font style="font-weight: bold; font-style: italic;">1.6 times </font>the second highest percentage of
                market capitalization. Finally, expressed as a percentage of company revenue, the payments are <font style="font-weight: bold; font-style: italic;">60.1 times </font>the peer group median and <font style="font-weight: bold; font-style: italic;">3.2 times </font>the second highest. No matter how viewed (as a dollar value, percentage of market capitalization, or percentage of revenue), Mr. Kiani&#8217;s Good Reason termination payments are at the 100th percentile of Masimo&#8217;s
                peer group.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">139.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">In fact, the payments were so astronomically high that Mr. Kiani feared an acquiring company would refuse to pay them and instead challenge their legality; therefore Mr. Kiani insisted the payments be structured to
                transfer instantly</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">53</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">upon a sale: &#8220;I was worried that the company that&#8217;s buying us would not honor the change of control. That&#8217;s why it had to be done during the actual moment when the change
              of control occurred. My memory is, Regina [Olshan, Mr. Kiani&#8217;s counsel,] came up with a clever idea of this rabbi trust idea, which I don&#8217;t quite understand, but the idea is that the money goes into that trust and then I get it whenever I
              leave, so this way I don&#8217;t have to fight with the new owner of Masimo.&#8221; (Kiani Tr. at 125:6-14.)</div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">140.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Remarkably, at a time when Masimo was vulnerable to activism and the amount of the Special Payment to Mr. Kiani upon a Change in Control approached <font style="font-weight: bold; font-style: italic;">$1 billion</font>,
                the Current Directors agreed to the Second Amendment adding additional triggers without seeking <font style="font-weight: bold; font-style: italic;">any </font>reduction in the amounts due upon a Change in Control (or consideration of any
                kind).</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">141.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Even worse, the Current Directors did so despite recognizing and appreciating the preclusive and entrenching nature of the DCCP. As Mr. Mikkelson testified, the risk of triggering the DCCP was a &#8220;<font style="font-weight: bold; font-style: italic;">very scary prospect </font>for me in that it&#8217;s a lot of shares and a lot of dollars&#8221; and that the DCCP acted as a &#8220;poison pill.&#8221; (Mikkelson Tr. at 62:19-24, 368:11-14 (emphasis added).)</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">54</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div>
              <div style="margin: 12pt 0px 12pt 27pt; line-height: normal; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt; font-weight: bold; text-indent: -27pt;">C.&#160;&#160; The Board Entrenches Itself With the Bylaw Amendments and the Employment
                Agreement After Politan Seeks to Engage on the Company&#8217;s Strategic Direction</div>
            </div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">142.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">On August 16, 2022, Politan publicly disclosed that it had made an investment in Masimo by filing a Schedule 13D with the SEC. Immediately before, and again shortly after, filing the Schedule 13D, Mr. Koffey
                requested a meeting with Mr. Kiani to begin constructively engaging with Masimo.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">143.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">After repeated requests, Mr. Kiani finally agreed to a meeting with Mr. Koffey on September 2, 2022. During that meeting, the parties discussed Masimo&#8217;s corporate governance, strategic initiatives, and financial
                performance. In addition, Mr. Koffey expressed Politan&#8217;s desire for representation on Masimo&#8217;s Board and made clear that Politan was approaching the situation with an open mind, would reserve judgment on any of Masimo&#8217;s strategic
                initiatives, and had a strong focus on return on invested capital in order to be a good steward of stockholder resources.</font></div>
            <div style="text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">144.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">At
                the conclusion of the meeting, Mr. Koffey requested that Mr. Kiani arrange for a follow-up meeting with Masimo&#8217;s entire Board (consisting of the four other directors). However, the Board refused to meet with Mr. Koffey.</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">55</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div>
              <div style="margin: 12pt 0px 12pt 81pt; line-height: normal; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt; font-style: italic; font-weight: bold; text-indent: -45pt;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Rather Than Engage With Politan, the Board
                Attempts to Entrench Itself by Amending Masimo&#8217;s Advance Notice Bylaws**Attempts to Entrench Itself by Amending Masimo&#8217;s Advance Notice Bylaws</div>
            </div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">145.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Instead of engaging with Politan in a constructive manner, the Board sought to entrench itself in office by making it all but impossible for Politan to nominate candidates for election to the Board.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">146.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">On September 7, 2022&#8212;less than a month after Politan filed its Schedule 13D and only <font style="font-weight: bold; font-style: italic;">three business days </font>after the meeting between Mr. Koffey and Mr.
                Kiani&#8212;the Board adopted and approved, effective September 9, 2022, certain amendments to the advance notice provisions in Masimo&#8217;s bylaws, and did so without consulting a single advisor other than their corporate law firm. That same day,
                the Board also adopted a poison pill, on which the Board did consult with a financial advisor.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">147.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">The timing and content of the Bylaw Amendments made clear that they were adopted for the express purpose of preventing Politan, or any other investment fund stockholder, from nominating a dissident slate of
                directors for election to the Board.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt; font-weight: bold; font-style: italic;">148.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Indeed, Mr. Mikkelson has <font style="font-style: italic;">admitted </font>that Politan expressing a desire for &#8220;two board seats,&#8221; which would potentially trigger the DCCP, was &#8220;<font style="font-weight: bold; font-style: italic;">one of the biggest pieces why that risk-reward balance for me was finally tipped in</font></font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">56</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: justify; line-height: 20.5pt;"><font style="font-size: 14pt; font-weight: bold; font-style: italic;">favor of adopting those bylaws, despite me believing there was&#8212;that they were difficult to comply with, but not
                impossible.</font><font style="font-size: 14pt;">&#8221; (Mikkelson Tr. at 62:19-63:6 (emphasis added).)</font><a href="#_bookmark47">24</a></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">149.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Notably, aside from Mr. Kiani, no member of the Current Board ever met with Politan. Instead, they relied entirely on Mr. Kiani&#8217;s judgment, never considering that it would be in Mr. Kiani&#8217;s self-interest to
                characterize Politan as a threat. In other words, if Mr. Kiani could convince the Board that Politan had threatened a proxy contest at the September 2<font style="font-size: 10pt;">nd </font>meeting rather than, as it did, requested that
                the Board consent to the addition of two director nominees, the Employment Agreement would preclude the Board from pre-approving Mr. Koffey and thereby disabling the DCCP.</font></div>
            <div style="text-align: justify; line-height: 34.8pt;">
              <div style="margin: 12pt 0px 12pt 36pt; line-height: normal; text-align: left;"><font style="font-size: 14pt; font-weight: bold; font-style: italic;">2.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt; font-weight: bold; font-style: italic;">The Board Refuses to Take Action to Disable the DCCP</font></div>
              <font style="font-size: 14pt; font-family: Arial,Helvetica,sans-serif;"> </font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">150.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Following the adoption of the Bylaw Amendments, on October 17, 2022, Politan requested that the Board agree to disable the DCCP to permit Masimo&#8217;s stockholders to elect Politan&#8217;s nominees to the Board without
                triggering massive payments to Mr. Kiani. (Exhibit F.) Politan noted that &#8220;[t]riggering this</font></div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;">
              <div style="margin-top: 0px; margin-bottom: 3pt;">____________________<br>
              </div>
              <div>
                <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                </div>
                <div style="text-align: justify; line-height: 15.95pt; margin-top: 4.05pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">24</font></sup> Mr. Mikkelson further
                  explained: &#8220;Why would they [Politan] want two board seats knowing the change-in-control provision existed, and that, I guess, was the most&#8212;was the overarching concern that, for me, dominated it&#8230;&#8221; (Mikkelson Tr. at 73:12-16.)</div>
              </div>
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">57</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">change of control provision would result in financially disastrous consequences for the Company and its stockholders&#8221; and requested that the Board &#8220;confirm that it would
              take all actions necessary or required to waive, terminate or amend the change of control provision in [Mr. Kiani&#8217;s Employment Agreement]&#8230;.&#8221; (<font style="font-style: italic;">Id.</font>)</div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">151.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">On October 19, 2022, the Board refused to do so. It claimed, through counsel that represented both the Outside Directors <font style="font-weight: bold; font-style: italic;">and </font>Mr. Kiani, that the
                Employment Agreement was the product of &#8220;extensive arms-length negotiations between representatives of Masimo&#8217;s independent directors and Mr. Kiani&#8221; and that &#8220;[a]s a contractual right, any waiver, termination or amendment to the change of
                control provisions cannot be effected unilaterally by the independent directors.&#8221; (Exhibit G.)</font></div>
            <div style="text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">152.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Notably,











                in response to Politan&#8217;s request, the Board did not: (i) meet to discuss the request, either before the litigation was commenced or during the four months following the request, (ii) consider forming a special committee or retaining
                separate, independent counsel to advise it on this matter, (iii) consider whether it could avoid triggering the DCCP by expanding the Board and appointing two Politan nominees when Politan first requested representation at the September 2,
                2022 meeting, (iv) explore the possibility of amending the Employment</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">58</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="line-height: 31.9pt; font-size: 14pt;">Agreement, (v) treat the DCCP as the void provision that it is, or (vi) request that Mr. Kiani agree to waive the DCCP.</div>
            <div style="line-height: 31.9pt; font-size: 14pt;">
              <div style="margin: 12pt 0px 12pt 81pt; line-height: normal; font-family: Arial, Helvetica, 'sans-serif'; font-style: italic; font-weight: bold; text-indent: -45pt;"><font style="font-weight: bold; font-style: italic;">3.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt"> </font><font style="font-weight: bold; font-style: italic;">Defendants Concede That the Third Amended Bylaws Were Preclusive By
                  Amending Them Yet Again</font></div>
            </div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 20.5pt;"><font style="font-size: 14pt;">153.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">After the Board adopted the Bylaw Amendments, Masimo faced a flood of criticism from commentators, academics, and even the activist defense bar.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">25</sup></font>&#160;<font style="font-size: 14pt;">Bowing slightly to
                that criticism, on December 1, 2022, the Board again amended Masimo&#8217;s Bylaws by adopting the Fourth Amended Bylaws.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">26</sup></font></div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;">
              <div style="margin-top: 0px; margin-bottom: 3pt;">____________________<br>
              </div>
              <div>
                <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                </div>
                <div style="line-height: normal; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">25</font></sup> Bylaw Amendments, Shareholder Activism, and Flying Close to the
                  Sun, SIDLEY AUSTIN, (Nov. 18, 2022), https://www.sidley.com/en/insights/newsupdates/2022/11/bylaw-amendments- shareholder-activism-and-flying-close-to-the-sun; Liz Hoffman, A fight for the boardroomofAmerica,SEMAFOR(Nov.3,2022),
                  semafor.com/article/11/03/2022/inside-a-new-corporate-move-that-turns-the-tables-on-activist-investors; Svea Herbst-Bayliss, Law firm Sidley warns clients aboutrulesthatmayhinderactivists,REUTERS,(Nov.18,2022),
                  https://www.reuters.com/legal/law-firm-sidley-warns-clients-about-rules-that-may-hinder-activists-2022-11-18/; Matt Levine, Credit Suisse Gives First Boston a SecondChance,BLOOMBERG,(Oct.27,2022),
                  https://www.bloomberg.com/opinion/articles/2022-10-27/credit-suisse-gives-first-boston-gets-a-second-chance.</div>
              </div>
            </div>
            <div style="line-height: 7.4pt; margin-top: 0.3pt;">
              <div style="line-height: 13.7pt; font-size: 14pt;"><br style="line-height: 13.7pt;">
              </div>
              <div style="line-height: normal; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">25</font></sup> The Fourth Amended Bylaws were similarly criticized for their &#8220;chilling
                effect&#8221; on the stockholder franchise. See, e.g., Press Release, Managed Funds Association, MFA Submits Amicus Curiae Brief Advocating For Shareholders&#8217; Rights In Corporate Elections, (Feb. 2, 2023),
                https://www.managedfunds.org/press-releases/mfa-submits-amicus-curiae-brief-advocating-for-shareholders-rights-in-corporate-elections/</div>
              <div class="BRPFPageFooter" style="font-size: 14pt;">
                <div style="line-height: 13.7pt;"><br style="line-height: 13.7pt;">
                </div>
              </div>
            </div>
          </div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div class="BRPFPageFooter"></div>
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">59</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            <div class="BRPFPageHeader"></div>
          </div>
          <div> <br>
          </div>
          <div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">154.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">While the Fourth Amended Bylaws presumably were intended to make the Board <font style="font-style: italic;">appear </font>more reasonable, they did little to ameliorate the most egregiously preclusive and
                inequitable elements of the Third Amended Bylaws.</font></div>
            <div>
              <div style="margin: 12pt 0px 12pt 27pt; font-family: Arial,Helvetica,'sans-serif'; font-size: 14pt; font-weight: bold; text-indent: -27pt;">D.&#160;&#160; Defendants Rescind the Bylaws and Adopt the Limited DCCP Waiver in a Desperate Attempt to Protect
                the Employment Agreement D</div>
            </div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">155.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">On February 3, 2023, the Court denied in part and deferred in part the Current Directors&#8217; partial motion to dismiss Politan&#8217;s claim challenging the Employment Agreement. Within two days, the Board amended Masimo&#8217;s
                bylaws yet again.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">156.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">On February 5, 2023, in an implicit admission that they cared more about Mr. Kiani&#8217;s Employment Agreement than they did about any stated desire for greater &#8220;transparency,&#8221; the Board adopted the Fifth Amended Bylaws,
                which rescinded the Bylaw Amendments in their entirety.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">157.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Defendants&#8217; counsel claimed that the Board rescinded the Bylaw Amendments because it &#8220;wanted to remove any question as to whether it was trying, for entrenchment purposes or otherwise, to preclude a fair proxy
                contest.&#8221; (Feb. 6, 2023 Hearing Tr. at 4:3-6.) In fact, Defendants were desperate to buy time to try to save Mr. Kiani&#8217;s Employment Agreement, so they decided to sacrifice the Bylaw Amendments they had so vociferously defended and propose
                the Limited DCCP Waiver. (Exhibit H.) Pursuant thereto, Mr. Kiani would waive application of the</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">60</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">DCCP as to all stockholders for Masimo&#8217;s 2023 annual meeting <font style="font-weight: bold; font-style: italic;">only </font>if the trial scheduled to commence on
              February 14, 2023 was adjourned until September 2023. (<font style="font-style: italic;">Id.</font>)</div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">158.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">Defendants&#8217; reason for seeking to delay the trial was obvious&#8212; they were convinced that that if the trial went forward as scheduled, the Court would invalidate the DCCP. Indeed, Defendants&#8217; counsel acknowledged
                that, if the issue of the DCCP&#8217;s facial invalidity were submitted to the Court for resolution as a matter of law, Defendants were likely to lose.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">159.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 14pt;">The Limited DCCP Waiver, however, only serves to underscore the unavoidable conclusion that the DCCP is invalid. The unsigned form of waiver submitted by Defendants states that:</font></div>
            <div style="text-align: justify; margin-right: 94.65pt; margin-left: 132pt; line-height: 15.95pt; font-size: 14pt;">The undersigned agrees and acknowledges that the valid election to the Board at the 2023 annual meeting of stockholders of any
              two individuals nominated by Company stockholders (the &#8220;Exception Directors&#8221;) in lieu of two of the Company&#8217;s current Directors will not be deemed to constitute a Change in Control for purposes of Section 9(iii) of the Agreement.</div>
            <div style="text-align: justify; margin-right: 94.65pt; margin-left: 132pt; line-height: 15.95pt; font-size: 14pt;"> <br>
            </div>
            <div style="text-align: justify; margin-right: 94.65pt; margin-left: 132pt; line-height: 15.95pt; font-size: 14pt;">
              <div style="line-height: 0pt;"><br style="line-height: 0pt;">
              </div>
              <div style="line-height: 15.95pt; margin-top: 4.45pt; font-family: Arial,Helvetica,sans-serif;">For the avoidance of doubt, for purposes of determining whether a Change in Control has occurred in respect of any other or subsequent event,
                including election of stockholder-nominated individuals at the 2024 annual meeting, the Exception Directors will not be considered directors who were members of the Board at the beginning of the 24 month period immediately preceding such
                event.</div>
            </div>
          </div>
        </div>
        <div><font style="font-size: 14pt;"> <br>
          </font></div>
        <div>
          <div style="line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt; font-style: italic;">(Id.)</div>
          <div><br>
          </div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div class="BRPFPageFooter"></div>
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">61</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            <div class="BRPFPageHeader"></div>
          </div>
          <div> <br>
          </div>
          <div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">160.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">As described, pursuant to Section 9(iii) of the Employment Agreement, as amended, to avoid triggering the DCCP, a new director must be &#8220;approved by a vote of at least a majority of the directors then in office
                either who were directors at the beginning of such [24-month] period or whose election or nomination for election was previously so approved.&#8221; However, because the Limited DCCP Waiver does not treat Exception Directors as directors who were
                members of the Board at the beginning of the 24-month period preceding the election or appointment of a new director, the Exception Directors are not permitted to vote to approve any such new director.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">161.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Thus, in violation of Delaware statutory law and Masimo&#8217;s Bylaws, the Limited DCCP Waiver creates two separate classes of directors, with different voting rights: (i) the continuing directors, who have the authority
                to approve new directors under the DCCP (provided that the candidates did not assume office pursuant to an actual or threatened proxy contest), and (ii) the Exception Directors, who lack such authority.</font></div>
            <div style="text-align: center; line-height: 15.95pt; margin-top: 12pt; margin-bottom: 12pt; font-size: 14pt; font-weight: bold;"><u>STANDARD OF REVIEW</u></div>
            <div style="text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">162.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">To
                the extent the conduct and acts challenged herein are void, <font style="font-style: italic;">ultra vires </font>and/or constitute waste, the business judgment rule has no application.</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">62</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">163.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">As set forth above, the Board approved the Employment Agreement (containing the Special Payment, the DCCP, the Single Trigger, the Chairman Provision, the Lead Independent Director Provision, the Automatic Renewal
                Provision, and the Unanimous Termination Provision), subsequently refused to disable the DCCP, and adopted the Limited DCCP Waiver for the sole or primary purpose of coercing Masimo&#8217;s stockholders into supporting the incumbent Board and
                thereby interfering with and impeding the effective exercise of the stockholder franchise.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">164.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Accordingly, the Board&#8217;s adoption and maintenance of the Employment Agreement, refusal to disable the DCCP, and adoption of the Limited DCCP Waiver is &#8220;presumptively inequitable and will be invalidated, unless the
                directors are able to rebut that presumption by showing a compelling justification for their actions.&#8221; <font style="font-style: italic;">Hubbard v. Hollywood Park Realty Enters., Inc</font>., 1991 WL 3151, at *8 (Del. Ch. Jan. 14, 1991)
                (citing <font style="font-style: italic;">Blasius Indus., Inc. v. Atlas Corp.</font>, 564 A.2d 651 (Del. Ch. 1988)).</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt; font-style: italic;">165.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">The Board cannot make any such showing. Moreover, regardless of whether the <font style="font-style: italic;">Blasius </font>standard applies here, the Employment Agreement operates as a &#8220;defensive measure[] in
                response to a perceived threat to corporate policy and effectiveness which touches upon issues of control.&#8221; <font style="font-style: italic;">Unitrin, Inc. v. Am. Gen.</font></font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">63</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;"><font style="font-style: italic;">Corp</font>., 651 A.2d 1361, 1372 n.9 (Del. 1995). Thus, with respect to each defensive measure now in place, whether in isolation or in
              combination, the Director Defendants &#8220;bear the burden of proving (i) that their motivations were proper and not selfish, (ii) that they did not preclude stockholders from exercising their right to vote or coerce them into voting a particular
              way, and (iii) that the directors&#8217; actions were reasonable in relation to their legitimate objective.&#8221; <font style="font-style: italic;">Pell v. Kill, </font>135 A.3d 764, 787 (Del. Ch. 2016) (citing <font style="font-style: italic;">Unocal










                Corp. v. Mesa Petroleum Co., </font>493 A.2d 946 (Del. 1985)).</div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt; font-style: italic;">166.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">The Board&#8217;s actions are also invalid under <font style="font-style: italic;">Schnell v. Chris-Craft Indus., Inc.</font>, 285 A.2d 437, 439 (Del. 1971). <font style="font-style: italic;">Schnell </font>recognizes
                that any attempt to &#8220;utilize the corporate machinery and the Delaware Law for the purpose of perpetuating [oneself] in office&#8221; by &#8220;obstructing the legitimate efforts of dissident stockholders in the exercise of their rights to undertake a
                proxy contest&#8221; must be denied because those are &#8220;inequitable purposes, contrary to established principles of corporate democracy.&#8221; <font style="font-style: italic;">Id.</font></font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">167.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">In all events, the Board unlawfully abdicated its fiduciary duties by effectively placing control over the nomination and election of directors in the hands of Mr. Kiani. <font style="font-style: italic;">Grimes v.
                  Donald</font>, 1995 WL 54441, at *7 (Del. Ch. Jan. 11, 1995), <font style="font-style: italic;">aff&#8217;d</font>, 673 A.2d 1207 (Del. 1996).</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">64</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="line-height: 0pt;"><br style="line-height: 0pt;">
            </div>
            <div style="text-align: center; line-height: 15.95pt; margin-top: 12pt; margin-bottom: 12pt; font-size: 14pt; font-weight: bold;"><u>DEMAND FUTILITY ALLEGATIONS</u></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">168.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">All of the claims asserted herein are direct claims because they seek redress for injury to the stockholder franchise arising from Defendants&#8217; interference with stockholders&#8217; right to nominate directors to the Board
                and improper entrenchment of the Board. Further, Plaintiffs allege that the DCCP and the Limited DCCP Waiver violate the DGCL as well as public policy and that the Board abdicated its non-delegable duty to manage the business and affairs of
                the Company by entering into and maintaining the Employment Agreement. Those claims are direct.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">169.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">If and to the extent that any of Plaintiffs&#8217; claims are not, in whole or in part, direct claims, Plaintiffs bring such claims derivatively in the right and for the benefit of Masimo.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">170.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">CalSTRS was a stockholder of Masimo at the time of all the wrongdoing described herein, has continually been a stockholder since such times, and is currently a stockholder.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">171.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Plaintiffs have not made a demand on Masimo&#8217;s Board to institute any action relating hereto because such a demand would be futile. Demand would be futile because, at a minimum, there exists a reasonable doubt about
                whether</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">65</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="line-height: 31.9pt; font-size: 14pt;">a majority of Masimo&#8217;s Board is sufficiently disinterested and independent to objectively consider a demand.</div>
            <div style="text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">172.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">As
                alleged herein, demand is excused with respect to any claims that could be brought derivatively because:</font></div>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z766cac95f7a04bf586c4b7112497ca3a">

                <tr>
                  <td style="width: 132pt;"><br>
                  </td>
                  <td style="width: 35.95pt; vertical-align: top; font-size: 14pt;">&#8226;</td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="font-size: 14pt;">The Current Directors have acted for the primary purpose of entrenching themselves in office;</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 11.85pt;" class="DSPFListTable" id="z34125d2b97d34d768ec7e9af45b7bb5a">

                <tr>
                  <td style="width: 132pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top; font-size: 14pt;">&#8226;</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div style="font-size: 14pt;">The Current Directors are interested in maintaining their Board seats and therefore are interested in maintaining the Employment Agreement as a defensive measure;</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;" class="DSPFListTable" id="z2cf93dfa4d4341f2a73a97e171909024">

                <tr>
                  <td style="width: 132pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top; font-size: 14pt;">&#8226;</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div style="font-size: 14pt;">The challenged Employment Agreement contains such egregious terms that it could not have been the product of a valid, good faith exercise of business judgment; and</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 11.95pt;" class="DSPFListTable" id="z2ea10080f1354177a12c010e4df9dfff">

                <tr>
                  <td style="width: 132pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top; font-size: 14pt;">&#8226;</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div style="font-size: 14pt;">The Current Directors face a substantial likelihood of personal liability for the claims asserted herein.</div>
                  </td>
                </tr>

            </table>
            <div style="text-align: center; line-height: 15.95pt; margin-top: 12pt; margin-bottom: 12pt; font-size: 14pt; font-weight: bold;"><u>COUNT I</u><br>
              (Declaratory Judgment &#8211; The Employment Agreement is Not Enforceable)</div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">173.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Plaintiffs repeat and reallege the preceding paragraphs as if fully set forth herein.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">174.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">The Employment Agreement&#8217;s purpose is to alter the intra- governance powers of the directors improperly and inequitably (in favor of Mr. Kiani and the incumbent Board) and to alter the intra-governance franchise
                rights of the stockholders. To accomplish this illegal end, the Employment Agreement includes the following &#8220;Invalid Provisions:&#8221;</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">66</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="line-height: 0pt;"><br style="line-height: 0pt;">
            </div>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 3pt;" class="DSPFListTable" id="z124f017d8f51423faef4851e5b8a6799">

                <tr>
                  <td style="width: 132pt;"><br>
                  </td>
                  <td style="width: 35.95pt; vertical-align: top; font-size: 14pt;">a.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="font-size: 14pt;">the Special Payment;</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;" class="DSPFListTable" id="ze5ca28af5e2d4433a3134b792825b4f5">

                <tr>
                  <td style="width: 132pt;"><br>
                  </td>
                  <td style="width: 35.95pt; vertical-align: top; font-size: 14pt;">b.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="font-size: 14pt;">the DCCP;</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 11.95pt;" class="DSPFListTable" id="z839e4d6fef334511bb494df3c0b699b2">

                <tr>
                  <td style="width: 132pt;"><br>
                  </td>
                  <td style="width: 35.95pt; vertical-align: top; font-size: 14pt;">c.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="font-size: 14pt;">the Single Trigger;</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;" class="DSPFListTable" id="z2b7134a83023438084d65ce3623da084">

                <tr>
                  <td style="width: 132pt;"><br>
                  </td>
                  <td style="width: 35.95pt; vertical-align: top; font-size: 14pt;">d.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="font-size: 14pt;">the Dead Hand Provision;</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12.1pt;" class="DSPFListTable" id="z12e903047ef34054868315422b350363">

                <tr>
                  <td style="width: 132pt;"><br>
                  </td>
                  <td style="width: 35.95pt; vertical-align: top; font-size: 14pt;">e.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="font-size: 14pt;">the Chairman Provision;</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;" class="DSPFListTable" id="z8ad6efbfffea45fda964515f58e00147">

                <tr>
                  <td style="width: 132pt;"><br>
                  </td>
                  <td style="width: 35.95pt; vertical-align: top; font-size: 14pt;">f.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="font-size: 14pt;">the Lead Independent Director Provision;</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 11.95pt;" class="DSPFListTable" id="z2630694fe7c04dd9b6f7f360774c878d">

                <tr>
                  <td style="width: 132pt;"><br>
                  </td>
                  <td style="width: 35.95pt; vertical-align: top; font-size: 14pt;">g.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="font-size: 14pt;">the Automatic Renewal Provision; and</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt; margin-top: 12pt;" class="DSPFListTable" id="zf2460fdeed3c48e9a36553b34ca83ffb">

                <tr>
                  <td style="width: 131.75pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top; font-size: 14pt;">h.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="font-size: 14pt;">the Unanimous Termination Provision.</div>
                  </td>
                </tr>

            </table>
            <div style="text-align: justify; text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">175.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">The Invalid Provisions are integral to the Employment Agreement and are not severable.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">176.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">For all the reasons alleged herein, the effect of the Employment Agreement is to strip the Board of its power to such a degree that the result is a complete abdication of the Board&#8217;s statutory and fiduciary duties
                to manage in the best interests of the Company and its stockholders. In addition, the Employment Agreement imposes, without justification, unreasonable and inequitable burdens on the stockholders&#8217; franchise with the intent to entrench Mr.
                Kiani and keep his chosen board in perpetual control of the Company. Accordingly, the Employment Agreement is void <font style="font-style: italic;">ab initio, ultra vires</font>, and/or constitutes waste, and should be declared of no
                force and effect. In the alternative, the Employment Agreement is</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">67</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">voidable as a product of breaches of fiduciary duty and should be declared of no force and effect.</div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">177.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Solely in the alternative, to the extent the Employment Agreement is not set aside in its entirety, but one or more of the Invalid Provisions is found to be void <font style="font-style: italic;">ab initio, ultra
                  vires</font>, waste or otherwise voidable as a product of breach of fiduciary duty, such Invalid Provisions should be severed from the Employment Agreement and declared of no force and effect.</font></div>
            <div style="text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">178.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Equitable










                defenses, including laches, are inapplicable.</font></div>
            <div style="text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">179.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Plaintiffs










                have no adequate remedy at law.</font></div>
            <div style="text-align: center; line-height: 15.95pt; margin-top: 12pt; margin-bottom: 12pt; font-size: 14pt; font-weight: bold;"><u>COUNT II</u><br>
              (Declaratory Judgment &#8211; Limited DCCP Waiver)</div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">180.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Plaintiffs repeat and reallege the preceding paragraphs as if fully set forth herein.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">181.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">The Limited DCCP Waiver is void <font style="font-style: italic;">ab initio, ultra vires</font>, and waste and/or voidable as a product of breach of fiduciary duty and should be declared of no force and effect. If
                given effect, the Limited DCCP Waiver would create different classes of directors that are not authorized under Masimo&#8217;s certificate of incorporation, and thus violates Section 141(d) of the DGCL. In addition, the Limited DCCP Waiver
                imposes, without justification, unreasonable and inequitable</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">68</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">burdens on the stockholders&#8217; franchise with the intent to entrench Mr. Kiani and keep his chosen board in perpetual control of the Company.</div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">182.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Specifically, pursuant to Section 9(iii) of the Employment Agreement, to avoid triggering the DCCP, and thus the Special Payment to Mr. Kiani, new directors to Masimo&#8217;s Board must be &#8220;approved by a vote of at least
                a majority of the directors then in office either who were directors at the beginning of such [24 month] period or whose election or nomination for election was previously so approved.&#8221; As alleged herein, the ability to declare a new
                director as a continuing director is disabled via the Dead Hand Provision if the new director comes to the Board via an actual or threatened proxy contest.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">183.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">The Limited DCCP Waiver purports to sidestep the Dead Hand Provision for any new directors seated to Masimo&#8217;s Board at the 2023 annual meeting. In particular, the Limited DCCP Waiver provides that &#8220;for purposes of
                determining whether a Change in Control has occurred in respect of any other or subsequent event, including election of stockholder-nominated individuals at the 2024 annual meeting, the Exception Directors will not be considered directors
                who were members of the Board at the beginning of the 24-month period immediately preceding such event.&#8221;</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">69</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">184.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Thus, if given effect, the Limited DCCP Waiver will exacerbate the Employment Agreement&#8217;s ongoing impediment to the franchise by creating two separate classes of directors, with different voting rights: (i) the
                continuing directors (<font style="font-style: italic;">i.e.</font>, Mr. Kiani&#8217;s selected directors) who will have the authority to approve new directors under the DCCP, and (ii) the Exception Directors (<font style="font-style: italic;">i.e</font>.,










                any new director elected at 2023 annual meeting), who lack such authority. Simply put, because the Limited DCCP Waiver does not treat Exception Directors as directors who were members of the Board at the beginning of the 24-month period
                preceding the election or appointment of a new director, the Exception Directors are not permitted to vote to approve any such new director for at least 24-months, a period that may well run over the course of three election cycles.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">185.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">The restriction in the Limited DCCP Waiver on the Exception Directors&#8217; authority to vote to approve new directors is void <font style="font-style: italic;">ab initio, ultra vires</font>, and waste, and it should be
                declared of no force and effect. In the alternative, that restriction is voidable and should be declared of no force and effect as a product of breach of fiduciary duty.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">186.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Plaintiffs have no adequate remedy at law.</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">70</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="line-height: 0pt;"><br style="line-height: 0pt;">
            </div>
            <div style="text-align: center; line-height: 15.95pt; margin-top: 12pt; margin-bottom: 12pt; font-size: 14pt; font-weight: bold;"><u>COUNT III</u><br>
              (Breach of Fiduciary Duties Against the 2015 Directors)</div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">187.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Plaintiffs repeat and reallege the preceding paragraphs as if fully set forth herein.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">188.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">The 2015 Directors owed Masimo&#8217;s stockholders the uncompromising fiduciary duties of care and loyalty, which preclude them from abdicating their statutory and fiduciary duties to the Company and its stockholders,
                erecting inequitable barriers to the free exercise of the franchise, taking any action to favor their own interests over the interests of Masimo and its stockholders, and/or committing waste.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">189.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">In breach of their fiduciary duties, the 2015 Directors approved the 2015 Employment Agreement, which, through the Invalid Provisions, improperly and inequitably alters the intra-governance powers of the directors
                (in favor of Mr. Kiani and the incumbent Board) and the franchise rights of Masimo&#8217;s stockholders. As alleged herein, the initial and ongoing effect of the 2015 Employment Agreement <font style="font-style: italic;">in toto </font>or
                through operation of one or more of the Invalid Provisions is to strip the then- and current Board of its power to such a degree that the result is a complete abdication of any Masimo Board&#8217;s statutory and fiduciary duties to manage the
                Company in the best interests of the Company and its stockholders.</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">71</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">190.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">In addition, the 2015 Employment Agreement either <font style="font-style: italic;">in toto </font>or through operation of one or more of the Invalid Provisions imposed, and continues to impose, without
                justification, unreasonable and inequitable burdens on the stockholders&#8217; franchise with the intent to entrench Mr. Kiani and keep his chosen board in perpetual control of the Company. Given the illegal and improper impediment on the
                franchise the 2015 Employment Agreement causes, and its concomitant entrenchment effect, the 2015 Directors were self-interested in the adoption of the Employment Agreement and its Invalid Provisions.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">191.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">The Company did not receive fair consideration for the 2015 Employment Agreement, and in approving it, the 2015 Directors ignored the obvious risks to the Company and the stockholders that the 2015 Employment
                Agreement created. Regardless, the Board&#8217;s desire to retain Mr. Kiani did not justify adopting the panoply of Invalid Provisions contained in the 2015 Employment Agreement, which impose an uncapped tax on the stockholder franchise and exert
                dead hand control over the actions of <font style="font-style: italic;">all </font>future Boards. The right to nominate and elect directors who may oppose Mr. Kiani&#8217;s wishes is a fundamental right that belongs exclusively to Masimo&#8217;s
                stockholders. The Board breached its fiduciary duties by bartering away that right based on a thinly veiled excuse that it was necessary to do so to retain Mr. Kiani as Masimo&#8217;s CEO and Chairman.</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">72</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">192.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">To the extent the 2015 Employment Agreement or one or more of the Invalid Provisions is void <font style="font-style: italic;">ab initio</font>, <font style="font-style: italic;">ultra vires </font>and/or
                constitutes waste, no limitations period applies. Because Masimo failed to disclose material facts and circumstances concerning the 2015 Directors&#8217; adoption of the 2015 Employment Agreement, any limitations period that would otherwise apply
                is equitably tolled.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">193.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Plaintiffs are entitled to a declaration that the 2015 Directors breached their fiduciary duties in connection with the implementation of the 2015 Employment Agreement, the Invalid Provisions, and their ongoing
                illegal and inequitable effects, and are entitled to all equitable and just relief required to remedy those breaches of fiduciary duty.</font></div>
            <div style="text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">194.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Plaintiffs










                have no adequate remedy at law.</font></div>
            <div style="line-height: 15.4pt; margin-top: 0.55pt;"><br style="line-height: 15.4pt;">
            </div>
            <div style="text-align: center; line-height: 15.95pt; margin-top: 12pt; margin-bottom: 12pt; font-size: 14pt; font-weight: bold;"><u>COUNT IV</u><br>
              (Breach of Fiduciary Duties Against the 2017 Directors)</div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">195.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Plaintiffs repeat and reallege the preceding paragraphs as if fully set forth herein.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">196.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">The 2017 Directors owed Masimo&#8217;s stockholders the uncompromising fiduciary duties of care and loyalty, which preclude them from abdicating their statutory and fiduciary duties to the Company and its stockholders,
                erecting inequitable barriers to the free exercise of the franchise, taking any action</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">73</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">to favor their own interests over the interests of Masimo and its stockholders, and/or committing waste.</div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">197.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">In breach of their fiduciary duties, the 2017 Directors determined to maintain the 2015 Employment Agreement&#8217;s improper and inequitable effect on the intra-governance powers of the directors (in favor of Mr. Kiani
                and the incumbent Board) and the franchise rights of the stockholders. Then, the 2017 Directors doubled down on their breaches of fiduciary duties by approving the First Amendment to the 2015 Employment Agreement.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">198.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">The First Amendment made the DCCP substantially more preclusive and coercive by (i) removing the Burn-Off Provision, which would have reduced the RSUs and cash payment by ten percent per year, (ii) doubling the
                look- back period in the DCCP from 12 months to 24 months, and (iii) establishing the strict Single Trigger by eliminating the requirement that Mr. Kiani terminate his employment to receive the Special Payment.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">199.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">The Company did not receive fair consideration when the 2017 Directors determined to maintain the 2015 Employment Agreement with the Invalid Provisions intact while also agreeing to adopt the First Amendment. In
                doing so, the 2017 Directors ignored obvious risks to the Company and the Stockholders that the 2015 Employment Agreement created. Regardless, the Board&#8217;s desire to retain Mr.</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">74</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">Kiani did not justify maintaining the panoply of Invalid Provisions contained in the 2015 Employment Agreement, while simultaneously amending the DCCP to make it
              substantially more preclusive and coercive.</div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">200.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">To the extent the 2015 Employment Agreement or one or more of the Invalid Provisions is void <font style="font-style: italic;">ab initio</font>, <font style="font-style: italic;">ultra vires </font>and/or
                constitutes waste, no limitations period applies. Because Masimo failed to disclose material facts and circumstances concerning the 2015 Directors&#8217; adoption of the 2015 Employment Agreement, any limitations period that would otherwise apply
                is equitably tolled.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">201.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Plaintiffs are entitled to a declaration that the 2017 Directors breached their fiduciary duties in connection with their ongoing assent to the maintenance of the 2015 Employment Agreement, and the Invalid
                Provisions, and their ongoing illegal and inequitable effects. Plaintiffs are further entitled to a declaration that the 2017 Directors breached their fiduciary duties in connection their approval of the First Amendment. Plaintiffs are
                entitled to all equitable and just relief required to remedy those breaches of fiduciary duty.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">202.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Plaintiffs have no adequate remedy at law.</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">75</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="line-height: 0pt;"><br style="line-height: 0pt;">
            </div>
            <div style="text-align: center; margin-right: 30.9pt; margin-left: 31.8pt; line-height: 15.95pt; margin-top: 3pt; font-size: 14pt; font-weight: bold;"><u>COUNT V</u></div>
            <div style="text-align: center; margin-right: 112.8pt; margin-left: 113.85pt; line-height: 15.95pt; font-size: 14pt; font-weight: bold;">(Breach of Fiduciary Duties Against the Current Directors &#8211; Continued Maintenance of the Employment
              Agreement and Adoption of the Second Amendment)</div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">203.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Plaintiffs repeat and reallege the preceding paragraphs as if fully set forth herein.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">204.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">The Current Directors owe Masimo&#8217;s stockholders the uncompromising fiduciary duties of care and loyalty, which preclude them from abdicating their statutory and fiduciary duties to the Company and its stockholders,
                erecting inequitable barriers to the free exercise of the franchise, taking any action to favor their own interests over the interests of Masimo and its stockholders, and/or committing waste.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">205.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">In early 2022, the Current Directors determined to amend the 2015 Employment Agreement. Yet, at that time, no effort was undertaken to ameliorate the 2015 Employment Agreement&#8217;s (or any of the Invalid Provisions&#8217;)
                improper and inequitable effect on the intra-governance powers of the directors (in favor of Mr. Kiani and the incumbent Board) and the franchise rights of the stockholders. That was a remarkable failure by these fiduciaries for, as of that
                time, the improper and inequitable effect the 2015 Employment Agreement was having on the Board&#8217;s ability to manage the Company, as well as its smothering effect on the franchise, was obvious.</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">76</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">206.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Indeed, in January 2022, the value of the Special Payment, as disclosed in Masimo&#8217;s own proxy statement, was nearly <font style="font-weight: bold; font-style: italic;">one billion dollars</font>. Therefore, it was
                (or should have been) apparent to the Board that the sheer size of the potential payout to Mr. Kiani would not only preclude the Outside Directors from exercising their duties to wrest authority back from Mr. Kiani, but it would, at this
                critical juncture in the Company&#8217;s life, discourage stockholders from both nominating and voting for candidates for election to Masimo&#8217;s Board who had not been blessed by Mr. Kiani.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">207.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">More specifically, as of January 2022, the Company was on the precipice of the Sound United acquisition, which the Current Directors knew was a material departure from Masimo&#8217;s historical operational focus,
                rendering it vulnerable to stockholder activism. Indeed, Mr. Cohen testified that while the Board was considering the Sound United acquisition, which was announced in February 2022, &#8220;[i]t was raised at the board meeting that if there&#8217;s an
                adverse negative impact on the share price, you may find that activists and/or strategics who want to take advantage of our depressed stock price show up.&#8221; (Cohen Tr. at 167:5-24.)</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">208.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Not only were the Current Directors on high alert for activism, but they also knew the 2015 Employment Agreement was, in fact, a poison pill. As Mr. Mikkelson testified, triggering the DCCP was a &#8220;<font style="font-weight: bold; font-style: italic;">very scary prospect </font>for me in</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">77</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">that it&#8217;s a lot of shares and a lot of dollars.&#8221; And, it was &#8220;<font style="font-weight: bold; font-style: italic;">one of the biggest pieces why that risk-reward balance
                for me was finally tipped in favor of adopting</font>&#8221; the preclusive Bylaw Amendments. (Mikkelson Tr. at 62:19-63:6 (emphasis added).)</div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">209.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Thus, fearing activism and desiring to erect a formidable defense to their incumbency, the Current Directors determined in early January 2022 to maintain the 2015 Employment Agreement and its Invalid Provisions. To
                make matters worse, the Current Directors approved the Second Amendment, which provided no consideration to Masimo, and thus constitutes waste, without so much as attempting to renegotiate the 2015 Employment Agreement to remove the illegal
                and inequitable impediments the 2015 Employment Agreement placed on the stockholder franchise.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">210.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Plaintiffs are entitled to a declaration that the Current Directors are breaching their fiduciary duties in connection with their ongoing assent to the maintenance of the Employment Agreement, the Invalid
                Provisions, and their ongoing illegal and inequitable effects. Plaintiffs are further entitled to a declaration that the Current Directors breached their fiduciary duties in connection with their approval of the Second Amendment. Plaintiffs
                are entitled to all equitable and just relief required to remedy those breaches of fiduciary duty.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 34.8pt;"><font style="font-size: 14pt;">211.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Plaintiffs have no adequate remedy at law.</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">78</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="line-height: 0pt;"><br style="line-height: 0pt;">
            </div>
            <div style="text-align: center; line-height: 15.95pt; margin-top: 12pt; margin-bottom: 12pt; font-size: 14pt; font-weight: bold;"><u>COUNT VI</u><br>
              (Breach of Fiduciary Duties Against the Current Directors &#8211; Adoption of Inequitable Defensive Provisions And Acting to Entrench Mr. Kiani)</div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">212.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Plaintiffs repeat and reallege the preceding paragraphs as if fully set forth herein.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">213.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">The Current Directors owe Masimo&#8217;s stockholders the uncompromising fiduciary duties of care and loyalty, which preclude them from abdicating their statutory and fiduciary duties to the Company and its stockholders,
                erecting inequitable barriers to the free exercise of the franchise, taking any action to favor their own interests over the interests of Masimo and its stockholders, and/or committing waste.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">214.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">The Current Directors&#8217; reaction to Politan&#8217;s attempt to nominate two directors to stand for election at the Company&#8217;s 2023 annual meeting was and continues to be in breach of their fiduciary duties through their
                adoption and maintenance of inequitable defensive measures, including through the Current Directors&#8217; refusal to take any action in response to Politan&#8217;s request that the Board disable the DCCP in the event that two Politan nominees are
                elected to the Board.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">215.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">In particular, following Politan&#8217;s request to disable the DCCP the Current Directors did not (i) meet to discuss the request, either before the litigation was commenced or during the four months since, (ii) consider
                creating a special</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">79</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">committee to evaluate the request, (iii) consider whether they could avoid triggering the DCCP by expanding the Board and appointing Mr. Koffey when Politan first requested
              representation at the September 2, 2022 meeting, (iv) explore the possibility of amending the Employment Agreement, (v) treat the DCCP as the void provision that it is, or (vi) request that Mr. Kiani waive the DCCP. Instead, the Current
              Directors determined to maintain the Employment Agreement.</div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">216.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Notably, in refusing to take any action in response to Politan&#8217;s request, the Outside Directors did not obtain separate, independent counsel to advise them as to their rights and obligations. Indeed, the Board&#8217;s
                four Outside Directors, including Mr. Mikkelson, who described the prospect of triggering the DCCP as &#8220;very scary,&#8221; continue to be advised by the same hopelessly-conflicted counsel advising Mr. Kiani, who stands to reap a
                half-billion-dollar windfall if the DCCP is triggered.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">217.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">In addition, despite the Current Directors&#8217; belief that the Employment Agreement was already a poison pill, the Current Directors further breached their fiduciary duties when adopting a separate poison pill upon
                news that Politan had acquired a position in the Company. The combined effect of this array of illegal and improper defensive measures is to prohibit any stockholder from acquiring more than 10 percent of the company, while simultaneously
                imposing a</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">80</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">draconian and unprecedented tax on the stockholders&#8217; desire to nominate, much less elect, any directors who would remove the pill.</div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">218.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">The validity of a poison pill is predicated upon stockholders&#8217; ultimate right to elect directors who can redeem it. Here, the Employment Agreement ensures Masimo&#8217;s stockholders cannot freely elect such directors,
                thereby ensuring the pill remains in place indefinitely.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">219.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Further, the Current Defendants have exacerbated the illegal and inequitable nature of their array of defensive measures through the adoption of the Limited DCCP Waiver. If the Limited DCCP Waiver is allowed to
                stand, it will ensure that the risk of triggering the Special Payment to Kiani will remain in place for 24 more months, which could span three annual elections. The Company&#8217;s combined array of defensive measures constitutes an illegal and
                inequitable attack on the franchise, it lacks any justification, is draconian, and is well outside any range of reasonableness.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">220.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">The foregoing breaches of fiduciary duty are also working inequitably to further entrench Mr. Kiani. Specifically, Mr. Kiani is up for re-election in 2024. Under the terms of the Employment Agreement, Mr. Kiani is
                entitled to receive the Special Payment if the DCCP is triggered, even if he retains his positions as Chairman and CEO. (Employment Agreement &#167;&#167; 8.4, 9(iii).)</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">81</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">Moreover, if the Chairman Provision is triggered, he may elect to terminate his employment and receive the Special Payment. (<font style="font-style: italic;">Id. </font>&#167;&#167;










              7.4, 8.4.)</div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">221.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">As such, regardless of whether Politan (or any other stockholder) succeeds in electing candidates to Masimo&#8217;s Board in 2023, stockholders will be forced to vote on Mr. Kiani&#8217;s re-election with the Sword of
                Damocles&#8212;in the form of a potential half-billion-dollar payout to Mr. Kiani&#8212;hanging over their heads. If, for example, both incumbent directors win in 2023, but Mr. Kiani is defeated in 2024, he would no longer be Chairman (even if he
                remains CEO) and he could elect to terminate his employment and receive his massive payout.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">222.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Even worse, if the Limited DCCP Waiver is declared valid and Politan (or another stockholder) succeeds in electing one or more candidates to the Board in 2023, then a defeat for Mr. Kiani in 2024 presumably would
                trigger the DCCP and permit him to remain as CEO and still receive a half-billion-dollar payout.</font></div>
            <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">223.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Plaintiffs are entitled to a declaration that the Current Directors breached their fiduciary duties in connection with their adoption and maintenance of inequitable defensive measures, whose effect has been
                exacerbated through adoption of the Limited DCCP Waiver and which, if allowed to stand, will only work to</font></div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">82</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="line-height: 31.9pt; font-size: 14pt;">entrench Mr. Kiani. Plaintiffs are entitled to all equitable and just relief required to remedy those breaches of fiduciary duty.</div>
            <div style="text-indent: 72pt; line-height: 31.9pt;"><font style="font-size: 14pt;">224.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 14pt;">Plaintiffs










                have no adequate remedy at law.</font></div>
            <div style="text-align: center; line-height: 15.95pt; margin-top: 12pt; font-size: 14pt; font-weight: bold;"><u>PRAYER FOR RELIEF</u></div>
            <div style="margin-left: 132pt; line-height: 15.95pt; margin-top: 11.95pt; font-size: 14pt;">WHEREFORE, Plaintiffs respectfully request the following relief:</div>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;" class="DSPFListTable" id="zb82116fa41e0498bbf72f95ef27a9dfb">

                <tr>
                  <td style="width: 131.75pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top; font-size: 14pt;">(i)</td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="font-size: 14pt;">Declaring the Employment Agreement unenforceable;</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12.1pt;" class="DSPFListTable" id="zf4a1a7849e8d4c30b0d64fe732a001b6">

                <tr>
                  <td style="width: 131.95pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top; font-size: 14pt;">(ii)</td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="font-size: 14pt;">Alternatively, declaring the Invalid Provisions unenforceable;</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;" class="DSPFListTable" id="z5b2d32c4a0f641a087b924e357baffeb">

                <tr>
                  <td style="width: 131.95pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top; font-size: 14pt;">(iii)</td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="font-size: 14pt;">Declaring the Limited DCCP Waiver unenforceable;</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 11.95pt;" class="DSPFListTable" id="z63513b4685c94a37a104be227d570954">

                <tr>
                  <td style="width: 132pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top; font-size: 14pt;">(iv)</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div style="font-size: 14pt;">Declaring that the 2015 Directors breached their fiduciary duties by (a) approving the 2015 Employment Agreement and/or (b) one or more of the Invalid Provisions;</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 11.95pt;" class="DSPFListTable" id="zdf2199b7592b47789d38ecc1b59924fb">

                <tr>
                  <td style="width: 132pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top; font-size: 14pt;">(v)</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div style="font-size: 14pt;">Declaring that the 2017 Directors breached their fiduciary duties by (a) maintaining the 2015 Employment Agreement and/or (b) one or more of the Invalid Provisions and (c) approving the First Amendment;</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12.05pt;" class="DSPFListTable" id="z2c6884c4a9714c7f83ca7cd092591935">

                <tr>
                  <td style="width: 132pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top; font-size: 14pt;">(vi)</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div style="font-size: 14pt;">Declaring that the Current Directors breached their fiduciary duties by (a) maintaining the 2015 Employment Agreement, and/or (b) one or more of the Invalid Provisions (c) approving the Second Amendment,
                      (d) erecting inequitable defenses in response to Politan, (e) adopting the Limited DCCP Waiver and</div>
                  </td>
                </tr>

            </table>
            <div style="text-align: justify; margin-left: 168pt; line-height: 15.95pt; margin-top: 0.05pt; font-size: 14pt;">(f) entrenching Mr. Kiani;</div>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 11.95pt;" class="DSPFListTable" id="z17d1e2568b8a4707a65a25e1e0dfde4c">

                <tr>
                  <td style="width: 132pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top; font-size: 14pt;">(viii)</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div style="font-size: 14pt;">Finding the Current Directors personally liable for the Special Payment if any compensation should be provided to Mr. Kiani pursuant to it;</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 11.95pt;" class="DSPFListTable" id="z76efd17f012e498c9e48c8c619b6abc7">

                <tr>
                  <td style="width: 132pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top; font-size: 14pt;">(ix)</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div style="font-size: 14pt;">Permanently enjoining Masimo and its Board of Directors from taking any actions to enforce (a) the Employment Agreement and/or (b) one or more of the Invalid Provisions;</div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">83</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="line-height: 0pt;"><br style="line-height: 0pt;">
            </div>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 3pt;" class="DSPFListTable" id="z65d0e71e4f0646dab93503ef94f70f6a">

                <tr>
                  <td style="width: 132pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top; font-size: 14pt;">(x)</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div style="font-size: 14pt;">Awarding Plaintiffs their fees, costs, and expenses, including their attorneys&#8217; fees and costs, incurred in connection with this action; and</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 11.95pt;" class="DSPFListTable" id="ze129ede5f6bb452aa9dca68b5e62fedc">

                <tr>
                  <td style="width: 132pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top; font-size: 14pt;">(xi)</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div style="font-size: 14pt;">Granting Plaintiffs such other and further relief as the Court deems just and proper.</div>
                  </td>
                </tr>

            </table>
          </div>
          <div><br>
          </div>
          <div><font style="font-size: 14pt;"><br>
            </font> </div>
          <font style="font-size: 14pt;"> </font>
          <div>
            <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: Arial, Helvetica, sans-serif; font-size: 10pt;">

                <tr>
                  <td valign="top" align="left" style="width: 35%; font-size: 14pt;"><br>
                  </td>
                  <td valign="top" style="width: 12%; font-size: 14pt;">&#160;</td>
                  <td valign="top" style="width: 6%; font-size: 14pt;">&#160;</td>
                  <td valign="top" align="left" style="width: 35%; font-size: 14pt;">
                    <div>MORRIS, NICHOLS, ARSHT &amp; </div>
                    <div>TUNNELL LLP</div>
                  </td>
                  <td valign="top" style="width: 12%; font-size: 14pt;">&#160;</td>
                </tr>
                <tr>
                  <td valign="top" align="left" rowspan="1" style="width: 35%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 6%; font-size: 14pt;">&#160;</td>
                  <td valign="top" align="left" rowspan="1" style="width: 35%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;">&#160;</td>
                </tr>
                <tr>
                  <td valign="top" align="left" rowspan="1" style="width: 35%; font-size: 14pt;">OF COUNSEL:</td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 6%; font-size: 14pt;">&#160;</td>
                  <td valign="top" align="left" rowspan="1" style="width: 35%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;">&#160;</td>
                </tr>
                <tr>
                  <td valign="top" align="left" rowspan="1" style="width: 35%; font-size: 14pt;"><br>
                  </td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 6%; font-size: 14pt;">&#160;</td>
                  <td valign="top" align="left" rowspan="1" style="width: 35%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;">&#160;</td>
                </tr>
                <tr>
                  <td valign="top" align="left" colspan="1" rowspan="2" style="width: 35%; padding-bottom: 2px; font-size: 14pt;">
                    <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;">
                      <div style="text-align: left; line-height: 17.55pt; font-family: Arial,Helvetica,sans-serif;">Michael E. Swartz</div>
                    </div>
                    <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;">Frank W. Olander
                      <div style="text-align: left; line-height: 15.85pt; font-family: Arial,Helvetica,sans-serif;">SCHULTE ROTH &amp; ZABEL LLP</div>
                      <div style="text-align: left; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif;">919 Third Avenue </div>
                      <div style="text-align: left; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif;">New York, NY 10022 </div>
                      <div style="text-align: left; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif;">(212) 756-2000</div>
                    </div>
                  </td>
                  <td valign="top" style="width: 12%; padding-bottom: 2px; font-size: 14pt;">&#160;</td>
                  <td valign="top" style="width: 6%; padding-bottom: 2px; font-size: 14pt;">&#160;</td>
                  <td valign="top" align="left" style="width: 35%; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; font-size: 14pt;"><font style="font-style: italic;">/s/&#160; </font><br>
                    </div>
                  </td>
                  <td valign="top" style="width: 12%; padding-bottom: 2px; font-size: 14pt;">&#160;</td>
                </tr>
                <tr>
                  <td valign="top" style="width: 12%; font-size: 14pt;">&#160;</td>
                  <td valign="top" style="width: 6%; font-size: 14pt;">&#160;</td>
                  <td valign="top" align="left" style="width: 35%;">
                    <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; font-size: 14pt;">
                      <div style="text-align: left; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif;">John P. DiTomo (#4850) </div>
                      <div style="text-align: left; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif;">Alexandra M. Cumings (#6146) </div>
                      <div style="text-align: left; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif;">1201 N. Market Street</div>
                      <div style="text-align: left; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif;">Wilmington, DE 19899-1347</div>
                      <div style="text-align: left; line-height: 16.05pt; font-family: Arial,Helvetica,sans-serif;">(302) 658-9200</div>
                    </div>
                  </td>
                  <td valign="top" style="width: 12%; font-size: 14pt;">&#160;</td>
                </tr>
                <tr>
                  <td valign="top" align="justify" style="width: 35%;">
                    <div align="justify" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; font-size: 14pt;"><br>
                    </div>
                  </td>
                  <td valign="top" style="width: 12%; font-size: 14pt;">&#160;</td>
                  <td valign="top" style="width: 6%; font-size: 14pt;">&#160;</td>
                  <td valign="top" align="justify" style="width: 35%;">
                    <div align="justify" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; font-size: 14pt;"><br>
                    </div>
                  </td>
                  <td valign="top" style="width: 12%; font-size: 14pt;">&#160;</td>
                </tr>
                <tr>
                  <td valign="top" align="justify" rowspan="1" style="width: 35%; font-size: 14pt;"><font style="font-style: italic;">Attorneys for Plaintiffs</font></td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 6%; font-size: 14pt;">&#160;</td>
                  <td valign="top" align="justify" rowspan="1" style="width: 35%; font-size: 14pt;">
                    <div style="text-align: left; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif; font-style: italic;">Attorneys for Politan Capital<br>
                    </div>
                    <div style="text-align: left; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif; font-style: italic;">Management LP and Politan Capital NY<br>
                    </div>
                    <div style="text-align: left; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif; font-style: italic;">LLC<br>
                    </div>
                  </td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;"><br>
                  </td>
                </tr>
                <tr>
                  <td valign="top" align="justify" rowspan="1" style="width: 35%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 6%; font-size: 14pt;">&#160;</td>
                  <td valign="top" align="justify" rowspan="1" style="width: 35%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;">&#160;</td>
                </tr>
                <tr>
                  <td valign="top" align="justify" rowspan="1" style="width: 35%; font-size: 14pt;">
                    <div style="text-align: left; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif;">Richard Brand </div>
                    <div style="text-align: left; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif;">Nishal R. Ramphal</div>
                    <div style="text-align: left; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif;">CADWALADER, WICKERSHAM &amp; </div>
                    <div style="text-align: left; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif;">TAFT LLP</div>
                    <div style="text-align: left; line-height: 16.1pt; font-family: Arial,Helvetica,sans-serif;">200 Liberty Street, </div>
                    <div style="text-align: left; line-height: 16.1pt; font-family: Arial,Helvetica,sans-serif;">New York, NY 10281 </div>
                    <div style="text-align: left; line-height: 16.1pt; font-family: Arial,Helvetica,sans-serif;">(212) 504-6000</div>
                  </td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 6%; font-size: 14pt;">&#160;</td>
                  <td valign="top" align="justify" rowspan="1" style="width: 35%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;">&#160;</td>
                </tr>
                <tr>
                  <td valign="top" align="justify" rowspan="1" style="width: 35%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 6%; font-size: 14pt;">&#160;</td>
                  <td valign="top" align="justify" rowspan="1" style="width: 35%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;">&#160;</td>
                </tr>
                <tr>
                  <td valign="top" align="justify" rowspan="1" style="width: 35%; font-size: 14pt;">
                    <div style="text-align: left; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif; font-style: italic;">Attorneys for Politan Capital<br>
                    </div>
                    <div style="text-align: left; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif; font-style: italic;">Management LP and Politan Capital </div>
                    <div style="text-align: left; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif; font-style: italic;">NY LLC<br>
                    </div>
                  </td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 6%; font-size: 14pt;">&#160;</td>
                  <td valign="top" align="justify" rowspan="1" style="width: 35%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;">&#160;</td>
                </tr>

            </table>
          </div>
          <br>
          <div><br>
          </div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">84</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            <div class="BRPFPageHeader"></div>
          </div>
          <div> <br>
          </div>
          <div>
            <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: Arial, Helvetica, sans-serif; font-size: 10pt;">

                <tr>
                  <td valign="top" align="left" style="width: 35%; font-size: 14pt;"><br>
                  </td>
                  <td valign="top" style="width: 12%; font-size: 14pt;">&#160;</td>
                  <td valign="top" style="width: 6%; font-size: 14pt;">&#160;</td>
                  <td valign="top" align="left" style="width: 35%; font-size: 14pt;">ASHBY &amp; GEDDES</td>
                  <td valign="top" style="width: 12%; font-size: 14pt;">&#160;</td>
                </tr>
                <tr>
                  <td valign="top" align="left" rowspan="1" style="width: 35%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 6%; font-size: 14pt;">&#160;</td>
                  <td valign="top" align="left" rowspan="1" style="width: 35%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;">&#160;</td>
                </tr>
                <tr>
                  <td valign="top" align="left" rowspan="1" style="width: 35%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 6%; font-size: 14pt;">&#160;</td>
                  <td valign="top" align="left" rowspan="1" style="width: 35%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;">&#160;</td>
                </tr>
                <tr>
                  <td valign="top" align="left" rowspan="1" style="width: 35%; font-size: 14pt; padding-bottom: 2px;">OF COUNSEL: <br>
                  </td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt; padding-bottom: 2px;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 6%; font-size: 14pt; padding-bottom: 2px;">&#160;</td>
                  <td valign="top" align="left" rowspan="1" style="width: 35%; font-size: 14pt; border-bottom: 2px solid rgb(0, 0, 0);"><font style="font-style: italic;">/s/&#160;&#160; </font><br>
                  </td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt; padding-bottom: 2px;">&#160;</td>
                </tr>
                <tr>
                  <td valign="top" align="left" colspan="1" style="width: 35%; padding-bottom: 2px; font-size: 14pt;">
                    <div><br>
                    </div>
                    <div>
                      <div align="justify" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;">
                        <div style="text-align: left; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif;">Irwin B. Schwartz </div>
                        <div style="text-align: left; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif;">William Adams</div>
                        <div style="text-align: left; line-height: 16.05pt; font-family: Arial,Helvetica,sans-serif;">BLA SCHWARTZ, PC</div>
                        <div style="text-align: left; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif;">515 South Flower Street, Suite 3600</div>
                        <div style="text-align: left; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif;">Los Angeles, CA 90071</div>
                        <div style="text-align: left; line-height: 16.05pt; font-family: Arial,Helvetica,sans-serif;">(213) 785-3683</div>
                        <div style="text-align: left; line-height: 16.05pt; font-family: Arial,Helvetica,sans-serif;"> <br>
                        </div>
                        <div style="text-align: left; line-height: 16.05pt; font-family: Arial,Helvetica,sans-serif;">
                          <div style="line-height: 15.95pt; font-style: italic;">Attorneys for California State </div>
                          <div style="line-height: 15.95pt; font-style: italic;">Teachers&#8217; Retirement System</div>
                        </div>
                      </div>
                    </div>
                  </td>
                  <td valign="top" style="width: 12%; font-size: 14pt;">&#160;</td>
                  <td valign="top" style="width: 6%; font-size: 14pt;">&#160;</td>
                  <td valign="top" align="left" style="width: 35%;">
                    <div align="left" style="font-size: 14pt;">
                      <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                      </div>
                      <div style="text-align: left; line-height: 15.95pt; margin-top: 0.5pt; font-family: Arial,Helvetica,sans-serif;">Catherine A. Gaul (#4310)</div>
                      <div style="text-align: left; line-height: 15.95pt; margin-top: 0.05pt; font-family: Arial,Helvetica,sans-serif;">500 Delaware Avenue, 8th Floor</div>
                      <div style="text-align: left; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif;">P.O. Box 1150 </div>
                      <div style="text-align: left; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif;">Wilmington, DE 19801 </div>
                      <div style="text-align: left; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif;">(302) 654-1888</div>
                      <div style="text-align: left; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif;"> <br>
                      </div>
                      <div style="text-align: left; line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif;">
                        <div style="line-height: 15.95pt; font-style: italic;">Attorneys for Politan Capital<br>
                        </div>
                        <div style="line-height: 15.95pt; font-style: italic;">Management LP and Politan Capital NY<br>
                        </div>
                        <div style="line-height: 15.95pt; font-style: italic;">LLC</div>
                      </div>
                    </div>
                  </td>
                  <td valign="top" style="width: 12%; font-size: 14pt;">&#160;</td>
                </tr>
                <tr>
                  <td valign="top" align="justify" rowspan="1" style="width: 35%; font-size: 14pt;"><br>
                  </td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 6%; font-size: 14pt;">&#160;</td>
                  <td valign="top" align="justify" rowspan="1" style="width: 35%; font-size: 14pt;"><br>
                  </td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;"><br>
                  </td>
                </tr>
                <tr>
                  <td valign="top" align="justify" rowspan="1" style="width: 35%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 6%; font-size: 14pt;">&#160;</td>
                  <td valign="top" align="justify" rowspan="1" style="width: 35%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;">&#160;</td>
                </tr>
                <tr>
                  <td valign="top" align="justify" rowspan="1" style="width: 35%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 6%; font-size: 14pt;">&#160;</td>
                  <td valign="top" align="justify" rowspan="1" style="width: 35%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;">&#160;</td>
                </tr>
                <tr>
                  <td valign="top" align="justify" rowspan="1" style="width: 35%; font-size: 14pt;">
                    <div style="text-align: left; line-height: 12.55pt; font-family: Arial,Helvetica,sans-serif;">March 3, 2023</div>
                  </td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 6%; font-size: 14pt;">&#160;</td>
                  <td valign="top" align="justify" rowspan="1" style="width: 35%; font-size: 14pt;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 12%; font-size: 14pt;">&#160;</td>
                </tr>

            </table>
          </div>
          <div><br>
          </div>
          <div> <br>
          </div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">85</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            <div class="BRPFPageHeader"></div>
          </div>
          <div> <br>
          </div>
          <div><br>
          </div>
          <div><br>
          </div>
          <div><br>
          </div>
          <div style="font-size: 14pt;">
            <div style="font-family: Arial,Helvetica,'sans-serif'; text-align: center; font-size: 48pt;">EXHIBIT A</div>
            <div style="font-family: Arial,Helvetica,'sans-serif';"><br>
            </div>
            <div style="font-family: Arial,Helvetica,'sans-serif';"><br>
            </div>
            <div style="font-family: Arial,Helvetica,'sans-serif';"> <br>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <!--PROfilePageNumberReset%Num%1%-%-%-->
            <div> <br>
            </div>
          </div>
          <br>
          <div style="font-size: 14pt; font-weight: bold; text-align: center;">IN THE UNITED STATES DISTRICT COURT </div>
          <div style="font-size: 14pt; font-weight: bold; text-align: center;">FOR THE DISTRICT OF DELAWARE</div>
          <div style="text-align: center; margin-right: 30.9pt; margin-left: 31.8pt; margin-top: 3pt; font-size: 14pt;"> <br>
          </div>
          <div style="margin-top: 0.5pt; margin-bottom: 0.05pt;"><br>
          </div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 49%; vertical-align: top;">
                  <div>
                    <div style="margin-right: 11.5pt; margin-left: 10pt; font-size: 14pt;">JOSEPH P. AUSIKAITIS, derivatively on </div>
                    <div style="margin-right: 11.5pt; margin-left: 10pt; font-size: 14pt;">behalf of MASIMO CORPORATION,</div>
                    <div>&#160;</div>
                    <div style="font-size: 14pt; margin-left: 126pt;">Plaintiff,</div>
                    <div style="margin-left: 81.05pt; font-size: 14pt;"> <br>
                    </div>
                    <div style="font-size: 14pt; margin-left: 63pt;">v.</div>
                    <div>&#160;</div>
                    <div style="margin-left: 10pt; font-size: 14pt;">JOE KIANI, et al.,</div>
                    <div style="margin-right: 41.55pt; margin-left: 63.95pt; font-size: 14pt;"> <br>
                    </div>
                    <div style="font-size: 14pt; margin-left: 126pt;">Defendants,</div>
                    <div style="margin-left: 81.25pt; font-size: 14pt;"> <br>
                    </div>
                    <div style="font-size: 14pt; margin-left: 63pt;">-and-</div>
                    <div style="margin-right: 12.65pt; margin-left: 10pt; font-size: 14pt;"> <br>
                    </div>
                    <div style="margin-right: 11.5pt; margin-left: 10pt; font-size: 14pt;">MASIMO CORPORATION, a Delaware</div>
                    <div style="margin-right: 11.5pt; margin-left: 10pt; font-size: 14pt;">Corporation,</div>
                    ,
                    <div style="margin-right: 12.65pt; margin-left: 10pt; font-size: 14pt;"> <br>
                    </div>
                    <div style="font-size: 14pt; margin-left: 126pt;">Nominal Defendant.</div>
                    <div style="margin-left: 68.55pt; font-size: 14pt;"> <br>
                    </div>
                  </div>
                </td>
                <td style="width: 2%; vertical-align: top;">
                  <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                  <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                  <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                  <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                  <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                  <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                  <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                  <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                  <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                  <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                  <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                  <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                  <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                  <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                  <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                  <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                  <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                  <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                  <div style="margin-left: 12.4pt; font-size: 14pt;">) </div>
                  <div style="margin-left: 12.4pt; font-size: 14pt;">) </div>
                  <div style="margin-left: 12.4pt; font-size: 14pt;">) </div>
                </td>
                <td style="width: 49%; vertical-align: top;">
                  <div style="margin: 0px 0px 0px 5.4pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt;"> <br>
                  </div>
                  <div style="margin: 0px 0px 0px 5.4pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt;"> <br>
                  </div>
                  <div style="margin: 0px 0px 0px 5.4pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt;">C.A. No. 1:12-cv-01175-SLR</div>
                  <div>&#160;</div>
                  <div style="margin: 6pt 0px 0px 6.25pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt; font-weight: bold;"> <br>
                  </div>
                  <div style="margin: 6pt 0px 0px 6.25pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt; font-weight: bold;"> <br>
                  </div>
                  <div style="margin: 6pt 0px 0px 6.25pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt; font-weight: bold;"> <br>
                  </div>
                  <div style="margin: 6pt 0px 0px 6.25pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt; font-weight: bold;">JURY TRIAL DEMANDED</div>
                  <br>
                </td>
              </tr>

          </table>
          <div style="margin: 18pt 0px 0px; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt; font-weight: bold; text-align: center;"><u>STIPULATION AND AGREEMENT OF SETTLEMENT</u></div>
        </div>
        <br>
      </div>
      <font style="font-size: 14pt;"> </font>
      <div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">This Stipulation and Agreement of Settlement (&#8220;Agreement&#8221;) is entered into by and among: (1) plaintiff Joseph P. Ausikaitis (&#8220;Plaintiff&#8221;), in his capacity as
          a stockholder of Masimo Corporation (&#8220;Masimo&#8221;) and acting derivatively on behalf of Masimo; (2) defendants Joe Kiani, Steven J. Barker, Robert Coleman, Jack Lasersohn, Sanford Fitch, Edward Cahill, Jon Coleman, Mark P. De Raad, Rick Fishel,
          Yongsam Lee and Anand Sampath (collectively, &#8220;Defendants&#8221;); and (3) nominal defendant Masimo Corporation (&#8220;Masimo&#8221; or the &#8220;Company&#8221;). In this Agreement, Plaintiff, Defendants, and Masimo are referred to collectively as the "Parties." This
          Agreement is intended by the Parties to fully, finally and forever resolve, discharge and settle the Released Claims (as defined below), upon and subject to the terms and conditions hereof.</div>
        <font style="font-size: 12pt;"> </font>
        <div style="text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt; font-weight: bold;">I.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-weight: bold; font-size: 12pt;"><u>BACKGROUND TO THE SETTLEMENT</u></font></div>
        <font style="font-size: 12pt;"> </font>
        <div style="text-indent: 36pt; line-height: 28.6pt; font-size: 12pt;">WHEREAS, in the lawsuit captioned <font style="font-style: italic;">Ausikaitis v. Kiani</font>, et al., No. 12-cv-1175-SLR (D. Del.) (the &#8220;Action&#8221;), Plaintiff filed a verified
          shareholder derivative complaint on September 19,</div>
        <div>
          <div>
            <div style="line-height: 15.95pt; font-size: 14pt;"><br>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-1-</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="line-height: 15.95pt; font-size: 14pt;">
              <div style="line-height: 0pt;"><br style="line-height: 0pt;">
              </div>
              <div style="text-align: center; line-height: 13.1pt; margin-top: 3.75pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 3 of 43 PageID #:
                7349</div>
              <font style="font-size: 12pt;"> </font>
              <div style="line-height: 11.4pt;"><font style="font-size: 12pt;"><br style="line-height: 11.4pt;">
                </font> </div>
              <font style="font-size: 12pt;"> </font>
              <div style="line-height: 11.4pt;"><font style="font-size: 12pt;"><br style="line-height: 11.4pt;">
                </font> </div>
              <font style="font-size: 12pt;"> </font>
              <div style="line-height: 11.4pt;"><font style="font-size: 12pt;"><br style="line-height: 11.4pt;">
                </font> </div>
              <font style="font-size: 12pt;"> </font>
              <div style="text-align: justify; line-height: 26.2pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">2012 (the &#8220;Complaint&#8221;) asserting derivative claims on behalf of Masimo Corporation for purported breaches of fiduciary duties and
                unjust enrichment against Defendants Joe Kiani, Steven J. Barker, Robert Coleman, Jack Lasersohn, Sanford Fitch, Edward Cahill, Jon Coleman, Mark P. De Raad, Rick Fishel, Yongsam Lee and Anand Sampath (collectively, &#8220;Defendants&#8221;) and
                Nominal Defendant Masimo Corporation (&#8220;Masimo&#8221; or the &#8220;Company&#8221;).</div>
              <font style="font-size: 12pt;"> </font>
              <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">WHEREAS, the Complaint challenges the board of directors of Masimo&#8217;s stock options granting practices and executive and director compensation from 2008
                through&#160; 2011 (collectively, the &#8220;Stock Option Grants&#8221;). Plaintiff claims that, among other things, the Defendants breached their fiduciary duties by approving, granting and/or accepting the Stock Option Grants in violation of Masimo&#8217;s 2007
                Stock Incentive Plan, Masimo&#8217;s CEO and Executive Officer Equity Award Compensation Policy and/or Non-Employee Director Compensation Policy, including by granting excessive compensation and improperly &#8220;timing&#8221;&#160; the Stock Option Grants.
                Plaintiff further claims that the Defendants were unjustly enriched as a result of the challenged Stock Option Grants. Plaintiff also claims that Masimo&#8217;s board of directors (the &#8220;Board&#8221;) breached their fiduciary duties by causing Masimo to
                issue proxy statements from 2009 through 2012 that contained materially false or misleading information and/or omissions, including but not limited to materially false or misleading statements or omissions relating to the improper &#8220;timing&#8221;
                and granting practices concerning the challenged Stock Option Grants.</div>
              <font style="font-size: 12pt;"> </font>
              <div style="text-indent: 36pt; line-height: 28.6pt; font-size: 12pt;">WHEREAS, on November 15, 2012, the Defendants and Masimo moved to dismiss the Complaint.</div>
              <font style="font-size: 12pt;"> </font>
              <div style="text-align: justify; text-indent: 36pt; line-height: 28.6pt; font-size: 12pt;">WHEREAS, on July 16, 2013, the Court entered an order denying the Motion to Dismiss the Complaint.</div>
              <font style="font-size: 12pt;"> </font></div>
            <font style="font-size: 12pt;"> </font>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-2-</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div>
              <div style="text-align: center; line-height: 13.1pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 3 of 43 PageID #: 7349</div>
              <font style="font-size: 12pt;"> </font></div>
            <font style="font-size: 12pt;"> </font>
            <div> <font style="font-size: 12pt;"><br>
              </font> </div>
            <font style="font-size: 12pt;"> </font></div>
          <font style="font-size: 12pt;"> </font>
          <div style="line-height: 0pt;"><font style="font-size: 12pt;"><br style="line-height: 0pt;">
            </font> </div>
          <font style="font-size: 12pt;"> </font>
          <div style="line-height: 0pt;"><font style="font-size: 12pt;"><br style="line-height: 0pt;">
            </font> </div>
          <font style="font-size: 12pt;"> </font>
          <div style="line-height: 11.4pt; margin-top: 0.25pt;"><font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">WHEREAS, the Court entered a Scheduling Order on September 5, 2013, setting trial for April 20, 2015.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">WHEREAS, beginning in September 2013, the Parties engaged in extensive discovery including written discovery, document requests, numerous depositions and
              expert discovery, and have expended significant resources related to that discovery.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">WHEREAS, on June 23, 2014, Plaintiff moved for leave to amend the Complaint, which the Court granted on June 25, 2014. The purpose of the amendment was
              to dismiss Edward&#160; Cahill from the case so as to preserve diversity jurisdiction.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">WHEREAS, on July 1, 2014, Plaintiff filed the First Amended Verified Shareholder Derivative Complaint (&#8220;First Amended Complaint&#8221;), which is the operative
              complaint in this action. In connection with filing the First Amended Complaint, Edward Cahill was dismissed as&#160; a defendant.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">WHEREAS, on July 10, 2014, the parties engaged in a mediation with Magistrate Judge Fallon which did not result in a settlement.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">WHEREAS, on July 18, 2014, Defendants answered the First Amended Complaint. WHEREAS, on October 1, 2014, Plaintiff moved for leave to amend the First
              Amended Complaint to add a new claim regarding individual Defendant Joe Kiani&#8217;s 2012 employment agreement, the reimbursement of certain travel and related expenses to Mr. Kiani and certain disclosures made by the Board regarding the above
              (&#8220;Additional 2012 Employment Agreement Issues&#8221;). Defendants filed an opposition to that motion on October 20, 2014. The motion is pending. </div>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">WHEREAS, on October 14, 2014, Defendants and Masimo filed several motions for summary judgment and/or partial summary judgment.</div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-3-</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: center; text-indent: 36pt; line-height: 26.2pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 5 of 43 PageID #: 7351</div>
            <font style="font-size: 12pt;"> </font>
            <div style="line-height: 22.8pt;"><font style="font-size: 12pt;"><br style="line-height: 22.8pt;">
              </font> </div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">WHEREAS, on October 15, 2014, Plaintiff moved for summary judgment.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">WHEREAS, on October 31, 2014, Plaintiff filed his opposition to Defendants&#8217; motions for summary judgment and/or partial summary judgment. Included in
              this opposition was an argument that Defendants breached their fiduciary duties by awarding certain director options before those directors were eligible to receive them because prior options had not yet fully vested (the &#8220;Additional Full
              Vesting Issues&#8221;).</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">WHEREAS, on December 11, 2014, the Court held oral argument on the Parties&#8217; respective summary judgment motions. The motions are pending.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">WHEREAS, after the July 10, 2014 mediation, the Parties continued to engage in extensive arm&#8217;s-length and good-faith efforts to explore resolution of the
              controversy by settlement, including a private mediation with Jed D. Melnick, Esq. of JAMS on March 17,&#160;&#160; 2015.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">WHEREAS, after extensive negotiations, Plaintiff, through his counsel, and Defendants, through their counsel, reached an agreement to settle the Action.
              The agreement was set forth in&#160; a Memorandum of Understanding (&#8220;MOU&#8221;) that was executed by the Parties on April 13, 2015, providing for the settlement of the Action, including the Additional 2012 Employment&#160; Agreement Issues and the
              Additional Full Vesting Issues. The settlement was reached after arm's-length negotiations, through the mediator, between the Parties who were all represented by counsel with relevant experience and expertise.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt; font-weight: bold;">II.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-weight: bold; font-size: 12pt;"><u>DEFENDANTS&#8217; DENIALS OF WRONGDOING AND LIABILITY</u></font></div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">Each Defendant has denied and continues to deny each and all of the claims and contentions alleged in the Action. Each Defendant expressly&#160; has denied
              and continues to deny&#160; all charges of wrongdoing or liability arising out of or relating in any way to the events, conduct,</div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-4-</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: center; line-height: 26.2pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 6 of 43 PageID #: 7352</div>
            <font style="font-size: 12pt;"> </font>
            <div style="line-height: 22.8pt;"><font style="font-size: 12pt;"><br style="line-height: 22.8pt;">
              </font> </div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; line-height: 26.2pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">statements, acts or omissions alleged, or that could have been alleged, in the Action, and Defendants contend that many of the
              factual allegations in the Action are materially inaccurate. Defendants also have denied and continue to deny, <font style="font-style: italic;">inter alia</font>, the allegations that Plaintiff, Masimo, or Masimo&#8217;s stockholders have
              suffered damage, or that Plaintiff, Masimo, or&#160; Masimo&#8217;s stockholders have been harmed in any way by the conduct alleged in the Action or otherwise. Defendants have further asserted that, at all times, they acted in good faith and in a manner
              they reasonably believed to be and that was in the best interests of Masimo and its stockholders. Nonetheless, Defendants have concluded that further defense of the Action would be protracted and expensive, and that it is desirable that the
              Action be fully and finally settled in the manner and upon the terms and conditions set forth in this Agreement. Defendants also have taken into account the uncertainty and risks inherent in any litigation, especially in complex&#160;&#160; cases like
              the Action. Defendants are entering into this Agreement because the proposed settlement would eliminate the burden and expense of further litigation, and because the settlement provides substantial benefits and is in the best interests of
              Masimo and its stockholders.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt; font-weight: bold;">III.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-weight: bold; font-size: 12pt;"><u>PLAINTIFF&#8217;S CLAIMS AND THE BENEFITS OF THE SETTLEMENT</u></font></div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">Plaintiff believes that the claims asserted in the Action have merit. However, Plaintiff recognizes and acknowledges the expense and length of continued
              legal proceedings necessary to prosecute the Action through trial and the appeals process. Plaintiff&#8217;s counsel have taken into account the uncertain outcome and the risk of any litigation, especially in complex litigations such as the Action,
              as well as the difficulties and delays inherent in such litigation. Plaintiff&#8217;s counsel believe that the settlement set forth in this Agreement confers substantial benefits upon Masimo and its stockholders. Based upon their evaluation and the
              mediator&#8217;s recommendation,</div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-5-</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: center; line-height: 26.2pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 7 of 43 PageID #: 7353</div>
            <font style="font-size: 12pt;"> </font>
            <div style="line-height: 22.8pt;"><font style="font-size: 12pt;"><br style="line-height: 22.8pt;">
              </font> </div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; line-height: 26.2pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Plaintiff&#8217;s counsel determined that the settlement set forth in this Agreement is in the best interests of Plaintiff, Masimo, and
              Masimo&#8217;s stockholders.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-indent: 36pt; line-height: 28.6pt; font-size: 12pt;">NOW, THEREFORE, IT IS HEREBY STIPULATED AND AGREED by and among the Parties, by and through their respective counsel of record, that, subject to the approval of the Court,
              the Released Claims shall be fully, finally, and forever compromised, settled and released, and the Action shall be dismissed with prejudice, upon and subject to the terms and conditions of this Agreement, as follows. </div>
            <div style="text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt; font-weight: bold;">IV.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-weight: bold; font-size: 12pt;"><u>TERMS OF THE SETTLEMENT</u></font></div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt; font-weight: bold;">1.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-weight: bold;">DEFINITIONS</font></div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 28.6pt; font-size: 12pt;">As used in this Agreement, the following terms have the meanings specified below.&#160; In&#160; the event of any inconsistency between any definition set forth
              below and any definition set forth in any other document related to the settlement set forth in this Agreement, the definition set&#160; forth below shall control.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt;">1.1</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt;"><font style="font-weight: bold;">&#8220;</font>Effective Date<font style="font-weight: bold;">&#8221; </font>means the first date by which all of the events and conditions specified in <font style="font-weight: bold;">&#182; </font>4.2









                hereof have occurred or been met.</font></div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt;">1.2</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt;">&#8220;Final&#8221; means, with respect to any order of court, including, without limitation,&#160; the Judgment, that such order represents a final and binding determination of all issues within its scope and is not subject to
                further review on appeal or otherwise. Without limitation, an order becomes &#8220;Final&#8221; when: (a) no appeal has been filed and the prescribed time for commencing any appeal has expired; or (b) an appeal has been filed and either (i) the appeal
                has been dismissed and the prescribed time, if any, for commencing any further appeal has expired, or (ii) the order has been affirmed in its entirety and the prescribed time, if any, for commencing any further appeal has expired. For
                purposes of this paragraph, an &#8220;appeal&#8221; includes appeals as of right, discretionary&#160;&#160; appeals,&#160;&#160; interlocutory&#160;&#160; appeals,&#160;&#160; proceedings&#160;&#160; involving&#160;&#160; writs&#160;&#160; of&#160;&#160; certiorari or</font></div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-6-</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: center; text-indent: 36pt; line-height: 26.2pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 8 of 43 PageID #: 7354</div>
            <font style="font-size: 12pt;"> </font>
            <div style="line-height: 22.8pt;"><font style="font-size: 12pt;"><br style="line-height: 22.8pt;">
              </font> </div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; line-height: 26.2pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">mandamus, and any other proceedings of like kind. Any appeal or other proceeding pertaining solely to an order issued in connection
              with an application for attorneys&#8217; fees or expenses and/or compensation to Plaintiff or his counsel shall not in any way delay or preclude the Judgment&#160; from becoming Final.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">1.3</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt;">&#8220;Judgment&#8221; means the judgment to be entered by the Court dismissing the Action with prejudice as articulated in Paragraph 4.1 and containing the release of claims defined herein at Paragraphs 1.4 and 1.6.</font></div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">1.4</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt;">&#8220;Released Claims&#8221; shall collectively mean any and all claims for relief (including Unknown Claims as defined in &#182; 1.6 hereof), rights, demands, causes of action, liabilities, debts, obligations, matters, issues and
                suits of any kind whatsoever, whether known or unknown, contingent or absolute, matured or unmatured, in law or in equity, discoverable or&#160; undiscoverable, whether or not concealed or hidden, that have been, could or might have been, or in
                the future might be asserted by Plaintiff (in both Plaintiff&#8217;s individual capacity and Plaintiff&#8217;s capacity derivatively on behalf of Masimo), Masimo, or any of Masimo&#8217;s stockholders (in their capacity as stockholders derivatively on behalf
                of Masimo), based upon, arising out of, or in any way relating to: (a) any matter set forth, alleged or otherwise referred to in the Action including those matters asserted in the Complaint and First Amended Complaint, as well as the
                Additional 2012 Employment Agreement Issues and the Additional Full Vesting Issues; and (b) the settlement of the Action, and the attorneys&#8217; fees, costs, and expense incurred in defense of the Action. Notwithstanding the foregoing, Released
                Claims shall not include any claims to enforce the terms of this Agreement.</font></div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt;">1.5</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt;">&#8220;Released









                Persons&#8221; means each and all of Defendants on behalf of themselves and of their heirs, predecessors, successors, representatives and assigns, and with respect to</font></div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-7-</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: center; text-indent: 36pt; line-height: 26.2pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 9 of 43 PageID #: 7355</div>
            <font style="font-size: 12pt;"> </font>
            <div style="line-height: 22.8pt;"><font style="font-size: 12pt;"><br style="line-height: 22.8pt;">
              </font> </div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; line-height: 26.2pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">corporate entities on behalf of each of their respective past, present or future directors, officers, employees, partnerships and
              partners, principals, agents, controlling stockholders, attorneys, accountants, auditors, investment banks and investment bankers, underwriters, advisors, financial advisors, personal or legal representatives, analysts, agents, associates,
              servants, insurers, co- insurers and reinsurers, predecessors, successors, parents, subsidiaries, divisions, assigns,&#160; trustees, beneficiaries, joint ventures and joint venturers, spouses, heirs, executors,&#160; administrators, related or
              affiliated entities, members of a Defendant&#8217;s family, any entity in&#160; which any Defendant and/or any member(s) of that Defendant&#8217;s family has or have a controlling interest (directly or indirectly), and any trust of which any Defendant is the
              settlor or which is for the benefit of any Defendant and/or member(s) of his family.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">1.6</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt;">&#8220;Unknown Claims&#8221; means any Released Claim that Plaintiff (in both Plaintiff&#8217;s individual capacity and Plaintiff&#8217;s capacity derivatively on behalf of Masimo), Masimo, or any&#160;&#160; of Masimo&#8217;s stockholders (in their
                capacity as stockholders derivatively on behalf of Masimo)&#160;&#160; do not know or suspect to exist in his, her or its favor at the time of the release of the Released Persons, including claims which, if known by him, her or it, might have
                affected his, her or its settlement with and release of the Released Persons, or might have affected his, her&#160; or its decision not to object to this settlement. Unknown Claims include those claims in which some or all of the facts
                comprising the claim may be unsuspected, or even undisclosed or hidden. In this regard, with respect to the Released Claims, the Parties stipulate and agree that, upon the Effective Date, Plaintiff (in both Plaintiff&#8217;s individual capacity
                and Plaintiff&#8217;s capacity derivatively on behalf of Masimo) and Masimo shall expressly waive, and each of Masimo&#8217;s stockholders (in their capacity as stockholders derivatively on behalf of Masimo) shall be&#160; deemed to have and by operation of
                the Judgment shall have expressly waived, the provisions,</font></div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-8-</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: center; line-height: 26.2pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 10 of 43 PageID #: 7356</div>
            <font style="font-size: 12pt;"> </font>
            <div style="line-height: 22.8pt;"><font style="font-size: 12pt;"><br style="line-height: 22.8pt;">
              </font> </div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; line-height: 26.2pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">rights and benefits conferred by &#167; 1542 of the California Civil Code, and by any law of any state or territory of the United States
              or any other state, sovereign, or jurisdiction, or any principle of common or foreign law that is similar, comparable or equivalent to &#167; 1542 of the California Civil Code, which provides:</div>
            <font style="font-size: 12pt;"> </font>
            <div style="font-size: 12pt; font-style: italic; font-weight: bold; text-align: justify;">
              <div style="margin: 12pt 138.55pt 12pt 135.3pt; line-height: normal; font-family: Arial, Helvetica, 'sans-serif'; font-style: italic; font-weight: bold;">A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT
                TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR.</div>
            </div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">Plaintiff (in both Plaintiff&#8217;s individual capacity and Plaintiff&#8217;s capacity derivatively on behalf of Masimo), Masimo, and Masimo&#8217;s stockholders (in
              their capacity as stockholders derivatively on behalf of Masimo) may hereafter discover facts in addition to or different from those which he, she, or it now knows or believes to be true with respect to the subject matter of the Released
              Claims, but, upon the Effective Date, each Plaintiff (in both Plaintiff&#8217;s individual capacity and Plaintiff&#8217;s capacity derivatively on behalf of Masimo) and Masimo shall expressly settle and release, and each of Masimo&#8217;s stockholders (in
              their capacity as stockholders derivatively on behalf of Masimo) shall be deemed to have and by operation of the Judgment shall have fully, finally, and forever settled and released, any and all Released Claims, known or unknown, suspected or
              unsuspected, contingent or non-contingent, whether or not concealed or hidden, that now exist, or heretofore have existed upon any theory of law or equity now existing or coming into existence in the future, including, but not limited to,
              conduct that is negligent, intentional, with or without malice, or a breach of any duty, law or rule, without regard to the subsequent discovery or existence of such different or additional&#160; facts.&#160; The&#160; Parties acknowledge, and each of
              Plaintiff (in both Plaintiff&#8217;s individual capacity and Plaintiff&#8217;s capacity derivatively on behalf of Masimo), Masimo, and Masimo&#8217;s stockholders (in their capacity as</div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-9-</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: center; line-height: 26.2pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 11 of 43 PageID #: 7357</div>
            <font style="font-size: 12pt;"> </font>
            <div style="line-height: 22.8pt;"><font style="font-size: 12pt;"><br style="line-height: 22.8pt;">
              </font> </div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; line-height: 26.2pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">stockholders derivatively on behalf of Masimo) shall be deemed by operation of the Judgment to have acknowledged, that the
              foregoing waiver was separately bargained for and agreed upon with the express intention of releasing Unknown Claims, and is a key element of the settlement&#160; of which this release is a part.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt; font-weight: bold;">2.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-weight: bold;">SETTLEMENT CONSIDERATION</font></div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt;">2.1</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt;">As a result of, among other things, discussions between and among the Parties, it is agreed that, in consideration for the full settlement and release of all Released and Unknown Claims (as defined herein), Masimo,
                the Board and the committees thereof (as appropriate) have agreed to implement, to the extent they have not already done so, the corporate governance measures described in the Corporate Governance Term Sheet attached as Exhibit A hereto,
                and that such corporate governance measures will remain in effect for a period of five (5) years following final approval of the Settlement. After the time period has expired, Masimo, the Board and the committees thereof may exercise their
                discretion in deciding whether to continue any of the aforementioned practices or procedures.</font></div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt;">2.2</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt;">Without admitting any wrongdoing, Defendants acknowledge that the filing and prosecution of the Action, discussions with Plaintiff&#8217;s counsel and resulting Board deliberations were substantial and material causes of
                the Board&#8217;s decision to undertake the corporate governance measures reflected in Exhibit A.</font></div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt;">2.3</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt;">In no event, however, shall Masimo or the Defendants be obligated to adopt, implement or enforce any measures that, either now or in the future, conflict with or are&#160; otherwise inconsistent with the listing
                requirements of any exchange on which its stock is traded, any regulation of the U.S. Securities &amp; Exchange Commission, or any applicable law, rule, or regulation.&#160;&#160; Masimo and the Defendants shall not be in breach of this Agreement if
                they determine not to implement or continue any of the items listed in Exhibit A in order to comply</font></div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-10-</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: center; line-height: 26.2pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 12 of 43 PageID #: 7358</div>
            <font style="font-size: 12pt;"> </font>
            <div style="line-height: 22.8pt;"><font style="font-size: 12pt;"><br style="line-height: 22.8pt;">
              </font> </div>
            <font style="font-size: 12pt;"> </font>
            <div style="line-height: 26.2pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">with listing requirements of any exchange on which its stock is traded, any regulation of the U.S. Securities &amp; Exchange Commission, or any
              applicable law, rule, or regulation.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt; font-weight: bold;">3.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-weight: bold;">RELEASES</font></div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">3.1<font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt;">&#160;</font><u>Releases</u>. Upon the Effective Date,
              Plaintiff (in both Plaintiff&#8217;s individual capacity and Plaintiff&#8217;s capacity derivatively on behalf of Masimo), Masimo, and each of Masimo&#8217;s stockholders (in their capacity as stockholders derivatively on behalf of Masimo) shall be deemed to
              have and by operation of the Judgment shall have fully, finally, and forever released, relinquished and discharged all Released Claims against the Released Persons including Unknown Claims, and shall have covenanted not to sue the Released
              Persons with respect to all such Released Claims, and shall be permanently barred and enjoined from instituting, commencing, or prosecuting the Released Claims against the Released Persons except to enforce the releases and the other terms
              and conditions contained in the Agreement or the Judgment entered pursuant thereto. Nothing herein shall in any way impair or restrict the rights of any of&#160; the Parties to enforce the terms of this Agreement.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">3.2<font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt;">&#160;</font><u>Releases by the Released Persons</u>. Upon the
              Effective Date, each of the Released Persons shall be deemed to have, and by operation of the Judgment shall have, fully, finally and forever released, relinquished and discharged Plaintiff and Plaintiff&#8217;s counsel from all claims, arising out
              of, relating to, or in connection with the institution, prosecution, assertion, settlement or resolution of the claims asserted or which could have been asserted in the Action, including&#160; but not limited to the claims as set forth in the
              Complaint and First Amended Complaint and including the Additional 2012 Employment Agreement Issues and Additional Full Vesting&#160; Issues, except to enforce the releases and the other terms and conditions contained in the Agreement or the
              Judgment entered pursuant thereto. Nothing herein shall in any way impair or restrict the rights of any of the Parties to enforce the terms of this Agreement.</div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-11-</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: center; line-height: 26.2pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 13 of 43 PageID #: 7359</div>
            <font style="font-size: 12pt;"> </font>
            <div style="line-height: 22.8pt;"><font style="font-size: 12pt;"><br style="line-height: 22.8pt;">
              </font> </div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt; font-weight: bold;">4.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-weight: bold;">CONDITIONS AND EFFECTIVE DATE</font></div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt;">4.1</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt;">As soon as practicable upon execution of this Agreement, Plaintiff&#8217;s counsel shall submit the Agreement together with its Exhibits to the Court and shall apply for entry of an&#160; Order (the "Preliminary Approval
                Order"), substantially in the form of Exhibit B attached hereto, requesting:&#160; (a) preliminary approval of the Settlement; (b) approval of the Notice of Pendency&#160;&#160; of Derivative Action, Proposed Settlement of Derivative Action, and
                Settlement Hearing (&#8220;Notice&#8221;) substantially in the form of Exhibit C attached hereto; (c) approval of the final Judgment substantially in the form of Exhibit D; and (d) a date for a hearing on final approval of the Settlement (the
                "Settlement Hearing").</font></div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt;">4.2</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt;">The &#8220;Effective Date&#8221; of this Agreement shall be deemed to occur when each and every one of the following conditions shall have occurred:</font></div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt;">(a)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt;">The Court has granted, in all material respects, the Preliminary Approval Order;</font></div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt;">(b)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt;">The









                Court has granted, in all material respects, the Judgment; and</font></div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">(c)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt;">The









                Judgment has become Final.</font></div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">4.3</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt;">The Parties agree to, and agree to cause their respective counsel to, cooperate to the extent reasonably necessary to effectuate and implement all terms and conditions of this Agreement, and to exercise their
                reasonable best efforts to accomplish the foregoing terms and conditions of this Agreement.</font></div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">4.4</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt;">Should any of the foregoing conditions set forth in Paragraph 4.2 fail to occur, including if the Court should decline to grant the requested approval, this Agreement shall terminate, and be null and void and of no
                force and effect for all purposes, and all negotiations, transactions, and proceedings connected with the Agreement shall be without prejudice to the</font></div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-12-</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: center; line-height: 26.2pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 11.5pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 14 of 43 PageID #: 7360</div>
            <div style="line-height: 22.8pt;"><br style="line-height: 22.8pt;">
            </div>
            <div style="line-height: 26.2pt; font-family: Arial,Helvetica,sans-serif; font-size: 11.5pt;">rights of any party in the Action, who shall be restored to their respective positions immediately prior to the execution of the Agreement.</div>
            <div style="text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 11.5pt; font-weight: bold;">5.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 11.5pt; font-weight: bold;">NOTICE; ATTORNEYS&#8217; FEES AND EXPENSES</font></div>
            <div style="text-align: justify; text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 11.5pt;">5.1</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 11.5pt;">Upon the Court&#8217;s entry of the Preliminary Approval Order, notice of the terms set forth in the Agreement shall be provided to current record holders and beneficial owners of common stock of Masimo as follows:</font></div>
            <div style="text-align: justify; text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 11.5pt;">(a)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 11.5pt;">Not later than ten (10) calendar days after the date the Court enters the Preliminary Approval Order, Masimo shall cause the Notice to be mailed to the current&#160; record holders and beneficial owners of common stock
                of Masimo via first-class mail through&#160;&#160; the U.S. Postal Service, or an equivalent method of mailing;</font></div>
            <div style="text-align: justify; text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 11.5pt;">(b)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 11.5pt;">Plaintiff&#8217;s counsel, Levi &amp; Korsinsky, LLP, will provide the&#160; Notice in response to written requests for the Notice by interested persons; and</font></div>
            <div style="text-align: justify; text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 11.5pt;">(c)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 11.5pt;">At least ten (10) calendar days prior to the Settlement Hearing Masimo shall file with the Court proof, by affidavit or declaration, of mailing of the Notice.</font></div>
            <div style="text-align: justify; text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 11.5pt;">5.2</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 11.5pt;">The cost of mailing and publishing the Notice under the terms of this Agreement shall be borne by Masimo and/or its insurers, and neither Plaintiff nor Defendants shall otherwise be responsible for any costs
                associated with providing notice of this Agreement or the Settlement Hearing.</font></div>
            <div style="text-align: justify; text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 11.5pt;">5.3</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 11.5pt; width: 36pt;">&#160;</font><font style="font-size: 11.5pt;">In light of benefits produced for Masimo by Plaintiff and Plaintiff&#8217;s counsel in connection with this Agreement and the Action leading up to it, Plaintiff and Plaintiff&#8217;s counsel intend to seek an award from the
                Court of two million dollars ($2,000,000) as compensation for attorneys&#8217; fees and expenses, subject to Court approval (&#8220;Fee and Expense Award&#8221;). In connection with such distribution of the Fee and Expense Award, Plaintiff and his counsel
                may request that the Court approve payment of a service award to Plaintiff to be paid out of the Fee </font></div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-13-</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="line-height: 26.2pt; color: rgb(0, 0, 255); font-size: 12pt; text-align: center;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 15 of 43 PageID #: 7361</div>
            <font style="font-size: 12pt;"> </font>
            <div style="line-height: 22.8pt;"><font style="font-size: 12pt;"><br style="line-height: 22.8pt;">
              </font> </div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; line-height: 26.2pt; font-size: 12pt;">and Expense Award in an amount not to exceed $20,000, which request will not be opposed by Defendants or Masimo. Plaintiff and Plaintiff&#8217;s counsel agree not to request that
              any greater aggregate amount be awarded to Plaintiff&#8217;s counsel or Plaintiff by the Court, agree not to seek payment of attorney&#8217;s fees and expenses from any other person or entity, and agree that no other or greater payments or awards shall
              be requested from the Court. Plaintiff and Plaintiff&#8217;s counsel all agree and represent that any Fee and Expense Award approved by the Court will not&#160; otherwise be distributed directly or indirectly to any current or former Masimo
              stockholders.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">5.4</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt;">Defendants agree to support the Fee and Expense Award as fair and reasonable in light of the settlement and this Agreement. However, the Parties expressly agree that entry of the Judgment and the Effective Date of
                the Agreement (including the effectiveness of the Releases) are not conditioned upon the approval by the Court of any such attorneys' fees, expenses, or service award to Plaintiff and/or Plaintiff&#8217;s counsel.</font></div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">5.5</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt;">Within Twenty (20) calendar days of entry of the Judgment, consistent with the provisions of &#182; 5.3, Masimo shall cause its insurer(s) or their successor(s) to pay the Fee and Expense Award awarded by the Court (but
                not more than the amount stated in &#182; 5.3),&#160; to Plaintiff&#8217;s counsel, Levi &amp; Korsinsky LLP, by wire transfer to Levi &amp; Korsinsky&#8217;s trust account pursuant to wire instructions and W-9 information to be provided by Levi &amp; Korsinsky
                LLP. Plaintiff&#8217;s counsel shall have sole discretion in determining the division and timing of the distribution of the Fee and Expense Award, including any service award.&#160; Any such payment&#160; shall be made subject to the joint and several
                obligations of Plaintiff&#8217;s counsel to make appropriate refunds or repayment to Masimo if any specified condition to the Agreement is not satisfied or, as a result of any successful appeal, further proceedings on remand requiring the return
                of the Fee and Expense Award, and/or successful collateral attack, the Court&#8217;s approval of</font></div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-14-</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="line-height: 26.2pt; color: rgb(0, 0, 255); font-size: 12pt; text-align: center;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 16 of 43 PageID #: 7362</div>
            <font style="font-size: 12pt;"> </font>
            <div style="line-height: 22.8pt;"><font style="font-size: 12pt;"><br style="line-height: 22.8pt;">
              </font> </div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; line-height: 26.2pt; font-size: 12pt;">the Agreement and/or entry of Judgment is reversed or materially modified, or if the Fee and Expense Award are reduced or reversed.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">5.6</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt;">Defendants, Masimo, and their respective insurers shall have no responsibility, obligation, or liability whatsoever with respect to, the allocation of the Fee and Expense Award among Plaintiff&#8217;s counsel, or any
                other person who may assert some claim thereto. Except as provided herein, the Released Persons shall bear no other expenses, costs, damages or fees alleged or incurred by the Plaintiff, by any other Company stockholder, or by any of their
                attorneys, experts, advisors, agents or representatives, and the Released Persons shall have no responsibility for, and no liability with respect to, the fee and/or expense allocation among Plaintiff&#8217;s counsel and/or any other person who
                may assert any claim thereto.</font></div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt; font-weight: bold;">6.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-weight: bold;">MISCELLANEOUS PROVISIONS</font></div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt;">6.1</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt;"><u>Plaintiff&#8217;s









                  Representation &amp; Warranty</u>. Plaintiff represents and warrants that he was a stockholder of Masimo from November 5, 2007 through the date of this Agreement, and at all times has continued to be an uninterrupted stockholder of Masimo
                through the prosecution of this Action and the Effective Date of this Agreement. </font></div>
            <div style="text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt;">6.2</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt;"><u>Confidentiality</u>.
                All orders and agreements made during the course of this Action that relate to the confidentiality of information shall survive this Agreement. </font></div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">6.3</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt;"><u>Severability</u>.
                The failure by any particular Defendant or Masimo to comply with any term of this Agreement or the Court Order approving this Agreement shall not give rise to a claim against any other Defendants or Parties who have complied. Nor shall the
                failure by any Defendant or Masimo to comply with any term of this Agreement or the Court Order approving this Agreement affect the Releases of other Defendants or Parties who have complied. </font></div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-15-</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: center; line-height: 26.2pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 17 of 43 PageID #: 7363</div>
            <font style="font-size: 12pt;"> </font>
            <div style="line-height: 22.8pt;"><font style="font-size: 12pt;"><br style="line-height: 22.8pt;">
              </font> </div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">6.4<font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt;">&#160;</font><u>No Admission of Fault</u>. This Agreement shall in no event be
              construed as or deemed to be evidence of an admission or concession by Defendants or Masimo with respect to any claim of any fault, liability, wrongdoing, or damage whatsoever.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">6.5<font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt;">&#160;</font><u>Advice of Counsel</u>. Each party hereto
              received independent legal advice from attorneys of his, her, or its choosing with respect to the advisability of entering this Agreement, the releases provided for in this Agreement and the other terms and conditions of&#160; this&#160; Agreement.
              This Agreement has been&#160; negotiated by the Parties and counsel, and in the event&#160; that the Court or any other court is called upon to interpret this Agreement, no one party or group or parties shall be deemed to have drafted this Agreement.
              It is not to be construed against any party as the drafting party.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt;">6.6</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt;"><u>Entire









                  Agreement</u>. This Agreement embodies the entire agreement of the Parties. There are no further or other promises, agreements, understandings, terms, conditions or obligations other than those contained herein. This Agreement supersedes
                all previous communications, representations or agreements, either verbal or written, between the Parties or their attorneys, including the MOU executed by the Parties effective April 13, 2015. </font></div>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">6.7<font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt;">&#160;</font><u>No Rights of Subrogation</u>. Plaintiff
              represents and warrants that no person, entity, firm, corporation, or insurance company, has received any rights of subrogation, or substitution&#160; to the claims made, or which could have been asserted by Plaintiff in the Action, and that there
              are no liens&#8212;voluntary, involuntary, statutory, or otherwise&#8212;relating to Plaintiff&#8217;s Claims in the Action, or this Agreement. Defendants and Masimo represent and warrant that no person, entity, firm, corporation, or insurance company, has
              received any rights of subrogation, or substitution&#160; to the claims, if any, which could have been asserted by Defendants and/or Masimo in the</div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-16-</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: center; line-height: 26.2pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 18 of 43 PageID #: 7364</div>
            <font style="font-size: 12pt;"> </font>
            <div style="line-height: 22.8pt;"><font style="font-size: 12pt;"><br style="line-height: 22.8pt;">
              </font> </div>
            <font style="font-size: 12pt;"> </font>
            <div style="line-height: 26.2pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Action, and that there are no liens&#8212;voluntary, involuntary, statutory, or otherwise&#8212;relating to such claims or this Agreement.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">6.8<font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt;">&#160;</font><u>No Transfer or Assignment of Claims</u>.
              Plaintiff represents and warrants he has not assigned, transferred or conveyed, nor purported to assign, transfer or convey to any person, entity, firm, corporation, or insurance company, any rights, claims or causes of action (or any portion
              thereof) he may have, or have had, against any or all of the Defendants, with respect to Plaintiff&#8217;s claims in the Action or any matters described in the Action. Defendants represent and warrant they have not assigned, transferred or
              conveyed, nor purported to assign, transfer or convey to any person, entity, firm, corporation, or insurance company, any rights, claims, or causes of action (or any portion thereof) they may have, or have had, against Plaintiff, with respect
              to the claims, if any, which could have been asserted by Defendants and/or Masimo in&#160;&#160; the Action.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">6.9<font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt;">&#160;</font><u>Authority to Execute</u>. The individuals executing this Agreement
              on behalf of the Parties represent and warrant that they have the authority to act on behalf of their principal and execute this document on their principal&#8217;s behalf.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">6.10<font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt;">&#160;</font><u>Limited&#160; Right of Appeal</u>. The Parties
              covenant and agree not to appeal the Judgment.&#160; Nothing in this paragraph should be construed to grant or confer any right of appeal&#160; to any party or nonparty to this action, other than as already exists and as provided by applicable law, if
              any.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">6.11<font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt;">&#160;</font><u>Execution of Agreement in Counterparts</u>.
              This Agreement requires authorized signatures on behalf of all Parties, in each of the signature lines set forth below, but may be executed in counterparts. All counsel who execute this Agreement on behalf of their clients represent and
              warrant that they have authority to do so on behalf of their respective clients.</div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-17-</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div style="text-align: center; line-height: 26.2pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 19 of 43 PageID #: 7365</div>
            <font style="font-size: 12pt;"> </font>
            <div style="line-height: 22.8pt;"><font style="font-size: 12pt;"><br style="line-height: 22.8pt;">
              </font> </div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">6.12<font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt;">&#160;</font><u>Stay of All Proceedings</u>. Pending Court
              approval of the Agreement, the Parties agree to stay any and all proceedings other than those incidental to the Agreement itself. The Parties shall agree to extensions of time with respect to pleadings and other Court deadlines and filings as
              are appropriate in the context of this Agreement.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">6.13<font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt;">&#160;</font><u>Third Party Beneficiaries</u>. No third parties are intended
              beneficiaries of this Agreement and the promises contained therein, with the exception of those non-Parties who are among the Released Persons to whom the Releases contained in &#182; 3.1 extend.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">6.14<font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt;">&#160;</font><u>Amendments</u>. This Agreement may be amended only by a written
              instrument executed by all Parties or by attorneys authorized to act on their behalf.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">6.15<font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt;">&#160;</font><u>Governing Law</u>.&#160; This Agreement shall be governed by the laws
              of the state of Delaware.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">6.16<font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt;">&#160;</font><u>No Press Releases or Statements to the Press</u>.
              Other than as required by law, none of the Parties, or any of the Parties&#8217; respective attorneys or representatives, shall issue any press release or make any other statement to the press concerning this Agreement or the settlement of the
              Action.</div>
            <font style="font-size: 12pt;"> </font>
            <div style="text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">6.17<font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt;">&#160;</font><u>The Court Shall Retain Jurisdiction</u>. The Court shall retain
              jurisdiction over the implementation and enforcement of this Agreement.</div>
            <div style="text-indent: 36pt; line-height: 26.2pt; font-size: 11.5pt;">
              <div style="text-align: justify; text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">6.18</font><font style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">Section Headings for Convenience Only. The section headings used throughout this Agreement are for convenience only and shall not
                  affect the construction or interpretation of the Agreement.</font></div>
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-18-</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <br>
            <div style="text-align: justify; line-height: 26.2pt;">
              <div>
                <div style="line-height: 11.4pt; margin-top: 0.25pt;">
                  <div style="text-align: center; line-height: 25.1pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 20 of 43 PageID #: 7366</div>
                  <div style="line-height: 22.8pt;"><font style="font-size: 12pt;"><br style="line-height: 22.8pt;">
                    </font> </div>
                  <div style="text-indent: 36pt; line-height: 22.8pt; color: rgb(61, 61, 61); font-size: 12pt;">IN WITNESS WHEREOF, the Parties hereto have caused the Agreement to be executed by their duly authorized attorneys.</div>
                  <div style="line-height: 22.8pt; color: rgb(61, 61, 61); font-size: 12pt;">
                    <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: Arial, Helvetica, sans-serif; font-size: 10pt;">

                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                          <td valign="top" style="width: 38%; font-size: 12pt;" colspan="2"><strong><br>
                            </strong></td>
                          <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;">DATED:&#160; May 5, 2015 <br>
                          </td>
                          <td valign="top" style="width: 3%; font-size: 12pt;">&#160;</td>
                          <td valign="top" style="width: 35%; font-size: 12pt;">Respectfully submitted, <br>
                          </td>
                          <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 3%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 12%; font-size: 12pt;" rowspan="1">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;">
                            <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; font-size: 12pt;"><br>
                            </div>
                          </td>
                          <td valign="top" style="width: 3%; padding-bottom: 2px; font-size: 12pt;">&#160;<br>
                          </td>
                          <td valign="top" nowrap="nowrap" align="left" style="width: 35%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 12pt;">/s/ Brian E. Farnan<br>
                          </td>
                          <td valign="top" style="width: 12%; padding-bottom: 2px; font-size: 12pt;">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                          <td valign="top" style="width: 3%; font-size: 12pt;">&#160;</td>
                          <td valign="bottom" nowrap="nowrap" align="left" style="width: 35%; font-size: 12pt;">
                            <div>Brian E. Farnan (#4089)<br>
                            </div>
                            <div><font style="font-family: Arial,Helvetica,sans-serif; color: rgb(61, 61, 61);">Michael J. Farnan (#5165) </font> </div>
                            <div>
                              <div style="font-family: Arial,Helvetica,'sans-serif'; text-align: left;"><font style="font-family: Arial,Helvetica,sans-serif; color: rgb(61, 61, 61);">FARNAN LLP</font></div>
                              <div style="margin-top: 0.4pt; margin-bottom: 0px; color: rgb(61, 61, 61); font-family: Arial,Helvetica,'sans-serif'; text-align: left;">919 Market Street, 12th Floor </div>
                              <div style="margin-top: 0.4pt; margin-bottom: 0px; color: rgb(61, 61, 61); font-family: Arial,Helvetica,'sans-serif'; text-align: left;">Wilmington, DE 19801</div>
                              <div style="color: rgb(61, 61, 61); font-family: Arial,Helvetica,'sans-serif'; text-align: left;">Telephone: (302) 777-0300</div>
                              <div style="margin-top: 0.5pt; margin-bottom: 0px; color: rgb(61, 61, 61); font-family: Arial,Helvetica,'sans-serif'; text-align: left;">Facsimile: (302) 777-0301 </div>
                              <div style="margin-top: 0.5pt; margin-bottom: 0px; color: rgb(61, 61, 61); font-family: Arial,Helvetica,'sans-serif'; text-align: left;">bfarnan@farnanlaw.com&#160;</div>
                              <div style="margin-top: 0.5pt; margin-bottom: 0px; color: rgb(61, 61, 61); font-family: Arial,Helvetica,'sans-serif'; text-align: left;">mfarnan@farnanlaw.com</div>
                              <font style="font-family: Arial,Helvetica,sans-serif; color: rgb(61, 61, 61);"> </font></div>
                          </td>
                          <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                          <td valign="top" style="width: 3%; font-size: 12pt;">&#160;</td>
                          <td valign="top" style="width: 35%; font-size: 12pt;"><br>
                          </td>
                          <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 3%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 35%; font-size: 12pt;" rowspan="1">
                            <div style="margin-top: 0.5pt; margin-bottom: 0px; color: rgb(61, 61, 61); font-family: Arial,Helvetica,'sans-serif'; text-align: left;">LEVl &amp; KORSINSKY LLP </div>
                            <div style="margin-top: 0.5pt; margin-bottom: 0px; color: rgb(61, 61, 61); font-family: Arial,Helvetica,'sans-serif'; text-align: left;">EDUARD KORSINSKY</div>
                            <div style="margin-top: 0.5pt; margin-bottom: 0px; color: rgb(61, 61, 61); font-family: Arial,Helvetica,'sans-serif'; text-align: left;">Steven J. Purcell</div>
                            <div style="margin-top: 0.5pt; margin-bottom: 0px; color: rgb(61, 61, 61); font-family: Arial,Helvetica,'sans-serif'; text-align: left;">30 Broad Street, 24th Floor </div>
                            <div style="margin-top: 0.5pt; margin-bottom: 0px; color: rgb(61, 61, 61); font-family: Arial,Helvetica,'sans-serif'; text-align: left;">New York, NY 10004</div>
                            <div style="margin-top: 0.5pt; margin-bottom: 0px; color: rgb(61, 61, 61); font-family: Arial,Helvetica,'sans-serif'; text-align: left;">Tel: (212) 363-7500</div>
                            <div style="margin-top: 0.5pt; margin-bottom: 0px; color: rgb(61, 61, 61); font-family: Arial,Helvetica,'sans-serif'; text-align: left;">Fax: (866) 367-6510</div>
                          </td>
                          <td valign="top" style="width: 12%; font-size: 12pt;" rowspan="1">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 3%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 12%; font-size: 12pt;" rowspan="1">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                          <td valign="top" style="width: 3%; font-size: 12pt;">&#160;</td>
                          <td valign="top" style="width: 35%; font-size: 12pt;"><font style="font-style: italic;">Attorneys for Plaintiff</font> <br>
                          </td>
                          <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 3%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 12%; font-size: 12pt;" rowspan="1">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 3%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 12%; font-size: 12pt;" rowspan="1">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt; padding-bottom: 2px;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 3%; font-size: 12pt; padding-bottom: 2px;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 35%; font-size: 12pt; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">/s/ J. Clayton Athey <br>
                          </td>
                          <td valign="top" style="width: 12%; font-size: 12pt; padding-bottom: 2px;" rowspan="1">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 3%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 35%; font-size: 12pt;" rowspan="1">
                            <div>J. Clayton Athey (#4378) <br>
                            </div>
                            <div>
                              <div style="text-align: left;">Eric J. Juray (#5765) </div>
                              <div>
                                <div style="text-align: left;">PRICKETT, JONES &amp; ELLIOTT<br>
                                </div>
                                <div style="text-align: left; line-height: 13.7pt;">1310 King Street, P.O. Box 1328</div>
                                <div style="text-align: left; line-height: 13.7pt;">Wilmington, DE 19899</div>
                                <div style="text-align: left; line-height: 13.7pt;">Teleph one: (302) 888-6500</div>
                                <div style="text-align: left; line-height: 13.7pt;">Facsimile: (302) 658-8111</div>
                                <div style="text-align: left; line-height: 13.7pt;">jcathey@prickett.com</div>
                                <div style="text-align: left; line-height: 13.7pt;">ejuray@prickett.com</div>
                              </div>
                            </div>
                          </td>
                          <td valign="top" style="width: 12%; font-size: 12pt;" rowspan="1">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 3%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 12%; font-size: 12pt;" rowspan="1">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 3%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 12%; font-size: 12pt;" rowspan="1">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 3%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 35%; font-size: 12pt;" rowspan="1">
                            <div style="text-align: left; line-height: 13.7pt;">PAUL HASTINGS LLP</div>
                            <div style="text-align: left; line-height: 13.7pt;">Peter M. Stone</div>
                            <div style="text-align: left; line-height: 13.7pt;">1117 S. California Avenue</div>
                            <div style="text-align: left; line-height: 13.7pt;">Palo Alto, CA 94304</div>
                            <div style="text-align: left; line-height: 13.7pt;">Telephone: (650) 320-1800</div>
                          </td>
                          <td valign="top" style="width: 12%; font-size: 12pt;" rowspan="1">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 3%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 12%; font-size: 12pt;" rowspan="1">&#160;</td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height: 22.8pt; color: rgb(61, 61, 61); font-size: 12pt;"> <br>
                  </div>
                </div>
                <font style="font-size: 12pt;"> </font> </div>
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter"></div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-19-</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
          </div>
          <div style="line-height: 11.4pt; margin-top: 0.25pt;"><br>
            <div style="line-height: 11.4pt; margin-top: 0.25pt;">
              <div style="text-align: center; line-height: 25.1pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 21 of 43 PageID #: 7367</div>
              <div style="line-height: 22.8pt;"><font style="font-size: 12pt;"><br style="line-height: 22.8pt;">
                </font> </div>
            </div>
            <div style="line-height: 11.4pt; margin-top: 0.25pt;"><br>
              <div style="line-height: 22.8pt; color: rgb(61, 61, 61); font-size: 12pt;">
                <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: Arial, Helvetica, sans-serif; font-size: 10pt;">

                    <tr>
                      <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                      <td valign="top" style="width: 38%; font-size: 12pt;" colspan="2"><strong><br>
                        </strong></td>
                      <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                    </tr>
                    <tr>
                      <td valign="top" style="width: 50%; font-size: 12pt;">&#160;<br>
                      </td>
                      <td valign="top" style="width: 3%; font-size: 12pt;">&#160;</td>
                      <td valign="top" style="width: 35%; font-size: 12pt;">Facsimile (650) 320-1900<br>
                      </td>
                      <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                    </tr>
                    <tr>
                      <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                      <td valign="top" style="width: 3%; font-size: 12pt;" rowspan="1">&#160;</td>
                      <td valign="top" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                      <td valign="top" style="width: 12%; font-size: 12pt;" rowspan="1">&#160;</td>
                    </tr>
                    <tr>
                      <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                      <td valign="top" style="width: 3%; font-size: 12pt;" rowspan="1">&#160;</td>
                      <td valign="top" style="width: 35%; font-size: 12pt;" rowspan="1">
                        <div>PAUL HASTINGS LLP <br>
                        </div>
                        <div>William F. Sullivan<br>
                        </div>
                        <div>
                          <div style="text-align: left; line-height: 13.7pt;">515 S. Flower Street, 25th Floor<br>
                          </div>
                          <div style="text-align: left; line-height: 13.7pt;">Los Angeles, CA 90071<br>
                          </div>
                          <div style="text-align: left; line-height: 13.7pt;">Telephone: (213) 683-6000</div>
                          <div style="text-align: left; line-height: 13.7pt;">Facsimile: (213) 627-0705</div>
                        </div>
                      </td>
                      <td valign="top" style="width: 12%; font-size: 12pt;" rowspan="1">&#160;</td>
                    </tr>
                    <tr>
                      <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                      <td valign="top" style="width: 3%; font-size: 12pt;" rowspan="1">&#160;</td>
                      <td valign="top" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                      <td valign="top" style="width: 12%; font-size: 12pt;" rowspan="1">&#160;</td>
                    </tr>
                    <tr>
                      <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                      <td valign="top" style="width: 3%; font-size: 12pt;" rowspan="1">&#160;</td>
                      <td valign="top" style="width: 35%; font-size: 12pt;" rowspan="1">
                        <div style="font-style: italic;">Attorneys for Individual Defendants Joe Kiani,<br>
                        </div>
                        <div><font style="font-style: italic;">Steven J. Barker, Robert coleman, Jack<br>
                          </font></div>
                        <div><font style="font-style: italic;">Lasersohn, Sanford Fitch, Jon Coleman Mark<br>
                          </font></div>
                        <div style="font-style: italic;">P. de Raad, Rick Fishel, Yongsam Lee, and </div>
                        <div><font style="font-style: italic;">Anand Sampath, and former Individual<br>
                          </font></div>
                        <div><font style="font-style: italic;">Defendant Edward Cahill</font><br>
                        </div>
                      </td>
                      <td valign="top" style="width: 12%; font-size: 12pt;" rowspan="1">&#160;</td>
                    </tr>
                    <tr>
                      <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                      <td valign="top" style="width: 3%; font-size: 12pt;" rowspan="1">&#160;</td>
                      <td valign="top" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                      <td valign="top" style="width: 12%; font-size: 12pt;" rowspan="1">&#160;</td>
                    </tr>
                    <tr>
                      <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                      <td valign="top" style="width: 3%; font-size: 12pt;" rowspan="1">&#160;</td>
                      <td valign="top" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                      <td valign="top" style="width: 12%; font-size: 12pt;" rowspan="1">&#160;</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;">
                        <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; font-size: 12pt;"><br>
                        </div>
                      </td>
                      <td valign="top" style="width: 3%; padding-bottom: 2px; font-size: 12pt;">&#160;<br>
                      </td>
                      <td valign="top" nowrap="nowrap" align="left" style="width: 35%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 12pt;">/s/ Anne C. Foster<br>
                      </td>
                      <td valign="top" style="width: 12%; padding-bottom: 2px; font-size: 12pt;">&#160;</td>
                    </tr>
                    <tr>
                      <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                      <td valign="top" style="width: 3%; font-size: 12pt;">&#160;</td>
                      <td valign="bottom" nowrap="nowrap" style="width: 35%; font-size: 12pt; text-align: left;">
                        <div>Anne C. Foster (#2513)</div>
                        <div>Susan Hannigan (#5342) </div>
                        <div>
                          <div>RICHARDS, LAYTON &amp; FINGER, P.A.<br>
                          </div>
                          <div style="line-height: 13.7pt;">920 N. King Street<br>
                          </div>
                          <div style="line-height: 13.7pt;">Wilmington, DE 19801</div>
                          <div style="line-height: 13.7pt;">Teleph one: (302) 651-7700</div>
                          <div style="line-height: 13.7pt;">Facsimile: (302) 651-7701</div>
                          <div style="line-height: 13.7pt;">foster@rlf.com</div>
                          <div style="line-height: 13.7pt;">hannigan@rlf.com</div>
                        </div>
                      </td>
                      <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                    </tr>
                    <tr>
                      <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                      <td valign="top" style="width: 3%; font-size: 12pt;">&#160;</td>
                      <td valign="top" style="width: 35%; font-size: 12pt;"><br>
                      </td>
                      <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                    </tr>
                    <tr>
                      <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                      <td valign="top" style="width: 3%; font-size: 12pt;" rowspan="1">&#160;</td>
                      <td valign="top" style="width: 35%; font-size: 12pt;" rowspan="1"><font style="font-style: italic;">Attorneys for Nominal Defendant Masimo Corp.</font><br>
                      </td>
                      <td valign="top" style="width: 12%; font-size: 12pt;" rowspan="1">&#160;</td>
                    </tr>
                    <tr>
                      <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                      <td valign="top" style="width: 3%; font-size: 12pt;" rowspan="1">&#160;</td>
                      <td valign="top" style="width: 35%; font-size: 12pt;" rowspan="1"><br>
                      </td>
                      <td valign="top" style="width: 12%; font-size: 12pt;" rowspan="1">&#160;</td>
                    </tr>
                    <tr>
                      <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                      <td valign="top" style="width: 3%; font-size: 12pt;" rowspan="1">&#160;</td>
                      <td valign="top" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                      <td valign="top" style="width: 12%; font-size: 12pt;" rowspan="1">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
            <div style="line-height: 11.4pt; margin-top: 0.25pt;"><font style="font-size: 12pt;"> <br>
              </font></div>
            <font style="font-size: 12pt;"> </font> <font style="font-size: 12pt;"> </font> <font style="font-size: 12pt;"> </font></div>
          <div style="line-height: 11.4pt; margin-top: 0.25pt;"><font style="font-size: 11.5pt;"><br>
            </font></div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageFooter"></div>
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-20-</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            <div class="BRPFPageHeader"></div>
          </div>
          <div style="line-height: 11.4pt; margin-top: 0.25pt;"><br>
            <div style="line-height: 0pt;"><br style="line-height: 0pt;">
            </div>
            <div style="text-align: center; line-height: 13.7pt; margin-top: 4.6pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 11.5pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 22 of 43 PageID #:
              7368</div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt; text-align: center;"><font style="font-size: 48pt;">EXHIBIT A</font><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
            </div>
            <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageFooter">
                <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                </div>
              </div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <!--PROfilePageNumberReset%Num%1%%%--> </div>
          <div style="line-height: 11.4pt; margin-top: 0.25pt; text-align: center;"><br>
            <font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 255); font-family: Arial,Helvetica,'sans-serif'; font-size: 11.5pt; font-style: normal; font-variant: normal; text-transform: none;">Case
              1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 23 of 43 PageID #: 7369</font></div>
          <div style="text-align: center; margin-top: 12pt; font-size: 12pt; font-weight: bold;"> <br>
          </div>
          <div style="text-align: center; margin-top: 12pt; font-size: 12pt; font-weight: bold;">CORPORATE GOVERNANCE TERM SHEET</div>
          <div style="text-align: center; margin-top: 12pt; font-size: 12pt; font-weight: bold;">Exhibit A to Stipulation of Settlement and Agreement<br>
            <font style="font-style: italic;">Ausikaitis v. Kiani, et al.</font>, C.A. No. 12-cv-1175-SLR</div>
          <div style="text-align: center; margin-top: 12pt; font-size: 12pt; font-weight: bold;"> <br>
          </div>
          <table cellspacing="0" cellpadding="0" id="z67b7fb0dcb6f408dbe49f76ebee2a659" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">a)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The Board has appointed Craig Reynolds as a new independent director.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z54786dd4c26b4258993e2058ebbb61cc" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">b)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The Board has appointed new independent director Craig Reynolds to the Compensation Committee.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z00d17a9c1d164dcb8dd31a9e8b6b7c51" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">c)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The Board shall appoint Mr. Reynolds as Chairman of the Compensation&#160; Committee&#160; within&#160; the next thirty days.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="ze690eb360a82470f88636c26b7f6e80b" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">d)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The Board has also appointed independent director Sanford Fitch to the Compensation Committee.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="za0eff811a30146ada2e4a4fd66536bc5" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">e)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The Board has appointed General Counsel Tom McClenahan to replace CFO Mark de Raad as corporate secretary.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z45169152efea4124a396cfab274b81dc" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">f)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">Stock options will not be granted during a blackout period to any person who is an incumbent Section 16 officer and/or a director. The Compensation Committee&#160; in its minutes&#160; or consents or the General
                    Counsel or Compliance Officer in a written report to the Compensation Committee shall certify that the subject awards were not granted during a blackout period.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z2f1a2a8bb0e14da4b5b59924b7f754bf" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">g)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The Board will vote to increase the size of the Board to at least 7 directors, subject to the Board finding an appropriate and suitable independent candidate to nominate for a directorship on the Board.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z41cb39ae5f564f06be35b9ecc2a5dfa4" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">h)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">Within one year, the Board will engage a third party&#160; to review&#160; the process&#160; by which stock options and other equity award grants are made&#160; and&#160; delivered.&#160; This&#160; engagement will include (I) a review of the
                    Company's committee charters and other governing documents, and any applicable compensation plans, including the Plan, and (2) the development of a checklist of key provisions to be reviewed prior to the issuance and delivery&#160; of any&#160;
                    incentive awards.&#160; The&#160; checklist must&#160; require&#160; that&#160; the&#160; GeneraI&#160;&#160; Counsel or his/her designee analyze and confirm that, with respect to any contemplated incentive award: (i) the overall shares available under the applicable plan are
                    sufficient to cover the proposed grant, and (ii) the individual limits set forth in the applicable plan would not be exceeded by awarding the proposed grant. Such&#160; evaluation&#160; shall&#160; include an&#160; analysis of the proposed grant and all
                    other grants occurring during the relevant period.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z0ee8f98773424ae8a266a9608decd2b1" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">i)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The General Counsel and/or the Compliance Officer will report annually to the Board on the Company's compliance with its procedures, policies and guidelines for issuing stock options.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z90e6ae9a4b004256bd42bb8ff17b3bb7" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">j)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The Company's external financial statement auditors will periodically debrief the Compensation Committee regarding any changes to stock grant accounting policies and regulatory guidance.</div>
                </td>
              </tr>

          </table>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">1</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <div style="text-align: center;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 255); font-family: Arial,Helvetica,'sans-serif'; font-size: 11.5pt; font-style: normal; font-variant: normal; text-transform: none;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 24 of 43 PageID #: 7370</font></div>
          <div style="text-align: center;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 255); font-family: Arial,Helvetica,'sans-serif'; font-size: 11.5pt; font-style: normal; font-variant: normal; text-transform: none;"> <br>
            </font></div>
          <table cellspacing="0" cellpadding="0" id="zade6c9eba62e44c2b24b89435127aaf4" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">k)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The Board shall implement a policy requiring reporting of suspected violations of Masimo's compensation plans to the Company's Chief Compliance Officer and/or General Counsel.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="zb13a37b83f634b36bde4b0222039cb74" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">1)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The Board and the Compensation Committee shall agree to comply at all times with any applicable Masimo compensation plan.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z4f23f163f7d74b1ea93bb05288999c68" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">m)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The Board, via the&#160; Company's&#160; stock&#160; option&#160; administrator&#160; or&#160; otherwise,&#160; shall&#160; retain adequate documentation of all awards made under the Company's plan.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="zaae181483ca24392b6bab0f5b2c9f757" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">n)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The Board and the Compensation Committee will receive training by an independent consultant concerning laws and regulations governing all operative compensation plans and the Company's Insider Trading policy.
                    This requirement will include periodic (every 3 years) refresher training as well as training for any new member of the Board and/or Compensation Committee.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z50379eed425b46ca81421af38a8a4ee8" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">o)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The Compensation Committee has met in-person and telephonically with a new independent compensation consultant.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z7ea41bfecfd54bf8a1a25c8d026b5c15" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">p)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The Compensation Committee will continue to meet in-person and telcphonically with an independent compensation consultant periodically. Such consultant shall assist the Compensation Committee with analyzing,
                    and shall make&#160; recommendations with respect to, compensation programs, policies and practices.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z0ddd0b0152e64064ba4b15b7f413f14c" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">q)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">Where awards are to be made to non-executive directors, the Board or&#160; Compensation Committee will award non-executive director compensation that is&#160; comprised&#160; of&#160; a&#160; mix&#160; of cash and equity-based
                    compensation rather than just stock options.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z3eea059e94df4679a9dbd6cc99728338" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">r)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The Compensation Committee will formally review and approve all disclosures in proxy statements containing executive compensation disclosures before the proxy statements are publicly filed. Such review will
                    be with the assistance of the independent compensation consultant.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z739fbf4a91b1497585c7ae1d9d5faa71" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">s)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The Compensation Committee will meet separately or with the full Board for&#160; each regularly scheduled meeting. At the Compensation Committee meeting, the Compensation Committee will hold an executive session
                    outside of the presence&#160; of&#160; any&#160; Masimo executive officer. The minutes for the Compensation Committee meetings will reflect that such an executive session took place.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z5bebf116d41f4e1885427d1e7b353216" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">t)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The Board and/or Compensation Committee shall disclose to shareholders its reasons for deviating, granting an exception to or amending any previously disclosed policy governing stock option grants if the
                    Board and/or Compensation Committee determines that the deviation, granting of an exception or policy amendment is material to shareholders.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="zd32c10068f534473ab07be642a8350e1" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">u)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The Board will amend the Compensation Committee's Charter to remove the provision that automatically amends the Charter if the Compensation Committee were to approve an action or interpretation that is
                    inconsistent with the Charter.</div>
                </td>
              </tr>

          </table>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <div style="text-align: center;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 255); font-family: Arial,Helvetica,'sans-serif'; font-size: 11.5pt; font-style: normal; font-variant: normal; text-transform: none;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 25 of 43 PageID #: 7371</font></div>
          <div style="text-align: center;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 255); font-family: Arial,Helvetica,'sans-serif'; font-size: 11.5pt; font-style: normal; font-variant: normal; text-transform: none;"> <br>
            </font></div>
          <table cellspacing="0" cellpadding="0" id="z3b5909c6e88b4861a333ea955eebb4b8" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">v)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The Board's Committees shall have standing authorizations, at their discretion, to obtain legal or other advisors of their choice, who shall report directly to the Board or the Committee.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="zfd52f19ef03445b79b317b191ed9c458" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">w)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">All independent directors of the Company must satisfy the definition of an "independent director" as set forth in NASDAQ Listing Rules, or such other primary exchange where the Company's securities are
                    listed, and must have no material relationships with the Company, including members of the Company's senior management, that would impair such director's independence as determined by the Board. On at least an annual basis (and whenever
                    an individual is considered by the Nominating and Corporate Governance Committee for election as a director), the Board will analyze each current or prospective director's eligibility to be classified as "independent" under the standard
                    set forth above, taking into consideration, among other things, (i) transactions between the Company and any other entity with which a director or a member of a director's immediate family or household is affiliated, (ii) charities in
                    which a director was a partner, controlling shareholder, director, executive officer, trustee or member that have a relationship with the Company that may be relevant to independence considerations, (iii) employment by the Company of a
                    member of a director's immediate family or household, and (iv) if a current director, the length of the director's service on the Board of the Company.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="zb144f65e23f64882a62104d2eda68d95" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">x)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">Any individual who has been an employee of the Company within the past three (3) years shall be presumed to be non-independent, subject to a formal determination by the independent directors that,
                    notwithstanding such employment, such individual can be deemed independent.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z6353dec5ae9f4a279fd673ac64860532" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">y)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">In the event that a majority of the Company's shareholders vote against the election of a director nominee, the nominee shall submit a letter of resignation as soon as reasonably practicable and such
                    resignation will be effective upon the Board of Directors' acceptance of such letter of resignation.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z571b87f3a5184ba7b2139776926b4028" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">z)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">All properly submitted shareholder proposals shall be evaluated by a Committee of independent directors, chaired by an Independent Chairman and assisted by outside advisors, if necessary. The Committee shall
                    recommend to the Board for or against such shareholder proposal and the reasons for such recommendation. With respect to each shareholder proposal required to be included in a Company proxy statement, the Board shall publish any
                    recommendation it may have for or against such proposal and the reason for such recommendation in a proxy statement.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z70940161c9fd4a608cab30a5052f6a32" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">aa)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">Masimo has or shall appoint a Chief Compliance Officer, who may&#160; be&#160; the&#160; Company's chief legal officer. The Chief Compliance Officer will have responsibility for and shall review existing policies,
                    practices, and procedures pertaining to applicable laws, rules, and regulations to ensure the Company's compliance therewith. In determining&#160; whether&#160; the role of chief legal officer should or should not be separated from the role of
                    Chief Compliance Officer, the Board will consider at least the following factors: (i) whether comparable companies are separating the roles of general counsel and chief compliance officer, and why or why not; (ii) the current
                    composition of the Company's legal department</div>
                </td>
              </tr>

          </table>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">3</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <div style="text-align: center;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 255); font-family: Arial,Helvetica,'sans-serif'; font-size: 11.5pt; font-style: normal; font-variant: normal; text-transform: none;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 26 of 43 PageID #: 7372</font></div>
          <div><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 255); font-family: Arial,Helvetica,'sans-serif'; font-size: 11.5pt; font-style: normal; font-variant: normal; text-transform: none;"> <br>
            </font></div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

                <tr>
                  <td style="width: 27pt; vertical-align: top; font-size: 12pt;"><br>
                  </td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div style="font-size: 12pt;">and the skill sets and experience of the members of the legal department; (iii) the current and historical levels of the Company's compliance-related issues; and (iv) the current management structure of the
                      Company.</div>
                  </td>
                </tr>

            </table>
          </div>
          <table cellspacing="0" cellpadding="0" id="zefcc346216fe43198dc3ef7163466d6a" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">bb)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The Board's Nominating, Compliance and Corporate Governance Committee ("NCCG Committee") shall assess Masimo's compliance with all federal and state rules and regulations and all codes of ethics and conduct.
                    The Chair of the NCCG Committee may consult with Masimo's General Counsel's Office and/or retain outside advisors. Masimo's Chief Compliance Officer shall report directly to the NCCG Committee. The NCCG Committee's responsibilities are
                    or will be recorded in the NCCG Committee's Charter and does or will include the following:</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z2e2fcbbcba3143e1afa62c6612978d42" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: 27pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The development of a legal compliance and ethics program designed to evaluate, maintain and correct, when appropriate, Masimo's overall compliance with all federal and state rules and regulations and all
                    codes of ethics and conduct.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="za9ddf53563e443888535d8bac845c259" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: 27pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">Whenever it appears that a violation of any federal or state law or code of ethics or conduct has occurred or is about to occur, the NCCG Committee may determine whether an investigation is necessary. If the
                    NCCG Committee determines that an investigation is warranted, the committee may notify the Audit Committee, the Chief Executive Officer, the General Counsel and the Chief Financial Officer of its determination, and has the sole
                    authority to select, retain and terminate consultants, legal counsel or other advisors, including director search firms, to advise the Committee, at the expense of the Company, and to approve the terms of any such engagement and the
                    fees of any such consultants, legal counsel or advisors. In selecting a consultant or other advisor, the Committee will take into account factors that may be required by applicable law or listing standards or that it otherwise considers
                    appropriate.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z3e065e4cf390493a80879841fde13ac3" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: 27pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">In consultation with the Audit Committee, the NCGC Committee may review and, if appropriate, improve or suggest improvement to Masimo' s existing procedures for the receipt, retention and consideration of
                    reports or evidence of violations of applicable federal or state law or code of ethics or conduct.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z72d1bdf2efd8416a89b33248d5c161c1" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: 27pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The NCCG Committee may inform the Audit Committee, the Chief Executive Officer, the General Counsel and the Chief Financial Officer of a report of evidence of a violation (except, in the case of the Chief
                    Executive Officer, General Counsel and Chief Financial Officer only, where the Chair of the NCCG Committee believes that such a report would be inappropriate).</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="zab50025c8f6345849535c2373e6a25e3" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">cc)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The Company has or will establish a formal review, consistent with the requirements of the Dodd-Frank Act and any other federal law or regulation, to consider and, where appropriate, effect compensation
                    clawbacks for executives who engaged in acts or omissions that are ultimately determined, by final judicial decision or order for which there is no further right to appeal, to involve intentional misconduct or a knowing violation of the
                    law.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z57d23b181a794fe5b9d4bdd4f0c59fbb" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">dd)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The NCCG Committee shall meet at least twice per fiscal year.</div>
                </td>
              </tr>

          </table>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">4</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <div style="text-align: center;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 255); font-family: Arial,Helvetica,'sans-serif'; font-size: 11.5pt; font-style: normal; font-variant: normal; text-transform: none;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 27 of 43 PageID #: 7373</font></div>
          <div><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 255); font-family: Arial,Helvetica,'sans-serif'; font-size: 11.5pt; font-style: normal; font-variant: normal; text-transform: none;"> <br>
            </font></div>
          <table cellspacing="0" cellpadding="0" id="zcfe4d970e4f44ef2aff85c0276d25742" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">ee)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">Neither the Chairman of the Board, if not independent, nor any other Section 16 corporate officer shall serve as a member of the NCCG Committee.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z2808b6f2d72648bc9a038bdc45757305" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">ff)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The Company has or will establish procedures by which the NCCG Committee of the Company is responsible for formally considering and recommending to the Board candidates to be nominated for election or
                    reelection to the Board at each annual meeting of stockholders or to be elected by the Board as necessary to fill vacancies and newly created directorships.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z32f153f3c2b64392b06fa326d5068c96" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">gg)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The Board will engage in succession planning for its Section 16 officers.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="zec4fb14914fc49588f1f95f1fd6750fd" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">hh)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The Compensation Committee Chair will be responsible for (i) coordinating and monitoring executive sessions of the Board concerning matters relating to executive compensation, (ii) acting as principal liaison
                    with the Company's Chairman and Chief Executive Officer concerning matters relating to executive compensation, and (iii) determining the nature, and quantity of information provided to the independent directors by the Company's
                    management, including information specifically requested by the Chair.</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z8de6741c6bb34847a109d288d035a910" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 12pt;">

              <tr>
                <td style="width: -9pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; font-size: 12pt;">ii)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;">The NCCG Chair will be responsible for (i) coordinating and monitoring executive sessions of the Board concerning matters relating to corporate governance, (ii) acting as principal liaison with the Company's
                    Chairman and Chief Executive Officer concerning matters relating to corporate governance, and (iii) determining the nature, and quantity of information provided to the independent directors by the Company's management, including
                    information specifically requested by the Chair.</div>
                </td>
              </tr>

          </table>
          <font style="font-size: 11.5pt;"> <br>
          </font></div>
        <div><font style="font-size: 11.5pt;"><br>
          </font>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">5</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            <div class="BRPFPageHeader"></div>
          </div>
          <div>
            <div>
              <div style="line-height: 11.4pt; margin-top: 0.25pt;"><font style="font-size: 11.5pt;"><br>
                </font></div>
              <div><font style="font-size: 11.5pt;"> <br>
                </font></div>
              <div>
                <div style="text-align: center; line-height: 13.7pt; margin-top: 4.6pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 11.5pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 28 of 43 PageID
                  #: 7374</div>
                <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                </div>
                <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                </div>
                <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                </div>
                <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                </div>
                <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                </div>
                <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                </div>
                <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                </div>
                <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                </div>
                <div style="line-height: 11.4pt;">
                  <div style="line-height: 11.4pt; text-align: center;"><font style="font-size: 48pt;">EXHIBIT B</font><br style="line-height: 11.4pt;">
                  </div>
                  <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                  </div>
                </div>
                <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                </div>
                <div style="line-height: 11.4pt;"><font style="font-size: 11.5pt;"><br>
                  </font><br>
                </div>
                <br>
              </div>
              <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                <div class="BRPFPageFooter"></div>
                <div class="BRPFPageBreak" style="page-break-after: always;">
                  <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                <div class="BRPFPageHeader"></div>
              </div>
              <div>
                <div style="font-size: 14pt;">
                  <div style="text-align: center;"> <font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 255); font-family: Arial,Helvetica,'sans-serif'; font-size: 11.5pt; font-style: normal; font-variant: normal; text-transform: none;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 29 of 43 PageID #: 7375</font> </div>
                  <div><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 255); font-family: Arial,Helvetica,'sans-serif'; font-size: 11.5pt; font-style: normal; font-variant: normal; text-transform: none;"> <br>
                    </font></div>
                  <div><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 255); font-family: Arial,Helvetica,'sans-serif'; font-size: 11.5pt; font-style: normal; font-variant: normal; text-transform: none;"> <br>
                    </font></div>
                </div>
                <br>
                <div style="font-size: 14pt; font-weight: bold; text-align: center;">IN THE UNITED STATES DISTRICT COURT </div>
                <div style="font-size: 14pt; font-weight: bold; text-align: center;">FOR THE DISTRICT OF DELAWARE</div>
                <div style="text-align: center; margin-right: 30.9pt; margin-left: 31.8pt; margin-top: 3pt; font-size: 14pt;"> <br>
                </div>
                <div style="margin-top: 0.5pt; margin-bottom: 0.05pt;"><br>
                </div>
                <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 49%; vertical-align: top;">
                        <div>
                          <div style="margin-right: 11.5pt; margin-left: 10pt; font-size: 14pt;">JOSEPH P. AUSIKAITIS, derivatively on </div>
                          <div style="margin-right: 11.5pt; margin-left: 10pt; font-size: 14pt;">behalf of MASIMO CORPORATION,</div>
                          <div>&#160;</div>
                          <div style="font-size: 14pt; margin-left: 126pt;">Plaintiff,</div>
                          <div style="margin-left: 81.05pt; font-size: 14pt;"> <br>
                          </div>
                          <div style="font-size: 14pt; margin-left: 63pt;">v.</div>
                          <div>&#160;</div>
                          <div style="margin-left: 10pt; font-size: 14pt;">JOE KIANI, et al.,</div>
                          <div style="margin-right: 41.55pt; margin-left: 63.95pt; font-size: 14pt;"> <br>
                          </div>
                          <div style="font-size: 14pt; margin-left: 126pt;">Defendants,</div>
                          <div style="margin-left: 81.25pt; font-size: 14pt;"> <br>
                          </div>
                          <div style="font-size: 14pt; margin-left: 63pt;">-and-</div>
                          <div style="margin-right: 12.65pt; margin-left: 10pt; font-size: 14pt;"> <br>
                          </div>
                          <div style="margin-right: 11.5pt; margin-left: 10pt; font-size: 14pt;">MASIMO CORPORATION, a Delaware</div>
                          <div style="margin-right: 11.5pt; margin-left: 10pt; font-size: 14pt;">Corporation,</div>
                          ,
                          <div style="margin-right: 12.65pt; margin-left: 10pt; font-size: 14pt;"> <br>
                          </div>
                          <div style="font-size: 14pt; margin-left: 126pt;">Nominal Defendant.</div>
                        </div>
                      </td>
                      <td style="width: 2%; vertical-align: top;">
                        <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                        <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                        <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                        <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                        <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                        <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                        <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                        <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                        <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                        <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                        <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                        <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                        <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                        <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                        <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                        <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                        <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                        <div style="margin-left: 12.4pt; font-size: 14pt;"> </div>
                        <div style="margin-left: 12.4pt; font-size: 14pt;"> </div>
                      </td>
                      <td style="width: 49%; vertical-align: top;">
                        <div style="margin: 0px 0px 0px 5.4pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt;"> <br>
                        </div>
                        <div style="margin: 0px 0px 0px 5.4pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt;"> <br>
                        </div>
                        <div style="margin: 0px 0px 0px 5.4pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt;">C.A. No. 1:12-cv-1175-SLR</div>
                        <div>&#160;</div>
                        <div style="margin: 6pt 0px 0px 6.25pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt; font-weight: bold;"> <br>
                        </div>
                        <div style="margin: 6pt 0px 0px 6.25pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt; font-weight: bold;"> <br>
                        </div>
                        <div style="margin: 6pt 0px 0px 6.25pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt; font-weight: bold;"> <br>
                        </div>
                        <div style="margin: 6pt 0px 0px 6.25pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt; font-weight: bold;"><u>JURY TRIAL DEMANDED</u></div>
                      </td>
                    </tr>

                </table>
              </div>
              <div>
                <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                </div>
                <div style="text-align: center; line-height: 13.1pt; margin-top: 12pt; margin-bottom: 12pt; font-size: 12pt; font-weight: bold;">[PROPOSED] ORDER ON UNOPPOSED MOTION FOR<br>
                  <u>PRELIMINARY APPROVAL OF SETTLEMENT</u></div>
              </div>
              <div>
                <div style="text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">WHEREAS, Plaintiff Joseph P. Ausikaitis has moved, pursuant to Federal Rule of Civil Procedure 23.1, for an order (i) preliminarily approving the settlement of the
                  Action, in accordance with a Stipulation and Agreement of Settlement (&#8220;Agreement&#8221;), which, together with the Exhibits annexed thereto, sets forth the terms and conditions for a proposed settlement and dismissal of the Action with
                  prejudice; (ii) approving for distribution the form of notice&#160; described in the Agreement; and (iii) scheduling a fairness hearing before the Court to determine whether the proposed settlement should be finally approved; and</div>
                <div style="text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">WHEREAS, the Court, having considered the Unopposed Motion for Preliminary Approval of Derivative Settlement and Notice to Masimo Stockholders, the Agreement, and the
                  Exhibits annexed thereto:</div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div class="BRPFPageFooter"></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                  <div class="BRPFPageHeader"></div>
                </div>
                <div style="text-align: center; line-height: 26.2pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 30 of 43 PageID #: 7376</div>
                <div style="line-height: 22.8pt;"><br style="line-height: 22.8pt;">
                </div>
                <div style="text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">NOW, THEREFORE, IT IS HEREBY ORDERED:</div>
                <div style="text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">1.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt;">Plaintiff&#8217;s








                    Unopposed Motion for Preliminary Approval of Derivative Settlement and Notice to Masimo Stockholders (D.I. _____) is GRANTED.</font></div>
                <div style="text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">2.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt;">This








                    Court does hereby preliminarily approve, subject to further consideration at the Settlement Hearing described below, the Agreement and the settlement set forth therein, including the terms and conditions for settlement and dismissal
                    with prejudice of this Action.</font></div>
                <div style="text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">3.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt;">A
                    hearing (the &#8220;Settlement Hearing&#8221;) shall be held on June [17], 2015 at [[9]:00 a.m.] before this Court in Courtroom 4B, located at J. Caleb Boggs Federal Building, 844 N. King Street, Wilmington, DE 19801, to determine whether the
                    settlement provided for in the Agreement is fair, reasonable, and adequate to Masimo Corporation (&#8220;Masimo&#8221;) and its current stockholders as of April<u> ___</u>, 2015, and should be approved by the Court; whether a Judgment as provided
                    in &#182; 1.3 of the Agreement should be entered herein; and to award attorneys&#8217; fees to Plaintiff&#8217;s counsel and a service award to Plaintiff.</font></div>
                <div style="text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">4.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt;">This








                    Court approves, as to the form and content, the Notice of Pendency of Derivative Action, Proposed Settlement of Derivative Action, and Settlement Hearing (the &#8220;Notice&#8221;), attached as Exhibit C to the Agreement, and finds that the mailing
                    of these notices, substantially in the manner and form set forth in the Agreement and this Order, meets the requirements of Federal Rule of Civil Procedure 23.1 and due process, as the best notice practicable under the circumstances,
                    and shall constitute due and sufficient notice to Masimo&#8217;s stockholders. The cost of mailing the Notice shall be borne by Masimo and/or its insurers. Any interested party may request, in writing to Plaintiff&#8217;s counsel at the address
                    below, to receive a copy of the Notice.</font></div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div class="BRPFPageFooter">
                    <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                    </div>
                  </div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                  <div class="BRPFPageHeader"></div>
                </div>
                <div style="text-align: center; line-height: 26.2pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 31 of 43 PageID #: 7377</div>
                <div style="line-height: 22.8pt;"><br style="line-height: 22.8pt;">
                </div>
                <div style="text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">5.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt;">Not








                    later than ten (10) calendar days after the date the Court enters this Order, Masimo shall cause the Notice to be mailed to the current record holders and beneficial owners&#160; of common stock of Masimo via first-class mail through the
                    U.S. Postal Service, or an equivalent method of mailing.</font></div>
                <div style="text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">6.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt;">Plaintiff&#8217;s








                    counsel, Levi &amp; Korsinsky will provide the Notice in response to written requests for the Notice by interested persons.</font></div>
                <div style="text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">7.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt;">At








                    least ten (10) calendar days prior to the Settlement Hearing, Masimo shall file with the Court proof, by affidavit or declaration, of such mailing and publishing.</font></div>
                <div style="text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">8.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt;">All








                    Masimo stockholders shall be bound by all orders, determinations and judgments in this Action concerning the settlement, whether favorable or unfavorable to the Masimo stockholders.</font></div>
                <div style="text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">9.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt;">Pending








                    final determination of whether the settlement should be approved, no Masimo stockholders, either directly, representatively, or in any other capacity, shall commence or prosecute against any of the Released Persons, any action or
                    proceeding in any court or tribunal asserting any of the Released Claims.</font></div>
                <div style="text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">10.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt;">All








                    papers in support of the settlement shall be filed with the Court and served at least fifteen (15) calendar days before the date of the Settlement Hearing.</font></div>
                <div style="text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">11.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt;">Any








                    current Masimo stockholders as of April ___, 2015, the date the Agreement was filed, may appear and show cause, if he, she or it has any reason why the settlement should not be approved as fair, reasonable and adequate, or why a
                    Judgment should not be entered thereon, or why attorneys&#8217; fees should not be awarded to Plaintiff&#8217;s Counsel; provided, however, that no Masimo stockholders shall be heard or entitled to contest the approval of the terms and conditions
                    of the settlement unless that person has, at least fourteen (14) calendar days before the</font></div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div class="BRPFPageFooter">
                    <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                    </div>
                  </div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                  <div class="BRPFPageHeader"></div>
                </div>
                <div style="text-align: center; line-height: 26.2pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 32 of 43 PageID #: 7378</div>
                <div style="line-height: 22.8pt;"><br style="line-height: 22.8pt;">
                </div>
                <div style="line-height: 22.8pt;"><br style="line-height: 22.8pt;">
                </div>
                <div style="line-height: 26.2pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Settlement Hearing, filed with the Clerk of Court and served on the following counsel (delivered by hand or sent by first class mail) written
                  objections and copies of any papers and briefs in support thereof:</div>
                <div style="line-height: 26.2pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">
                  <div style="line-height: 13.1pt; margin-left: 45pt;">Eduard Korsinsky </div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">Steven J. Purcell</div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">LEVI &amp; KORSINSKY LLP</div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">30 Broad Street, 24th Floor </div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">New York, NY 10004</div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">Tel:&#160; (212) 363-7500</div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">Fax:&#160; (866) 367-6510</div>
                  <div style="line-height: 13.1pt;"><br style="line-height: 13.1pt;">
                  </div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">Brian E. Farnan </div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">Michael J. Farnan </div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">FARNAN LLP</div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">919 Market Street, 12th Floor </div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">Wilmington, DE 19801</div>
                  <div style="line-height: 13.1pt;"><br style="line-height: 13.1pt;">
                  </div>
                  <div style="line-height: 13.1pt; font-style: italic; margin-left: 45pt;">Attorneys for Plaintiff Joseph P. Ausikaitis</div>
                  <div style="line-height: 13.1pt;"><br style="line-height: 13.1pt;">
                  </div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">PAUL HASTINGS LLP </div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">PETER M. STONE</div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">1117 S. California Avenue </div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">Palo Alto, CA 94304 </div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">Telephone: (650) 320-1800</div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">Facsimile: (650) 320-1900</div>
                  <div style="line-height: 13.1pt;"><br style="line-height: 13.1pt;">
                  </div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">PAUL HASTINGS LLP </div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">WILLIAM F. SULLIVAN</div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">515 S. Flower Street, 25th Floor </div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">Los Angeles, CA 90071 </div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">Telephone: (213) 683-6000</div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">Facsimile: (213) 627-0705</div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;"> <br>
                  </div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">PRICKETT, JONES &amp; ELLIOTT</div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">J. CLAYTON ATHEY </div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">ERIC J. JURAY</div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">1310 King Street, P.O. Box 1328</div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">Wilmington, DE 19899</div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">Telephone: (302) 888-6500</div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">Facsimile: (302) 658-8111</div>
                  <div style="line-height: 13.1pt;"><br style="line-height: 13.1pt;">
                  </div>
                  <div style="line-height: 13.1pt; font-style: italic; margin-left: 45pt;">Attorneys for Individual Defendants Joe Kiani, </div>
                  <div style="line-height: 13.1pt; font-style: italic; margin-left: 45pt;">Steven J. Barker, Robert Coleman, Jack </div>
                  <div style="line-height: 13.1pt; font-style: italic; margin-left: 45pt;">Lasersohn, Sanford Fitch, Jon Coleman, Mark P.</div>
                  <div style="line-height: 13.1pt; font-style: italic;"> <br>
                  </div>
                  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                    <div class="BRPFPageFooter">
                      <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                      </div>
                    </div>
                    <div style="page-break-after: always;" class="BRPFPageBreak">
                      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                    <div class="BRPFPageHeader"></div>
                  </div>
                  <div style="text-align: center; line-height: 13.1pt; color: rgb(0, 0, 255);">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 33 of 43 PageID #: 7379</div>
                  <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                  </div>
                  <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                  </div>
                  <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                  </div>
                  <div style="line-height: 13.1pt; font-style: italic; margin-left: 45pt;">de Raad, Rick Fishel, Yongsam Lee, and Anand </div>
                  <div style="line-height: 13.1pt; font-style: italic; margin-left: 45pt;">Sampath, and former Individual Defendant </div>
                  <div style="line-height: 13.1pt; font-style: italic; margin-left: 45pt;">Edward Cahill</div>
                  <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                  </div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">RICHARDS, LAYTON &amp; FINGER, P.A. </div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">ANNE C. FOSTER</div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">SUSAN HANNIGAN</div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">920 N. King Street </div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">Wilmington, DE 19801</div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">Telephone: (302) 651-7700</div>
                  <div style="line-height: 13.1pt; margin-left: 45pt;">Facsimile: (302) 651-7701</div>
                  <div style="line-height: 13.1pt;"><br style="line-height: 13.1pt;">
                  </div>
                  <div style="line-height: 13.1pt; font-style: italic; margin-left: 45pt;">Attorneys for Nominal Defendant Masimo Corp.</div>
                  <div class="BRPFPageFooter">
                    <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                    </div>
                  </div>
                </div>
                <div class="BRPFPageFooter">
                  <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                  </div>
                </div>
              </div>
              <div> <br>
              </div>
              <div>
                <div style="text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">The written objections and copies of any papers and briefs in support thereof to be filed in Court shall be delivered by hand or sent by first class mail to:</div>
                <div style="font-size: 12pt; text-indent: 36pt;">
                  <div>Clerk of Court</div>
                  <div>United States District Court</div>
                  <div>District of Delaware</div>
                  <div>844 North King St Unit 18</div>
                  <div>Wilmington, DE 19801-3570</div>
                </div>
                <div style="text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">Any Masimo stockholder who fails to object or otherwise request to be heard in the manner prescribed above will be deemed to have waived the right to object to any aspect
                  of the settlement or to otherwise request to be heard (including the right to appeal) and will be forever barred from raising such objection or request to be heard in this or any other action or proceeding, and shall be bound by the
                  settlement, the Judgment, and the releases given.</div>
                <div style="text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">12.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt;">All








                    replies to any objections shall be filed and served at least seven (7) calendar days before the Settlement Hearing.</font></div>
                <div style="text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">13.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt;">Neither








                    the Agreement, its Exhibits, terms, or provisions, nor any of the negotiations or proceedings connected with it, shall be deemed, used or construed as an admission or concession by any of the defendants in this Action, or as evidence of
                    the truth or</font></div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div class="BRPFPageFooter">
                    <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                    </div>
                  </div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                  <div class="BRPFPageHeader"></div>
                </div>
                <div style="line-height: 26.2pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">
                  <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                  </div>
                  <div style="text-align: center; line-height: 13.1pt; margin-top: 3.75pt; color: rgb(0, 0, 255);">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 34 of 43 PageID #: 7380</div>
                </div>
                <div style="line-height: 26.2pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;"> <br>
                </div>
                <div style="line-height: 26.2pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">validity of any of the allegations in this Action, or of any liability, fault or wrongdoing of any kind.</div>
                <div style="text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">14.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt;">The








                    Court reserves the right to adjourn the date of the Settlement Hearing or to modify any other dates set forth herein without further notice to the Masimo stockholders, and retains jurisdiction to consider all further applications
                    arising out of or connected to the settlement. The Court may approve the settlement, with such modifications as may be agreed to by the parties, if appropriate, without further notice to the Masimo stockholders.</font></div>
                <div style="line-height: 26.2pt;">
                  <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: Arial, Helvetica, sans-serif; font-size: 10pt;">

                      <tr>
                        <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                        <td valign="top" colspan="2" style="width: 38%; font-size: 12pt;"><strong></strong><br>
                        </td>
                        <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="top" style="width: 50%;">
                          <div style="margin-left: 9pt; font-size: 12pt;">
                            <div style="margin-left: 9pt">
                              <div style="margin-left: 9pt">
                                <div style="margin-left: 9pt">
                                  <div style="margin-left: 9pt">
                                    <div style="margin-left: 9pt">
                                      <div style="margin-left: 9pt">
                                        <div style="margin-left: 9pt">
                                          <div style="margin-left: 9pt">
                                            <div style="margin-left: 9pt">IT IS SO ORDERED. <br>
                                            </div>
                                          </div>
                                        </div>
                                      </div>
                                    </div>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </td>
                        <td valign="top" style="width: 3%; font-size: 12pt;">&#160;</td>
                        <td valign="top" style="width: 35%; font-size: 12pt;">&#160;</td>
                        <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="top" rowspan="1" style="width: 50%; font-size: 12pt;">&#160;</td>
                        <td valign="top" rowspan="1" style="width: 3%; font-size: 12pt;">&#160;</td>
                        <td valign="top" rowspan="1" style="width: 35%; font-size: 12pt;">&#160;</td>
                        <td valign="top" rowspan="1" style="width: 12%; font-size: 12pt;">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="top" rowspan="1" style="width: 50%; padding-bottom: 2px; font-size: 12pt;">&#160;</td>
                        <td valign="top" rowspan="1" style="width: 3%; padding-bottom: 2px; font-size: 12pt;">&#160;</td>
                        <td valign="top" rowspan="1" style="width: 35%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 12pt;">&#160;</td>
                        <td valign="top" rowspan="1" style="width: 12%; padding-bottom: 2px; font-size: 12pt;">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                        <td valign="top" style="width: 3%; font-size: 12pt;">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" align="left" style="width: 35%; font-size: 12pt;">Honorable Sue L. Robinson</td>
                        <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                        <td valign="top" style="width: 3%; font-size: 12pt;">&#160;</td>
                        <td valign="top" style="width: 35%; font-size: 12pt;">United States District Judge</td>
                        <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                        <td valign="top" style="width: 3%; font-size: 12pt;">&#160;</td>
                        <td valign="top" style="width: 35%; font-size: 12pt;">&#160;</td>
                        <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                      </tr>

                  </table>
                  <font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;"> </font></div>
                <div style="line-height: 26.2pt;"><br>
                  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                    <div class="BRPFPageFooter">
                      <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                      </div>
                    </div>
                    <div style="page-break-after: always;" class="BRPFPageBreak">
                      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                    <div class="BRPFPageHeader"></div>
                  </div>
                  <div class="BRPFPageFooter">
                    <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                    </div>
                  </div>
                </div>
                <div class="BRPFPageFooter">
                  <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                  </div>
                </div>
              </div>
              <div>
                <div>
                  <div style="text-align: center; line-height: 13.7pt; margin-top: 4.6pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 11.5pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 35 of 43 PageID
                    #: 7381</div>
                  <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                  </div>
                  <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                  </div>
                  <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                  </div>
                  <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                  </div>
                  <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                  </div>
                  <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                  </div>
                  <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                  </div>
                  <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                  </div>
                  <div style="line-height: 11.4pt;">
                    <div style="line-height: 11.4pt; text-align: center;"><font style="font-size: 48pt;">EXHIBIT C</font><br style="line-height: 11.4pt;">
                    </div>
                    <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                    </div>
                  </div>
                  <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                  </div>
                  <div style="line-height: 11.4pt;"><font style="font-size: 11.5pt;"><br>
                    </font><br>
                  </div>
                  <br>
                </div>
                <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                  <div class="BRPFPageFooter"></div>
                  <div class="BRPFPageBreak" style="page-break-after: always;">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                  <div class="BRPFPageHeader"></div>
                </div>
                <div>
                  <div>
                    <div>&#160;
                      <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                      </div>
                      <div style="text-align: center; line-height: 13.1pt; margin-top: 6pt; color: #0000FF; font-size: 12pt;">Case 1:12-cv-01175-SLR&#160; &#160; Document 229-1&#160; &#160; Filed 05/06/15&#160; &#160; Page 36 of 43 PageID #: 7382</div>
                      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                      </div>
                      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                      </div>
                      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                      </div>
                      <div style="line-height: 10.25pt; margin-top: 0.55pt;"><br style="line-height: 10.25pt;">
                      </div>
                      <div style="font-family: Arial, Helvetica, 'sans-serif'; text-align: right;">EXHIBIT C</div>
                      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                      </div>
                      <div style="line-height: 10.85pt; margin-top: 0.45pt;"><br style="line-height: 10.85pt;">
                      </div>
                      <div style="text-indent: 36pt; line-height: 10.85pt;"><font style="font-family: Arial,Helvetica,sans-serif;">TO:</font><font style="display: inline-block; text-indent: 0px; width: 36pt;" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-family: Arial,Helvetica,sans-serif;">ALL CURRENT STOCKHOLDERS OF MASIMO, INC. (&#8220;MASIMO&#8221; OR THE &#8220;COMPANY&#8221;) COMMON STOCK AS OF APRIL 30, 2015.</font></div>
                      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                      </div>
                      <div style="text-indent: 36pt; line-height: 10.85pt; font-family: Arial,Helvetica,sans-serif;">PLEASE TAKE NOTICE that the stockholder derivative action entitled Joseph P. Ausikaitis, derivatively on behalf of Masimo Corporation v.
                        Joe Kiani, et al., Case No. 12-cv-1175-SLR (the &#8220;Action&#8221;), is being settled and the parties have entered into a Stipulation of Settlement dated April<u> ___</u>, 2015 (&#8220;Stipulation&#8221;).</div>
                      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                      </div>
                      <div style="text-indent: 36pt; line-height: 10.85pt; font-family: Arial,Helvetica,sans-serif;">IF YOU ARE A CURRENT OWNER OF MASIMO COMMON STOCK, YOUR RIGHTS MAY BE AFFECTED BY PROCEEDINGS IN THE ACTION.&#160; PLEASE NOTE THAT THE ACTION
                        IS NOT A&#160; &#8220;CLASS ACTION&#8221; AND NO INDIVIDUAL STOCKHOLDER HAS THE RIGHT BE COMPENSATED AS A RESULT OF THIS SETTLEMENT.</div>
                      <div style="line-height: 10.85pt;"><br style="line-height: 10.85pt;">
                      </div>
                      <div style="text-indent: 36pt; line-height: 10.85pt; font-family: Arial,Helvetica,sans-serif;">On [June 17, 2015, at 9:00 a.m.], a settlement hearing (the &#8220;Settlement Hearing&#8221;) will be held before The Honorable Sue L. Robinson,
                        District Court Judge for the District of Delaware, in Courtroom 4B, located at J. Caleb Boggs Federal Building, 844 N. King Street, Wilmington, DE 19801, to determine: (i) whether the terms of the settlement should be approved as
                        fair, reasonable, and adequate; and (ii) whether the Action should be dismissed on the merits and with prejudice.</div>
                      <div style="line-height: 10.85pt;"><br style="line-height: 10.85pt;">
                      </div>
                      <div style="text-indent: 36pt; line-height: 10.85pt; font-family: Arial,Helvetica,sans-serif;">The terms of the settlement set forth in the Stipulation include the adoption and/or implementation of a variety of corporate governance
                        measures, including enhanced requirements for granting stock options to Section 16 officers and/or a director, the appointment of a new Chairman of the Compensation Committee, and a vote of the Board of Directors to increase the
                        number of directors serving on the Company&#8217;s Board of Directors.</div>
                      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                      </div>
                      <div style="text-indent: 36pt; line-height: 10.85pt; font-family: Arial,Helvetica,sans-serif;">Any current stockholder of Masimo that wishes to enter an appearance and object to the settlement shall have a right to appear and to be
                        heard at the Settlement Hearing, provided that he or she was a stockholder of record as of April 30, 2015, and that they follow the steps listed below. Any stockholder of Masimo who satisfies this requirement may enter an appearance
                        through counsel of such member&#8217;s own choosing and at such member&#8217;s own expense or may appear on his, her, or its own. However, no stockholder of Masimo shall be heard at the settlement hearing unless, no later than fourteen (14)
                        days prior to the date of the settlement hearing, such stockholder has filed with the Court and delivered to Plaintiffs&#8217; Counsel, counsel for the Individual Defendants and nominal party&#160;&#160; Masimo (listed below):&#160; (a) a written notice
                        of intention to appear; (b) proof of ownership of Masimo stock, including the date(s) such Person acquired his, her or its Masimo shares; (c) a statement of objections to any matter before the Court; and (d) the grounds therefore or
                        the reasons for wanting to appear and be heard, as well as all documents or writings the Court shall be asked to consider. Only stockholders who have followed the procedures above and have filed and delivered valid and timely
                        written notices of objection will be entitled to be heard at the Settlement Hearing unless the Court orders otherwise.</div>
                      <div style="line-height: 10.85pt;"><br style="line-height: 10.85pt;">
                      </div>
                      <div style="text-indent: 36pt; line-height: 10.85pt; font-family: Arial,Helvetica,sans-serif;">If you wish to object to the settlement, you must file a written objection setting forth the grounds for such an objection with the Court
                        on or before [June 3], 2015, with service on the following parties:</div>
                      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                      </div>
                      <div style="text-indent: 36pt; line-height: 10.85pt; font-family: Arial,Helvetica,sans-serif;">[Counsel listed on following page]</div>
                      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                        <div class="BRPFPageFooter">
                          <table cellspacing="0" cellpadding="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z04fe12c14f42418bb247f449f7c98368">

                              <tr>
                                <td style="width: 100%; vertical-align: top;">&#160;</td>
                              </tr>

                          </table>
                          <div style="line-height: 0.65pt;"><br style="line-height: 0.65pt;">
                          </div>
                        </div>
                        <div style="page-break-after: always;" class="BRPFPageBreak">
                          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                        <div class="BRPFPageHeader"></div>
                      </div>
                      <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                      </div>
                      <div style="text-align: center; line-height: 13.1pt; margin-top: 6pt; color: #0000FF; font-size: 12pt;">Case 1:12-cv-01175-SLR&#160; &#160; Document 229-1&#160; &#160; Filed 05/06/15&#160; &#160; Page 37 of 43 PageID #: 7383</div>
                      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                      </div>
                      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                      </div>
                      <br>
                      <div>
                        <div class="BRPFPageHeader">
                          <div style="line-height: 13.7pt;"><br style="line-height: 13.7pt;">
                          </div>
                        </div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">LEVI &amp; KORSINSKY LLP</div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">Edward Korsinsky</div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">Steven J. Purcell</div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">Christopher Kupka</div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">30 Broad Street, 24th Floor</div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">New York, NY 10004</div>
                        <div style="line-height: 13.7pt;"><br style="line-height: 13.7pt;">
                        </div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">FARNAN LLP</div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">Brian E. Farnan</div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">Michael J. Farnan</div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">919 Market Street, 12th Floor</div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">Wilmington, DE 19801</div>
                        <div style="line-height: 13.7pt;"><br style="line-height: 13.7pt;">
                        </div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">Counsel for Plaintiff</div>
                        <div style="line-height: 13.7pt;"><br style="line-height: 13.7pt;">
                        </div>
                        <div style="line-height: 13.7pt;"><br style="line-height: 13.7pt;">
                        </div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">PAUL HASTINGS LLP</div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">Peter M. Stone</div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">1117 South California Avenue</div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">Palo Alto, CA 94304</div>
                        <div style="line-height: 13.7pt;"><br style="line-height: 13.7pt;">
                        </div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">PAUL HASTINGS LLP</div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">William F. Sullivan</div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">515 South Flower Street, 25th Floor</div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">Los Angeles, CA 90071</div>
                        <div style="line-height: 13.7pt;"><br style="line-height: 13.7pt;">
                        </div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">PRICKET, JONES, &amp; ELLIOT, P.A.</div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">J. Clayton Athey</div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">1310 King Street</div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">P.O. Box 1328</div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">Wilmington, DE 19899</div>
                        <div style="line-height: 13.7pt;"><br style="line-height: 13.7pt;">
                        </div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">Counsel for the Individual Defendants</div>
                        <div style="line-height: 13.7pt;"><br style="line-height: 13.7pt;">
                        </div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">RICHARDS, LAYTON &amp; FINGER, P.A.</div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">Anne C. Foster</div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">920 North King Street</div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">Wilmington, DE 19801</div>
                        <div style="line-height: 13.7pt;"><br style="line-height: 13.7pt;">
                        </div>
                        <div style="line-height: 13.7pt; font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">Counsel for Nominal Party Masimo Corporation</div>
                        <div class="BRPFPageFooter">
                          <div style="line-height: 13.7pt;"><br style="line-height: 13.7pt;">
                          </div>
                        </div>
                      </div>
                      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                      </div>
                      <div style="text-indent: 36pt; line-height: 10.85pt; font-family: Arial,Helvetica,sans-serif;">Inquiries may be made to Steven J. Purcell of Levi &amp; Korsinsky LLP, 30 Broad Street, 24th Floor New York, NY 10004, telephone (212)
                        363-7500.</div>
                      <div style="text-indent: 36pt; line-height: 10.85pt; font-family: Arial,Helvetica,sans-serif;"> <br>
                      </div>
                      <div style="text-indent: 36pt; line-height: 10.85pt; font-family: Arial,Helvetica,sans-serif;"> <br>
                      </div>
                      <div style="line-height: 10.85pt;"><font style="font-family: Arial,Helvetica,sans-serif;"> </font>
                        <table cellspacing="0" cellpadding="0" border="0" align="left" id="z6c109bf7e9064ed9a1ba5bfc21a56fb6" style="width: 50%; color: #000000; font-family: Arial, Helvetica, 'sans-serif'; font-size: 10pt;">

                            <tr>
                              <td style="width: 50%; text-align: left; vertical-align: top;">
                                <div><font style="font-family: Arial,Helvetica,sans-serif;">DATED:</font> ____ _________________<font style="font-family: Arial,Helvetica,sans-serif;">, 2015</font> <br>
                                </div>
                              </td>
                              <td style="width: 50%; text-align: left; vertical-align: top;">
                                <div style="line-height: 10.85pt; clear: both;"><font style="font-family: Arial,Helvetica,sans-serif;">BY ORDER OF THE COURT</font></div>
                                <div style="line-height: 10.85pt; margin-top: 0.15pt; font-family: Arial,Helvetica,sans-serif;">U.S. DISTRICT COURT</div>
                                <div style="line-height: 10.85pt; margin-top: 0.2pt; font-family: Arial,Helvetica,sans-serif;">FOR THE DISTRICT OF DELAWARE</div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width: 50%;">
                                <div>&#160;</div>
                              </td>
                              <td style="width: 50%;">
                                <div>&#160;</div>
                              </td>
                            </tr>

                        </table>
                      </div>
                      <br style="clear: both;">
                      <div style="margin-left: 274.4pt; line-height: 10.85pt; margin-top: 0.2pt; font-family: Arial,Helvetica,sans-serif;"> <br>
                      </div>
                      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                        <div class="BRPFPageFooter">
                          <table cellspacing="0" cellpadding="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z6f79499aa31749b99656e8177b0b911a">

                              <tr>
                                <td style="width: 100%; vertical-align: top;">&#160;</td>
                              </tr>

                          </table>
                          <div style="line-height: 0.65pt;"><br style="line-height: 0.65pt;">
                          </div>
                        </div>
                        <div style="page-break-after: always;" class="BRPFPageBreak">
                          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                        <div class="BRPFPageHeader"></div>
                      </div>
                      <div class="BRPFPageFooter">
                        <div style="line-height: 0.65pt;"><br style="line-height: 0.65pt;">
                        </div>
                        <div style="line-height: 0.65pt;"><br style="line-height: 0.65pt;">
                        </div>
                        <div style="line-height: 0.65pt;">
                          <div>
                            <div style="text-align: center; line-height: 13.7pt; margin-top: 4.6pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 11.5pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 38 of
                              43 PageID #: 7384</div>
                            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                            </div>
                            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                            </div>
                            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                            </div>
                            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                            </div>
                            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                            </div>
                            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                            </div>
                            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                            </div>
                            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                            </div>
                            <div style="line-height: 11.4pt;">
                              <div style="line-height: 11.4pt; text-align: center;"><font style="font-size: 48pt;">EXHIBIT D</font><br style="line-height: 11.4pt;">
                              </div>
                              <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                              </div>
                            </div>
                            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                            </div>
                            <div style="line-height: 11.4pt;"><font style="font-size: 11.5pt;"><br>
                              </font><br>
                            </div>
                            <br>
                          </div>
                          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                            <div class="BRPFPageFooter"></div>
                            <div class="BRPFPageBreak" style="page-break-after: always;">
                              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                            <div class="BRPFPageHeader"></div>
                          </div>
                          <div>
                            <div>
                              <div>&#160;
                                <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                        <div style="line-height: 0.65pt;"><br style="line-height: 0.65pt;">
                        </div>
                        <div style="line-height: 0.65pt;"><br style="line-height: 0.65pt;">
                        </div>
                        <div style="line-height: 0.65pt;"><br style="line-height: 0.65pt;">
                        </div>
                        <div style="line-height: 0.65pt;"><br style="line-height: 0.65pt;">
                        </div>
                        <div style="line-height: 0.65pt;"><br style="line-height: 0.65pt;">
                        </div>
                        <div style="line-height: 0.65pt;"><br style="line-height: 0.65pt;">
                        </div>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <div>
                <div>
                  <div style="font-size: 14pt; font-weight: bold; text-align: center;">IN THE UNITED STATES DISTRICT COURT </div>
                  <div style="font-size: 14pt; font-weight: bold; text-align: center;">FOR THE DISTRICT OF DELAWARE</div>
                  <div style="text-align: center; margin-right: 30.9pt; margin-left: 31.8pt; margin-top: 3pt; font-size: 14pt;"> <br>
                  </div>
                  <div style="margin-top: 0.5pt; margin-bottom: 0.05pt;"><br>
                  </div>
                  <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

                      <tr>
                        <td style="width: 49%; vertical-align: top;">
                          <div>
                            <div style="margin-right: 11.5pt; margin-left: 10pt; font-size: 14pt;">JOSEPH P. AUSIKAITIS, derivatively on </div>
                            <div style="margin-right: 11.5pt; margin-left: 10pt; font-size: 14pt;">behalf of MASIMO CORPORATION,</div>
                            <div>&#160;</div>
                            <div style="font-size: 14pt; margin-left: 126pt;">Plaintiff,</div>
                            <div style="margin-left: 81.05pt; font-size: 14pt;"> <br>
                            </div>
                            <div style="font-size: 14pt; margin-left: 63pt;">v.</div>
                            <div>&#160;</div>
                            <div style="margin-left: 10pt; font-size: 14pt;">JOE KIANI, et al.,</div>
                            <div style="margin-right: 41.55pt; margin-left: 63.95pt; font-size: 14pt;"> <br>
                            </div>
                            <div style="font-size: 14pt; margin-left: 126pt;">Defendants,</div>
                            <div style="margin-left: 81.25pt; font-size: 14pt;"> <br>
                            </div>
                            <div style="font-size: 14pt; margin-left: 63pt;">-and-</div>
                            <div style="margin-right: 12.65pt; margin-left: 10pt; font-size: 14pt;"> <br>
                            </div>
                            <div style="margin-right: 11.5pt; margin-left: 10pt; font-size: 14pt;">MASIMO CORPORATION, a Delaware</div>
                            <div style="margin-right: 11.5pt; margin-left: 10pt; font-size: 14pt;">Corporation,</div>
                            ,
                            <div style="margin-right: 12.65pt; margin-left: 10pt; font-size: 14pt;"> <br>
                            </div>
                            <div style="font-size: 14pt; margin-left: 126pt;">Nominal Defendant.</div>
                          </div>
                        </td>
                        <td style="width: 2%; vertical-align: top;">
                          <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                          <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                          <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                          <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                          <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                          <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                          <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                          <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                          <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                          <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                          <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                          <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                          <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                          <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                          <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                          <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                          <div style="margin-left: 12.4pt; font-size: 14pt;">)</div>
                          <div style="margin-left: 12.4pt; font-size: 14pt;">&#160;</div>
                          <div style="margin-left: 12.4pt; font-size: 14pt;">&#160;</div>
                        </td>
                        <td style="width: 49%; vertical-align: top;">
                          <div style="margin: 0px 0px 0px 5.4pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt;"> <br>
                          </div>
                          <div style="margin: 0px 0px 0px 5.4pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt;"> <br>
                          </div>
                          <div style="margin: 0px 0px 0px 5.4pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt;">C.A. No. 1:12-cv-1175-SLR</div>
                          <div>&#160;</div>
                          <div style="margin: 6pt 0px 0px 6.25pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt; font-weight: bold;"> <br>
                          </div>
                          <div style="margin: 6pt 0px 0px 6.25pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt; font-weight: bold;"> <br>
                          </div>
                          <div style="margin: 6pt 0px 0px 6.25pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt; font-weight: bold;"> <br>
                          </div>
                          <div style="margin: 6pt 0px 0px 6.25pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt; font-weight: bold;"><u>JURY TRIAL DEMANDED</u></div>
                        </td>
                      </tr>

                  </table>
                </div>
                <div>
                  <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                  </div>
                  <div style="text-align: center; line-height: 13.1pt; margin-top: 12pt; margin-bottom: 12pt; font-size: 12pt; font-weight: bold;"><u>[PROPOSED] FINAL JUDGMENT AND ORDER OF DISMISSAL</u></div>
                </div>
              </div>
              <div>
                <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                </div>
                <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                </div>
                <div style="text-indent: 36pt; line-height: 26.2pt; font-size: 12pt;">This matter came before the Court for hearing pursuant to the Order of this Court, dated __________, 2015, on the application of Plaintiff for approval of the settlement
                  set forth in the Stipulation and Agreement of Settlement dated April ___, 2015, and the Exhibits thereto (the &#8220;Agreement&#8221;). Due and adequate notice having been given to the stockholders of Masimo Corporation (&#8220;Masimo&#8221;) as required in said
                  Order, and the Court having considered all objections raised, if any, and having considered all arguments made and papers filed and proceedings had herein, and otherwise being fully informed and good cause appearing therefore, IT IS
                  HEREBY ORDERED, ADJUDGED, AND DECREED that:</div>
                <div style="text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">1.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt;">For








                    purposes of this Final Judgment and Order of Dismissal (&#8220;the Judgment&#8221;) the Court incorporates by reference the definitions in the Agreement, and all capitalized terms used</font></div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div class="BRPFPageFooter"></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                  <div class="BRPFPageHeader"></div>
                </div>
                <div style="text-align: center; line-height: 26.2pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 40 of 43 PageID #: 7386</div>
                <div style="line-height: 22.8pt;"><br style="line-height: 22.8pt;">
                </div>
                <div style="line-height: 22.8pt;"><br style="line-height: 22.8pt;">
                </div>
                <div style="line-height: 26.2pt; font-size: 12pt;">herein shall have the same meanings as set forth in the Agreement unless otherwise defined herein.</div>
                <div style="text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt;">2.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt;">This








                    Court has jurisdiction over the subject matter of the Action, including all matters necessary to effectuate the settlement, and over all parties, including nominal defendant Masimo and its stockholders.</font></div>
                <div style="text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt;">3.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt;">Pursuant








                    to Rule 23.1 of the Federal Rules of Civil Procedure, this Court hereby approves the settlement set forth in the Agreement in all respects, and finds that said settlement is, in all respects, fair, just, reasonable, and adequate to, and
                    in the best interests of, Masimo, Masimo&#8217;s stockholders, and Plaintiff.</font></div>
                <div style="text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt;">4.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt;">This








                    Court further finds the settlement set forth in the Agreement is the result of arm&#8217;s-length negotiations between experienced counsel representing the interests of the Parties. Accordingly, the settlement embodied in the Agreement is
                    hereby approved in all respects and shall be consummated in accordance with its terms and provisions. The Parties are hereby directed to perform the terms of the Agreement.</font></div>
                <div style="text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt;">5.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt;">The








                    Action and all claims contained therein, as well as all of the Released Claims, are dismissed with prejudice. The Parties are to bear their own costs, except as otherwise provided in the Agreement.</font></div>
                <div style="text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt;">6.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt;">The








                    methods of dissemination of the Notice as provided for in the Agreement constituted the best notice practicable under the circumstances to Masimo&#8217;s stockholders and meets the requirements of Federal Rule of Civil Procedure 23.1, due
                    process under the United States Constitution, and any other applicable law, and constituted due and sufficient notice to all persons entitled thereto.</font></div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div class="BRPFPageFooter">
                    <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                    </div>
                  </div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                  <div class="BRPFPageHeader"></div>
                </div>
                <div style="text-align: center; line-height: 26.2pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 41 of 43 PageID #: 7387</div>
                <div style="line-height: 22.8pt;"><br style="line-height: 22.8pt;">
                </div>
                <div style="line-height: 22.8pt;"><br style="line-height: 22.8pt;">
                </div>
                <div style="text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">7.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt;">Upon








                    the Effective Date, Plaintiff (in both Plaintiff&#8217;s individual capacity and Plaintiff&#8217;s capacity derivatively on behalf of Masimo), Masimo, and each of Masimo&#8217;s stockholders (in their capacity as stockholders derivatively on behalf of
                    Masimo) shall be deemed to have and by operation of the Judgment shall have fully, finally, and forever released, relinquished and discharged all Released Claims against the Released Persons including Unknown Claims, and shall have
                    covenanted not to sue the Released Persons with respect to all such Released Claims, and shall be permanently barred and enjoined from instituting, commencing, or prosecuting the Released Claims against the Released Persons. Nothing
                    herein shall in any way impair or restrict the rights of any of the Parties to enforce the terms of the Agreement.</font></div>
                <div style="text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">8.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt;">Upon








                    the Effective Date, each of the Released Persons shall be deemed to have, and by operation of the Judgment shall have, fully, finally and forever released, relinquished and discharged Plaintiff and Plaintiff&#8217;s counsel from all claims,
                    arising out of, relating to, or in connection with the institution, prosecution, assertion, settlement or resolution of the claims asserted or could have been asserted in the Action, including but not limited to as set forth in the
                    Complaint, First Amended Complaint, including the Additional 2012 Employment Agreement Issues and Additional Full Vesting Issues, except to enforce the releases and the other terms and conditions contained in the Agreement or the
                    Judgment entered pursuant thereto. Nothing herein shall in any way impair or restrict the rights of any of the Parties to enforce the terms of the Agreement.</font></div>
                <div style="text-indent: 36pt; line-height: 26.2pt;"><font style="font-size: 12pt;">9.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt;">Without








                    affecting the finality of this Judgment in any way, this Court hereby retains continuing jurisdiction over: (a) implementation of the settlement and Agreement; (b) the Parties thereto for the purpose of construing, enforcing, and
                    administering the Agreement, the</font></div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div class="BRPFPageFooter">
                    <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                    </div>
                  </div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                  <div class="BRPFPageHeader"></div>
                </div>
                <div style="text-align: center; line-height: 26.2pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 42 of 43 PageID #: 7388</div>
                <div style="line-height: 22.8pt;"><br style="line-height: 22.8pt;">
                </div>
                <div style="line-height: 22.8pt;"><br style="line-height: 22.8pt;">
                </div>
                <div style="line-height: 26.2pt; font-size: 12pt;">settlement provided therein, and the provisions of this Judgment; and (c) any other matter related or ancillary thereto.</div>
                <div style="text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt;">10.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt;">The








                    Court finds that the Action was filed, prosecuted, and defended in good faith, and that during the course of the action, the Parties and their respective counsel at all times complied with the requirements of Federal Rule of Civil
                    Procedure 11, and all other similar rules and statutes.</font></div>
                <div style="text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt;">11.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt;">In








                    the event that the Agreement does not become effective in accordance with the terms of the Agreement or the Effective Date does not occur, then this Judgment shall be rendered null and void to the extent provided by and in accordance
                    with the Agreement and shall be vacated and, in such event, all orders entered and releases delivered in connection therewith shall be null and void to the extent provided by and in accordance with the Agreement. Notwithstanding
                    anything contained in the Agreement or this Judgment to the contrary, in the event the Effective Date does not occur, the dismissal with prejudice shall be vacated.</font></div>
                <div style="text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt;">12.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt;">Neither








                    the Agreement, nor the settlement contained therein, nor any of the negotiations or proceedings connected with it, shall be deemed, used or construed as an admission or concession by any of the Defendants in this Action, or as evidence
                    of the truth or validity of any of the allegations in this Action, or of any liability, fault or wrongdoing of any kind. Neither the Agreement, nor the settlement, nor any act performed or document executed pursuant to, or in
                    furtherance of the Agreement or the settlement, shall be admissible in any proceeding for any purpose, except to enforce the terms of the Agreement and except that the Released Parties may file the Agreement and/or the Judgment in any
                    action that may be brought against them in order to support a defense or counterclaim based on principles of res judicata,</font></div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div class="BRPFPageFooter">
                    <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                    </div>
                  </div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                  <div class="BRPFPageHeader"></div>
                </div>
                <div style="text-align: center; line-height: 26.2pt; color: rgb(0, 0, 255); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">Case 1:12-cv-01175-SLR&#160;&#160;&#160; Document 229-1&#160;&#160;&#160; Filed 05/06/15&#160;&#160;&#160; Page 43 of 43 PageID #: 7389</div>
                <div style="line-height: 22.8pt;"><br style="line-height: 22.8pt;">
                </div>
                <div style="line-height: 22.8pt;"><br style="line-height: 22.8pt;">
                </div>
                <div style="line-height: 26.2pt; font-size: 12pt;">collateral estoppel, release, good faith settlement, judgment bar or reduction, or any other theory of claim preclusion or issue preclusion or similar defense or counterclaim.</div>
                <div style="text-indent: 36pt; line-height: 28.6pt;"><font style="font-size: 12pt;">13.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt;">This








                    Judgment is a final, appealable judgment and should be entered forthwith by the Clerk in accordance with Rule 58 of the Federal Rules of Civil Procedure.</font></div>
                <div style="line-height: 29.65pt;">
                  <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: Arial, Helvetica, sans-serif; font-size: 10pt;">

                      <tr>
                        <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                        <td valign="top" colspan="2" style="width: 38%; font-size: 12pt;"><strong></strong><br>
                        </td>
                        <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="top" style="width: 50%;">
                          <div style="margin-left: 9pt; font-size: 12pt;">
                            <div style="margin-left: 9pt">
                              <div style="margin-left: 9pt">
                                <div style="margin-left: 9pt">
                                  <div style="margin-left: 9pt">
                                    <div style="margin-left: 9pt">
                                      <div style="margin-left: 9pt">
                                        <div style="margin-left: 9pt">
                                          <div style="margin-left: 9pt">
                                            <div style="margin-left: 9pt"><font style="font-weight: bold;">IT IS SO ORDERED. </font><br>
                                            </div>
                                          </div>
                                        </div>
                                      </div>
                                    </div>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </td>
                        <td valign="top" style="width: 3%; font-size: 12pt;">&#160;</td>
                        <td valign="top" style="width: 35%; font-size: 12pt;">&#160;</td>
                        <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="top" rowspan="1" style="width: 50%; font-size: 12pt;">&#160;</td>
                        <td valign="top" rowspan="1" style="width: 3%; font-size: 12pt;">&#160;</td>
                        <td valign="top" rowspan="1" style="width: 35%; font-size: 12pt;">&#160;</td>
                        <td valign="top" rowspan="1" style="width: 12%; font-size: 12pt;">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="top" rowspan="1" style="width: 50%; padding-bottom: 2px; font-size: 12pt;">&#160;</td>
                        <td valign="top" rowspan="1" style="width: 3%; padding-bottom: 2px; font-size: 12pt;">&#160;</td>
                        <td valign="top" rowspan="1" style="width: 35%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 12pt;">&#160;</td>
                        <td valign="top" rowspan="1" style="width: 12%; padding-bottom: 2px; font-size: 12pt;">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                        <td valign="top" style="width: 3%; font-size: 12pt;">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" align="left" style="width: 35%; font-size: 12pt;">Honorable Sue L. Robinson</td>
                        <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                        <td valign="top" style="width: 3%; font-size: 12pt;">&#160;</td>
                        <td valign="top" style="width: 35%; font-size: 12pt;">United States District Judge</td>
                        <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                        <td valign="top" style="width: 3%; font-size: 12pt;">&#160;</td>
                        <td valign="top" style="width: 35%; font-size: 12pt;">&#160;</td>
                        <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                      </tr>

                  </table>
                </div>
                <br>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div class="BRPFPageFooter">
                    <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                    </div>
                  </div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                  <div class="BRPFPageHeader"></div>
                </div>
                <div class="BRPFPageFooter">
                  <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                  </div>
                  <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                  </div>
                  <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                  </div>
                </div>
                <div class="BRPFPageFooter">
                  <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                  </div>
                </div>
              </div>
              <div>
                <div>
                  <div>
                    <div>
                      <div>
                        <div class="BRPFPageFooter">
                          <div style="line-height: 0.65pt;">
                            <div><br>
                              <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                              </div>
                              <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                              </div>
                              <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                              </div>
                              <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                              </div>
                              <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                              </div>
                              <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                              </div>
                              <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                              </div>
                              <div style="line-height: 11.4pt;">
                                <div style="line-height: 11.4pt; text-align: center;"><font style="font-size: 48pt;">EXHIBIT D</font><br style="line-height: 11.4pt;">
                                </div>
                                <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                </div>
                              </div>
                              <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                              </div>
                              <div style="line-height: 11.4pt;">
                                <div><br>
                                </div>
                                <font style="font-size: 11.5pt;"><br>
                                </font><br>
                              </div>
                              <br>
                            </div>
                            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                              <div class="BRPFPageFooter"></div>
                              <div class="BRPFPageBreak" style="page-break-after: always;">
                                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                            </div>
                            <div>
                              <div>
                                <div>&#160;
                                  <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                          <div style="line-height: 0.65pt;"><br style="line-height: 0.65pt;">
                          </div>
                          <div style="line-height: 0.65pt;"><br style="line-height: 0.65pt;">
                          </div>
                          <div style="line-height: 0.65pt;"><br style="line-height: 0.65pt;">
                          </div>
                          <div style="line-height: 0.65pt;"><br style="line-height: 0.65pt;">
                          </div>
                          <div style="line-height: 0.65pt;"><br style="line-height: 0.65pt;">
                          </div>
                          <div style="line-height: 0.65pt;"><br style="line-height: 0.65pt;">
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </div>
                <div>
                  <div>
                    <div style="font-size: 12pt;">
                      <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                      </div>
                      <div style="text-align: center; line-height: 11.95pt; margin-top: 12pt; font-weight: bold;">AMENDED AND RESTATED EMPLOYMENT AGREEMENT</div>
                      <div style="text-indent: 36pt; line-height: 11.95pt; margin-top: 12pt;">THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT <font style="font-style: italic;">("<font style="font-weight: bold;">Agreement</font>") </font>is made</div>
                      <div style="text-indent: 36pt; line-height: 12.55pt; margin-top: 12pt;">and entered into as of February 7, 2012, by and between Masimo Corporation, a Delaware corporation <font style="font-style: italic;">("<font style="font-weight: bold;">Company</font><font style="font-weight: normal;">")</font>, </font>and Joe Kiani <font style="font-style: italic;">("<font style="font-weight: bold;">Executive</font>").</font></div>
                      <div style="text-align: center; line-height: 11.4pt; margin-top: 12pt; font-weight: bold;">RECITALS</div>
                      <div style="margin: 12pt 0px 0px; text-indent: 36pt;">A.<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>Executive is a founder of the Company and has been its
                        Chairman and Chief Executive Officer <font style="font-weight: bold; font-style: italic;"><font style="font-weight: normal;">("</font>CEO<font style="font-weight: normal;">")</font> </font>since its inception. The Board of
                        Directors of the Company (the <font style="font-weight: bold; font-style: italic;"><font style="font-weight: normal;">"</font>Board<font style="font-weight: normal;">")</font> </font>recognizes that the Executive's contributions
                        as Chairman and CEO have been instrumental to the success of the Company. Executive and Company entered into an employment contract dated May 2, 2011 (the <font style="font-style: italic;">"<font style="font-weight: bold;">Prior
                            Agreement<font style="font-weight: normal;">"</font></font><font style="font-weight: normal;">)</font>. </font>The Board and Executive desire to amend and restate the Prior Agreement pursuant to the terms hereof to assure the
                        Company of the Executive's continued employment in an executive capacity and to compensate him therefor.</div>
                      <div style="margin: 12pt 0px 0px; text-indent: 36pt;">B.<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>Company considers the establishment and maintenance of a sound
                        management to be essential to protecting and enhancing the best interests of the Company and its shareholders.</div>
                      <div style="margin: 12pt 0px 0px; text-indent: 36pt;">C.<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>Company's Board of Directors has determined that appropriate
                        steps should be taken to retain Executive and to reinforce and encourage his continued attention and dedication to his assigned duties.</div>
                      <div style="margin: 12pt 0px 0px; text-indent: 36pt;">D.<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>The Company desires to retain the services of the Executive,
                        and the Executive desires to be employed by the Company pursuant to the terms and conditions of this Agreement.</div>
                      <div style="margin: 12pt 0px 0px; font-family: Arial, Helvetica, 'sans-serif'; text-indent: 36pt;">NOW, THEREFORE, in consideration of the premises, the mutual promises and the mutual covenants and agreements hereinafter set forth,
                        the Company and the Executive hereby agree as follows:</div>
                      <div style="margin: 12pt 0px 0px; text-align: justify; text-indent: 36pt;">1.<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>EMPLOYMENT. During the Employment Period
                        (as hereinafter defined), Company hereby agrees to continue to employ Executive and Executive hereby agrees to continue to serve the Company, on the terms and conditions contained in this Agreement.</div>
                      <div style="margin: 12pt 0px 0px; text-indent: 36pt;">2.<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>POSITION AND DUTIES. Executive shall serve the Company as its
                        Chairman of the Board and Chief Executive Officer and shall report to the Board of Directors. Executive shall be assigned the responsibilities of such office as they may be modified from time to time by the Board of Directors of the
                        Company provided that such duties are consistent with Executive's present duties and with Executive's position. Executive hereby accepts such employment and agrees to devote substantially all of his full business and professional
                        time and energy to the business and affairs of the Company. Notwithstanding the foregoing, the Executive shall be permitted to serve (i) as an employee, consultant, officer and/or director of, and provide services to, Cercacor
                        Laboratories, Inc., a Delaware corporation (f/k/a Masimo Laboratories, Inc.) <font style="font-weight: bold; font-style: italic;"><font style="font-weight: normal;">("</font>Cercacor<font style="font-weight: normal;">"),</font> </font>and



                        (ii) on the board of directors of any other company or entity.</div>
                      <div style="margin: 12pt 0px 0px; text-indent: 36pt;">3.<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>EMPLOYMENT PERIOD. The <font style="font-weight: bold; font-style: italic;"><font style="font-weight: normal;">"</font>Employment Period<font style="font-weight: normal;">"</font> </font>shall mean the period commencing on the date hereof, and ending on the later of (i) the third
                        (3rd) anniversary date of</div>
                      <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                      </div>
                      <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                      </div>
                      <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                      </div>
                      <div style="line-height: 13.7pt;"><br style="line-height: 13.7pt;">
                      </div>
                      <div style="line-height: 8pt; font-size: 8pt;">
                        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                            <tr>
                              <td style="width: 50%; vertical-align: top;">
                                <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt;">LEGAL_US_W # 68591820.1</div>
                              </td>
                              <td style="width: 50%; vertical-align: top;">&#160;</td>
                            </tr>
                            <tr>
                              <td style="width: 50%; vertical-align: top;">
                                <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">CONFIDENTIAL</div>
                              </td>
                              <td style="width: 50%; vertical-align: top;">
                                <div style="text-align: right; font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">MASI_0000008090</div>
                              </td>
                            </tr>

                        </table>
                        <div class="BRPFPageFooter">
                          <div><br>
                          </div>
                        </div>
                      </div>
                      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                        <div style="page-break-after: always;" class="BRPFPageBreak">
                          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                      </div>
                      <!--PROfilePageNumberReset%Num%2%%%-->
                      <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                      </div>
                      <div style="margin: 12pt 0px 0px; font-family: Arial, Helvetica, 'sans-serif';">this Agreement or (ii) three years following the date on which notice of non-renewal of this Agreement is given to the other by either the Executive or
                        the Company. This Agreement shall be renewed automatically on a daily basis so that the outstanding term is always three (3) years following any effective notice of nomenewal or of termination given by this Company or the Executive.</div>
                      <div style="margin: 12pt 0px 0px; text-indent: 36pt;">4.<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>PLACE OF PERFORMANCE. In connection with his employment by the
                        Company, the Executive shall be based at the Company's office or facility where, on the date hereof, the Executive is regularly rendering services on behalf of the Company and shall not be required to be absent therefrom on travel
                        status or otherwise more than a reasonable number of days in any calendar year. For purposes of the preceding sentence, the parties hereto agree that a <font style="font-style: italic;">"<font style="font-weight: bold;">reasonable
                            number of days</font>" </font>shall mean such number of days which is not in excess of one hundred twenty-five percent (125%) of the number of days on which the Executive was on travel status or otherwise required by the
                        Company to be absent from this principal&#160; place of performance during the calendar year immediately prior to the year of computation.</div>
                      <div style="margin: 12pt 0px 0px; text-indent: 36pt;">5.<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>COMPENSATION.</div>
                      <div style="margin: 12pt 0px 0px; text-indent: 81pt;"><font style="font-family: Arial,Helvetica,sans-serif;">5.1</font><font style="display: inline-block; font-size: 1px; width: 36pt;" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-family: Arial,Helvetica,sans-serif;">BASE SALARY. In consideration for services performed pursuant to this Agreement, Company will pay or cause to be paid to the Executive, and Executive will be entitled to receive and
                          hereby agrees to accept, an initial annual base salary of seven hundred twenty-eight thousand two hundred two dollars ($728,202) subject to increases in the discretion of the Board or its annual review Compensation Committee <font style="font-weight: bold; font-style: italic;"><font style="font-weight: normal;">("</font>Base Salary<font style="font-weight: normal;">"),</font> </font>payable in accordance with the Company's normal payroll payment policy.</font></div>
                      <div style="margin: 12pt 0px 0px; text-indent: 81pt;"><font style="font-family: Arial,Helvetica,sans-serif;">5.2</font><font style="display: inline-block; font-size: 1px; width: 36pt;" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-family: Arial,Helvetica,sans-serif;">BONUS. Without limiting any Additional Amount (as defined below) payable pursuant to Section 5.4(ii) hereof, Executive shall be eligible to receive an annual bonus equal to 50% of
                          his Base Salary based on the Company's attaining certain financial goals established by the Board (or designated committee); provided that, in the event the Board (or designated committee) determines that the Company achieved each
                          of the financial measures included in the criteria for the "Company Factor" for a "Plan Year" under the Company's Executive Annual Cash Bonus Award Plan, as may be amended or restated from time to time (each as defined therein),
                          Executive shall automatically receive a bonus equal to 50% of Executive's Base Salary (or such higher percentage approved by the Board (or designated committee)) for such year. In addition,&#160; Executive may be entitled&#160; to receive
                          such additional bonus amounts as the Board (or such Committee as may be designated by the Board) shall determine in its discretion, such as the Masimo Executive Annual Cash Bonus Award Plan and Masimo Executive Multi-Year Cash
                          Bonus Award Plan. In determining such additional amounts, if any, the Board (or Compensation Committee) shall consider among other things Executive's contribution to the accomplishment of the Company's long-range business goals,
                          the success of various corporate strategies in which Executive participated, and Executive's unique services in connection with the maintenance or increase in shareholder values in the Company.</font></div>
                      <div style="margin: 12pt 0px 0px; text-indent: 81pt;"><font style="font-family: Arial,Helvetica,sans-serif;">5.3</font><font style="display: inline-block; font-size: 1px; width: 36pt;" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-family: Arial,Helvetica,sans-serif;">STOCK OPTIONS AND RELATED INCENTIVE PLANS. Executive shall be eligible to participate in the Company's existing incentive programs and any additional or successor incentive plan or
                          plans, including the Masimo Corporation 2007 Stock Incentive Plan. Each fiscal year, Executive shall be granted a non-qualified stock option to purchase an</font></div>
                      <div><font style="font-family: Arial,Helvetica,sans-serif;"> <br>
                        </font></div>
                      <font style="font-family: Arial,Helvetica,sans-serif;"> </font></div>
                    <div style="font-size: 12pt;">
                      <div><br>
                      </div>
                      <font style="font-family: Arial,Helvetica,sans-serif;"><br>
                      </font></div>
                    <div style="font-size: 12pt;"><font style="font-family: Arial,Helvetica,sans-serif;"><br>
                      </font>
                      <table cellspacing="0" cellpadding="0" border="0" id="z4c5ee1ffc00f4db983e4049c91fdb0cf" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                          <tr>
                            <td style="width: 100%; vertical-align: top;" colspan="2">
                              <div style="text-align: center; font-family: Arial, Helvetica, sans-serif; font-size: 8pt;">-<font class="BRPFPageNumber"> 2</font> -</div>
                            </td>
                          </tr>
                          <tr>
                            <td style="width: 50%; vertical-align: top;">
                              <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt;">LEGAL_US_W # 68591820.1</div>
                            </td>
                            <td style="width: 50%; vertical-align: top;">&#160;</td>
                          </tr>
                          <tr>
                            <td style="width: 50%; vertical-align: top;">
                              <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">CONFIDENTIAL</div>
                            </td>
                            <td style="width: 50%; vertical-align: top;">
                              <div style="text-align: right; font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">MASI_0000008091</div>
                            </td>
                          </tr>

                      </table>
                      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                        <div style="page-break-after: always;" class="BRPFPageBreak">
                          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                      </div>
                      <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                      </div>
                      <div style="margin: 12pt 0px 0px; font-family: Arial, Helvetica, 'sans-serif';">aggregate of at least 300,000 shares of Common Stock (as adjusted for stock splits, stock dividends, recapitalizations and similar transactions) that
                        vests at a rate of 20% per year, with an exercise price equal to 100% of the fair market value (as defined under the applicable stock&#160; option plan pursuant to which the grant was made) of one share of Common Stock on the date of
                        grant. All option grants made to Executive pursuant to such plans shall provide for an expiration date consistent with the provisions of such plans, without regard to termination of employment; provided, however, in no event shall
                        any option remain exercisable beyond its stated expiration date.</div>
                      <div style="margin: 12pt 0px 0px; text-indent: 36pt;">5.4<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>EXPENSES.</div>
                      <div style="margin: 12pt 0px 0px; text-indent: 81pt;"><font style="font-family: Arial,Helvetica,sans-serif;">(i)</font><font style="display: inline-block; font-size: 1px; width: 36pt;" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-family: Arial,Helvetica,sans-serif;">Company shall reimburse Executive for all reasonable expenses incurred and paid by Executive in the course of the performance of his duties pursuant to this Agreement. In addition,
                          Company&#160; shall reimburse Executive for all reasonable travel and&#160; lodging expenses for Executive's immediate family, if Executive elects to have his immediate family accompany him during his business travel. Notwithstanding
                          anything to the contrary set forth in Company's Business Travel and Expense Policy, dated October 22, 2003, as may be amended or restated from time to time (the <font style="font-weight: bold; font-style: italic;"><font style="font-weight: normal;">"</font>Travel and Expense Policy<font style="font-weight: normal;">")</font> </font>or Company's 2006 Employee Handbook, as may be amended or restated from time to time (the <font style="font-weight: bold; font-style: italic;"><font style="font-weight: normal;">"</font>Employee Handbook<font style="font-weight: normal;">"),</font> </font>for purposes of this Agreement, <font style="font-weight: bold; font-style: italic;"><font style="font-weight: normal;">"</font>reasonable<font style="font-weight: normal;">"</font> </font>expenses shall be deemed to include travel and hospitality expenses for first class airplane travel
                          and accommodations and expenses for travel using private or chartered aircraft. In addition, the following Company reimbursement policies and provisions shall not apply to Executive: (i) the Travel and Expense Policy; and (ii) the
                          section entitled "Expense Reimbursements" in the Employee Handbook. Expenses reimbursable under this paragraph must be reimbursed within a reasonable period of time following Executive's submission of the reimbursement request and
                          supporting documentation reasonably requested by the Company and in no event later than the end of the calendar year following the calendar year in which the expenses were incurred by Executive.</font></div>
                      <div style="margin: 12pt 0px 0px; text-indent: 81pt;"><font style="font-family: Arial,Helvetica,sans-serif;">(ii)</font><font style="display: inline-block; font-size: 1px; width: 36pt;" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-family: Arial,Helvetica,sans-serif;">Notwithstanding anything herein to the contrary, in the event that some or all of the total amount of expenses of Executive reimbursed for any calendar year pursuant to Section
                          5.4(i) hereof is deemed under the Internal Revenue&#160; Code of 1986, as amended, the Treasury Regulations or other guidance issued thereunder, or the taxation rules and regulations of any State applicable to Executive (collectively,
                          the <font style="font-weight: bold; font-style: italic;"><font style="font-weight: normal;">"</font>Taxation Regulations<font style="font-weight: normal;">")</font> </font>to be taxable compensation to Executive (each, a <font style="font-weight: bold; font-style: italic;"><font style="font-weight: normal;">"</font>Taxable Reimbursement<font style="font-weight: normal;">"),</font> </font>Company shall pay Executive an additional amount for such
                          calendar year (each, an <font style="font-weight: bold; font-style: italic;"><font style="font-weight: normal;">"</font>Additional Amount<font style="font-weight: normal;">")</font> </font>equal to the quotient obtained by
                          dividing (i)(Y) the total amount of the Taxable Reimbursement for such calendar year, multiplied by (Z) Executive's combined effective federal and state tax rate percentage for such calendar year (the <font style="font-weight: bold; font-style: italic;"><font style="font-weight: normal;">"</font>Combined Tax Rate<font style="font-weight: normal;">"),</font> </font>by (ii)(a) 100% less (b) the Combined Tax Rate. The Company shall pay the Additional
                          Amount for a Taxable Reimbursement to Executive by no later than April 15th of the year immediately following the year in which Executive receives such Taxable Reimbursement; <font style="font-style: italic;">provided that, </font>in



                          the event Executive has not provided the Company with his final tax return for the immediately preceding year by April 15th, (A) the Company shall assume that Executive's Combined Tax Rate is 40%, and (B) upon Executive furnishing
                          his final tax return for such prior year to the Company, in the event (y) the Combined Tax Rate, as reflected&#160; on the final return, is more than 40%, the Company shall pay Executive, within 30 days after receiving the final
                          return, the remaining</font></div>
                      <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                      </div>
                      <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                      </div>
                      <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                      </div>
                      <div style="line-height: 12.55pt;">
                        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                            <tr>
                              <td style="width: 100%; vertical-align: top;" colspan="2">
                                <div style="text-align: center; font-family: Arial, Helvetica, sans-serif; font-size: 8pt;">- <font class="BRPFPageNumber">3 </font>-</div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width: 50%; vertical-align: top;">
                                <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt;">LEGAL_US_W # 68591820.1</div>
                              </td>
                              <td style="width: 50%; vertical-align: top;">&#160;</td>
                            </tr>
                            <tr>
                              <td style="width: 50%; vertical-align: top;">
                                <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">CONFIDENTIAL</div>
                              </td>
                              <td style="width: 50%; vertical-align: top;">
                                <div style="text-align: right; font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">MASI_0000008092</div>
                              </td>
                            </tr>

                        </table>
                      </div>
                      <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                      </div>
                      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                        <div class="BRPFPageBreak" style="page-break-after: always;">
                          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                      </div>
                      <div style="margin-top: 12pt; margin-bottom: 0px; font-family: Arial,Helvetica,'sans-serif';">Additional Amount owed to Executive under this Section 5.4(ii), and (z) the Combined&#160; Tax Rate, as reflected on the final return, is less
                        than 40%, Executive shall reimburse the Company, within 30 days after providing the final return to the Company, the difference between the amount previously reimbursed to Executive under clause (A) hereof and the Additional Amount.
                        The Additional Amount payable under this Section 5.4(ii) shall in no way limit, impair or otherwise modify Executive's right to receive a bonus pursuant to Section 5.2 hereof.</div>
                      <div style="margin: 12pt 0px 0px; text-indent: 36pt;">5.5<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>FRINGE BENEFITS. The Executive shall be entitled to continue
                        to participate in or receive benefits under all of the Company's employee benefits plans and arrangements in effect on the date hereof or plans or arrangements providing the Executive with at least equivalent benefits thereunder,
                        The Company agrees that, without the Executive's consent, it will not make any changes in such plans or arrangements which would adversely affect the Executive's rights or benefits thereunder. The Executive shall be entitled to
                        participate in or receive benefits under any pension&#160; plan, profit-sharing plan, savings plan, stock option plan, life insurance, health-and-accident plan or arrangement made available by the Company in the future to its executives
                        and key management employees, subject to and on a basis consistent with the terms, conditions and overall administration of such plans and arrangements. Nothing paid to the Executive under any plan or arrangement presently in effect
                        or made available in the future shall be deemed to be in lieu of compensation to the Executive hereunder.</div>
                      <div style="margin: 12pt 0px 0px; text-indent: 36pt;">5.6<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>VACATIONS. The Executive shall be entitled to the number of
                        paid vacation days in each calendar&#160; year determined by the Company's Board&#160; from time to time for its senior executive officers (prorated in any calendar year during which the Executive is employed by the Company for less than the
                        entire such year in accordance with the number of days in such calendar year during which he is so employed). The Executive shall also be entitled to all paid holidays given by the Company to its senior executive officers.</div>
                      <div style="margin: 12pt 0px 0px; text-indent: 36pt;">5.7<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>PERQUISITES. The Executive shall be entitled to continue to
                        receive the fringe benefits appertaining to the office of Chairman and CEO of the Company in accordance with present practice.</div>
                      <div style="margin: 12pt 0px 0px; text-indent: 36pt;">6.<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>CONFIDENTIAL INFORMATION. Executive has entered into and
                        agrees to be bound by the terms and conditions of the Company's Employee Confidentiality Agreement (the <font style="font-weight: bold; font-style: italic;"><font style="font-weight: normal;">"</font>Confidentiality Agreement<font style="font-weight: normal;">").</font> </font>Executive agrees to execute such other documents (including, but not limited to, new versions of the Confidentiality Agreement) as may be necessary in order to protect the
                        Company's confidential information.</div>
                      <div>
                        <div style="margin: 12pt 0px 0px; text-indent: 36pt;">7.<font style="display: inline-block; text-indent: 0px; width: 36pt;" class="TRGRRTFtoHTMLTab">&#160;</font>TERMINATION.</div>
                        <div style="margin-top: 12pt; margin-bottom: 0px; text-indent: 81pt;"><font style="font-family: Arial,Helvetica,sans-serif;">7.1</font><font style="display: inline-block; width: 36pt;" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-family: Arial,Helvetica,sans-serif;">DEATH.&#160;</font>The Executive's employment hereunder shall terminate upon his death.</div>
                        <div style="margin: 12pt 0px 0px; text-indent: 81pt;"><font style="font-family: Arial,Helvetica,sans-serif;">7.2</font><font style="display: inline-block; width: 36pt;" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-family: Arial,Helvetica,sans-serif;">DISABILITY.&#160; </font>If, as a result of the Executive's incapacity due to physical or mental illness, the Executive shall have been absent from his duties hereunder on a full time basis for one
                          hundred twenty (120) consecutive business days, and within thirty (30) days after written notice of termination is given shall not have returned to the performance of his duties</div>
                        <div style="margin-top: 12pt; margin-bottom: 0px;">
                          <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                          </div>
                          <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                          </div>
                          <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                          </div>
                          <div style="line-height: 12.55pt;">
                            <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                                <tr>
                                  <td style="width: 100%; vertical-align: top;" colspan="2">
                                    <div style="text-align: center; font-family: Arial, Helvetica, sans-serif; font-size: 8pt;">- <font class="BRPFPageNumber">4 </font>-</div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="width: 50%; vertical-align: top;">
                                    <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt;">LEGAL_US_W # 68591820.1</div>
                                  </td>
                                  <td style="width: 50%; vertical-align: top;">&#160;</td>
                                </tr>
                                <tr>
                                  <td style="width: 50%; vertical-align: top;">
                                    <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">CONFIDENTIAL</div>
                                  </td>
                                  <td style="width: 50%; vertical-align: top;">
                                    <div style="text-align: right; font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">MASI_0000008093</div>
                                  </td>
                                </tr>

                            </table>
                          </div>
                        </div>
                      </div>
                      <div style="line-height: 8pt;"><br style="line-height: 8pt;">
                      </div>
                      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                        <div class="BRPFPageBreak" style="page-break-after: always;">
                          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                      </div>
                      <div>
                        <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                        </div>
                        <div style="line-height: 11.4pt; margin-top: 12pt;">hereunder on a full time basis, the Company may terminate the Executive's employment hereunder.</div>
                        <div style="margin: 12pt 0px 0px; line-height: normal; text-indent: 72pt;"><font style="font-family: Arial,Helvetica,sans-serif;">7.3</font><font style="display: inline-block; font-size: 1px; width: 36pt;" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-family: Arial,Helvetica,sans-serif;">CAUSE. The Company may terminate the Executive's employment hereunder for Cause. For the purposes of this Agreement, the Company shall have <font style="font-weight: bold; font-style: italic;"><font style="font-weight: normal;">"</font>Cause<font style="font-weight: normal;">"</font> </font>to terminate the Executive's employment&#160; hereunder&#160; upon (i) the willful and continued&#160; failure by the
                            Executive to substantially perform his duties hereunder, other than any such failure resulting from the Executive's incapacity due to physical or mental illness, or (ii) the willful engaging by the Executive in gross misconduct
                            materially injurious to the Company, or (iii) the willful violation by the Executive of the provisions of Confidentiality Agreement hereof provided that such violation results in demonstrably material injury to the Company. For
                            purposes of this paragraph, no act, or failure to act, on the Executive's part shall be considered <font style="font-style: italic;">"<font style="font-weight: bold;">willfuf</font><font style="font-weight: normal;">"</font><font style="font-weight: bold;"> </font></font>unless done, or omitted to be done, by him not in good faith and without reasonable belief that his&#160;&#160; action or omission was in the best interests of the Company. Notwithstanding
                            the foregoing, the Executive&#160; shall not be deemed to have been terminated for Cause unless and until there shall have been delivered to the Executive a copy of a resolution, duly adopted by the affirmative vote of not less than
                            three-quarters of the entire membership of the Board at a meeting of the Board called and held for the purpose (after reasonable notice to the Executive and an opportunity for him, together with his counsel, to be heard before
                            the Board), finding that in the good faith opinion of the Board the Executive&#160; was guilty of conduct set forth above in clause (i), (ii), or&#160; (iii), and specifying the particulars thereof in detail.</font></div>
                        <div style="margin: 12pt 0px 0px; line-height: normal; text-indent: 72pt;"><font style="font-family: Arial,Helvetica,sans-serif;">7.4</font><font style="display: inline-block; font-size: 1px; width: 36pt;" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-family: Arial,Helvetica,sans-serif;">TERMINATION BY THE EXECUTIVE. The Executive may terminate his employment hereunder (i) for Good Reason, (ii) if his health should become impaired to an extent that makes the
                            continued performance of his duties hereunder hazardous to his physical or mental health or his life, or (iii) at any time by giving six months' written notice to the Company of his intention to terminate. For purposes of this
                            Agreement, <font style="font-weight: bold; font-style: italic;"><font style="font-weight: normal;">"</font>Good Reason<font style="font-weight: normal;">"</font> </font>shall mean (A)&#160; any assignment&#160; to the Executive of any
                            duties other than those contemplated&#160; by, or any limitation of the powers of the Executive in any respect not contemplated by Section 2 hereof, except in connection with termination of the Executive's employment for Cause, (B) a
                            reduction in the Executive's rate of compensation or a reduction in the Executive's fringe benefits or any other failure by the Company to comply with Section&#160; 5 hereof; or (C) any failure by the Company to comply with Section 4
                            hereof.</font></div>
                        <div style="margin: 12pt 0px 0px; line-height: normal; text-indent: 81pt;"><font style="font-family: Arial,Helvetica,sans-serif;">7.5</font><font style="display: inline-block; font-size: 1px; width: 36pt;" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-family: Arial,Helvetica,sans-serif;">NOTICE OF TERMINATION. Any termination&#160; by the Company pursuant to Section 7.3 or by the Executive pursuant to Section 7.4 above shall be communicated by written Notice of
                            Termination to the other party hereto. For purposes of this Agreement, a <font style="font-style: italic;">"<font style="font-weight: bold;">Notice of Termination</font>" </font>shall mean a notice which shall indicate the
                            specific termination provision in this Agreement relied upon and shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executive's employment&#160; under the provision so
                            indicated.</font></div>
                        <div style="margin: 12pt 0px 0px; line-height: normal; text-indent: 81pt;"><font style="font-family: Arial,Helvetica,sans-serif;">7.6</font><font style="display: inline-block; font-size: 1px; width: 36pt;" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-family: Arial,Helvetica,sans-serif;">DATE OF TERMINATION. <font style="font-style: italic;">"<font style="font-weight: bold;">Date of Termination</font>" </font>shall mean (i) if the Executive's employment is
                            terminated by his death, the date of his death, (ii) if the Executive's employment is terminated pursuant to Section 7.2 above, thirty (30) days after Notice of Termination is given (provided that the Executive shall not have
                            returned to the performance of his duties on a full-time basis during such thirty (30) day period), (iii) if the Executive's</font></div>
                        <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                        </div>
                        <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                        </div>
                        <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                        </div>
                        <div style="line-height: 12.55pt;">
                          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                              <tr>
                                <td style="width: 100%; vertical-align: top;" colspan="2">
                                  <div style="text-align: center; font-family: Arial, Helvetica, sans-serif; font-size: 8pt;">- <font class="BRPFPageNumber">5 </font>-</div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width: 50%; vertical-align: top;">
                                  <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt;">LEGAL_US_W # 68591820.1</div>
                                </td>
                                <td style="width: 50%; vertical-align: top;">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width: 50%; vertical-align: top;">
                                  <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">CONFIDENTIAL</div>
                                </td>
                                <td style="width: 50%; vertical-align: top;">
                                  <div style="text-align: right; font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">MASI_0000008094</div>
                                </td>
                              </tr>

                          </table>
                        </div>
                        <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                        </div>
                        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                          <div style="page-break-after: always;" class="BRPFPageBreak">
                            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                        </div>
                        <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                        </div>
                        <div style="margin: 12pt 0px 0px; line-height: normal; font-family: Arial, Helvetica, 'sans-serif';">employment is terminated pursuant to Section 7.3 or clause (iii) of Section 7.4 above, the date specified in the Notice of
                          Termination, or (iv) if the Executive's employment is terminated&#160; for any other reason, the date on which a Notice of Termination&#160; is given; provided that if within&#160; sixty (60) days after a Notice of Termination is given the party
                          receiving such Notice of Termination notifies the other party that a dispute exists concerning the termination, the Date of Termination shall be the date on which the dispute is finally determined, either by mutual written
                          agreement of the parties, by a binding and final arbitration award or by a final judgment, order or decree of a court of competent jurisdiction (the time for appeal therefrom having expired and no appeal having been perfected).</div>
                        <div style="text-indent: 36pt; line-height: 11.4pt; margin-top: 12pt;">8.<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>COMPENSATION UPON TERMINATION, DEATH OR
                          DURING DISABILITY.</div>
                        <div style="margin: 12pt 0px 0px; line-height: normal; text-indent: 81pt;"><font style="font-family: Arial,Helvetica,sans-serif;">8.1</font><font style="display: inline-block; font-size: 1px; width: 36pt;" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-family: Arial,Helvetica,sans-serif;">DEATH. If the Executive's employment shall be terminated by reason of his death, the Company shall pay to such person as he shall designate in a notice filed with the Company, or,
                            if no such person shall be designated, to his estate as a death benefit, an amount equal to one-half (1/2) of the Executive's Base Salary at the rate in effect on the date of the Executive's death. Such amount shall be paid for
                            three (3) years, in substantially equal monthly installments commencing within 30 days following the Executive's death. This amount shall be exclusive of and in addition to any payments the Executive's surviving spouse,
                            beneficiaries or estate may be entitled to receive pursuant to any pension or employee benefit plan or life insurance policy presently maintained by the Company.</font></div>
                        <div style="margin: 12pt 0px 0px; line-height: normal; text-indent: 81pt;"><font style="font-family: Arial,Helvetica,sans-serif;">8.2</font><font style="display: inline-block; font-size: 1px; width: 36pt;" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-family: Arial,Helvetica,sans-serif;">DISABILITY. During any period that the Executive fails to perform his duties hereunder as a result of incapacity due to physical or mental illness, the Executive shall continue to
                            receive his full Base Salary and incentive compensation until the Executive's employment is terminated pursuant to Section 7.2 hereof, or until the Executive terminates his employment pursuant to clause (ii) of Section 7.4
                            hereof, whichever first occurs. After termination, the Executive shall be paid three-fourths (3/4) of his Base Salary at the rate then in effect for two (2) years and, subject to Section 8.7, commencing within 30 days of the
                            Executive's termination. To the extent permitted by Treasury Regulation &#167; l.409A-3(i)(l)(ii)(A), such disability benefits shall be reduced by any disability payment otherwise payable by or pursuant to disability plans maintained
                            by the Company and actually paid to the Executive and shall be paid in substantially equal monthly installments at the same times as Base Salary is paid hereunder.</font></div>
                        <div style="text-indent: 81pt; line-height: 11.4pt; margin-top: 12pt;"><font style="font-family: Arial,Helvetica,sans-serif;">8.3</font><font style="display: inline-block; font-size: 1px; width: 36pt;" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-family: Arial,Helvetica,sans-serif;">CAUSE. If the Executive's employment shall be terminated for Cause, the Company shall pay the Executive his full Base Salary through the Date of Termination at the rate in effect
                            at the time Notice of Termination is given and the Company shall have no further obligations to the Executive under this Agreement.</font></div>
                        <div style="margin: 12pt 0px 0px; text-indent: 81pt;"><font style="font-family: Arial,Helvetica,sans-serif;">8.4</font><font style="display: inline-block; font-size: 1px; width: 36pt;" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-family: Arial,Helvetica,sans-serif;">OTHER. If the Company shall terminate the Executive's employment other than pursuant to Sections 7.1, 7.2 or 7.3 hereof or if the Executive shall terminate his employment pursuant
                            to clause (i) of Section 7.4 hereof, then the Company shall pay to Executive in cash a severance benefit equal to two times the sum of (i) Executive's Base Salary at the rate then in effect, and (ii) the average annual bonus
                            paid to Executive during the</font></div>
                        <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                        </div>
                        <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                        </div>
                        <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                        </div>
                        <div style="line-height: 12.55pt;">
                          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                              <tr>
                                <td style="width: 100%; vertical-align: top;" colspan="2">
                                  <div style="text-align: center; font-family: Arial, Helvetica, sans-serif; font-size: 8pt;">- <font class="BRPFPageNumber">6 </font>-</div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width: 50%; vertical-align: top;">
                                  <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt;">LEGAL_US_W # 68591820.1</div>
                                </td>
                                <td style="width: 50%; vertical-align: top;">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width: 50%; vertical-align: top;">
                                  <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">CONFIDENTIAL</div>
                                </td>
                                <td style="width: 50%; vertical-align: top;">
                                  <div style="text-align: right; font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">MASI_0000008095</div>
                                </td>
                              </tr>

                          </table>
                        </div>
                        <div style="line-height: 12.55pt; font-size: 8pt;"><br style="line-height: 12.55pt;">
                        </div>
                        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                          <div style="page-break-after: always;" class="BRPFPageBreak">
                            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                        </div>
                        <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                        </div>
                        <div style="margin-top: 12pt; margin-bottom: 0px; line-height: normal; font-family: Arial,Helvetica,'sans-serif';">immediately prior three (3) years. Such amount shall be paid in installments over two years in accordance with the
                          Company's normal payroll payment policy and, subject to Section 8.7, commencing within 30 days following Executive's termination of employment. <font style="font-family: Arial, Helvetica, sans-serif;">If </font>a <font style="font-family: Arial, Helvetica, sans-serif; font-weight: bold; font-style: italic;"><font style="font-weight: normal;">"</font>Change in Control<font style="font-weight: normal;">"</font> </font>as that term is defined in
                          Section 9 below shall occur while the Executive is still employed, then the Company shall pay to Executive the severance he would have received under this Section 8.4 had the Executive terminated his employment pursuant to clause
                          (i) of Section 7.4 hereof. Such payment shall be made in a lump sum within 30 days following the Change in Control. <font style="font-family: Arial,Helvetica,sans-serif;">If </font>the Executive's employment with the Company
                          thereafter terminates for any reason, Executive shall not be entitled to any payments under Sections 8.1, 8.2, 8.3 or 8.4 on account of such termination. <font style="font-family: Arial,Helvetica,sans-serif;">If </font>Executive
                          becomes (or would become) entitled to any payment under this Section 8.4 pursuant to a Change in Control or otherwise, the Company shall vest, effective as of immediately&#160; prior to such Change&#160; in Control or such other event that
                          would entitle Executive to a payment under this Section 8.4, all of Executive's&#160; stock options and other equity awards (if&#160; any) and issue the stock therefor as additional compensation, Company shall also pay the withholding tax
                          due on the issuance of such stock at the <font style="font-family: Arial,Helvetica,sans-serif; font-weight: bold; font-style: italic;"><font style="font-weight: normal;">"</font>Supplemental Payment Rate<font style="font-weight: normal;">"</font> </font>to the federal and state taxing authorities.</div>
                        <div style="text-indent: 36pt; line-height: 11.4pt; margin-top: 12pt;">8.5<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>EMPLOYEE BENEFIT PLANS.</div>
                        <div style="margin: 12pt 0px 0px; line-height: normal; text-indent: 81pt;"><font style="font-family: Arial,Helvetica,sans-serif;">(i)</font><font style="display: inline-block; font-size: 1px; width: 36pt;" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-family: Arial,Helvetica,sans-serif;">Unless the Executive's employment is terminated pursuant to Section 7.3 hereof, the Company shall maintain in full force and effect, for the continued benefit of the Executive for
                            the full term of this Agreement all employee benefit plans and programs in which the Executive was entitled to participate immediately prior to the Date of Termination provided that the Executive's continued participation is
                            possible under the general terms and provisions of such plans and programs.</font></div>
                        <div style="margin: 12pt 0px 0px; line-height: normal; text-indent: 81pt;"><font style="font-family: Arial,Helvetica,sans-serif;">(ii)</font><font style="display: inline-block; font-size: 1px; width: 36pt;" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-family: Arial,Helvetica,sans-serif;">In the event that the Executive's participation in any such plan or program is barred, the Company shall reimburse expenses actually incurred by the Executive during such period
                            to obtain similar coverage, but only to the extent Executive's requested reimbursement of expenses for similar coverage does not exceed the Company's premiums or contributions that the Company would otherwise pay under the terms
                            of this Agreement as of the date of the Executive's termination, or date of payment iflater, to continue Executive's participation in the underlying plan for the period the expenses were incurred by the Executive. Expenses
                            reimbursable under this paragraph shall&#160; be reimbursed&#160; within thirty (30) days following Executive's submission to the Company of the reimbursement request and supporting documentation reasonably requested by the Company and in
                            no event later than the end of the calendar year following the calendar year in which the expenses were incurred by Executive. The expenses eligible for reimbursement under this paragraph during any calendar&#160; year shall not
                            affect the expenses eligible for reimbursement under this paragraph in any other calendar year.</font></div>
                        <div style="margin: 12pt 0px 0px; line-height: normal; text-indent: 36pt;">8.6<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>PARTICIPATION IN FUTURE FINANCINGS. If
                          Executive's employment is terminated other than pursuant to Sections 7.1, 7.2 or 7.3 hereof or if Executive shall terminate his employment&#160; pursuant to clause (i) of Section 7.4 hereof, then until immediately prior to the time the
                          Company&#160; has completed&#160; an initial public offering, the Executive shall have a preemptive right to purchase or subscribe for (i) any shares of Common Stock, (ii) any other equity security of the Company, including, without
                          limitation, shares of Preferred Stock, (iii) any option, other than options granted pursuant to an employee stock option</div>
                        <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                        </div>
                        <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                        </div>
                        <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                        </div>
                        <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                        </div>
                        <div style="line-height: 12.55pt; font-size: 8pt;">
                          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                              <tr>
                                <td style="width: 100%; vertical-align: top;" colspan="2">
                                  <div style="text-align: center; font-family: Arial, Helvetica, sans-serif; font-size: 8pt;">- <font class="BRPFPageNumber">7 </font>-</div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width: 50%; vertical-align: top;">
                                  <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt;">LEGAL_US_W # 68591820.1</div>
                                </td>
                                <td style="width: 50%; vertical-align: top;">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width: 50%; vertical-align: top;">
                                  <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">CONFIDENTIAL</div>
                                </td>
                                <td style="width: 50%; vertical-align: top;">
                                  <div style="text-align: right; font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">MASI_0000008096</div>
                                </td>
                              </tr>

                          </table>
                        </div>
                        <div style="line-height: 12.55pt; font-family: Arial,Helvetica,sans-serif; font-size: 8pt;"><br>
                        </div>
                        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                          <div style="page-break-after: always;" class="BRPFPageBreak">
                            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                        </div>
                        <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                        </div>
                        <div style="margin: 12pt 0px 0px; line-height: normal; font-family: Arial, Helvetica, 'sans-serif';">plan, warrant or other right to subscribe for, purchase or otherwise acquire any equity security of the Company, or (iv) any debt
                          Securities (the <font style="font-family: Arial, Helvetica, sans-serif; font-weight: bold; font-style: italic;"><font style="font-weight: normal;">"</font>Offered Securities<font style="font-weight: normal;">").</font> </font>Executive



                          shall have a preemptive right to purchase or subscribe for that portion of the Offered Securities as the aggregate&#160; number of shares of Common Stock (as adjusted for any stock dividends, combinations or splits with respect to such
                          shares) then held by or issuable to Executive bears to the total number of outstanding shares of Common Stock (as adjusted for any stock dividends, combinations or splits with respect to such shares) of the Company then held by or
                          issuable to&#160; any person as a result of any convertible security, warrant or option, other than options granted pursuant to an employee stock option plan.</div>
                        <div style="margin: 12pt 0px 0px; line-height: normal; text-indent: 36pt;">8.7<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>CODE SECTION 409A COMPLIANCE.
                          Notwithstanding anything&#160; in this Section 8 to the contrary, if any benefit or amount payable to the Executive&#160; under this Section 8 on account of the Executive's termination of employment constitutes "nonqualified deferred
                          compensation" within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended or successor provision <font style="font-weight: bold; font-style: italic;"><font style="font-weight: normal;">("</font>409A</font>"),



                          payment of such benefit or amount shall commence when the Executive incurs a "separation&#160; from&#160; service" within the meaning of Treasury Regulation Section 1.409A-1(h), which provides that a separation from service will be deemed
                          to occur if the Company and the Executive reasonably anticipate that Executive shall perform no further services for the Company and any entity that would be considered a single employer with the Company under Code Section 414(b)
                          or 414(c) (whether an employee or an independent&#160; contractor) or that the level of bona fide services Executive&#160; will perform in the future (whether as an employee or an independent contractor) will permanently decrease to no more
                          than 49 percent of the average level of bona fide services performed (whether as an employee or independent contractor) over the immediately preceding 36-month period. Such payments or benefits shall be provided in accordance with
                          the timing provisions of this Section 8 by substituting the references to "termination of employment" or "termination" with "separation from service"; however, if at the time Executive incurs a separation from service, Executive
                          is a "specified employee" within the meaning of 409A, any benefit or amount payable to the Executive under this Section 8 on account of the Executive's termination of employment that constitutes nonqualified deferred compensation&#160;
                          subject to 409A shall be delayed until the first day of the seventh month following the Executive's separation from service (the <font style="font-weight: bold; font-style: italic;"><font style="font-weight: normal;">"</font>409A
                            Suspension Period<font style="font-weight: normal;">").</font> </font>Within 14 calendar days after the end of the 409A Suspension Period, the Company shall pay to the Executive (or his estate or beneficiary, as applicable) a
                          lump sum payment in cash equal to any payments (including interest on any such payments, at an interest rate of not less than the average prime interest rate, as published in the Wall Street Journal, over the 409A Suspension
                          Period) that the Company would otherwise have been required to provide under this Section 8 but for the imposition of the 409A Suspension Period. Thereafter, the Executive shall receive any remaining payments due under this
                          Section 8 in accordance with the terms of this Section (as if there had not been any suspension&#160; period beforehand).&#160; For purposes of this Agreement, each payment that is part of a series of installment&#160; payments shall be treated
                          as a separate payment for purposes of 409A. Notwithstanding anything in this Agreement to the contrary, all reimbursements and in-kind benefits&#160; provided&#160; under this Agreement shall be made in accordance with the following
                          requirements of 409A: (i) the reimbursement of eligible expenses will be made no later than the end of the calendar year following the calendar year in which the expenses were incurred by Executive; (ii) the amount of expenses
                          eligible for reimbursement, or in-kind benefits provided, during a calendar year may not affect the expenses</div>
                        <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                        </div>
                        <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                        </div>
                        <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                        </div>
                        <div style="line-height: 12.55pt;">
                          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                              <tr>
                                <td style="width: 100%; vertical-align: top;" colspan="2">
                                  <div style="text-align: center; font-family: Arial, Helvetica, sans-serif; font-size: 8pt;">- <font class="BRPFPageNumber">8</font> -<br>
                                  </div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width: 50%; vertical-align: top;">
                                  <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt;">LEGAL_US_W # 68591820.1</div>
                                </td>
                                <td style="width: 50%; vertical-align: top;">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width: 50%; vertical-align: top;">
                                  <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">CONFIDENTIAL</div>
                                </td>
                                <td style="width: 50%; vertical-align: top;">
                                  <div style="text-align: right; font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">MASI_0000008097</div>
                                </td>
                              </tr>

                          </table>
                        </div>
                        <div style="line-height: 12.55pt; font-family: Arial,Helvetica,sans-serif; font-size: 8pt;"><br>
                        </div>
                        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                          <div style="page-break-after: always;" class="BRPFPageBreak">
                            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                        </div>
                        <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                        </div>
                        <div style="margin: 12pt 0px 0px; line-height: normal; font-family: Arial, Helvetica, 'sans-serif';">eligible for reimbursement or in-kind benefits to be provided in any other calendar year; and (iii) any right to reimbursement of
                          eligible expenses or in-kind benefits is not subject to liquidation or exchange for any other benefit. In addition, notwithstanding anything in this Agreement to the contrary, (x) any tax gross-up payment provided under this
                          Agreement, including under Sections 5.4(ii) and 8.8 hereof, shall be paid no later than the end of Executive's taxable year next&#160; following Executive's taxable year in which Executive remits the related taxes, and (y)
                          reimbursement of expenses incurred due to a tax audit or litigation addressing the existence or amount of a tax liability must be made by the end of Executive's taxable year following Executive's&#160; taxable year in&#160; which the taxes
                          that are subject to the audit or litigation are remitted&#160; to the&#160; related&#160; taxing authority, or where as a result of such audit or litigation no taxes are remitted, the end of Executive's taxable year following the taxable year in
                          which the audit is completed or there is a final and non-appealable settlement or other resolution of the litigation.</div>
                        <div style="text-indent: 36pt; line-height: 10.85pt; margin-top: 12pt;">8.8<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>PARACHUTE PAYMENTS.</div>
                        <div style="margin: 12pt 0px 0px; line-height: normal; text-indent: 81pt;"><font style="font-family: Arial,Helvetica,sans-serif;">(i)</font><font style="display: inline-block; font-size: 1px; width: 36pt;" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-family: Arial,Helvetica,sans-serif;">If any payment or benefit (within the meaning of Section 280G(b)(2) of the Code) to the Executive or for the Executive's benefit paid or payable or distributed or distributable
                            pursuant to the terms of this Agreement or otherwise in connection with, or arising out of, the Executive's employment&#160; with the Company&#160; or a change in ownership or effective control of the Company or of a substantial portion
                            of its assets (a<font style="font-weight: bold; font-style: italic;"><font style="font-weight: normal;">"</font>Parachute Payment<font style="font-weight: normal;">"</font> </font>or <font style="font-weight: bold; font-style: italic;"><font style="font-weight: normal;">"</font>Parachute Payments<font style="font-weight: normal;">"),</font> </font>would be subject to the excise tax imposed by Section 4999 of the Code or any interest or penalties
                            are incurred by the Executive with respect to such excise tax (such excise tax, together with any such interest and penalties, are hereinafter collectively referred to as the <font style="font-weight: bold; font-style: italic;"><font style="font-weight: normal;">"</font>Excise Tax<font style="font-weight: normal;">"),</font> </font>then the Executive will be entitled to receive an additional payment (a <font style="font-style: italic;">"<font style="font-weight: bold;">Gross-Up Payment</font>") </font>in an amount such that after payment by the Executive of all taxes (including any interest or penalties, other than any taxes imposed&#160; by 409A or interest and
                            penalties imposed by reason of the Executive's failure to file timely a tax return or pay taxes shown to be due on the Executive's return),&#160; including&#160; any Excise Tax imposed&#160; upon the Gross-Up Payment, the Executive retains an
                            amount of the Gross-Up Payment equal to the Excise Tax imposed upon the Parachute Payment or Parachute Payments.</font></div>
                        <div style="margin: 12pt 0px 0px; line-height: normal; text-indent: 81pt;">(ii)<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>An initial determination as to
                          whether a Gross-Up Payment is required pursuant to this Agreement and the amount of such Gross-Up Payment shall be made at the Company's expense by the&#160; Company's regular outside auditors (the <font style="font-weight: bold; font-style: italic;"><font style="font-weight: normal;">"</font>Accounting Firm<font style="font-weight: normal;">").</font> </font>The Accounting Firm shall provide its determination (the <font style="font-weight: bold; font-style: italic;"><font style="font-weight: normal;">"</font>Determination<font style="font-weight: normal;">"),</font> </font>together with detailed supporting calculations and documentation, to the Company&#160; and the&#160;
                          Executive&#160; within ten days of the Termination Date, if applicable, or promptly upon request by the Company or by the Executive (provided the Executive reasonably believes that any of the Parachute Payments may be subject to the
                          Excise Tax) and if the Accounting Firm determines that no Excise Tax is payable by the Executive with respect to a Parachute Payment or Parachute Payments, it shall furnish the Executive with an opinion reasonably acceptable to
                          the Executive that no Excise Tax will be imposed with respect to any such Parachute Payment or Parachute Payments. Within ten days of the delivery of the Determination to the Executive, the Executive shall have the right to
                          dispute the Determination (the <font style="font-weight: bold; font-style: italic;"><font style="font-weight: normal;">"</font>Dispute<font style="font-weight: normal;">").</font> </font>The Gross-Up Payment, if any, as
                          determined pursuant to this Section 8.8(ii) shall be paid by the Company to the Executive within ten days of the receipt of the Accounting Firm's determination notwithstanding the existence of any Dispute.</div>
                        <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                        </div>
                        <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                        </div>
                        <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                        </div>
                        <div style="line-height: 12.55pt;">
                          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                              <tr>
                                <td style="width: 100%; vertical-align: top;" colspan="2">
                                  <div style="text-align: center; font-family: Arial, Helvetica, sans-serif; font-size: 8pt;">- <font class="BRPFPageNumber">9 </font>-</div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width: 50%; vertical-align: top;">
                                  <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt;">LEGAL_US_W # 68591820.1</div>
                                </td>
                                <td style="width: 50%; vertical-align: top;">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width: 50%; vertical-align: top;">
                                  <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">CONFIDENTIAL</div>
                                </td>
                                <td style="width: 50%; vertical-align: top;">
                                  <div style="text-align: right; font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">MASI_0000008098</div>
                                </td>
                              </tr>

                          </table>
                        </div>
                        <div style="line-height: 12.55pt; font-size: 8pt;"><br style="line-height: 12.55pt;">
                        </div>
                        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                          <div style="page-break-after: always;" class="BRPFPageBreak">
                            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                        </div>
                        <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                        </div>
                        <div style="line-height: 11.4pt; margin-top: 12pt;"><br style="line-height: 11.4pt;">
                        </div>
                        <div style="margin-top: 12pt; margin-bottom: 0px; line-height: normal; font-family: Arial,Helvetica,'sans-serif';"><font style="font-family: Arial,Helvetica,sans-serif;">If </font>there is no Dispute, the Determination shall be
                          binding, final and conclusive upon the Company and the Executive subject to the application of clause (iii) below. The Company and the Executive shall resolve any Dispute in accordance with the terms of this Agreement.
                          Notwithstanding the foregoing, in no event shall payment of the Gross-Up Payment occur later than the end of the Executive's taxable year following the Executive's taxable year in which the Executive pays the taxes giving rise to
                          the Gross-Up Payment.</div>
                        <div style="margin: 12pt 0px 0px; line-height: normal; text-indent: 81pt;">(iii)<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>As a result of the uncertainty&#160; in
                          the&#160; application&#160; of&#160; Sections&#160; 4999 and 280G of the Code, the Company and the Executive acknowledge that it is possible&#160; that&#160; a Gross-Up Payment (or a portion thereof) will be paid that should not have been paid (an <font style="font-weight: bold; font-style: italic;"><font style="font-weight: normal;">"</font>Excess Payment<font style="font-weight: normal;">")</font> </font>or a Gross-Up Payment (or&#160; a&#160; portion&#160; thereof)&#160; that&#160; should&#160; have&#160;
                          been&#160; paid&#160; will&#160; not have been paid (an <font style="font-weight: bold; font-style: italic;"><font style="font-weight: normal;">"</font>Underpayment<font style="font-weight: normal;">").</font> </font>An Underpayment shall&#160; be&#160;
                          deemed&#160; to&#160; have occurred&#160; (a) upon notice (formal or&#160; informal)&#160; to&#160; the&#160; Executive&#160; from&#160; any&#160; governmental&#160; taxing&#160; authority&#160; that the Executive's tax liability (whether in respect&#160; of&#160; the&#160; Executive's&#160; current&#160; taxable&#160;
                          year&#160; or&#160; in respect of any prior taxable&#160; year)&#160; may&#160; be increased&#160; by reason&#160; of the imposition&#160; of the Excise Tax on a Parachute Payment or Parachute Payments with respect to which the&#160; Company&#160; has failed to make a sufficient
                          Gross-Up Payment, (b) upon a determination by a court, (c) by reason of determination by the Company (which shall include the position&#160; taken&#160; by the Company,&#160; together with its consolidated group, on its federal income tax
                          return) or&#160; (d) upon&#160; the resolution&#160; of&#160; the Dispute to the Executive's satisfaction. If an Underpayment occurs, the Executive&#160; shall&#160; promptly notify the Company and the Company shall&#160; promptly,&#160; but&#160; in&#160; any&#160; event, at&#160; least
                          five days prior to the date on which the applicable government taxing authority has requested payment, pay to the Executive an additional Gross-Up Payment equal to the amount of the Underpayment&#160; plus&#160; any interest and penalties
                          (other than interest&#160; and&#160; penalties&#160; imposed&#160; by&#160; reason&#160; of&#160; the&#160; Executive's failure to&#160; file timely a tax&#160; return or pay taxes shown&#160; to be due on the Executive's&#160; return)&#160; imposed&#160; on the Underpayment. If, however,&#160; no&#160;
                          notice&#160; of&#160; an Underpayment&#160; having&#160; been&#160; made&#160; is received by the Company within one year of the date of the payment of the Gross-Up&#160; Payment&#160; by the Company to the Executive, then no payments shall be owed by the Company under
                          this Section 8.8(iii). An Excess Payment shall be deemed to have occurred upon a <font style="font-weight: bold; font-style: italic;"><font style="font-weight: normal;">"</font>Final Determination<font style="font-weight: normal;">"</font> </font>(as hereinafter defined) that the Excise Tax shall not be imposed&#160; upon&#160; a&#160; Parachute&#160; Payment&#160; or Parachute Payments (or portion thereof) with respect to which&#160; the&#160; Executive&#160; had&#160; previously
                          rec{;":ived a Gross-Up Payment. A <font style="font-weight: bold; font-style: italic;"><font style="font-weight: normal;">"</font>Final Determination<font style="font-weight: normal;">"</font> </font>shall be deemed to have
                          occurred when the Executive has received from the applicable government taxing authority&#160; a&#160; refund&#160; of taxes&#160; or other reduction in the Executive's tax liability by reason of the Excise Payment and upon either (x) the date a
                          determination is made by, or an agreement is entered into with, the applicable governmental taxing authority which finally and conclusively&#160; binds the Executive and such taxing authority, or in the event that a claim is brought
                          before a court of competent jurisdiction, the date upon which a final determination&#160; has been made by such court and either all appeals&#160; have been taken and finally resolved or the time for all appeals has expired or (y) the
                          statute of limitations&#160; with respect to the Executive's applicable&#160; tax return has expired. If an Excess Payment is determined to have been made, the Executive shall pay to the Company on demand (but not less than ten days after
                          the determination of such Excess Payment and written notice has been delivered to the Executive) the amount of the Excess Payment plus interest at an annual rate equal to the Applicable&#160; Federal Rate provided for in Section
                          1274(d) of the Code from the date the Gross-Up Payment (to which the Excess Payment relates) was paid to the Executive until the date of repayment to the Company. If, however, no notice of an Excess Payment having been made is
                          received by the Executive within one year of the date of the payment of the Gross-Up</div>
                        <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                        </div>
                        <div style="line-height: 12.55pt;">
                          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                              <tr>
                                <td style="width: 100%; vertical-align: top;" colspan="2">
                                  <div style="text-align: center; font-family: Arial, Helvetica, sans-serif; font-size: 8pt;">- <font class="BRPFPageNumber">10 </font>-</div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width: 50%; vertical-align: top;">
                                  <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt;">LEGAL_US_W # 68591820.1</div>
                                </td>
                                <td style="width: 50%; vertical-align: top;">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width: 50%; vertical-align: top;">
                                  <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">CONFIDENTIAL</div>
                                </td>
                                <td style="width: 50%; vertical-align: top;">
                                  <div style="text-align: right; font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">MASI_0000008099</div>
                                </td>
                              </tr>

                          </table>
                        </div>
                        <div style="line-height: 12.55pt; font-family: Arial,Helvetica,sans-serif; font-size: 8pt;"><br>
                        </div>
                        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                          <div style="page-break-after: always;" class="BRPFPageBreak">
                            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                        </div>
                        <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                        </div>
                        <div style="margin: 12pt 0px 0px; line-height: normal; font-family: Arial, Helvetica, 'sans-serif';">Payment by the Company to the Executive, then no payments shall be owed by the Executive under this Section 8.8(iii).</div>
                        <div style="margin: 12pt 0px 0px; line-height: normal; text-indent: 36pt;">(iv)<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>Notwithstanding anything contained in
                          this Agreement to the contrary, in the event that, according to the Determination, an Excise Tax will be imposed on any Parachute Payment or Parachute Payments, the Company shall pay to the applicable government taxing
                          authorities&#160; as Excise Tax withholding, the amount&#160; of the Excise Tax that the Company has actually withheld from the Parachute Payment or Parachute Payments or the Gross Up Payment.</div>
                        <div style="text-indent: 36pt; line-height: 11.4pt; margin-top: 12pt;">9.<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>CHANGE IN CONTROL OF THE COMPANY. For
                          purposes of this Agreement<font style="font-weight: bold; font-style: italic;"> <font style="font-weight: normal;">"</font>Change in Control<font style="font-weight: normal;">&#8221;</font> </font>shall be deemed to have occurred at
                          such time as:</div>
                        <div style="margin: 12pt 0px 0px; line-height: normal; text-indent: 81pt;">(i)<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>any person or more than one person
                          acting as a group within the meaning of Treasury Regulation&#167; 1.409A-3(i)(5)(v)(B) acquires (or has acquired during the twelve (12) month period ending on the date of the most recent acquisition by such person or persons)
                          beneficial ownership, as determined under the constructive ownership rules of Code Section 318(a), shares of capital stock of the Company entitling such person or persons to exercise more than 35% of the total voting power of all
                          voting shares of the Company; or</div>
                        <div style="margin: 12pt 0px 0px; line-height: normal; text-indent: 81pt;">(ii)<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>any person or more than one person
                          acting as a group within the meaning of Treasury Regulation&#167; 1.409A-3(i)(5)(v)(B) acquires (or has acquired during the twelve (12) month period ending on the date of the most recent acquisition by such person or persons) assets of
                          the Company that have a total fair market value equal to or more than 40% of the total gross fair market value of all the assets of the Company immediately before such acquisition or acquisitions; or</div>
                        <div style="margin: 12pt 0px 0px; line-height: normal; text-indent: 81pt;">(iii)<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>there shall occur a change in the
                          Board of Directors of the Company in which the individuals who constituted the Board of Directors of the Company at the beginning of the 12-month period immediately preceding such change (together with any other director whose
                          election by the Board of Directors of the Company or whose nomination for election by the stockholders of the Company was approved by a vote of at least a majority of the directors then in office either who were directors at the
                          beginning of such period or whose election or nomination for election was previously so approved)&#160; cease for any reason to constitute a majority of the directors then in office.</div>
                        <div style="text-indent: 36pt; line-height: 11.4pt; margin-top: 12pt;">10.<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>BINDING AGREEMENTS. This Agreement and all
                          rights of the Executive hereunder shall inure to the benefit of and be enforceable by the Executive's personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.</div>
                        <div style="text-indent: 36pt; line-height: 11.4pt; margin-top: 12pt;">11.<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>NON-WAIVER OF RIGHTS. The failure to
                          enforce, at any time, any of the provisions of this Agreement, or to require, at any time, performance by the other party of any of the provisions hereof shall in no way be construed to be a waiver of such provision or to affect
                          either the validity of this Agreement, or any part hereof, or the right of either party thereafter to enforce each and every provision in accordance with the terms of this Agreement.</div>
                        <div style="text-indent: 36pt; line-height: 11.4pt; margin-top: 12pt;">12.<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>INVALIDITY OF PROVISIONS. The invalidity
                          or unenforceability of any particular provision of this Agreement shall not affect the other provisions hereof, and this</div>
                        <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                        </div>
                        <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                        </div>
                        <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                        </div>
                        <div style="line-height: 12.55pt;">
                          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                              <tr>
                                <td style="width: 100%; vertical-align: top;" colspan="2">
                                  <div style="text-align: center; font-family: Arial, Helvetica, sans-serif; font-size: 8pt;">- <font class="BRPFPageNumber">11 </font>-</div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width: 50%; vertical-align: top;">
                                  <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt;">LEGAL_US_W # 68591820.1</div>
                                </td>
                                <td style="width: 50%; vertical-align: top;">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width: 50%; vertical-align: top;">
                                  <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">CONFIDENTIAL</div>
                                </td>
                                <td style="width: 50%; vertical-align: top;">
                                  <div style="text-align: right; font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">MASI_0000008100</div>
                                </td>
                              </tr>

                          </table>
                        </div>
                        <div style="line-height: 12.55pt; font-family: Arial,Helvetica,sans-serif; font-size: 8pt;"><br>
                        </div>
                        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                          <div style="page-break-after: always;" class="BRPFPageBreak">
                            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                        </div>
                        <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                        </div>
                        <div style="margin: 12pt 0px 0px;">Agreement shall be construed in all respects as if such invalid or unenforceable provisions were omitted.</div>
                        <div style="margin: 12pt 0px 0px; line-height: normal; text-indent: 36pt;">13.<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>ASSIGNMENTS. This Agreement is binding
                          upon the parties hereto and their respective successors, assigns, heirs and personal representatives. Except as otherwise provided herein, neither of the parties hereto may make any assignment of this Agreement, or any interest
                          herein, without the prior written consent&#160; of the other party, except that, without such consent,&#160; this Agreement shall be assigned to any corporation or entity which shall succeed to the business presently being operated by
                          Company, by operation of law or otherwise, including&#160; by dissolution, merger, consolidation, transfer of assets, or otherwise.</div>
                        <div style="margin: 12pt 0px 0px; text-indent: 36pt;">14.<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>COUNTERPARTS. This Agreement may be executed in one or more
                          counterparts, each of which shall be deemed to be an original but all of which together will constitute one and the same instrument.</div>
                        <div style="margin: 12pt 0px 0px; text-indent: 36pt;">15.<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>AMENDMENTS. No modification, amendment&#160; or waiver of any of
                          the provisions of this Agreement shall be effective unless in writing specifically referring hereto, and signed by the parties hereto.</div>
                        <div style="margin: 12pt 0px 0px; text-indent: 36pt;">16.<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>NOTICES. For the purposes of this Agreement, notices and
                          all other communications provided for in this Agreement shall be in writing and shall be deemed to have been duly given when delivered or mailed by United States certified mail, return receipt requested, postage prepaid, addressed
                          as follows:</div>
                        <div style="line-height: 11.4pt; margin-top: 12pt;">
                          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="zefc36b24f9b34e9dbb6901815a757d08">

                              <tr>
                                <td colspan="1" style="width: 7%; vertical-align: top;">&#160;</td>
                                <td style="width: 15%; vertical-align: top;">
                                  <div style="line-height: 12.55pt; font-family: Arial, Helvetica, sans-serif; font-size: 12pt;">&#160; If&#160; to the Executive:</div>
                                </td>
                                <td style="width: 78%; vertical-align: top;">
                                  <div style="line-height: 12.55pt; font-family: Arial, Helvetica, sans-serif; font-size: 12pt;">Joe Kiani</div>
                                </td>
                              </tr>
                              <tr>
                                <td colspan="1" style="width: 7%; vertical-align: top;">&#160;</td>
                                <td style="width: 15%; vertical-align: top;">&#160;</td>
                                <td style="width: 78%; vertical-align: top;">
                                  <div style="line-height: 12.55pt; font-family: Arial, Helvetica, sans-serif; font-size: 12pt;">1 Point Catalina</div>
                                </td>
                              </tr>
                              <tr>
                                <td colspan="1" style="width: 7%; vertical-align: top;">&#160;</td>
                                <td style="width: 15%; vertical-align: top;">&#160;</td>
                                <td style="width: 78%; vertical-align: top;">
                                  <div style="line-height: 12.55pt; font-family: Arial, Helvetica, sans-serif; font-size: 12pt;">Laguna Niguel, CA 92677</div>
                                </td>
                              </tr>
                              <tr>
                                <td colspan="1" style="width: 7%; vertical-align: top;">&#160;</td>
                                <td style="width: 15%; vertical-align: top;">&#160;</td>
                                <td style="width: 78%; vertical-align: top;">&#160;</td>
                              </tr>
                              <tr>
                                <td colspan="1" style="width: 7%; vertical-align: top;">&#160;</td>
                                <td style="width: 15%; vertical-align: top;">
                                  <div style="line-height: 12.55pt; font-family: Arial, Helvetica, sans-serif; font-size: 12pt;">&#160; If&#160; to the Company:</div>
                                </td>
                                <td style="width: 78%; vertical-align: top;">
                                  <div style="line-height: 12.55pt; font-family: Arial, Helvetica, sans-serif; font-size: 12pt;">Masimo Corporation</div>
                                </td>
                              </tr>
                              <tr>
                                <td rowspan="1" colspan="1" style="width: 7%; vertical-align: top;">&#160;</td>
                                <td rowspan="1" style="width: 15%; vertical-align: top;">&#160;</td>
                                <td rowspan="1" style="width: 78%; vertical-align: top;"><font style="font-size: 12pt;"> 40 Parker</font> <br>
                                </td>
                              </tr>
                              <tr>
                                <td colspan="1" style="width: 7%; vertical-align: top;">&#160;</td>
                                <td style="width: 15%; vertical-align: top;">&#160;</td>
                                <td style="width: 78%; vertical-align: top;">
                                  <div style="line-height: 12.55pt; font-family: Arial, Helvetica, sans-serif; font-size: 12pt;">Irvine, CA 92618</div>
                                </td>
                              </tr>
                              <tr>
                                <td colspan="1" style="width: 7%; vertical-align: top;">&#160;</td>
                                <td style="width: 15%; vertical-align: top;">&#160;</td>
                                <td style="width: 78%; vertical-align: top;">
                                  <div style="line-height: 12.55pt; font-family: Arial, Helvetica, sans-serif; font-size: 12pt;">Attention: Chairman of the Compensation</div>
                                </td>
                              </tr>
                              <tr>
                                <td colspan="1" style="width: 7%; vertical-align: top;">&#160;</td>
                                <td style="width: 15%; vertical-align: top;">&#160;</td>
                                <td style="width: 78%; vertical-align: top;">
                                  <div style="line-height: 12.55pt; font-family: Arial, Helvetica, sans-serif; font-size: 12pt;">Committee of the Board of Directors or</div>
                                </td>
                              </tr>

                          </table>
                          <font style="font-family: Arial,Helvetica,sans-serif;"> </font></div>
                        <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                        </div>
                        <div>
                          <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                          </div>
                          <div style="margin: 12pt 0px 0px;">to such other address as any party may have furnished to the other in writing in accordance herewith, except that notices of change of address shall be effective only upon receipt.</div>
                          <div style="margin: 12pt 0px 0px; text-indent: 36pt;">17.<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>SURVIVAL. Section 5.4 and Sections 6, 8, 10-13, 15-18 and
                            20 shall survive termination or expiration of this Agreement.</div>
                          <div style="margin: 12pt 0px 0px; text-indent: 36pt;">18.<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>ARBITRATION. Any controversy or claim arising out of or
                            relating to this Agreement or the making, performance or interpretation thereof shall be settled by arbitration in Orange County, California, in .accordance&#160; with the Rules of the American Arbitration Association then existing,
                            and judgment on the arbitration award may be entered in any court having jurisdiction over the subject matter of the controversy. Arbitrators shall be persons experienced in negotiating, making and consummating&#160; employment&#160;
                            matters. Notwithstanding the pendency of any such dispute or controversy, the Company should continue to pay Executive</div>
                          <div style="line-height: 12.55pt; margin-top: 12pt;"><br style="line-height: 12.55pt;">
                          </div>
                          <div style="line-height: 12.55pt; margin-top: 12pt;"><br style="line-height: 12.55pt;">
                          </div>
                          <div style="line-height: 12.55pt; margin-top: 12pt;"><br style="line-height: 12.55pt;">
                          </div>
                          <div style="line-height: 12.55pt; margin-top: 12pt;">
                            <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                                <tr>
                                  <td style="width: 100%; vertical-align: top;" colspan="2">
                                    <div style="text-align: center; font-family: Arial, Helvetica, sans-serif; font-size: 8pt;">- <font class="BRPFPageNumber">12 </font>-</div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="width: 50%; vertical-align: top;">
                                    <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt;">LEGAL_US_W # 68591820.1</div>
                                  </td>
                                  <td style="width: 50%; vertical-align: top;">&#160;</td>
                                </tr>
                                <tr>
                                  <td style="width: 50%; vertical-align: top;">
                                    <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">CONFIDENTIAL</div>
                                  </td>
                                  <td style="width: 50%; vertical-align: top;">
                                    <div style="text-align: right; font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">MASI_0000008101</div>
                                  </td>
                                </tr>

                            </table>
                          </div>
                          <div style="line-height: 12.55pt;"><br style="line-height: 12.55pt;">
                          </div>
                        </div>
                      </div>
                      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                        <div class="BRPFPageBreak" style="page-break-after: always;">
                          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                      </div>
                      <div style="margin-top: 12pt;">his full compensation&#160; in effect when the notice giving rise to the dispute was given (including,&#160; but not limited to, base salary and any bonus due) and continue Executive as a participant in all
                        compensation, benefit and insurance plans in which Executive was participating when the notice giving rise to the dispute was given, until the dispute is finally resolved. Amounts paid under this section are in addition to all other
                        amounts due under this Agreement and shall not be offset against or reduce any other amounts due under this Agreement. Judgment may be entered on the arbitrator's award in any court having jurisdiction; provided, however, that
                        Executive shall be entitled to seek specific performance of his right to be paid during the pendency of any dispute or controversy arising under or in connection with this Agreement.</div>
                      <div style="text-indent: 36pt; margin-top: 12pt;">19.<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>ENTIRE AGREEMENT. This Agreement supersedes all prior employment
                        agreements, both written and oral, between Company and Executive.</div>
                      <div style="text-indent: 36pt; margin-top: 12pt;">20.<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>INTERPRETATION. This Agreement shall in all respects be
                        interpreted, construed and governed by and in accordance with the laws of the State of California, without regard to conflicts of laws principles.</div>
                      <div style="text-align: center; margin-top: 12pt;">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]</div>
                      <div><br>
                      </div>
                      <div><br>
                      </div>
                      <div><br>
                      </div>
                      <div>
                        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                            <tr>
                              <td style="width: 100%; vertical-align: top;" colspan="2">
                                <div style="text-align: center; font-family: Arial, Helvetica, sans-serif; font-size: 8pt;">- <font class="BRPFPageNumber">13 </font>-</div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width: 50%; vertical-align: top;">
                                <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt;">LEGAL_US_W # 68591820.1</div>
                              </td>
                              <td style="width: 50%; vertical-align: top;">&#160;</td>
                            </tr>
                            <tr>
                              <td style="width: 50%; vertical-align: top;">
                                <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">CONFIDENTIAL</div>
                              </td>
                              <td style="width: 50%; vertical-align: top;">
                                <div style="text-align: right; font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">MASI_0000008102</div>
                              </td>
                            </tr>

                        </table>
                      </div>
                      <div><br>
                      </div>
                      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                        <div style="page-break-after: always;" class="BRPFPageBreak">
                          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                      </div>
                      <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                      </div>
                      <br>
                      <div><br>
                      </div>
                      <div style="font-family: Arial,Helvetica,'sans-serif'; text-indent: 45pt;">IN WITNESS WHEREOF, the Company at the direction of the Compensation Committee of the Board of Directors has caused this Employment Agreement to be executed as
                        of the day and year first above written.</div>
                      <div style="font-family: Arial,Helvetica,'sans-serif'; text-indent: 45pt;"> </div>
                      <div style="font-family: Arial,Helvetica,'sans-serif';"> </div>
                    </div>
                  </div>
                </div>
              </div>
              <div> <br>
              </div>
              <div>
                <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: Arial, Helvetica, sans-serif; font-size: 10pt;">

                    <tr>
                      <td valign="top" style="width: 50%;">
                        <div style="margin-left: 9pt; font-size: 12pt;">
                          <div style="margin-left: 9pt">
                            <div style="margin-left: 9pt">
                              <div style="margin-left: 9pt">
                                <div style="margin-left: 9pt">&#160;"Company"<br>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </td>
                      <td valign="top" colspan="2" style="width: 38%; font-size: 12pt;"><strong><font style="font-weight: normal;">MASIMO CORPORATION</font><br>
                        </strong></td>
                      <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                    </tr>
                    <tr>
                      <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                      <td valign="top" style="width: 3%; font-size: 12pt;">&#160;</td>
                      <td valign="top" style="width: 35%; font-size: 12pt;">&#160;</td>
                      <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;">
                        <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; font-size: 12pt;"><br>
                        </div>
                      </td>
                      <td valign="top" style="width: 3%; padding-bottom: 2px;">
                        <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; font-size: 12pt;">By: </div>
                      </td>
                      <td valign="top" nowrap="nowrap" align="left" style="width: 35%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 12pt;">/s/ Mark P. de Raad<br>
                      </td>
                      <td valign="top" style="width: 12%; padding-bottom: 2px; font-size: 12pt;">&#160;</td>
                    </tr>
                    <tr>
                      <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                      <td valign="top" style="width: 3%; font-size: 12pt;">Name:&#160; <br>
                      </td>
                      <td valign="bottom" nowrap="nowrap" align="left" style="width: 35%; font-size: 12pt;">Mark P. de Raad<br>
                      </td>
                      <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                    </tr>
                    <tr>
                      <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                      <td valign="top" style="width: 3%; font-size: 12pt;">Its: <br>
                      </td>
                      <td valign="top" style="width: 35%;">
                        <div style="font-size: 12pt;">
                          <div>
                            <div>
                              <div>Executive Vice President and Chief Financial<br>
                              </div>
                              <div>Officer </div>
                            </div>
                          </div>
                        </div>
                      </td>
                      <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                    </tr>
                    <tr>
                      <td valign="top" rowspan="1" style="width: 50%; font-size: 12pt;">&#160;</td>
                      <td valign="top" rowspan="1" style="width: 3%; font-size: 12pt;">&#160;</td>
                      <td valign="top" rowspan="1" style="width: 35%; font-size: 12pt;">&#160;</td>
                      <td valign="top" rowspan="1" style="width: 12%; font-size: 12pt;">&#160;</td>
                    </tr>
                    <tr>
                      <td valign="top" rowspan="1" style="width: 50%; font-size: 12pt;">&#160;</td>
                      <td valign="top" rowspan="1" style="width: 3%; font-size: 12pt;">&#160;</td>
                      <td valign="top" rowspan="1" style="width: 35%; font-size: 12pt;">&#160;</td>
                      <td valign="top" rowspan="1" style="width: 12%; font-size: 12pt;">&#160;</td>
                    </tr>
                    <tr>
                      <td valign="top" rowspan="1" style="width: 50%; padding-bottom: 2px; font-size: 12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; "Executive"<br>
                      </td>
                      <td valign="top" colspan="2" rowspan="1" style="width: 3%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 12pt;">/s/ Joe Kiani<br>
                      </td>
                      <td valign="top" rowspan="1" style="width: 12%; padding-bottom: 2px; font-size: 12pt;">&#160;</td>
                    </tr>
                    <tr>
                      <td valign="top" rowspan="1" style="width: 50%;">
                        <div style="margin-left: 9pt; font-size: 12pt;">
                          <div style="margin-left: 9pt">
                            <div style="margin-left: 9pt">
                              <div style="margin-left: 9pt">
                                <div style="margin-left: 9pt"><br>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </td>
                      <td valign="top" colspan="2" rowspan="1" style="width: 3%; font-size: 12pt;">Joe Kiani&#160; <br>
                      </td>
                      <td valign="top" rowspan="1" style="width: 12%; font-size: 12pt;">&#160;</td>
                    </tr>
                    <tr>
                      <td valign="top" rowspan="1" style="width: 50%; font-size: 12pt;">&#160;</td>
                      <td valign="top" rowspan="1" style="width: 3%; font-size: 12pt;">&#160;</td>
                      <td valign="top" rowspan="1" style="width: 35%; font-size: 12pt;">&#160;</td>
                      <td valign="top" rowspan="1" style="width: 12%; font-size: 12pt;">&#160;</td>
                    </tr>

                </table>
              </div>
              <div> <br>
              </div>
              <div> <br>
              </div>
              <div>
                <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                    <tr>
                      <td style="width: 100%; vertical-align: top;" colspan="2">
                        <div style="text-align: center; font-family: Arial, Helvetica, sans-serif; font-size: 8pt;">- <font class="BRPFPageNumber">14 </font>-</div>
                      </td>
                    </tr>
                    <tr>
                      <td style="width: 50%; vertical-align: top;">
                        <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt;">LEGAL_US_W # 68591820.1</div>
                      </td>
                      <td style="width: 50%; vertical-align: top;">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width: 50%; vertical-align: top;">
                        <div style="font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">CONFIDENTIAL</div>
                      </td>
                      <td style="width: 50%; vertical-align: top;">
                        <div style="text-align: right; font-family: Arial, Helvetica, sans-serif; font-size: 8pt; font-weight: bold;">MASI_0000008103</div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          </div>
          <div style="line-height: 11.4pt; margin-top: 0.25pt;"><font style="font-size: 11.5pt;"><br>
            </font></div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
        </div>
        <div><font style="font-size: 11.5pt;"> <br>
          </font>
          <div style="line-height: normal;"><br>
            <div>
              <div class="BRPFPageFooter">
                <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                </div>
                <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                </div>
                <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                </div>
              </div>
              <div class="BRPFPageFooter">
                <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                </div>
              </div>
            </div>
            <div>
              <div>
                <div>
                  <div>
                    <div>
                      <div class="BRPFPageFooter">
                        <div style="line-height: 0.65pt;">
                          <div><br>
                            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                            </div>
                            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                            </div>
                            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                            </div>
                            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                            </div>
                            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                            </div>
                            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                            </div>
                            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                            </div>
                            <div style="line-height: 11.4pt;">
                              <div style="line-height: 11.4pt; text-align: center;"><font style="font-size: 48pt;">EXHIBIT C</font><br style="line-height: 11.4pt;">
                              </div>
                              <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                              </div>
                            </div>
                            <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                            </div>
                            <div style="line-height: 11.4pt;">
                              <div><br>
                              </div>
                              <font style="font-size: 11.5pt;"><br>
                              </font><br>
                            </div>
                            <br>
                          </div>
                          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                            <div class="BRPFPageFooter"></div>
                            <div class="BRPFPageBreak" style="page-break-after: always;">
                              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                          </div>
                          <div>
                            <div>
                              <div>&#160;
                                <div style="line-height: 0pt;"><br style="line-height: 0pt;">
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                        <div style="line-height: 0.65pt;"><br style="line-height: 0.65pt;">
                        </div>
                        <div style="line-height: 0.65pt;"><br style="line-height: 0.65pt;">
                        </div>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
            <br>
            <div style="text-align: center; margin-top: 12pt; font-size: 12pt; font-weight: bold;">AMENDED AND RESTATED EMPLOYMENT AGREEMENT</div>
            <div style="text-indent: 36pt; margin-top: 12pt; font-size: 12pt;">THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this <font style="font-style: italic;">&#8220;</font><font style="font-weight: bold; font-style: italic;">Agreement</font><font style="font-style: italic;">&#8221;</font>) is made and entered into as of November 4, 2015, by and between Masimo Corporation, a Delaware corporation (the <font style="font-style: italic;">&#8220;</font><font style="font-weight: bold; font-style: italic;">Company</font><font style="font-style: italic;">&#8221;</font>), and Joe Kiani (the <font style="font-style: italic;">&#8220;</font><font style="font-weight: bold; font-style: italic;">Executive</font><font style="font-style: italic;">&#8221;</font>).</div>
            <div style="text-align: center; margin-top: 12pt; font-size: 12pt; font-weight: bold;">RECITALS</div>
            <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">A.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">The
                Executive is the founder of the Company and has been its Chairman of the Board and Chief Executive Officer (&#8220; <font style="font-weight: bold; font-style: italic;">CEO </font>&#8221;) since its inception. The Board of Directors of the Company
                (the <font style="font-style: italic;">&#8220;</font><font style="font-weight: bold; font-style: italic;">Board<font style="font-style: italic; font-weight: normal;">"</font></font>) recognizes that the Executive&#8217;s contributions as Chairman of
                the Board and CEO have been instrumental to the success of the Company. The Executive and the Company entered into an amended and restated employment contract dated February 7, 2012 (the <font style="font-style: italic;">&#8220;</font><font style="font-weight: bold; font-style: italic;">Prior Agreement</font><font style="font-style: italic;">&#8221;</font>). The Board and the Executive desire to amend and restate the Prior Agreement pursuant to the terms hereof to assure the
                Company of the Executive&#8217;s continued employment in an executive capacity and to compensate him therefor.</font></div>
            <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">B.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">The
                Company considers the establishment and maintenance of a sound management to be essential to protecting and enhancing the best interests of the Company and its stockholders.</font></div>
            <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">C.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">The
                Board has determined that appropriate steps should be taken to retain the Executive and to reinforce and encourage his continued attention and dedication to his assigned duties.</font></div>
            <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">D.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">The
                Company desires to retain the services of the Executive, and the Executive desires to be employed by the Company pursuant to the terms and conditions of this Agreement.</font></div>
            <div style="text-indent: 36pt; margin-top: 12pt; font-size: 12pt;">NOW, THEREFORE, in consideration of the premises, the mutual promises and the mutual covenants and agreements hereinafter set forth, the Company and the Executive hereby agree
              that the Prior Agreement is amended and restated in its entirety as follows:</div>
            <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">1.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">EMPLOYMENT.







                During the <font style="font-style: italic;">&#8220;</font><font style="font-weight: bold; font-style: italic;">Employment Period</font><font style="font-style: italic;">&#8221;</font>, as that term is defined in Section 2 hereof, the Company hereby
                agrees to continue to employ the Executive and the Executive hereby agrees to continue to serve the Company, on the terms and conditions contained in this Agreement.</font></div>
            <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">2.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">POSITION







                AND DUTIES. The Executive shall serve the Company as its Chairman of the Board and CEO and shall report to the Board. The Executive&#8217;s responsibilities, duties and authority shall remain consistent with the Executive&#8217;s present
                responsibilities, duties and authority as the Chairman of the Board and CEO. The Executive hereby accepts such employment and agrees to devote substantially all of his full business and professional time and energy to the business and
                affairs of the Company. Notwithstanding the foregoing, the Executive shall be permitted to (i) serve as an employee, consultant, officer and/or director of, and provide services to, Cercacor Laboratories, Inc., a Delaware corporation (f/k/a
                Masimo Laboratories, Inc.), (ii) serve on the board of directors of any company or entity, (iii) manage the Executive&#8217;s</font></div>
            <div><br>
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter">
                <div><br>
                </div>
              </div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <!--PROfilePageNumberReset%Num%2%%%-->
            <div><br>
            </div>
            <div style="margin-top: 12pt; font-size: 12pt;">personal investments, (iv) engage in other personal activities on a basis substantially consistent with past practice and (v) without limiting the foregoing, provide the services and engage in the
              activities previously disclosed to the Board.</div>
            <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">3.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">EMPLOYMENT







                PERIOD. The <font style="font-style: italic;">&#8220;</font><font style="font-weight: bold; font-style: italic;">Employment Period</font><font style="font-style: italic;">&#8221;</font> shall mean the period commencing on the date hereof and ending on
                December 31, 2017; <font style="font-style: italic;">provided that </font>, beginning on January 1, 2018 and on January 1 of each year thereafter, the Employment Period shall be extended automatically for an additional year unless a
                notice of non&#8722;renewal of this Agreement (<font style="font-style: italic;">&#8220;</font><font style="font-weight: bold; font-style: italic;">Notice of Non-Renewal</font><font style="font-style: normal;">&#8221;</font>) is given by either the Executive
                or the Company to the other party at least one year prior to the scheduled expiration of the Employment Period.</font></div>
            <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">4.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">PLACE
                OF PERFORMANCE. In connection with his employment by the Company, the Executive shall be based at the Company&#8217;s office or facility where, on the date hereof, the Executive is regularly rendering services on behalf of the Company and shall
                not be required to be absent therefrom on travel status or otherwise more than a reasonable number of days in any calendar year. For purposes of the preceding sentence, the parties hereto agree that a <font style="font-style: italic;">&#8220;</font><font style="font-weight: bold; font-style: italic;">reasonable number of days</font><font style="font-style: italic;">&#8221;</font> shall mean such number of days which is not in excess of one hundred twenty&#8722;five percent (125%) of the number of
                days on which the Executive was on travel status or otherwise required by the Company to be absent from such office or facility during the calendar year immediately prior to the year of computation.</font></div>
            <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">5.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">COMPENSATION.</font></div>
            <div style="text-indent: 81pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">5.1</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">BASE SALARY. In consideration for services performed pursuant to this Agreement, the Company will pay or cause to be paid to the Executive, and the Executive will be entitled
                to receive and hereby agrees to accept, effective August 1, 2015, an annual base salary of one million dollars ($1,000,000) subject to increases in the discretion of the Board or the Compensation Committee of the Board (<font style="font-style: italic;">&#8220;</font><font style="font-weight: bold; font-style: italic;">Base Salary</font><font style="font-style: italic;">&#8221;</font>), payable in accordance with the Company&#8217;s normal payroll payment policy.</font></div>
            <div style="text-indent: 81pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">5.2</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">BONUS. The Executive shall be eligible to receive an annual bonus equal to one-hundred percent (100%) of his Base Salary based on the Company&#8217;s attaining certain financial
                goals established by the Board (or designated committee); <font style="font-style: italic;">provided that</font>, in the event the Board (or designated committee) determines that the Company achieved each of the financial measures included
                in the criteria for the &#8220;Company Factor&#8221; for a &#8220;Plan Year&#8221; under the Masimo Corporation Executive Annual Cash Bonus Award Plan, as may be amended or restated from time to time, or any successor plan (each as defined therein), the Executive
                shall automatically receive a bonus equal to one-hundred percent (100%) of the Executive&#8217;s Base Salary (or such higher percentage approved by the Board (or designated committee)) for such year. In addition, the Executive may be entitled to
                receive such additional bonus amounts as the Board (or designated committee) shall determine in its discretion, such as pursuant to the Masimo Corporation Executive Multi&#8722;Year Cash Bonus Award Plan, as may be amended or restated from time
                to time, or any successor plan. In determining such additional amounts, if any, the Board (or Compensation Committee of the Board) shall consider among other things the Executive&#8217;s contribution to the accomplishment of the Company&#8217;s
                long&#8722;range business goals, the success of</font></div>
            <div><br>
            </div>
            <div><br>
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter">
                <div><br>
                </div>
              </div>
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div><br>
            </div>
            <div style="margin-top: 12pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">various corporate strategies in which the Executive participated, and the Executive&#8217;s unique services in connection with the maintenance or increase in
              stockholder values in the Company.</div>
            <div style="text-indent: 81pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">5.3</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">STOCK OPTIONS AND RELATED INCENTIVE PLANS. The Executive shall be eligible to participate in the Company&#8217;s existing incentive programs and any additional or successor
                incentive plan or plans, including the Masimo Corporation 2007 Stock Incentive Plan (the <font style="font-style: italic;">&#8220;</font><font style="font-weight: bold; font-style: italic;">Stock Incentive Plan</font><font style="font-style: italic;">&#8221;</font>). During each of fiscal years 2016 and 2017, the Executive shall be granted a non-qualified stock option to purchase an aggregate of at least 300,000 shares of the Company&#8217;s common stock (<font style="font-style: italic;">&#8220;</font><font style="font-weight: bold; font-style: italic;">Common Stock</font><font style="font-style: italic;">&#8221;</font>) (as adjusted for stock splits, stock dividends, recapitalizations and similar transactions) that vests at
                a rate of twenty percent (20%) per year, with an exercise price per share equal to one-hundred percent (100%) of the fair market value (as defined under the applicable stock option plan pursuant to which the grant was made) of one share of
                Common Stock on the date of grant. All option grants made to the Executive pursuant to such plans shall provide for an expiration date consistent with the provisions of such plans, without regard to termination of employment; <font style="font-style: italic;">provided</font>, <font style="font-style: italic;">however</font>, that in no event shall any option remain exercisable beyond its stated expiration date. During each fiscal year during the Employment Period
                after fiscal year 2017, the Executive shall receive equity grants of the value at least consistent with equity grants made to comparable chief executive officers of comparable companies (taking account revenues, market capitalization and
                industry).</font></div>
            <div style="text-indent: 81pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">5.4</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">EXPENSES. The Company shall reimburse the Executive for all reasonable expenses incurred and paid by the Executive in the course of the performance of his duties pursuant to
                this Agreement. In addition, the Company shall reimburse the Executive for all reasonable travel and lodging expenses for the Executive&#8217;s immediate family, if the Executive elects to have his immediate family accompany him during his
                business travel. Notwithstanding anything to the contrary set forth in the Company&#8217;s Business Travel and Expense Policy, dated October 22, 2003, as may be amended or restated from time to time (the <font style="font-style: italic;">&#8220;</font><font style="font-weight: bold; font-style: italic;">Travel and Expense Policy</font><font style="font-style: italic;">&#8221;</font>) or the Company&#8217;s 2006 Employee Handbook, as may be amended or restated from time to time (the <font style="font-style: italic;">&#8220;</font><font style="font-weight: bold; font-style: italic;">Employee Handbook</font><font style="font-style: italic;">&#8221;</font>), for purposes of this Agreement, <font style="font-style: italic;">&#8220;</font><font style="font-weight: bold; font-style: italic;">reasonable</font><font style="font-style: italic;">&#8221;</font> expenses shall be deemed to include travel and hospitality expenses for first class airplane travel and accommodations and expenses
                for travel using private or chartered aircraft. In addition, the following Company reimbursement policies and provisions shall not apply to the Executive: (i) the Travel and Expense Policy; and (ii) the section entitled &#8220;Expense
                Reimbursements&#8221; in the Employee Handbook. Expenses reimbursable under this paragraph must be reimbursed within a reasonable period of time following the Executive&#8217;s submission to the Company of the reimbursement request and supporting
                documentation reasonably requested by the Company and in no event later than the end of the calendar year following the calendar year in which the expenses were incurred by the Executive.</font></div>
            <div style="text-indent: 81pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">5.5</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">FRINGE BENEFITS. The Executive shall be entitled to continue to participate in or receive benefits under all of the Company&#8217;s employee benefits plans and arrangements that he
                participates in on the date hereof or plans or arrangements providing the Executive with at least equivalent benefits thereunder. The Company agrees that, without the Executive&#8217;s prior written consent, it will not make any changes in such
                plans or arrangements</font></div>
            <div><br>
            </div>
            <div><br>
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter">
                <div><br>
                </div>
              </div>
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">3</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div><br>
            </div>
            <div style="margin-top: 12pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">which would adversely affect the Executive&#8217;s rights or benefits thereunder without the provision of at least equivalent benefits thereunder. The Executive
              shall be entitled to participate in or receive benefits under any pension plan, profit&#8722;sharing plan, savings plan, stock option plan, life insurance, health&#8722;and&#8722;accident plan or arrangement made available by the Company in the future to its
              executives and key management employees, subject to and on a basis consistent with the terms, conditions and overall administration of such plans and arrangements. No amounts paid or benefits provided to the Executive under any plan or
              arrangement presently in effect or made available in the future shall be deemed to be in lieu of compensation to the Executive hereunder.</div>
            <div style="text-indent: 81pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">5.6</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">VACATIONS. The Executive shall be entitled to the number of paid vacation days in each calendar year determined by the Board from time to time for the Company&#8217;s senior
                executive officers (prorated in any calendar year during which the Executive is employed by the Company for less than the entire such year in accordance with the number of days in such calendar year during which he is so employed). The
                Executive shall also be entitled to all paid holidays given by the Company to its senior executive officers.</font></div>
            <div style="text-indent: 81pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">5.7</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">PERQUISITES. The Executive shall be entitled to continue to receive the fringe benefits appertaining to the offices of Chairman of the Board and CEO of the Company in
                accordance with present practice, except that the Executive shall not be entitled to any tax reimbursements, gross-ups or similar payments.</font></div>
            <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">6.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">CONFIDENTIAL







                INFORMATION. The Executive has entered into and agrees to be bound by the terms and conditions of the Company&#8217;s Equity-Holder Non-Competition and Confidentiality Agreement dated as of the date hereof and attached as <u>Exhibit</u> A hereto
                (the &#8220;<font style="font-weight: bold; font-style: italic;">Restrictive Covenant Agreement</font>&#8221;).</font></div>
            <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">7.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">TERMINATION.</font></div>
            <div style="text-indent: 81pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">7.1</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">DEATH. The Executive&#8217;s employment hereunder shall terminate upon his death.</font></div>
            <div style="text-indent: 81pt; margin-top: 12pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">7.2<font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font>DISABILITY. If, as a result of the
              Executive&#8217;s incapacity due to physical or mental illness, the Executive shall have been absent from his duties hereunder on a full time basis for one hundred twenty (120) consecutive business days, and within thirty (30) days after written &#8220;<font style="font-weight: bold; font-style: italic;">Notice of Termination</font>&#8221;, as that term is defined in Section 7.5 hereof, is given shall not have returned to the performance of his duties hereunder on a full-time basis, the Company may
              terminate the Executive&#8217;s employment hereunder.</div>
            <div style="text-indent: 81pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">7.3</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">CAUSE. The Company may terminate the Executive&#8217;s employment hereunder for Cause. For the purposes of this Agreement, the Company shall have &#8220;<font style="font-weight: bold; font-style: italic;">Cause</font>&#8221; to terminate the Executive&#8217;s employment hereunder upon (i) the willful and continued failure by the Executive to substantially perform his duties hereunder, other than any such failure resulting from the
                Executive&#8217;s incapacity due to physical or mental illness or (ii) the willful engaging by the Executive in gross misconduct materially injurious to the Company, or (iii) the willful violation by the Executive of the confidentiality and trade
                secret protection provisions of</font></div>
            <div><br>
            </div>
            <div><br>
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter">
                <div><br>
                </div>
              </div>
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">4</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div><br>
            </div>
            <div style="text-indent: 36pt; margin-top: 12pt; font-size: 12pt;">Restrictive Covenant Agreement attached hereto, provided that such violation results in demonstrably material injury to the Company. For purposes of this paragraph, no act, or
              failure to act, on the Executive&#8217;s part shall be considered &#8220;<font style="font-family: Arial,Helvetica,sans-serif; font-weight: bold; font-style: italic;">willful</font>&#8221; unless done, or omitted to be done, by him not in good faith and
              without reasonable belief that his action or omission was in the best interests of the Company. Notwithstanding the foregoing, the Executive shall not be deemed to have been terminated for Cause unless and until there shall have been
              delivered to the Executive a copy of a resolution, duly adopted by the affirmative vote of not less than three&#8722;quarters of the entire membership of the Board at a meeting of the Board called and held for the purpose (after reasonable notice
              to the Executive and an opportunity for him, together with his counsel, to be heard before the Board), resolving that in the good faith opinion of the Board the Executive engaged in conduct set forth above in clause (i), (ii), or (iii), and
              specifying the particulars thereof in detail.</div>
            <div style="text-indent: 81pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">7.4</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">TERMINATION BY THE EXECUTIVE. The Executive may terminate his employment hereunder (i) for Good Reason, (ii) if his health should become impaired to an extent that makes the
                continued performance of his duties hereunder hazardous to his physical or mental health or his life, or (iii) at any time by giving six (6) months&#8217; written notice to the Company of his intention to terminate. For purposes of this
                Agreement, &#8220;<font style="font-weight: bold; font-style: italic;">Good Reason</font>&#8221; shall mean (A) except in connection with a termination of the Executive&#8217;s employment for Cause, any diminution in the Executive&#8217;s responsibilities, duties
                and authority set forth in Section 2 hereof, whether due to the assignment to the Executive of any responsibilities, duties or authority that constitute such a diminution or otherwise, including (i) the Executive ceasing to serve as a Chief
                Executive Officer of a publicly-traded company or (ii) the Executive ceasing to serve as the Chairman of the Board of the Company or the designation of any director other than the Executive as the lead director of the Board, (B) a reduction
                in the Executive&#8217;s rate of compensation or a reduction in the Executive&#8217;s fringe benefits or any other failure by the Company to comply with Section 5 hereof, (C) any failure by the Company to comply with Section 4 hereof, (D) the provision
                of a Notice of Non-Renewal by the Company, or (E) the occurrence of a &#8220;<font style="font-weight: bold; font-style: italic;">Change in Control</font>&#8221;, as that term is defined in Section 9 hereof, <font style="font-style: italic;">provided
                  that </font>, in each case of clauses (A) through (C) above, &#8220;Good Reason&#8221; shall not be deemed to exist unless (x) Executive provides the Company a Notice of Termination within ninety (90) days following the initial occurrence of such
                event, (y) the Company fails to cure the event giving rise to Good Reason within thirty (30) days following its receipt of such Notice of Termination (the &#8220;<font style="font-weight: bold; font-style: italic;">Cure Period</font>&#8221;) and (z)
                Executive&#8217;s resignation for Good Reason is effective within thirty (30) days after the expiration of the Cure Period.</font></div>
            <div style="text-indent: 81pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">7.5</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">NOTICE OF TERMINATION. Any termination by the Company pursuant to Section 7.2 or 7.3 hereof or by the Executive pursuant to Section 7.4 hereof shall be communicated by
                written Notice of Termination to the other party hereto. For purposes of this Agreement, a &#8220;<font style="font-weight: bold; font-style: italic;">Notice of Termination</font>&#8221; shall mean a notice which shall indicate the specific termination
                provision in this Agreement relied upon and shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executive&#8217;s employment under the provision so indicated.</font></div>
            <div><br>
            </div>
            <div><br>
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter">
                <div><br>
                </div>
              </div>
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">5</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div><br>
            </div>
            <div style="text-indent: 81pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">7.6</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">DATE OF TERMINATION. &#8220;<font style="font-weight: bold; font-style: italic;">Date of Termination</font>&#8221; shall mean (i) if the Executive&#8217;s employment is terminated by his
                death, the date of his death, (ii) if the Executive&#8217;s employment is terminated pursuant to Section 7.2 hereof, thirty (30) days after Notice of Termination is given (<font style="font-style: italic;">provided that </font>the Executive
                shall not have returned to the performance of his duties on a full&#8722;time basis during such thirty (30) day period), (iii) if the Executive&#8217;s employment is terminated pursuant to Section 7.3 hereof or clause (iii) of Section 7.4 hereof, the
                date specified in the Notice of Termination, or (iv) if the Executive&#8217;s employment is terminated for any other reason, the date on which a Notice of Termination is given; <font style="font-style: italic;">provided that </font>if within
                sixty (60) days after a Notice of Termination is given the party receiving such Notice of Termination notifies the other party that it disputes the termination, the Date of Termination shall be the date on which the dispute is finally
                determined, either by mutual written agreement of the parties, or by a final determination by the Superior Court of California for the County of Orange.</font></div>
            <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">8.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">COMPENSATION







                UPON TERMINATION, DEATH OR DURING DISABILITY.</font></div>
            <div style="text-indent: 81pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">8.1</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">DEATH. If the Executive&#8217;s employment shall be terminated by reason of his death during the Employment Period, the Company shall pay to such person as he shall designate in a
                notice filed with the Company, or, if no such person shall be designated, to his estate as a death benefit, an annual amount equal to one&#8722;half (1/2) of the Executive&#8217;s Base Salary at the rate in effect on the date of the Executive&#8217;s death.
                Such amount shall be paid each year for each of three (3) consecutive years following the Executive&#8217;s death, in substantially equal monthly installments commencing within thirty (30) days following the Executive&#8217;s death. This amount shall
                be exclusive of and in addition to any payments the Executive&#8217;s surviving spouse, beneficiaries or estate may be entitled to receive pursuant to any pension or employee benefit plan or life insurance policy maintained by the Company. For
                avoidance of doubt, if the Executive has not specifically designated a beneficiary of these payments, no other beneficiary designation in effect for any other Company benefit or insurance shall serve as a beneficiary designation for these
                payments and they will instead be paid to his estate.</font></div>
            <div style="text-indent: 81pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">8.2</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">DISABILITY. During any period during the Employment Period that the Executive fails to perform his duties hereunder as a result of incapacity due to physical or mental
                illness, the Executive shall continue to receive his full Base Salary and incentive compensation until the Executive&#8217;s employment is terminated pursuant to Section 7.2 hereof, or until the Executive terminates his employment pursuant to
                clause (ii) of Section 7.4 hereof, whichever first occurs. After any such termination, the Executive shall be paid an annual amount equal to three&#8722;fourths (3/4) of his Base Salary at the rate then in effect, payable each year for a period
                of two (2) consecutive years following the date of such termination and, subject to Section 8.6 hereof, commencing within thirty (30) days following the Executive&#8217;s termination. To the extent permitted by Treasury Regulation &#167;
                1.409A&#8722;3(i)(1)(ii) (A), such disability benefits shall be reduced by any disability payment otherwise payable by or pursuant to disability plans maintained by the Company and actually paid to the Executive and shall be paid in substantially
                equal monthly installments in accordance with the Company&#8217;s normal payroll payment policy.</font></div>
            <div><br>
            </div>
            <div><br>
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter">
                <div><br>
                </div>
              </div>
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">6</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div><br>
            </div>
            <div style="text-indent: 81pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">8.3</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">CAUSE. If the Executive&#8217;s employment shall be terminated for Cause, the Company shall pay the Executive his full Base Salary through the Date of Termination at the rate in
                effect at the time Notice of Termination is given and the Company shall have no further obligations to the Executive under this Agreement.</font></div>
            <div style="text-indent: 81pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">8.4</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">OTHER. If, during the Employment Period, the Company shall terminate the Executive&#8217;s employment other than pursuant to Sections 7.1, 7.2 or 7.3 hereof or if the Executive
                shall terminate his employment pursuant to clause (i) of Section 7.4</font> <font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">hereof (each, a &#8220;<font style="font-weight: bold; font-style: italic;">Qualifying
                  Termination</font>&#8221;), then:</font></div>
            <div style="text-indent: 135pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">(i)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;"><font style="font-style: italic;">Standard Severance </font>. The Company shall pay to the Executive in cash a severance benefit equal to two times the sum of (i) the
                Executive&#8217;s Base Salary at the rate then in effect, and (ii) the average annual bonus paid to the Executive during the immediately prior three (3) years. Such amount shall be paid over a period of two (2) years in substantially equal
                installments in accordance with the Company&#8217;s normal payroll payment policy and, subject to Section 8.6 hereof, commencing within thirty (30) days following the Executive&#8217;s termination of employment.</font></div>
            <div style="text-indent: 135pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">(ii)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;"><font style="font-style: italic;">Equity Treatment. </font>The Company shall vest, effective as of immediately prior to such Qualifying Termination, all of the Executive&#8217;s
                stock options and other equity awards (if any).</font></div>
            <div style="text-indent: 135pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">(iii)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;"><font style="font-style: italic;">Other Payments </font>.</font></div>
            <div style="text-indent: 162pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">(1)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">Effective as of the date hereof, the Company shall grant the Executive a one-time grant of 2,700,000 restricted share units (&#8220;<font style="font-weight: bold; font-style: italic;">RSUs</font>&#8221;) (as adjusted for stock splits, stock dividends, recapitalizations and similar transactions) under the Stock Incentive Plan and the restricted share unit award agreement attached as <u>Exhibit</u> B hereto (the &#8220;<font style="font-weight: bold; font-style: italic;">Award Agreement</font>&#8221;). Each RSU shall vest effective as of immediately prior to a Qualifying Termination (the &#8220;<font style="font-weight: bold; font-style: italic;">Vesting Date</font>&#8221;)
                during the Employment Period, <font style="font-style: italic;">provided that </font>270,000 RSUs (as adjusted for stock splits, stock dividends, recapitalizations and similar transactions) shall terminate without the payment of any
                consideration to the Executive, to the extent then unvested, on January 1 of each year, beginning on January 1, 2018. Each RSU shall represent the right to receive, on the tenth (10th) day following the Vesting Date (subject to Section 8.6
                hereof), one share of Common Stock. Notwithstanding the foregoing, the Board, in its sole discretion, may accelerate the vesting of some or all of the RSUs at any time prior to the Vesting Date, provided that payment of the RSUs accelerated
                in accordance with this sentence shall be made in shares of Common Stock on the (10th) day following the date of the Executive&#8217;s &#8220;separation from service&#8221; within the meaning of Treasury Regulation Section 1.409A&#8722;1(h) (subject to Section 8.6
                hereof). In the event of any inconsistency between the terms of this Agreement and the Award Agreement or the Plan, the terms of this Agreement shall govern.</font></div>
            <div style="text-align: justify; text-indent: 162pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">(2)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">Upon a Qualifying Termination, the Company shall pay to the Executive in a single lump sum on the sixtieth (60th) day following the Executive&#8217;s termination of employment
                (subject to Section 8.6 hereof) a cash amount equal to thirty-five million dollars ($35,000,000) (the &#8220;<font style="font-weight: bold; font-style: italic;">Cash Payment<font style="font-weight: normal; font-style: normal;">"</font></font>,
                and together with the RSUs, the &#8220;<font style="font-weight: bold; font-style: italic;">Special</font></font></div>
            <div><br>
            </div>
            <div><br>
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter">
                <div><br>
                </div>
              </div>
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">7</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div><br>
            </div>
            <div style="margin-top: 12pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;"><font style="font-weight: bold; font-style: italic;">Payment </font>&#8221;), <font style="font-style: italic;">provided that </font>the Cash Payment shall be
              reduced by three million five-hundred thousand dollars ($3,500,000) on January 1 of each year, beginning on January 1, 2018. A portion of the cash and shares of Common Stock delivered under the Special Payment with a value not to exceed
              thirty-five million dollars ($35,000,000) (the <font style="font-style: italic;">&#8220;</font><font style="font-weight: bold; font-style: italic;">Non-Competition Payment</font><font style="font-style: italic;">&#8221;</font>) is being paid to the
              Executive in consideration of the Executive&#8217;s agreement to comply with Sections 1 and 11 of the Restrictive Covenant Agreement and shall be subject to repayment to the Company in the event of a final determination by the Superior Court of
              California for the County of Orange that the Executive has materially breached such covenants. The Company agrees that the Non- Competition Payment constitutes reasonable compensation under Section 280G(b)(4)(A) of the Internal Revenue Code
              of 1986, as amended (the <font style="font-style: italic;">&#8220;</font><font style="font-weight: bold; font-style: italic;">Code</font><font style="font-style: normal;">&#8221;</font>).</div>
            <div style="text-indent: 135pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">(iv)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;"><font style="font-style: italic;">Rabbi Trust </font>. Immediately prior to a Change in Control, the Company shall fund a grantor trust (the <font style="font-style: italic;">&#8220;</font><font style="font-weight: bold; font-style: italic;">Trust</font><font style="font-style: italic;">&#8221;</font>) and the Executive shall enter into an escrow agreement to provide for the payment of (i) the benefits under
                Sections 8.4(i) and 8.4(iii)(2) hereof and (ii) the RSUs under Section 8.4(iii)(1) hereof (together with the payments under clause (i), the <font style="font-style: italic;">&#8220;</font><font style="font-weight: bold; font-style: italic;">Benefits</font>&#8221;),



                and the Company shall place amounts in escrow, funded in cash and shares of Common Stock, as applicable, equal to one hundred percent (100%) of the aggregate Benefits assuming that the Executive incurred a termination of employment
                entitling him to the Benefits immediately following the Change in Control. The cash amounts held in the Trust shall be credited with interest at the prime interest rate as published in the Wall Street Journal. Alternatively, in lieu of
                interest, the Executive may elect at the time the Trust is funded in accordance with this Section for cash amounts held in the Trust to be deemed invested in any of the investment alternatives then available under the Company&#8217;s 401(k)
                retirement plan or otherwise specified by the Executive. In addition, the Executive may elect at any time for the shares of Common Stock that are held in the Trust to be sold and any cash received therefrom to be held in the Trust and
                either credited with interest or deemed invested, in either case in accordance with the preceding sentences. In the event the Executive&#8217;s employment terminates on or prior to the second anniversary of the Change in Control in a manner
                entitling him to the Benefits, the Executive shall be entitled to receive, in full satisfaction of the Benefits, and on the payment dates specified in this Section 8.4, the amounts contributed to the Trust, as adjusted to reflect the
                applicable interest or gains (or losses) of any deemed investments, as applicable. Notwithstanding the establishment of any such Trust, the Executive&#8217;s rights to the Benefits will be solely those of a general unsecured creditor. In the
                event the Executive&#8217;s employment is not terminated on or prior to the second anniversary of the Change in Control in a manner entitling him to the Benefits, the amounts held in the Trust shall revert to the Company, provided that such
                reversion shall have no effect on the Executive&#8217;s continuing entitlement to receive the Benefits in accordance with this Section 8.4. In addition, any amount remaining in the Trust immediately following the date that the last payment of the
                Benefits to which the Executive becomes or could become entitled has been made shall revert to the Company as of such date.</font></div>
            <div style="text-indent: 81pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">8.5</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">EMPLOYEE BENEFIT PLANS.</font></div>
            <div style="margin-top: 12pt; text-indent: 135pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">(i)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">Unless the Executive&#8217;s employment is terminated pursuant to Section 7.3 hereof, the Company shall maintain in full force and effect, for the continued benefit of the
                Executive for the full Employment Period as then in effect without regard to any</font></div>
            <div><br>
            </div>
            <div><br>
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter">
                <div><br>
                </div>
              </div>
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">8</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div><br>
            </div>
            <div style="margin-top: 12pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">termination of employment, all employee benefit plans and programs in which the Executive was entitled to participate immediately prior to the Date of
              Termination, <font style="font-style: italic;">provided that </font>the Executive&#8217;s continued participation is possible under the general terms and provisions of such plans and programs.</div>
            <div style="text-indent: 135pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">(ii)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">In the event that the Executive&#8217;s participation in any such plan or program is barred, the Company shall reimburse expenses actually incurred by the Executive during such
                period to obtain similar coverage, but only to the extent the Executive&#8217;s requested reimbursement of expenses for similar coverage does not exceed the Company&#8217;s premiums or contributions that the Company would otherwise pay under the terms
                of this Agreement as of the date of the Executive&#8217;s termination, or date of payment if later, to continue the Executive&#8217;s participation in the underlying plan for the period the expenses were incurred by the Executive. Expenses reimbursable
                under this paragraph shall be reimbursed within thirty (30) days following the Executive&#8217;s submission to the Company of the reimbursement request and supporting documentation reasonably requested by the Company and in no event later than
                the end of the calendar year following the calendar year in which the expenses were incurred by the Executive. The expenses eligible for reimbursement under this paragraph during any calendar year shall not affect the expenses eligible for
                reimbursement under this paragraph in any other calendar year.</font></div>
            <div style="text-indent: 81pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">8.6</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">CODE SECTION 409A COMPLIANCE. Notwithstanding anything in this Agreement to the contrary, if any benefit or amount payable to the Executive under this Agreement on account of
                the Executive&#8217;s termination of employment constitutes &#8220;nonqualified deferred compensation&#8221; within the meaning of Section 409A (&#8220;<font style="font-weight: bold; font-style: italic;">409A</font><font style="font-style: normal;">&#8221;</font>) of
                the Code, payment of such benefit or amount shall commence when the Executive incurs a &#8220;separation from service&#8221; within the meaning of Treasury Regulation Section 1.409A&#8722;1(h), which provides that a separation from service will be deemed to
                occur if the Company and the Executive reasonably anticipate that the Executive shall perform no further services for the Company and any entity that would be considered a single employer with the Company under Sections 414(b) or 414(c) of
                the Code (whether an employee or an independent contractor) or that the level of bona fide services the Executive will perform in the future (whether as an employee or an independent contractor) will permanently decrease to no more than
                forty-nine percent (49%) of the average level of bona fide services performed (whether as an employee or independent contractor) over the immediately preceding thirty-six (36) month period. Such payments or benefits shall be provided in
                accordance with the timing provisions of this Agreement by substituting the references to &#8220;termination of employment&#8221; or &#8220;termination&#8221; with &#8220;separation from service&#8221;; however, if at the time the Executive incurs a separation from service,
                the Executive is a &#8220;specified employee&#8221; within the meaning of 409A, any benefit or amount payable to the Executive under this Agreement on account of the Executive&#8217;s termination of employment that constitutes nonqualified deferred
                compensation subject to 409A shall be delayed until the first day of the seventh month following the Executive&#8217;s separation from service (the <font style="font-style: italic;">&#8220;</font><font style="font-weight: bold; font-style: italic;">409A



                  Suspension Period</font><font style="font-style: italic;">&#8221;</font>). Within five (5) calendar days after the date the Executive incurs such separation from service, the Company shall contribute to the Trust an amount in cash or shares of
                Common Stock, as applicable, equal to any payments that the Company would otherwise have been required to pay under this Agreement during the 409A Suspension Period (plus the required</font></div>
            <div><br>
            </div>
            <div><br>
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter">
                <div><br>
                </div>
              </div>
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">9</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div><br>
            </div>
            <div style="margin-top: 12pt; font-size: 12pt;">interest on any cash amounts, calculated as described in the following sentence). Within fourteen (14) calendar days after the end of the 409A Suspension Period, the Company shall pay to the
              Executive (or his estate or beneficiary, as applicable), from the assets of the Trust or otherwise, a lump sum payment in cash or shares of Common Stock, as applicable, equal to any payments (including interest on any such cash payments, at
              an interest rate equal to the average prime interest rate, as published in the Wall Street Journal, over the 409A Suspension Period) that the Company would otherwise have been required to pay under this Agreement during the 409A Suspension
              Period. Notwithstanding the foregoing, in lieu of interest, the Executive may elect at the time the Trust is funded in accordance with this Section for cash amounts held in the Trust to be deemed invested in any of the investment alternatives
              then available under the Company&#8217;s 401(k) retirement plan or otherwise specified by the Executive, and within fourteen (14) calendar days after the end of the 409A Suspension Period, the Executive shall be entitled to receive, in full
              satisfaction of the payments that the Company would otherwise have been required to pay under this Agreement during the 409A Suspension Period, the amounts contributed to the Trust, as adjusted to reflect the gains (or losses) of such deemed
              investments. Thereafter, the Executive shall receive any remaining payments due under this Agreement in accordance with the terms of this Agreement (as if there had not been any suspension period beforehand). In addition, the Executive may
              elect at any time, to the extent permitted by law, for shares of Common Stock that are held in the Trust to be sold and any cash received therefrom to be held in the Trust and either credited with interest or deemed invested, in either case
              in accordance with the preceding sentences. For purposes of this Agreement, each payment that is part of a series of installment payments shall be treated as a separate payment for purposes of 409A. Notwithstanding anything in this Agreement
              to the contrary, all reimbursements and in&#8722;kind benefits provided under this Agreement shall be made in accordance with the following requirements of 409A: (i) the reimbursement of eligible expenses will be made no later than the end of the
              calendar year following the calendar year in which the expenses were incurred by the Executive;<font style="font-family: Arial,Helvetica,sans-serif;"> (ii)</font> <font style="font-family: Arial,Helvetica,sans-serif;">the amount of expenses
                eligible for reimbursement, or in&#8722;kind benefits provided, during a calendar year may not affect the expenses eligible for reimbursement or in&#8722;kind benefits to be provided in any other calendar year; and (iii) any right to reimbursement of
                eligible expenses or in&#8722;kind benefits is not subject to liquidation or exchange for any other benefit.</font></div>
            <div style="text-indent: 81pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">8.7</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">PARACHUTE PAYMENTS.</font></div>
            <div style="text-indent: 135pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">(i)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">Notwithstanding any other provisions of this Agree-ment, in the event that any payment or benefit received or to be received by the Executive (including any payment or
                benefit received in connection with a Change in Control or the termination of the Executive&#8217;s employment, whether pursuant to the terms of this Agreement or any other plan, arrangement or agreement) (all such payments and benefits,
                including the Severance Payments, being hereinafter referred to as the &#8220;<font style="font-weight: bold; font-style: italic;">Total Payments</font>&#8221;) would be subject (in whole or part), to any excise tax imposed under Section 4999 of the
                Code (the &#8220;<font style="font-weight: bold; font-style: italic;">Excise Tax</font>&#8221;), then, after taking into account any reduction in the Total Payments provided by reason of Section 280G of the Code in such other plan, arrangement or
                agreement, the cash portion of Total Payments payable pursuant to the terms of this Agreement shall first be reduced, and the noncash portion of the Total Payments payable pursuant to the terms of this Agreement shall thereafter be reduced,
                to the extent necessary so that no portion of the Total Payments is subject to the Excise Tax but only if</font></div>
            <div><br>
            </div>
            <div><br>
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter">
                <div><br>
                </div>
              </div>
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">10</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div><br>
            </div>
            <div style="margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">(A)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">the net amount of such Total Payments, as so reduced (and after subtracting the net amount of federal, state and local income taxes on such reduced Total Payments and after taking into account the
                phase out of itemized deductions and personal exemptions attributable to such reduced Total Payments) is greater than or equal to (B) the net amount of such Total Payments without such reduction (but after subtracting the net amount of
                federal, state and local income taxes on such Total Payments and the amount of Excise Tax to which the Executive would be subject in respect of such unreduced Total Payments and after taking into account the phase out of itemized deductions
                and personal exemptions attributable to such unreduced Total Payments); <font style="font-style: italic;">provided</font>, <font style="font-style: italic;">however</font>, <font style="font-style: italic;">that </font>the Executive may
                elect which portion of the Total Payments payable pursuant to the terms of this Agreement shall be so reduced (or eliminated).</font></div>
            <div style="text-indent: 135pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">(ii)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">For purposes of determining whether and the extent to which the Total Payments will be subject to the Excise Tax, (i) no portion of the Total Payments the receipt or
                enjoyment of which the Executive shall have waived at such time and in such manner as not to constitute a &#8220;payment&#8221; within the meaning of Section 280G(b) of the Code shall be taken into account, (ii) no portion of the Total Payments shall
                be taken into account which, in the opinion of a nationally-recognized professional services firm or firms (the &#8220;<font style="font-weight: bold; font-style: italic;">Calculating Firm</font>&#8221;) reasonably acceptable to the Executive, does not
                constitute a &#8220;parachute payment&#8221; within the meaning of Section 280G(b)(2) of the Code (including by reason of Section 280G(b)(4)(A) of the Code) and, in calculating the Excise Tax, no portion of such Total Payments shall be taken into
                account which, in the opinion of the Calculating Firm, constitutes reasonable compensation for services actually rendered, within the meaning of Section 280G(b)(4)(B) of the Code, in excess of the &#8220;base amount&#8221; (within the meaning of
                Section 280G(b)(3) of the Code) allocable to such reasonable compensation, and (iii) the value of any non&#8209;cash benefit or any deferred payment or benefit included in the Total Payments shall be determined by the Calculating Firm in
                accordance with the principles of Sections 280G(d)(3) and (4) of the Code.</font></div>
            <div style="text-indent: 135pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">(iii)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">At the time that payments are made under this Agree-ment, the Company shall provide the Executive with a written statement setting forth the manner in which such payments
                were calculated and the basis for such calculations including, without limitation, any opinions or other advice the Company has received from the Calculating Firm or other advisors or consultants (and any such opinions or advice which are
                in writing shall be attached to the statement).</font></div>
            <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">9.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">CHANGE
                IN CONTROL OF THE COMPANY. For purposes of this Agreement &#8220;<font style="font-weight: bold; font-style: italic;">Change in Control</font>&#8221; shall be deemed to have occurred at such time as:</font></div>
            <div style="text-indent: 135pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">(i)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">any person or more than one person acting as a group within the meaning of Treasury Regulation &#167; 1.409A&#8722;3(i)(5)(v)(B) acquires (or has acquired during the twelve (12) month
                period ending on the date of the most recent acquisition by such person or persons) beneficial ownership, as determined under the constructive ownership rules of Section 318(a) of the Code, shares of capital stock of the Company entitling
                such person or persons to exercise more than thirty-five percent (35%) of the total voting power of all voting shares of the Company; or</font></div>
            <div><br>
            </div>
            <div><br>
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter">
                <div><br>
                </div>
              </div>
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">11</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader"></div>
            </div>
            <div><br>
            </div>
            <div style="text-indent: 135pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">(ii)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">any person or more than one person acting as a group within the meaning of Treasury Regulation &#167; 1.409A&#8722;3(i)(5)(v)(B) acquires (or has acquired during the twelve (12) month
                period ending on the date of the most recent acquisition by such person or persons) assets of the Company that have a total fair market value equal to or more than forty percent (40%) of the total gross fair market value of all the assets
                of the Company immediately before such acquisition or acquisitions; or</font></div>
            <div style="text-indent: 135pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">(iii)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">there shall occur a change in the Board in which the individuals who constituted the Board at the beginning of the twelve (12) month period immediately preceding such change
                cease for any reason to constitute two-thirds or more of the directors then in office. For purposes of this Section 9(iii), a director (other than a director whose initial assumption of office is in connection with an actual or threatened
                election contest, including but not limited to, a consent solicitation, relating to the election of directors of the Company) whose election by the Board or whose nomination for election by the stockholders of the Company was approved by a
                vote of at least a majority of the directors then in office either who were directors at the beginning of such period or whose election or nomination for election was previously so approved will be treated as a member of the Board at the
                beginning of the twelve (12) month period.</font></div>
            <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">10.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">BINDING







                AGREEMENT. This Agreement and all rights of the Executive hereunder shall inure to the benefit of and be enforceable by the Executive&#8217;s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees
                and legatees.</font></div>
            <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">11.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">NON&#8722;WAIVER







                OF RIGHTS. The failure to enforce, at any time, any of the provisions of this Agreement, or to require, at any time, performance by the other party of any of the provisions hereof shall in no way be construed to be a waiver of such
                provision or to affect either the validity of this Agreement, or any part hereof, or the right of either party thereafter to enforce each and every provision in accordance with the terms of this Agreement.</font></div>
            <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">12.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">INVALIDITY







                OF PROVISIONS. The invalidity or unenforceability of any particular provision of this Agreement shall not affect the other provisions hereof, and this Agreement shall be construed in all respects as if such invalid or unenforceable
                provisions were omitted.</font></div>
            <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">13.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">ASSIGNMENTS;







                COMPANY BOOKS.</font></div>
            <div style="margin-top: 12pt; text-indent: 135pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">(i)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">This Agreement is binding upon the parties hereto and their respective personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees
                and legatees. Except as otherwise provided herein, neither of the parties hereto may make any assignment of this Agreement, or any interest herein, without the prior written consent of the other party, except that, without such consent,
                this Agreement shall be assigned to any corporation or entity which shall succeed to the business presently being operated by the Company, by operation of law or otherwise, including by dissolution, merger, consolidation, transfer of
                assets, or otherwise.</font></div>
            <div><br>
            </div>
            <div><br>
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter">
                <div><br>
                </div>
              </div>
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">12</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader">
                <div><br>
                </div>
              </div>
            </div>
            <div><br>
            </div>
            <div style="text-indent: 135pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">(ii)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">The Company currently owns all right, title and interest in and to the two books authored by Skip Press tentatively entitled <font style="font-style: italic;">Microfixing </font>and







                <font style="font-style: italic;">False Claims </font>(collectively, &#8220;<font style="font-weight: bold; font-style: italic;">Company Books</font>&#8221;), both of which are works made for hire of the Company. The Company shall and hereby does
                irrevocably transfer and assign to the Executive, free and clear of all liens and encumbrances, (i) all right, title and interest in the Company Books (including all copyrights and other intellectual property rights therein or thereto)
                throughout the world, (ii) the right to enforce the copyrights and other intellectual property rights in and to the Company Books against third parties for past, present and future infringement, and (iii) all proceeds from any of the
                foregoing.</font></div>
            <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">14.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">COUNTERPARTS.







                This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original but all of which together will constitute one and the same instrument.</font></div>
            <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">15.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">AMENDMENTS.







                No modification, amendment or waiver of any of the provisions of this Agreement shall be effective unless in writing specifically referring hereto, and signed by the parties hereto.</font></div>
            <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">16.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">NOTICES.







                For the purposes of this Agreement, notices and all other communications provided for in this Agreement shall be in writing and shall be deemed to have been duly given when delivered by United States certified mail, return receipt
                requested, postage prepaid, addressed as follows:</font></div>
            <div>
              <div style="font-family: Arial,Helvetica,sans-serif; font-size: 12pt;"><br>
              </div>
            </div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="width: 60%; color: #000000; font-family: Arial, Helvetica, 'sans-serif'; font-size: 10pt;" id="z06a1fdd73f654a008521d4c4bb13b674">

                  <tr>
                    <td style="width: 50%; text-align: left; vertical-align: top;">
                      <div style="font-size: 12pt; margin-left: 117pt;">If to the Executive: <br>
                      </div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="font-size: 12pt;">At the address shown in the Company&#8217;s personnel records <br>
                      </div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width: 50.00%;">
                      <div style="font-size: 12pt;">&#160;</div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="font-size: 12pt;">&#160;</div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width: 50%; text-align: left; vertical-align: top;">
                      <div style="font-size: 12pt; margin-left: 117pt;">If to the Company: <br>
                      </div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="font-size: 12pt;">
                        <div style="text-align: left; font-family: Arial,Helvetica,sans-serif;">Masimo Corporation</div>
                        <div style="text-align: left; font-family: Arial,Helvetica,sans-serif;">52 Discovery</div>
                        <div style="text-align: left; font-family: Arial,Helvetica,sans-serif;">Irvine, CA 92618</div>
                        <div style="text-align: left; font-family: Arial,Helvetica,sans-serif;">Attention: Chairman of the Compensation</div>
                        <div style="text-align: left; font-family: Arial,Helvetica,sans-serif;">Committee of the Board of Directors</div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
            <div class="BRPFPageFooter">
              <div>
                <div style="margin-top: 12pt; font-size: 12pt;">or to such other address as any party may have furnished to the other in writing in accordance herewith, except that notices of change of address shall be effective only upon receipt.</div>
                <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">17.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">SURVIVAL.







                    Sections 6, 10&#8209;13 and 15&#8209;20 hereof shall survive termination or expiration of this Agreement. For purposes of this Agreement, &#8220;expiration&#8221; is the ending of this Agreement by reason of a Notice of Non-Renewal being given by one of the
                    parties in accordance with Section 3 hereof. Provisions of Sections 5.4 and 8 hereof that provide for obligations conditional on the existence of a state of affairs shall survive termination or expiration of this Agreement only to the
                    extent that any such state of affairs exists prior to termination or expiration of this Agreement. For the sake of clarity, all payments and benefits that may become owing as a result of the specified terminations shall only be due and
                    become owing for terminations that occur during the Employment Period as then in effect without regard</font></div>
                <div><br>
                </div>
                <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                  <div class="BRPFPageFooter"></div>
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">13</font></div>
                  <div class="BRPFPageBreak" style="page-break-after: always;">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                  <div class="BRPFPageHeader"></div>
                </div>
                <div><br>
                </div>
                <div style="margin-top: 12pt; font-size: 12pt;">to any termination of employment but shall be owing and paid regardless of whether the Employment Period has ended prior to such payments having been completed.</div>
                <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">18.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">JURISDICTION.







                    Any suit, action or proceeding arising out of or relating to this Agreement shall be brought in the Superior Court of California for the County of Orange, and the parties hereby irrevocably accept the exclusive personal jurisdiction of
                    such court for the purpose of any suit, action or proceeding. In addition, the parties each hereby irrevocably waive, to the fullest extent permitted by law, any objection which they may now or hereafter have to the laying of venue of
                    any suit, action or proceeding arising out of or relating to this Agreement in the Superior Court of California for the County of Orange, and hereby further irrevocably waive any claim that any suit, action or proceeding brought in such
                    court has been brought in an inconvenient forum. Notwithstanding the pendency of any such suit, action or proceeding, the Company shall continue to pay the Executive his full compensation in effect when the notice giving rise to any
                    dispute was given (including, but not limited to, base salary and any bonus due) and continue the Executive as a participant in all compensation, benefit and insurance plans in which the Executive was participating when the notice
                    giving rise to the dispute was given, until the dispute is finally resolved. Amounts paid under this Section are in addition to all other amounts due under this Agreement and shall not be offset against or reduce any other amounts due
                    under this Agreement. The Company also shall pay to the Executive, on an as-incurred basis, all legal fees and expenses incurred by the Executive in seeking to obtain or enforce any benefit or right provided by this Agreement, but in no
                    event shall the Company pay more than three million dollars ($3,000,000) in legal fees and expenses. Such payments shall be made within five (5) business days after delivery of the Executive&#8217;s written requests for payment accompanied
                    with such evidence of fees and expenses incurred as the Company reasonably may require. If, prior to the occurrence of a Change in Control, the Superior Court of California for the County of Orange makes a final determination that the
                    Executive did not prevail in any part of the actions to obtain or enforce any benefit or right provided by this Agreement, the Executive shall reimburse the Company for all such legal fees and expenses paid to him by the Company;
                    provided that, for the avoidance of doubt, if the Executive prevailed in any part of any such action, the Executive shall not be required to make such reimbursement. The Executive's obligation, if any, to reimburse the Company shall be
                    unsecured and no interest shall be charged thereon.</font></div>
                <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">19.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">ENTIRE







                    AGREEMENT. Except for the Restrictive Covenant Agreement, this Agreement supersedes all prior employment agreements, both written and oral, between the Company and the Executive, including, without limitation, the Prior Agreement and
                    the tolling agreement dated as of March 27, 2015 between the Company and the Executive.</font></div>
                <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">20.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">INTERPRETATION.







                    This Agreement shall in all respects be interpreted, construed and governed by and in accordance with the laws of the State of California, without regard to conflicts of laws principles.</font></div>
                <div style="margin-top: 0.5pt;"><br>
                </div>
                <div style="text-align: center; margin-top: 12pt; font-size: 12pt;">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]</div>
                <div><br>
                </div>
                <div><br>
                </div>
                <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                  <div class="BRPFPageFooter">
                    <div><br>
                    </div>
                  </div>
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">14</font></div>
                  <div class="BRPFPageBreak" style="page-break-after: always;">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                  <div class="BRPFPageHeader"></div>
                </div>
                <div><br>
                </div>
                <div style="text-indent: 36pt; margin-top: 12pt; font-size: 12pt;">IN WITNESS WHEREOF, the Company at the direction of the Compensation Committee of the Board has caused this Agreement to be executed as of the day and year first above
                  written.</div>
                <div style="margin-top: 12pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;">
                  <div>
                    <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: Arial, Helvetica, sans-serif; font-size: 10pt;">

                        <tr>
                          <td valign="top" style="width: 50%;">
                            <div style="margin-left: 9pt; font-size: 12pt;">
                              <div style="margin-left: 9pt">
                                <div style="margin-left: 9pt">
                                  <div style="margin-left: 9pt">
                                    <div style="margin-left: 9pt">"Company"<br>
                                    </div>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </td>
                          <td valign="top" colspan="2" style="font-size: 12pt;"><strong><font style="font-weight: normal;">MASIMO CORPORATION</font><br>
                            </strong></td>
                          <td valign="top" style="width: 10%; font-size: 12pt;">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                          <td valign="top" style="width: 5%; font-size: 12pt;">&#160;</td>
                          <td valign="top" style="width: 35%; font-size: 12pt;">&#160;</td>
                          <td valign="top" style="width: 10%; font-size: 12pt;">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;">
                            <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; font-size: 12pt;"><br>
                            </div>
                          </td>
                          <td valign="top" style="width: 5%; padding-bottom: 2px;">
                            <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; font-size: 12pt;">By: </div>
                          </td>
                          <td valign="top" nowrap="nowrap" align="left" style="width: 35%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 12pt;">/s/ Mark P. de Raad<br>
                          </td>
                          <td valign="top" style="width: 10%; padding-bottom: 2px; font-size: 12pt;">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                          <td valign="top" style="width: 5%; font-size: 12pt;">Name:&#160;&#160;&#160; <br>
                          </td>
                          <td valign="bottom" nowrap="nowrap" align="left" style="width: 35%; font-size: 12pt;">Mark P. de Raad<br>
                          </td>
                          <td valign="top" style="width: 10%; font-size: 12pt;">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                          <td valign="top" style="width: 5%; font-size: 12pt;">Its: <br>
                          </td>
                          <td valign="top" style="width: 35%;">
                            <div style="font-size: 12pt;">
                              <div>
                                <div>
                                  <div>Executive Vice President and</div>
                                  <div>Chief Financial Officer </div>
                                </div>
                              </div>
                            </div>
                          </td>
                          <td valign="top" style="width: 10%; font-size: 12pt;">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" rowspan="1" style="width: 50%; font-size: 12pt;">&#160;</td>
                          <td valign="top" rowspan="1" style="width: 5%; font-size: 12pt;">&#160;</td>
                          <td valign="top" rowspan="1" style="width: 35%; font-size: 12pt;">&#160;</td>
                          <td valign="top" rowspan="1" style="width: 10%; font-size: 12pt;">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" rowspan="1" style="width: 50%; font-size: 12pt;">&#160;</td>
                          <td valign="top" rowspan="1" style="width: 5%; font-size: 12pt;">&#160;</td>
                          <td valign="top" rowspan="1" style="width: 35%; font-size: 12pt;">&#160;</td>
                          <td valign="top" rowspan="1" style="width: 10%; font-size: 12pt;">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" rowspan="1" style="width: 50%; padding-bottom: 2px; font-size: 12pt;">&#160;</td>
                          <td valign="top" colspan="2" rowspan="1" style="border-bottom: 2px solid rgb(0, 0, 0); font-size: 12pt;">/s/ Joe Kiani<br>
                          </td>
                          <td valign="top" rowspan="1" style="width: 10%; padding-bottom: 2px; font-size: 12pt;">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" rowspan="1" style="width: 50%;">
                            <div style="margin-left: 9pt; font-size: 12pt;">
                              <div style="margin-left: 9pt">
                                <div style="margin-left: 9pt">
                                  <div style="margin-left: 9pt">
                                    <div style="margin-left: 9pt">"Executive" <br>
                                    </div>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </td>
                          <td valign="top" colspan="2" rowspan="1" style="font-size: 12pt;">Joe Kiani&#160; <br>
                          </td>
                          <td valign="top" rowspan="1" style="width: 10%; font-size: 12pt;">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" rowspan="1" style="width: 50%; font-size: 12pt;">&#160;</td>
                          <td valign="top" rowspan="1" style="width: 5%; font-size: 12pt;">&#160;</td>
                          <td valign="top" rowspan="1" style="width: 35%; font-size: 12pt;">&#160;</td>
                          <td valign="top" rowspan="1" style="width: 10%; font-size: 12pt;">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
                <br>
                <div><br>
                </div>
                <div><br>
                </div>
                <div><br>
                </div>
                <div><br>
                </div>
                <div><br>
                </div>
                <div style="text-align: center; font-size: 12pt;">[Signature Page to Amended and Restated Employment Agreement]</div>
                <div><br>
                </div>
                <div><br>
                </div>
                <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                  <div class="BRPFPageFooter">
                    <table cellspacing="0" cellpadding="0" id="z83056dec6f1f4d0aae200585bb797a51" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

                        <tr>
                          <td style="width: 100%; vertical-align: top;">
                            <div style="margin-left: 1pt; font-size: 8pt;">15</div>
                          </td>
                        </tr>

                    </table>
                    <div><br>
                    </div>
                  </div>
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">15</font></div>
                  <div class="BRPFPageBreak" style="page-break-after: always;">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                  <div class="BRPFPageHeader"></div>
                </div>
                <div><br>
                </div>
                <div style="text-align: center; margin-right: 30.9pt; margin-left: 30.7pt; margin-top: 4.2pt; font-size: 12pt; font-weight: bold;"><u>EXHIBIT A</u></div>
                <div style="margin-top: 0.5pt;"><br>
                </div>
                <div style="text-align: center; margin-right: 30.9pt; margin-left: 30.6pt; font-size: 12pt; font-weight: bold;">[RESTRICTIVE COVENANT AGREEMENT]</div>
                <div><br>
                </div>
                <div><br>
                </div>
                <div><br>
                </div>
                <div><br>
                </div>
                <div><br>
                </div>
                <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                  <div class="BRPFPageFooter">
                    <div><br>
                    </div>
                  </div>
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">16</font></div>
                  <div class="BRPFPageBreak" style="page-break-after: always;">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                  <div class="BRPFPageHeader"></div>
                </div>
                <div><br>
                </div>
                <div style="text-align: center; margin-right: 30.9pt; margin-left: 30.7pt; margin-top: 4.15pt; font-size: 12pt; font-weight: bold;"><u>EXHIBIT B</u></div>
                <div style="margin-top: 0.5pt;"><br>
                </div>
                <div style="text-align: center; margin-right: 30.9pt; margin-left: 30.65pt; font-size: 12pt; font-weight: bold;">[RESTRICTED SHARE UNIT AGREEMENT]</div>
                <div><br>
                </div>
                <div><br>
                </div>
                <div style="margin-top: 0.35pt;"><br>
                </div>
                <div><br>
                </div>
                <div><br>
                </div>
                <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                  <div class="BRPFPageFooter">
                    <div><br>
                    </div>
                  </div>
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">17</font></div>
                  <div class="BRPFPageBreak" style="page-break-after: always;">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                  <div class="BRPFPageHeader">
                    <div><br>
                    </div>
                  </div>
                </div>
                <div>
                  <div><br>
                  </div>
                  <div style="text-align: center; margin-top: 12pt; font-size: 12pt; font-weight: bold;">MASIMO CORPORATION 2007<br>
                    STOCK INCENTIVE PLAN</div>
                  <div style="text-align: center; margin-top: 12pt; font-size: 12pt; font-weight: bold;">RESTRICTED SHARE UNIT AWARD AGREEMENT</div>
                  <div style="margin-top: 12pt; font-size: 12pt;">You (the &#8220;<font style="font-weight: bold; font-style: italic;">Participant</font>&#8221;) are hereby awarded restricted share units (the &#8220;<font style="font-weight: bold; font-style: italic;">RSUs</font>&#8221;)



                    subject to the terms and conditions set forth in the employment agreement made and entered into as of November 4, 2015, by and between the Company and you (as it may be amended from time to time, the &#8220; <font style="font-weight: bold; font-style: italic;">Employment Agreement </font>&#8221;), this Restricted Share Unit Award Agreement (this &#8220;<font style="font-weight: bold; font-style: italic;">Award Agreement</font>&#8221;), and the Masimo Corporation 2007 Stock Incentive
                    Plan (the &#8220;<font style="font-weight: bold; font-style: italic;">Plan</font>&#8221;).</div>
                  <div style="margin-top: 12pt; font-size: 12pt;">Capitalized terms used but not otherwise defined herein shall have the meanings set forth in the Plan. In the event of any inconsistency between the terms of the Employment Agreement, this
                    Award Agreement and the Plan, the terms of the Employment Agreement shall govern, and in no event shall the RSUs be subject to forfeiture or cancellation except as set forth in the Employment Agreement.</div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt;">1.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;"><font style="font-weight: bold;"><u>Specific Terms</u></font>. The RSUs shall have the following terms:</font></div>
                  <div style="margin-top: 12pt;">
                    <table cellspacing="0" cellpadding="2" border="0" id="zd26b351d32eb43698422ae0385bef21f" style="border-collapse: collapse; width: 60%; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 10pt; text-align: left;">

                        <tr>
                          <td style="width: 50%; vertical-align: top;">
                            <div style="font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">Name of Participant</div>
                          </td>
                          <td style="width: 50%; vertical-align: top;">
                            <div style="font-family: Arial,Helvetica,sans-serif;">Joe Kiani</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="width: 50%; vertical-align: top;">
                            <div style="font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">Number of RSUs</div>
                          </td>
                          <td style="width: 50%; vertical-align: top;">
                            <div style="font-family: Arial,Helvetica,sans-serif;">2,700,000</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="width: 50%; vertical-align: top;">
                            <div style="font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">Award Date</div>
                          </td>
                          <td style="width: 50%; vertical-align: top;">
                            <div style="font-family: Arial,Helvetica,sans-serif;">November 4, 2015</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="width: 50%; vertical-align: top;">
                            <div style="font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">Vesting</div>
                          </td>
                          <td style="width: 50%; vertical-align: top;">
                            <div style="font-family: Arial,Helvetica,sans-serif;">As provided in the Employment Agreement.</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="width: 50%; vertical-align: top;">
                            <div style="font-family: Arial,Helvetica,sans-serif; margin-left: 90pt;">Settlement</div>
                          </td>
                          <td style="width: 50%; vertical-align: top;">
                            <div style="font-family: Arial,Helvetica,sans-serif;">As provided in the Employment Agreement.</div>
                          </td>
                        </tr>

                    </table>
                    <font style="font-size: 12pt;"> </font></div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt;">2.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;"><font style="font-weight: bold;"><u>Dividends</u>.&#160;</font>When Shares are delivered to you pursuant to the vesting of the RSUs as provided in the Employment Agreement, you shall also be entitled to receive with respect to each Share
                      issued (i) an amount equal to any cash dividends (plus simple interest at a rate of 5% per annum), provided that, at your election, you shall be credited in lieu of the foregoing with an additional number of restricted share units
                      (subject to same terms and conditions as the RSUs) on the applicable dividend record date determined by dividing the total amount of any cash dividends which were declared and paid to the holders of Shares on such dividend record date
                      by the closing price of a Share on such dividend record date and (ii) a number of Shares equal to any stock dividends, in each case which were declared and paid to the holders of Shares between the Grant Date and the date such Share
                      is issued. For purposes of this Award Agreement and the Employment Agreement, the term &#8220;RSUs&#8221; shall include any additional restricted share units which are credited to you in accordance with the preceding sentence.</font></div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt;">3.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;"><font style="font-weight: bold;"><u>Changes in Capitalization</u></font>. The Committee shall equitably adjust the number of Shares underlying the RSUs to reflect any increase or decrease in the number of issued Shares resulting from a
                      stock split, reverse stock split, stock dividend, spin-off, spin-out, merger, consolidation, combination, recapitalization or reclassification of the Shares, or any other changes in corporate structure.</font></div>
                  <div style="margin-top: 12pt;"><br>
                  </div>
                  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                    <div class="BRPFPageFooter">
                      <div><br>
                      </div>
                    </div>
                    <div class="BRPFPageBreak" style="page-break-after: always;">
                      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                    <div class="BRPFPageHeader"></div>
                  </div>
                  <!--PROfilePageNumberReset%Num%2%%%-->
                  <div><br>
                  </div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt;">4.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;"><font style="font-weight: bold;"><u>Restrictions on Transfer</u></font>. Except as set forth in the Plan, the RSUs may not be sold, pledged, or otherwise transferred without the prior written consent of the Committee. Notwithstanding the
                      foregoing or anything set forth in the Plan, you may transfer the RSUs (i) by instrument to an inter vivos or testamentary trust (or other entity) in which each beneficiary is a permissible gift recipient, as such is set forth in
                      clause (ii) of this Section, or (ii) by gift to charitable institutions or foundations or by gift or transfer for no consideration to any of your relatives as follows (or to an inter vivos trust, testamentary trust or other entity
                      primarily for the benefit of any of your relatives as follows): any child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, domestic partner, sibling, niece, nephew, mother-in-law, father-in-law,
                      son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive relationships. Any transferee of your rights shall succeed to and be subject to all of the terms of the Employment Agreement, this Award Agreement and
                      the Plan.</font></div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt;">5.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;"><font style="font-weight: bold;"><u>Withholding Taxes and Deferred Compensation</u></font>. The RSUs shall, in all respects, be subject to any applicable required tax withholding. Any amount payable to you under this Award Agreement on
                      account of your termination of employment which constitutes &#8220;nonqualified deferred compensation&#8221; within the meaning of Section 409A of the Code shall be made in accordance with Section 8.6 of the Employment Agreement.</font></div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt;">6.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;"><font style="font-weight: bold;"><u>Notices</u></font>. Any notice or communication required or permitted by any provision of this Award Agreement to be given to you shall be in writing and shall be delivered personally or sent by
                      certified mail, return receipt requested, addressed to you at the last address that the Company had for you on its records. Each party may, from time to time, by notice to the other party hereto, specify a new address for delivery of
                      notices relating to this Award Agreement. Any such notice shall be deemed to be given as of the date such notice is personally delivered or properly mailed.</font></div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt;">7.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;"><font style="font-weight: bold;"><u>Binding Effect</u></font>. Except as otherwise provided in this Award Agreement or in the Plan, every covenant, term, and provision of this Award Agreement shall be binding upon and inure to the benefit
                      of the parties hereto and their respective heirs, legatees, legal representatives, successors, transferees, and assigns.</font></div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt;">8.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;"><font style="font-weight: bold;"><u>Modifications</u></font>. This Award Agreement may only be modified or amended with your written agreement.</font></div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt;">9.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;"><font style="font-weight: bold;"><u>Headings</u></font>. Section and other headings contained in this Award Agreement are for reference purposes only and are not intended to describe, interpret, define or limit the scope or intent of this
                      Award Agreement or any provision hereof.</font></div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt;">10.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;"><font style="font-weight: bold;"><u>Counterparts</u></font>. This Award Agreement may be executed by the parties hereto in separate counterparts, each of which when so executed and delivered shall be an original, but all such counterparts
                      shall together constitute one and the same instrument.</font></div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                    <div class="BRPFPageFooter">
                      <div><br>
                      </div>
                    </div>
                    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
                    <div class="BRPFPageBreak" style="page-break-after: always;">
                      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                    <div class="BRPFPageHeader"></div>
                  </div>
                  <div><br>
                  </div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt;">11.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;"><font style="font-weight: bold;"><u>Governing Law</u></font>. The laws of the State of Delaware (without regard to conflicts of laws principles) shall govern the validity of this Award Agreement, the construction of its terms, and the
                      interpretation of the rights and duties of the parties hereto; provided that, to the extent any provision of this Award Agreement requires interpretation of any provision of the Employment Agreement, such provisions shall in all
                      respects be interpreted, construed and governed by and in accordance with the laws of the State of California (without regard to conflicts of laws principles).</font></div>
                  <div style="text-indent: 54pt; margin-top: 12pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;"><font style="font-weight: bold;">BY YOUR SIGNATURE BELOW</font>, along with the signature of the Company&#8217;s representative, you and
                    the Company agree that the RSUs are hereby awarded under and governed by the terms and conditions of the Employment Agreement, this Award Agreement and the Plan.</div>
                  <div style="text-indent: 54pt; margin-top: 12pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt;"> </div>
                  <div style="margin-top: 12pt; font-size: 12pt; font-weight: bold;"> </div>
                  <div style="margin-top: 12pt;">
                    <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: Arial, Helvetica, sans-serif; font-size: 10pt;">

                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                          <td valign="top" style="font-size: 12pt;" colspan="2"><strong>MASIMO CORPORATION<br>
                            </strong></td>
                          <td valign="top" style="width: 10%; font-size: 12pt;">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                          <td valign="top" style="width: 5%; font-size: 12pt;">&#160;</td>
                          <td valign="top" style="width: 35%; font-size: 12pt;">&#160;</td>
                          <td valign="top" style="width: 10%; font-size: 12pt;">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;">
                            <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; font-size: 12pt;"><br>
                            </div>
                          </td>
                          <td valign="top" style="width: 5%; padding-bottom: 2px;">
                            <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; font-size: 12pt;">By: </div>
                          </td>
                          <td valign="top" nowrap="nowrap" align="left" style="width: 35%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 12pt;">/s/ Mark P. de Raad<br>
                          </td>
                          <td valign="top" style="width: 10%; padding-bottom: 2px; font-size: 12pt;">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                          <td valign="top" style="width: 5%; font-size: 12pt;">Name: <br>
                          </td>
                          <td valign="bottom" nowrap="nowrap" align="left" style="width: 35%; font-size: 12pt;">Mark P. de Raad<br>
                          </td>
                          <td valign="top" style="width: 10%; font-size: 12pt;">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                          <td valign="top" style="width: 5%; font-size: 12pt;">Its: <br>
                          </td>
                          <td valign="top" style="width: 35%; font-size: 12pt;">Executive Vice President and Chief Financial Officer<br>
                          </td>
                          <td valign="top" style="width: 10%; font-size: 12pt;">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 5%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 10%; font-size: 12pt;" rowspan="1">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 5%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 10%; font-size: 12pt;" rowspan="1">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="font-size: 12pt;" rowspan="1" colspan="2"><font style="font-weight: bold;">PARTICIPANT</font>&#160; <br>
                          </td>
                          <td valign="top" style="width: 10%; font-size: 12pt;" rowspan="1">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 5%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 10%; font-size: 12pt;" rowspan="1">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; padding-bottom: 2px; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 5%; padding-bottom: 2px; font-size: 12pt;" rowspan="1">By: <br>
                          </td>
                          <td valign="top" style="width: 35%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 12pt;" rowspan="1">/s/ Joe Kiani <br>
                          </td>
                          <td valign="top" style="width: 10%; padding-bottom: 2px; font-size: 12pt;" rowspan="1">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 5%; font-size: 12pt;" rowspan="1">Name: <br>
                          </td>
                          <td valign="top" style="width: 35%; font-size: 12pt;" rowspan="1">Joe Kiani <br>
                          </td>
                          <td valign="top" style="width: 10%; font-size: 12pt;" rowspan="1">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 5%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 10%; font-size: 12pt;" rowspan="1">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 5%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 10%; font-size: 12pt;" rowspan="1">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 5%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 10%; font-size: 12pt;" rowspan="1">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                          <td valign="top" style="width: 5%; font-size: 12pt;">&#160;</td>
                          <td valign="top" style="width: 35%; font-size: 12pt;">&#160;</td>
                          <td valign="top" style="width: 10%; font-size: 12pt;">&#160;</td>
                        </tr>

                    </table>
                  </div>
                  <div style="margin-top: 12pt;"><br>
                  </div>
                  <div style="text-align: center; margin-top: 12pt; font-size: 12pt; font-style: italic; font-weight: bold;">[Signature Page to Restricted Unit Award Agreement]</div>
                  <div style="margin-top: 12pt;"><br>
                  </div>
                  <div><br>
                  </div>
                  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                    <div class="BRPFPageFooter">
                      <div><br>
                      </div>
                    </div>
                    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">3</font></div>
                    <div class="BRPFPageBreak" style="page-break-after: always;">
                      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                    <div class="BRPFPageHeader"></div>
                  </div>
                  <!--PROfilePageNumberReset%Num%1%%%-->
                  <div><br>
                  </div>
                  <div style="text-align: center; margin-top: 12pt; font-size: 12pt; font-weight: bold;">MASIMO CORPORATION</div>
                  <div style="text-align: center; margin-top: 12pt; font-size: 12pt; font-weight: bold;">EQUITY-HOLDER NON-COMPETITION AND CONFIDENTIALITY AGREEMENT</div>
                  <div style="margin-top: 12pt; font-size: 12pt;">This Equity-Holder Non-Competition and Confidentiality Agreement (this &#8220;<u>Agreement</u>&#8221;), dated November 4, 2015, is made by and between the undersigned equity-holder (&#8220;<u>Holder</u>&#8221;), on
                    the one hand, and Masimo Corporation, a Delaware corporation (&#8220;<u>Masimo</u>&#8221;), on the other hand.</div>
                  <div style="text-align: center; margin-top: 12pt; font-size: 12pt; font-weight: bold;">RECITALS</div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt; font-weight: bold;">A </font><font style="font-size: 12pt;">.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">Holder acknowledges that Holder is a substantial holder of an equity interest in Masimo, is the founder of Masimo and has been its Chairman of the Board and Chief Executive Officer since its inception, and
                      that Holder will receive substantial consideration as a result of any transaction in which Holder sells his entire equity interest in Masimo, together with the goodwill of Masimo (an &#8220;<u>Equity Sale</u>&#8221;). Therefore, Holder is willing
                      to enter into this Agreement as an inducement for any acquirer to enter into agreements to effectuate an Equity Sale and to protect such acquirer&#8217;s legitimate interests as a buyer of the stock, goodwill and assets (including
                      confidential, proprietary and/or trade secret information) of Masimo.</font></div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt; font-weight: bold;">B </font><font style="font-size: 12pt;">.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">Masimo and Holder acknowledge and agree that Masimo has conducted and engaged in the &#8220;Business&#8221; (as defined below) and that Masimo has undertaken to continue to conduct and engage in the Business and to seek
                      to make its products and services available to customers throughout each of the fifty (50) states of the United States and throughout the world (the &#8220;<u>Restricted&#160;Territory</u>&#8221;).</font></div>
                  <div style="margin-top: 12pt; font-size: 12pt;"><font style="font-weight: bold;">NOW, THEREFORE </font>, in exchange for good and valuable consideration, receipt of which is hereby acknowledged, Holder, intending to be legally bound,
                    hereby agrees as follows:</div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt;">1.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">During (i) Holder&#8217;s
                      employment with Masimo (other than in accordance with Holder&#8217;s position at and duties to Masimo and position at and duties to Cercacor Laboratories, Inc. (&#8220;<u>Cercacor</u>&#8221;) a Delaware corporation (f/k/a Masimo Laboratories, Inc.) or
                      as otherwise set forth in the Employment Agreement (as defined below)) and (ii) subject to the payment of the &#8220;Non-Competition Payment&#8221; (as defined in the Employment Agreement) to Holder pursuant to the terms of the Employment
                      Agreement, the &#8220;Restricted Period&#8221; (as defined below) in the Restricted Territory, Holder agrees that Holder will not, as an employee, agent, consultant, advisor, independent contractor, general partner, officer, director, investor,
                      lender, guarantor of any person, or in any other capacity, for Holder or on behalf of any other person, directly or indirectly participate or engage in the Business or acquire or hold any interest in any person engaged in the
                      Business. Notwithstanding the foregoing, Holder may (i) participate and engage in the Business as an investor, employee, consultant, officer and/or director of, and provide services to, Cercacor or Masimo, (ii) serve on the board of
                      directors of any company or entity that is not engaged in the Business, (iii) own, directly or indirectly, solely as an investment, (A) up to one percent (1%) of any class of &#8220;publicly traded securities&#8221; of any person or entity that
                      engages in the Business or (B) up to five percent (5%) of the securities that are not &#8220;publicly traded securities&#8221; of any person or entity that engages in the Business, provided in each case that Holder does not also actively manage
                      or serve as an advisor to such person or entity, and</font></div>
                  <div style="margin-top: 12pt;"><br>
                  </div>
                  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                    <div class="BRPFPageFooter">
                      <div><br>
                      </div>
                    </div>
                    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">1</font></div>
                    <div class="BRPFPageBreak" style="page-break-after: always;">
                      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                    <div class="BRPFPageHeader"></div>
                  </div>
                  <div><br>
                  </div>
                  <div style="margin-top: 12pt; font-size: 12pt;">provided further that the ownership restrictions in this clause (iii) shall not apply to Holder&#8217;s director or indirect ownership of securities of Masimo or Cercacor and (iv) work for a
                    division, entity or subgroup of any person or entity that engages in the Business so long as such division, entity or subgroup does not also engage in the Business. For purposes of this Agreement, (a) &#8220;publicly traded securities&#8221; shall
                    mean securities that are traded on a national securities exchange, (b) &#8220;<u>Business</u>&#8221; means the design, research, development, use, marketing, sale or distribution of any products or services in the field of non-invasive blood
                    constituent monitoring, and (c) the &#8220;<u>Restricted Period</u>&#8221; means the period commencing on the date of Holder&#8217;s Qualifying Termination (as defined in the Amended and Restated Employment Agreement dated as of the date hereof by and
                    between Masimo and Holder (the &#8220;<u>Employment Agreement</u>&#8221;) following an Equity Sale and ending on the fifth (5th) anniversary of the date of such Qualifying Termination.</div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt;">2.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">Masimo has and will
                      develop, compile and own certain proprietary and confidential information that has great value in its business (&#8220;<u>Confidential Information</u>&#8221;). Confidential Information includes information and physical material not generally
                      known or available outside Masimo and information and physical material entrusted to Masimo in confidence by third parties. Confidential Information includes, without limitation: (i) company &#8220;Inventions&#8221; (as defined below); and (ii)
                      technical data, trade secrets, know- how, research, product or service ideas or plans, software codes and designs, developments, laboratory notebooks, processes, formulas, techniques, mask works, engineering designs and drawings,
                      hardware configuration information, lists of, or information relating to, employees and consultants of Masimo (including, but not limited to, the names, contact information, jobs, compensation, and expertise of such employees and
                      consultants), lists of, or information relating to, suppliers and customers (including, but not limited to, customers of Masimo on whom Holder called or with whom Holder became acquainted during employment with Masimo), price lists,
                      pricing methodologies, cost data, market share data, marketing plans, licenses, contract information, business plans, financial forecasts, historical financial data, budgets or other business information disclosed to Holder by Masimo
                      either directly or indirectly, whether in writing, electronically, orally, or by observation. Holder acknowledges that such information is secret, valuable and owned by Masimo.</font></div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt;">3.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">During and after
                      Holder&#8217;s employment by Masimo, Holder agrees to keep confidential, and not disclose or make use of any Confidential Information except with Cercacor or as otherwise authorized by Masimo or as necessary for the performance of Holder&#8217;s
                      duties as a Masimo employee or director.</font></div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt;">4.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">During Holder&#8217;s
                      employment with Masimo, Holder will not disclose to Masimo or make use of any confidential, proprietary or trade secret information or material belonging to a former employer or other third party.</font></div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt;">5.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">Prior to Holder&#8217;s
                      employment with Masimo, Holder did not create any inventions, works of authorship, or trade secrets that relate to the Business as conducted and engaged in by Masimo, except for those identified on the list attached to this Agreement
                      as <u>Exhibit A</u> hereto.</font></div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt;">6.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">Holder agrees to
                      promptly disclose to Masimo or Cercacor, as appropriate, all discoveries, developments, designs, ideas, improvements, inventions, formulas, processes, techniques, know-</font></div>
                  <div style="margin-top: 12pt;"><br>
                  </div>
                  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                    <div class="BRPFPageFooter">
                      <div><br>
                      </div>
                    </div>
                    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
                    <div class="BRPFPageBreak" style="page-break-after: always;">
                      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                    <div class="BRPFPageHeader"></div>
                  </div>
                  <div><br>
                  </div>
                  <div style="margin-top: 12pt; font-size: 12pt;">how, and data works of authorship, (whether or not patentable or registrable under copyright or similar statutes) made, conceived, reduced to practice, or learned by Holder (either alone or
                    jointly with others) during Holder&#8217;s employment with Masimo, that are related to or useful in the Business as conducted and engaged in by Masimo, or which result from tasks assigned to Holder by Masimo, or from the use of premises
                    owned, leased, or otherwise acquired by Masimo. For the purposes of this Agreement, all of the foregoing are referred to as &#8220;<u>Inventions</u>&#8221;.</div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt;">7.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">Holder acknowledges
                      and agrees that all Inventions that relate to the Business as conducted and engaged in by Masimo, other than those listed in <u>Exhibit A</u> hereto, and other than those that holder is obligated to assign to Cercacor, belong to and
                      shall be the sole property of Masimo and shall be Inventions of Masimo subject to the provisions of this Agreement. Holder hereby assigns to Masimo all rights that Holder may have to such Inventions, except for inventions which Holder
                      is allowed to retain under California Labor Code section 2870, a copy of which is attached to this Agreement as <u>Exhibit B</u> hereto.</font></div>
                  <div style="text-align: justify; margin-top: 12pt;"><font style="font-size: 12pt;">8.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">Holder







                      agrees that all works of authorship to which Holder contributes and that relate to the Business as conducted and engaged in by Masimo during and as a part of Holder&#8217;s employment shall be considered &#8220;works made for hire&#8221; and shall be
                      the sole property of Masimo or Cercacor, as appropriate.</font></div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt;">9.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">Holder will
                      cooperate with Masimo and do whatever is necessary or appropriate to obtain patents, copyrights, or other legal protection on projects to which Holder contributes and are subject to an obligation of assignment to Masimo, and, if
                      Holder is incapacitated for any reason from doing so, Holder hereby authorizes Masimo to act as Holder&#8217;s agent and to take whatever reasonable action is needed on Holder&#8217;s part to carry out this Agreement. After Holder&#8217;s employment,
                      Masimo will pay Holder for his time for such assistance at an hourly rate equal to Holder&#8217;s highest full time compensation at Masimo calculated on an hourly basis.</font></div>
                  <div style="text-align: justify; margin-top: 12pt;"><font style="font-size: 12pt;">10.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">Upon termination of Holder&#8217;s employment for any reason, Holder will promptly assemble all property of Masimo in Holder&#8217;s possession or under Holder&#8217;s control and return it to Masimo.</font></div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt;">11.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">Except where
                      prohibited by law, Holder agrees that during (i) Holder&#8217;s employment and (ii) subject to the payment of the Non- Competition Payment to Holder pursuant to the terms of the Employment Agreement, the Restricted Period, Holder will not,
                      without express written authorization from Masimo, (a) solicit or induce any employee or consultant of Masimo to quit their employment or cease doing business with Masimo, or (b) other than on behalf of any charitable or non-profit
                      enterprise, solicit Masimo&#8217;s customers or suppliers, provided that each of the restrictions in this paragraph shall not apply in respect of Cercacor.</font></div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt;">12.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">Holder hereby
                      acknowledges and agrees that (a) this Agreement is necessary for the protection of the legitimate business interests of Masimo and any acquirer in acquiring and realizing the value of the stock, goodwill and assets of Masimo in
                      connection with an Equity Sale, (b) the scope of the covenants set forth in this Agreement in time, geography and types and limitations of activities restricted is reasonable and necessary to protect Masimo&#8217;s and any acquirer&#8217;s
                      legitimate interest in the goodwill, trade secrets, properties and assets and Confidential Information of Masimo, and (c) Holder has had adequate opportunity to consult with counsel</font></div>
                  <div style="margin-top: 12pt;"><br>
                  </div>
                  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                    <div class="BRPFPageFooter">
                      <div><br>
                      </div>
                    </div>
                    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">3</font></div>
                    <div class="BRPFPageBreak" style="page-break-after: always;">
                      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                    <div class="BRPFPageHeader"></div>
                  </div>
                  <div><br>
                  </div>
                  <div style="margin-top: 12pt; font-size: 12pt;">prior to entering into this Agreement. Notwithstanding anything set forth in this Agreement to the contrary, none of the restrictions in this Agreement shall prohibit Holder from
                    participating and engaging in the Business as an investor, employee, consultant, officer and/or director of, and providing services to, Cercacor.</div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt;">13.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">Holder agrees that
                      a violation of this Agreement may cause irreparable harm to Masimo&#8217;s reputation, customer relationships, and other aspects of its business for which an award of money damages would be inadequate. Holder therefore agrees that Masimo
                      shall be entitled to injunctive relief as appropriate to prevent Holder from violating this Agreement, in addition to any claims for money damages not to exceed repayment of the Non-Competition Payment pursuant to the terms of the
                      Employment Agreement.</font></div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt;">14.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">For purposes of
                      enforcing this Agreement, Holder hereby consents to jurisdiction in the Superior Court of California for the County of Orange, as well as any other jurisdiction allowed by law.</font></div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt;">15.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">This Agreement
                      shall be governed by the law of the state in which Holder resides, or Delaware if Holder resides outside the United States.</font></div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt;">16.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">Holder understands
                      that Holder&#8217;s obligations under this Agreement remain in effect even after Holder&#8217;s employment with Masimo terminates.</font></div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt;">17.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">This Agreement does
                      not guarantee Holder any term of employment or limit Holder&#8217;s or Masimo&#8217;s right to terminate Holder&#8217;s employment at any time, with or without cause and with or without notice.</font></div>
                  <div style="text-align: justify; margin-top: 12pt;"><font style="font-size: 12pt;">18.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">If a court finds any provision of this Agreement invalid or unenforceable as applied to any circumstance, the remainder of this Agreement and the application of such provision to other persons or circumstances shall be
                      interpreted so as best to effect the intent of the parties hereto.</font></div>
                  <div style="text-align: justify; margin-top: 12pt;"><font style="font-size: 12pt;">19.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">This Agreement is binding on Holder&#8217;s successors and assigns, and will benefit the successors and assigns of Masimo.</font></div>
                  <div style="margin-top: 12pt;"><font style="font-size: 12pt;">20.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">Except for the
                      applicable provisions of the Employment Agreement, this Agreement represents Holder&#8217;s entire agreement with Masimo with respect to the subject matter herein, superseding any previous oral or written understandings or agreements with
                      Masimo or any of its officers, including, without limitation, the Masimo Employee Confidentiality Agreement dated as of March 3, 2010, between Masimo and Holder. This Agreement may be amended or modified only in writing signed by all
                      the parties hereto.</font></div>
                  <div style="margin-top: 12pt;"><br>
                  </div>
                  <div style="text-align: center; margin-top: 12pt; font-size: 12pt;">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]</div>
                  <div style="margin-top: 12pt;"><br>
                  </div>
                  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                    <div id="BRPFPageFooter">
                      <div>
                        <div><br>
                        </div>
                      </div>
                      <div>
                        <div><br>
                        </div>
                      </div>
                    </div>
                    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">4</font></div>
                    <div style="page-break-after: always;" class="BRPFPageBreak">
                      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                  </div>
                  <div> <br>
                  </div>
                  <div>
                    <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; font-family: Arial, Helvetica, sans-serif; font-size: 10pt;">

                        <tr>
                          <td valign="top" align="left" style="font-size: 12pt;" colspan="2" rowspan="1">MASIMO <br>
                          </td>
                          <td valign="top" style="width: 7%; font-size: 12pt;">&#160;</td>
                          <td valign="top" style="font-size: 12pt;" rowspan="1" colspan="2">HOLDER <br>
                          </td>
                          <td valign="top" style="width: 7%; font-size: 12pt;">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" style="width: 8%; font-size: 12pt;" rowspan="1" colspan="1">&#160;</td>
                          <td valign="top" align="left" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 7%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 8%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" align="left" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 7%; font-size: 12pt;" rowspan="1">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" style="width: 8%; font-size: 12pt;" rowspan="1" colspan="1">&#160;<br>
                          </td>
                          <td valign="top" align="left" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 7%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 8%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" align="left" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 7%; font-size: 12pt;" rowspan="1">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" style="width: 8%; font-size: 12pt; padding-bottom: 2px;" colspan="1">By: <br>
                          </td>
                          <td valign="top" align="left" style="width: 35%; border-bottom: 2px solid rgb(0, 0, 0);">
                            <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; font-size: 12pt;">/s/ Mark P. de Raad<br>
                            </div>
                          </td>
                          <td valign="top" style="width: 7%; font-size: 12pt; padding-bottom: 2px;">&#160;</td>
                          <td valign="top" style="width: 8%; font-size: 12pt; padding-bottom: 2px;">Signature:&#160; <br>
                          </td>
                          <td valign="top" align="left" style="width: 35%; border-bottom: 2px solid rgb(0, 0, 0);">
                            <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; font-size: 12pt;">/s/ Joe Kiani<br>
                            </div>
                          </td>
                          <td valign="top" style="width: 7%; font-size: 12pt; padding-bottom: 2px;">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" style="width: 8%; font-size: 12pt;" colspan="1" rowspan="1">&#160;</td>
                          <td valign="top" align="left" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 7%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 8%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" align="left" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 7%; font-size: 12pt;" rowspan="1">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" style="width: 8%; font-size: 12pt;" colspan="1">Name: <br>
                          </td>
                          <td valign="top" align="left" style="width: 35%;">
                            <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; font-size: 12pt;">Mark P. de Raad<br>
                            </div>
                          </td>
                          <td valign="top" style="width: 7%; font-size: 12pt;">&#160;</td>
                          <td valign="top" style="width: 8%; font-size: 12pt;">Name: <br>
                          </td>
                          <td valign="top" align="left" style="width: 35%;">
                            <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; font-size: 12pt;">Joe Kiani<br>
                            </div>
                          </td>
                          <td valign="top" style="width: 7%; font-size: 12pt;">&#160;</td>
                        </tr>
                        <tr>
                          <td style="width: 8%; font-size: 12pt; text-align: left; vertical-align: bottom;" colspan="1">Title: <br>
                          </td>
                          <td valign="top" align="justify" style="width: 35%; font-size: 12pt;">
                            <div align="justify" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;">Executive Vice President and </div>
                            <div align="justify" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;">Chief Financial Officer<br>
                            </div>
                          </td>
                          <td valign="top" style="width: 7%; font-size: 12pt;">&#160;</td>
                          <td valign="top" style="width: 8%; font-size: 12pt;">
                            <div> <br>
                            </div>
                            <div>Date:<br>
                            </div>
                          </td>
                          <td valign="top" align="justify" style="width: 35%; font-size: 12pt;">
                            <div align="justify" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"> <br>
                            </div>
                            <div align="justify" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;">November 4, 2015<br>
                            </div>
                          </td>
                          <td valign="top" style="width: 7%; font-size: 12pt;">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" align="justify" style="width: 8%; font-size: 12pt;" colspan="1" rowspan="1">&#160;</td>
                          <td valign="top" align="justify" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 7%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 8%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" align="justify" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 7%; font-size: 12pt;" rowspan="1">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" align="justify" style="width: 8%; font-size: 12pt;" colspan="1" rowspan="1">&#160;</td>
                          <td valign="top" align="justify" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 7%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 8%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" align="justify" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 7%; font-size: 12pt;" rowspan="1">&#160;</td>
                        </tr>
                        <tr>
                          <td valign="top" align="justify" style="width: 8%; font-size: 12pt;" colspan="1" rowspan="1">&#160;</td>
                          <td valign="top" align="justify" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 7%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 8%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" align="justify" style="width: 35%; font-size: 12pt;" rowspan="1">&#160;</td>
                          <td valign="top" style="width: 7%; font-size: 12pt;" rowspan="1">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              </div>
            </div>
            <div style="line-height: 22.8pt; text-align: center;"><font style="font-size: 12pt;"> <br>
              </font></div>
            <div style="line-height: 22.8pt; text-align: center;"><font style="font-size: 12pt;"> <br>
              </font></div>
            <div style="line-height: 22.8pt; text-align: center;"><font style="font-size: 12pt;"> <br>
              </font></div>
            <div style="line-height: 22.8pt; text-align: center;"><font style="font-size: 12pt;">[Signature Page to Equity-Holder Non-Competition and Confidentiality Agreement]</font> </div>
            <div style="line-height: 22.8pt;"> <br>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">5</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <div> <br>
            </div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" id="ze682b254fdc74fe983ffdc154646934c" style="font-family: Arial,Helvetica,sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="width: 100%; vertical-align: top;" colspan="3">
                      <div style="text-align: center; font-family: Arial, Helvetica, sans-serif; font-size: 12pt;">EXHIBIT A</div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width: 100%; vertical-align: top;" colspan="3">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width: 100%; vertical-align: top;" colspan="3">
                      <div style="text-align: center; font-family: Arial, Helvetica, sans-serif; font-size: 12pt;">LIST OF PRIOR INVENTIONS<br>
                        AND ORIGINAL WORKS OF AUTHORSHIP*</div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width: 100%; vertical-align: top;" colspan="3">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width: 33.33%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                      <div style="text-align: center; font-family: Arial, Helvetica, sans-serif; font-size: 12pt;">Title</div>
                    </td>
                    <td style="width: 33.34%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                      <div style="text-align: center; font-family: Arial, Helvetica, sans-serif; font-size: 12pt;">Date</div>
                    </td>
                    <td style="width: 33.34%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                      <div style="text-align: center; font-family: Arial, Helvetica, sans-serif; font-size: 12pt;">Identifying Number</div>
                      <div style="text-align: center; font-family: Arial, Helvetica, sans-serif; font-size: 12pt;">or Brief Description</div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width: 33.33%; vertical-align: bottom;">
                      <div style="text-align: center; font-family: Arial, Helvetica, sans-serif; font-size: 12pt;">NONE</div>
                    </td>
                    <td style="width: 33.34%; vertical-align: bottom;">
                      <div style="text-align: center; font-family: Arial, Helvetica, sans-serif; font-size: 12pt;">NONE</div>
                    </td>
                    <td style="width: 33.34%; vertical-align: bottom;">
                      <div style="text-align: center; font-family: Arial, Helvetica, sans-serif; font-size: 12pt;">NONE</div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width: 33.33%; vertical-align: top;">&#160;</td>
                    <td style="width: 33.34%; vertical-align: top;">&#160;</td>
                    <td style="width: 33.34%; vertical-align: top;">&#160;</td>
                  </tr>

              </table>
            </div>
            <div style="text-indent: 36pt; line-height: 22.8pt; color: #3D3D3D; font-size: 11.5pt;">
              <div><br>
              </div>
            </div>
          </div>
          <font style="font-size: 11.5pt;"> </font></div>
        <div><br>
          <div><br>
          </div>
          <div><br>
          </div>
          <div><br>
          </div>
          <br>
          <font style="font-size: 11.5pt;"> </font>
          <div style="line-height: 12.55pt;"><br>
          </div>
        </div>
      </div>
      <div><font style="font-size: 11.5pt;"> <font style="font-size: 12pt;">Name of Holder:&#160; Joe Kiani<br>
            <br>
          </font></font></div>
      <div style="font-size: 12pt;">*If there are none, so state.</div>
      <div><font style="font-size: 11.5pt;"><br>
        </font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">6</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div><br>
        <div style="text-align: center; margin-top: 12pt; font-size: 12pt;">EXHIBIT B</div>
        <div style="text-align: center; margin-top: 12pt; font-size: 12pt;">CALIFORNIA LABOR CODE SECTION 2870<br>
          EMPLOYMENT AGREEMENTS; ASSIGNMENT OF RIGHTS</div>
        <div style="margin-top: 12pt; font-size: 12pt;">&#8220;(a)&#160; Any provision in an employment agreement which provides that an employee shall assign or offer to assign any of his or her rights in an invention to his or her employer shall not apply to an
          invention that the employee developed entirely on his or her own time without using the employer&#8217;s equipment, supplies, facilities, or trade secret information except for those inventions that either:</div>
        <div style="margin-left: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">(1)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">Relate at
            the time of conception or reduction to practice of the invention to the employer&#8217;s business, or actual or demonstrably anticipated research or development of the employer.</font></div>
        <div style="margin-left: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">(2)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">Result
            from any work performed by the employee for the employer.</font></div>
        <div style="margin-top: 12pt;"><font style="font-size: 12pt;">(b)</font>&#160; <font style="font-size: 12pt;">To the extent a provision in an employment agreement purports to require an employee to assign an invention otherwise excluded from being
            required to be assigned under subdivision (a), the provision is against the public policy of this state and is unenforceable.&#8221;</font></div>
        <div><br>
        </div>
        <div><br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter">
            <div><br>
            </div>
          </div>
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">7</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          <div class="BRPFPageHeader"></div>
        </div>
        <div class="BRPFPageFooter">
          <div><br>
          </div>
        </div>
      </div>
    </div>
    <div><font style="font-size: 11.5pt;"> </font><br>
      <div style="line-height: normal;">
        <div>
          <div class="BRPFPageFooter">
            <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
            </div>
            <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
            </div>
            <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
            </div>
          </div>
          <div class="BRPFPageFooter">
            <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
            </div>
          </div>
        </div>
        <div>
          <div>
            <div>
              <div>
                <div>
                  <div class="BRPFPageFooter">
                    <div style="line-height: 0.65pt;">
                      <div><br>
                        <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                        </div>
                        <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                        </div>
                        <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                        </div>
                        <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                        </div>
                        <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                        </div>
                        <div style="line-height: 11.4pt;">
                          <div style="line-height: 11.4pt; text-align: center;"><font style="font-size: 48pt;">EXHIBIT D</font><br style="line-height: 11.4pt;">
                          </div>
                          <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                          </div>
                        </div>
                        <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                        </div>
                        <div style="line-height: 11.4pt;">
                          <div><br>
                          </div>
                          <font style="font-size: 11.5pt;"><br>
                          </font><br>
                        </div>
                        <br>
                      </div>
                      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                        <div class="BRPFPageFooter"></div>
                        <div class="BRPFPageBreak" style="page-break-after: always;">
                          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                      </div>
                      <div>
                        <div>
                          <div>&#160; </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
      <div><br>
        <div><br>
        </div>
        <div style="text-align: center; margin-right: 30.9pt; margin-left: 31.85pt; margin-top: 3.3pt; font-size: 12pt; font-weight: bold;">FIRST AMENDMENT TO NOVEMBER 4, 2015</div>
        <div style="text-align: center; margin-right: 30.9pt; margin-left: 31.85pt; margin-top: 0.35pt; font-size: 12pt; font-weight: bold;">AMENDED AND RESTATED EMPLOYMENT AGREEMENT</div>
        <div style="text-indent: 36pt; margin-top: 12pt; font-size: 12pt;">THIS FIRST AMENDMENT TO THE NOVEMBER 4, 2015 AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this &#8220;<font style="font-weight: bold; font-style: italic;">Amendment</font>&#8221;) is made and
          entered into as of July 27, 2017, by and between Masimo Corporation, a Delaware corporation (the &#8220;<font style="font-weight: bold; font-style: italic;">Company</font>&#8221;), and Joe Kiani (the &#8220;<font style="font-weight: bold; font-style: italic;">Executive</font>&#8221;).</div>
        <div style="text-align: center; margin-right: 30.9pt; margin-left: 31.85pt; margin-top: 8.95pt; font-size: 12pt; font-weight: bold;">RECITALS</div>
        <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">A.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 12pt; width: 36pt;">&#160;</font><font style="font-size: 12pt;">The
            Executive is the founder of the Company and has been its Chairman of the Board and Chief Executive Officer (&#8220;<font style="font-weight: bold; font-style: italic;">CEO</font>&#8221;) since its inception. The Board of Directors of the Company (the &#8220;<font style="font-weight: bold; font-style: italic;">Board</font>&#8221;) recognizes that the Executive&#8217;s contributions as Chairman of the Board and CEO have been instrumental to the success of the Company. The Executive and the Company entered into an
            amended and restated employment agreement dated November 4, 2015 (the &#8220;<font style="font-weight: bold; font-style: italic;">Agreement</font>&#8221;). The Board and the Executive desire to amend the Agreement pursuant to the terms hereof to assure the
            Company of the Executive&#8217;s continued employment in an executive capacity and to compensate him therefor. </font></div>
        <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">B.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">The Company
            considers the establishment and maintenance of a sound management to be essential to protecting and enhancing the best interests of the Company and its stockholders.</font></div>
        <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">C.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">The Board
            has determined that appropriate steps should be taken to retain the Executive and to reinforce and encourage his continued attention and dedication to his assigned duties.</font></div>
        <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">D.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">The Company
            desires to continue to retain the services of the Executive, and the Executive desires to continue to be employed by the Company pursuant to the terms and conditions of the Agreement, as amended by this Amendment.</font></div>
        <div style="text-indent: 36pt; margin-top: 12pt; font-size: 12pt;">NOW, THEREFORE, in consideration of the premises, the mutual promises and the mutual covenants and agreements hereinafter set forth, the Company and the Executive hereby agree that
          the Agreement is amended as follows:</div>
        <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">1.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">Section 5.2
            of the Agreement is deleted and replaced with the following:</font></div>
        <div style="margin-top: 8.9pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt; margin-left: 81pt;">BONUS. The Executive shall be eligible to receive a target annual bonus equal to one-hundred percent (100%) of his Base Salary based on the
          Company&#8217;s performance against the performance criteria established by the Board (or designated committee) under the Company&#8217;s annual incentive plan for officers, and such annual bonus shall not be subject to positive discretion to increase his
          annual bonus above that determined based on performance against the performance criteria; <font style="font-style: italic;">provided that </font>the Executive&#8217;s annual bonus shall not exceed two hundred percent (200%) of his Base Salary for
          such year.</div>
        <div><br>
        </div>
        <div><br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter">
            <div><br>
            </div>
          </div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          <div class="BRPFPageHeader"></div>
        </div>
        <div><br>
        </div>
        <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">2.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">Section 5.3
            of the Agreement is deleted and replaced with the following:</font></div>
        <div style="margin-top: 8.95pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt; margin-left: 81pt;">STOCK OPTIONS AND RELATED INCENTIVE PLANS. The Executive shall be eligible to participate in the Company&#8217;s existing incentive programs and
          any additional or successor incentive plan or plans. During each fiscal year during the Employment Period after fiscal year 2016, the Executive shall receive equity grants having a value at least consistent with equity grants made to comparable
          chief executive officers of comparable companies (taking into account revenues, market capitalization and industry).</div>
        <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">3.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">Section 7.4
            of the Agreement is deleted and replaced with the following:</font></div>
        <div style="margin-top: 8.9pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt; margin-left: 81pt;">TERMINATION BY THE EXECUTIVE. The Executive may terminate his employment hereunder (i) for Good Reason, (ii) if his health should become
          impaired to an extent that makes the continued performance of his duties hereunder hazardous to his physical or mental health or his life, or (iii) at any time by giving six (6) months&#8217; written notice to the Company of his intention to terminate.
          For purposes of this Agreement, &#8220;<font style="font-weight: bold; font-style: italic;">Good Reason</font>&#8221; shall mean (A) except in connection with a termination of the Executive&#8217;s employment for Cause, any diminution in the Executive&#8217;s
          responsibilities, duties and authority set forth in Section 2 hereof, whether due to the assignment to the Executive of any responsibilities, duties or authority that constitute such a diminution or otherwise, including (i) the Executive ceasing
          to serve as a Chief Executive Officer of the Company or (ii) the Executive ceasing to serve as the Chairman of the Board of the Company or the designation of any director other than the Executive as the lead director of the Board, (B) a reduction
          in the Executive&#8217;s rate of compensation or a reduction in the Executive&#8217;s fringe benefits or any other failure by the Company to comply with Section 5 hereof, (C) any failure by the Company to comply with Section 4 hereof, (D) the provision of a
          Notice of Non-Renewal by the Company, (E) a &#8220;<font style="font-weight: bold; font-style: italic;">Change in Control,</font>&#8221; as that term is defined in Section 9 hereof, triggered as a result of clause (iii) thereof dealing with change in Board
          composition, or (F) if, following, or in connection with, a &#8220;<font style="font-weight: bold; font-style: italic;">Change in Control,</font>&#8221; as that term is defined in Section 9 hereof, triggered as a result of clauses (i) or (ii) thereof, (x)
          the highest level parent entity holding, directly or indirectly, majority voting control of the Company following the relevant transaction (the &#8220;<font style="font-weight: bold; font-style: italic;">Acquirer Parent</font>&#8221;), is not a
          publicly-traded entity, (y) the Executive does not become, or the Executive is removed from the position of (other than due to a removal in connection with a termination of employment under Sections 7.1, 7.2 or 7.3 hereof), the Chief Executive
          Officer and Chairman of the Board of Directors of the Acquirer Parent, with such position being, in all events, on terms and conditions (embodied in an employment agreement) reasonably acceptable to the Executive, it being agreed that terms and
          conditions of employment that provide for total compensation having a value comparable to the total compensation paid to comparable chief executive officers of companies comparable to the Acquirer Parent (taking into account revenues, market
          capitalization and industry) shall be reasonable, without considering any payments or benefits provided to the</div>
        <div><br>
        </div>
        <div style="margin-top: 0.55pt;"><br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter">
            <div><br>
            </div>
          </div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          <div class="BRPFPageHeader"></div>
        </div>
        <div><br>
        </div>
        <div style="font-family: Arial,Helvetica,sans-serif; font-size: 12pt; margin-left: 81pt;">Executive pursuant to this Agreement, or (z) any director other than the Executive is designated as the lead director of the Board of Directors of the
          Acquirer Parent; <font style="font-style: italic;">provided that</font>, in each case of clauses (A), (B), (C), (E) and (F) above, &#8220;Good Reason&#8221; shall not be deemed to exist unless (x) the Executive provides the Company a Notice of Termination
          within two (2) years following the initial occurrence of such event, (y) the Company fails to cure the event giving rise to Good Reason within thirty (30) days following its receipt of such Notice of Termination (the &#8220;<font style="font-weight: bold; font-style: italic;">Cure Period</font>&#8221;) and (z) the Executive&#8217;s resignation for Good Reason is effective within thirty (30) days after the expiration of the Cure Period.</div>
        <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">4.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">Section
            8.4(iii) of the Agreement is deleted and replaced with the following:</font></div>
        <div style="margin-left: 81pt; margin-top: 12pt;"><font style="font-size: 12pt; font-style: italic;">(iii)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt; font-style: italic;">Other Payments.</font></div>
        <div style="text-indent: 54pt; margin-left: 81pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">(1)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">On November 4, 2015, the Company granted the Executive a one-time grant of 2,700,000 restricted share units (&#8220;<font style="font-weight: bold; font-style: italic;">RSUs</font>&#8221;)
            (as adjusted for stock splits, stock dividends, recapitalizations and similar transactions) under the Masimo Corporation 2007 Stock Incentive Plan and a restricted share unit award agreement dated as of November 4, 2015 (the &#8220;<font style="font-weight: bold; font-style: italic;">Award Agreement</font>&#8221;). Except as provided in Section 8.4(iii)(3) below, each RSU shall vest effective as of immediately prior to a Qualifying Termination (the &#8220;<font style="font-weight: bold; font-style: italic;">Vesting Date</font>&#8221;) during the Employment Period. Each RSU shall represent the right to receive, on the tenth (10th) day following the Vesting Date (subject to Section 8.6 hereof), one share of common stock of the
            Company (&#8220;<font style="font-weight: bold; font-style: italic;">Common Stock</font>&#8221;). Notwithstanding the foregoing, the Board, in its sole discretion, may accelerate the vesting of some or all of the RSUs at any time prior to the Vesting Date,
            provided that payment of the RSUs accelerated in accordance with this sentence shall be made in shares of Common Stock on the (10th) day following the date of the Executive&#8217;s &#8220;separation from service&#8221; within the meaning of Treasury Regulation
            Section 1.409A&#8722;1(h) (subject to Section 8.6 hereof). In the event of any inconsistency between the terms of this Agreement and the Award Agreement or the Plan, the terms of this Agreement shall govern.</font></div>
        <div style="text-indent: 54pt; margin-left: 81pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif; font-weight: bold; font-style: italic;"><font style="font-weight: normal;">(2)</font></font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt; font-weight: normal;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">Upon a Qualifying Termination, the Company shall pay to
            the Executive in a single lump sum on the sixtieth (60th) day following the Executive&#8217;s termination of employment (subject to Section 8.6 hereof) a cash amount equal to thirty-five million dollars ($35,000,000) (the &#8220;<font style="font-weight: bold; font-style: italic;">Cash Payment</font>&#8221;). The Cash Payment (the &#8220;<font style="font-weight: bold; font-style: italic;">Non-Competition Payment</font>&#8221;) is being paid to the Executive in consideration of the Executive&#8217;s agreement to
            comply with Sections 1 and 11 of the Restrictive Covenant Agreement and shall be subject to repayment to the Company in the event of a final determination by the Superior Court of California for the County of Orange that the Executive has
            materially breached such covenants. The Company agrees that the Non-Competition Payment constitutes reasonable compensation under Section 280G(b)(4)(A) of the Internal Revenue Code of 1986, as amended (the &#8220;<font style="font-weight: bold; font-style: italic;">Code</font>&#8221;).</font></div>
        <div><br>
        </div>
        <div><br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter">
            <div><br>
            </div>
          </div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          <div class="BRPFPageHeader"></div>
        </div>
        <div><br>
        </div>
        <div style="text-indent: 54pt; margin-left: 81pt; margin-top: 12pt;"><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">(3)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt; font-family: Arial,Helvetica,sans-serif;">Upon the occurrence of a Change in Control prior to a Qualifying Termination, the RSUs and Cash Payment shall vest in equal installments on the first two anniversaries of the
            date of such Change in Control (each, a &#8220; <font style="font-weight: bold; font-style: italic;">Retention Vesting Date </font>&#8221;), subject to the Executive&#8217;s continuous employment through each applicable Retention Vesting Date, provided that if
            the Executive&#8217;s employment terminates due to a Qualifying Termination or pursuant to Sections 7.1 (Death) or 7.2 (Disability) hereof prior to the final Retention Vesting Date, any remaining unvested portions of the RSUs and Cash Payment shall
            immediately vest effective as of the date of such termination of employment. Payment of the RSUs that vest in accordance with this Section shall be made in shares of Common Stock on the (10th) day following the date of the Executive&#8217;s
            &#8220;separation from service&#8221; within the meaning of Treasury Regulation Section 1.409A&#8722;1(h) (subject to Section 8.6 hereof). The Cash Payment that vests in accordance with this Section shall be paid on the date of the Executive&#8217;s &#8220;separation from
            service&#8221; within the meaning of Treasury Regulation Section 1.409A&#8722;1(h) (subject to Section 8.6 hereof). Notwithstanding the foregoing, as soon as practicable following the final Retention Vesting Date, the service recipient shall use
            commercially reasonable efforts to accelerate payment of the RSUs and Cash Payment in accordance with the &#8220;plan termination&#8221; rules set forth in Treasury Regulation Section 1.409A&#8722;3(j)(4)(ix), in a manner designed to provide for earliest
            possible payment without any accelerated taxation or penalties by reason of Section 409A of the Code. In addition, upon the occurrence of a Change in Control prior to a Qualifying Termination, the Executive&#8217;s stock options and other equity
            awards (if any) shall vest in in accordance with their terms but in no event later than in two equal installments on each Retention Vesting Date, subject to the Executive&#8217;s continuous employment through each applicable Retention Vesting Date.</font></div>
        <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">5.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">The second
            to last sentence of Section 8.4(iv) of the Agreement is deleted and replaced with the following:</font></div>
        <div style="margin-top: 12pt; margin-bottom: 0px; font-family: Arial,Helvetica,'sans-serif'; font-size: 12pt; margin-left: 81pt;">In the event the Executive&#8217;s employment is not terminated on or prior to the fifth anniversary of the Change in
          Control in a manner entitling him to the Benefits, the amounts held in the Trust shall revert to the Company, provided that such reversion shall have no effect on the Executive&#8217;s continuing entitlement to receive the Benefits in accordance with
          this Section 8.4.</div>
        <div style="margin-top: 12pt; text-indent: -45pt; margin-left: 81pt;"><font style="font-size: 12pt;">6.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 12pt;">Each instance of the words &#8220;twelve (12)&#8221; appearing in clause (iii) of Section 9 of the
            Agreement shall be replaced with the words &#8220;twenty-four (24)&#8221;.</font></div>
        <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">7.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">The last
            sentence of Section 17 (Survival) of the Agreement is deleted and replaced with the following:</font></div>
        <div style="margin-top: 8.45pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt; margin-left: 81pt;">For the sake of clarity, all payments and benefits that may become owing as a result of the specified terminations or other vesting events
          shall only be due and become owing for terminations or other vesting events that occur during the Employment Period as then in effect without regard to any termination of</div>
        <div><br>
        </div>
        <div><br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter">
            <div><br>
            </div>
          </div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          <div class="BRPFPageHeader"></div>
        </div>
        <div><br>
        </div>
        <div style="margin-top: 3.4pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt; margin-left: 81pt;">employment but shall be owing and paid regardless of whether the Employment Period has ended prior to such payments having been completed.</div>
        <div style="margin-top: 12pt; text-indent: -45pt; margin-left: 81pt;"><font style="font-size: 12pt;">8.</font>&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 12pt;">PERMITTED DISCLOSURES. Pursuant to 18 U.S.C. &#167; 1833(b), the Executive will not be held
            criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret of the Company that (a) is made (i) in confidence to a federal, state, or local government official, either directly or indirectly, or
            to the Executive&#8217;s attorney and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (b) is made in a complaint or other document that is filed under seal in a lawsuit or other proceeding. If the Executive
            files a lawsuit for retaliation by the Company for reporting a suspected violation of law, the Executive may disclose the trade secret to the Executive&#8217;s attorney and use the trade secret information in the court proceeding, if the Executive
            (I) files any document containing the trade secret under seal, and (II) does not disclose the trade secret, except pursuant to court order. Nothing in this Agreement or the Restrictive Covenant Agreement is intended to conflict with 18 U.S.C. &#167;
            1833(b) or create liability for disclosures of trade secrets that are expressly allowed by such section. Nothing in this Agreement, the Restrictive Covenant Agreement or any agreement the Executive has with the Company shall prohibit or
            restrict the Executive from making any voluntary disclosure of information or documents related to any violation of law to any governmental agency or legislative body, or any self-regulatory organization, in each case, without advance notice to
            the Company.</font></div>
        <div style="margin-top: 12pt; text-indent: -45pt; margin-left: 81pt;"><font style="font-size: 12pt;">9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; ENTIRE AGREEMENT; REFERENCES. Other than as specifically amended, the Agreement will remain in full force and effect, provided that
            any section references contained in the Agreement shall be updated as necessary to reflect the provisions of this Amendment. References to &#8220;this Agreement&#8221; in the Agreement shall refer to the Agreement, as amended by this Amendment.</font></div>
        <div style="margin-top: 12pt; text-indent: -45pt; margin-left: 81pt;"><font style="font-size: 12pt;">10.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 12pt;">INTERPRETATION. This Amendment shall in all respects be interpreted, construed and governed by
            and in accordance with the laws of the State of California, without regard to conflicts of laws principles.</font></div>
        <div style="text-align: center; margin-right: 30.9pt; margin-left: 31.85pt; margin-top: 8.35pt; font-size: 12pt;">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]</div>
        <div><br>
        </div>
        <div><br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter">
            <div><br>
            </div>
          </div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          <div class="BRPFPageHeader"></div>
        </div>
        <div><br>
        </div>
        <div style="text-indent: 36pt; margin-top: 12pt; font-size: 12pt;">IN WITNESS WHEREOF, the Company at the direction of the Compensation Committee of the Board has caused this Amendment to be executed as of the day and year first above written.</div>
        <div style="margin: 12pt 0px 0px; font-family: Arial, Helvetica, 'sans-serif'; font-size: 12pt;">
          <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: Arial, Helvetica, sans-serif; font-size: 10pt;">

              <tr>
                <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                <td valign="top" style="font-weight: bold; font-size: 12pt;" colspan="2"><br>
                </td>
              </tr>
              <tr>
                <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 8%; font-size: 12pt; text-align: left;" rowspan="1"><font style="font-weight: normal;">"Company"</font> <br>
                </td>
                <td valign="top" style="width: 35%; font-size: 12pt; font-weight: bold; text-align: left;" rowspan="1">MASIMO CORPORATION</td>
              </tr>
              <tr>
                <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                <td valign="top" style="width: 8%; font-size: 12pt; text-align: left;">&#160;</td>
                <td valign="top" style="width: 35%; font-size: 12pt; text-align: left;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;">
                  <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; font-size: 12pt;"><br>
                  </div>
                </td>
                <td valign="top" style="width: 8%; padding-bottom: 2px;">
                  <div style="font-size: 12pt; text-align: left;">By </div>
                </td>
                <td valign="top" nowrap="nowrap" style="width: 35%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 12pt; text-align: left;">/s/&#160; <font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-style: normal; font-variant: small-caps; text-transform: none;">CRAIG REYNOLDS</font><br>
                </td>
              </tr>
              <tr>
                <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                <td valign="top" style="width: 8%; font-size: 12pt; text-align: left;">Name:<br>
                </td>
                <td valign="bottom" nowrap="nowrap" style="width: 35%; font-size: 12pt; text-align: left;">Craig Reynolds<br>
                </td>
              </tr>
              <tr>
                <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                <td valign="top" style="width: 8%; font-size: 12pt; text-align: left;">Its:<br>
                </td>
                <td valign="top" style="width: 35%; font-size: 12pt; text-align: left;">Chairperson of the Compensation Committee of the</td>
              </tr>
              <tr>
                <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 8%; font-size: 12pt; text-align: left;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 35%; font-size: 12pt; text-align: left;" rowspan="1">Board of Directors<br>
                </td>
              </tr>
              <tr>
                <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 8%; font-size: 12pt; text-align: left;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 35%; font-size: 12pt; text-align: left;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 8%; font-size: 12pt; text-align: left;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 35%; font-size: 12pt; text-align: left;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 8%; font-size: 12pt; text-align: left;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 35%; font-size: 12pt; text-align: left;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 8%; font-size: 12pt; text-align: left;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 35%; font-size: 12pt; text-align: left;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 50%; font-size: 12pt; padding-bottom: 2px;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 8%; font-size: 12pt; padding-bottom: 2px; text-align: left;" rowspan="1">"Executive"<br>
                </td>
                <td valign="top" style="width: 35%; font-size: 12pt; border-bottom: 2px solid rgb(0, 0, 0); text-align: left;" rowspan="1">/s/ JOE KIANI <br>
                </td>
              </tr>
              <tr>
                <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 8%; font-size: 12pt; text-align: left;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 35%; font-size: 12pt; text-align: left;" rowspan="1">Joe Kiani <br>
                </td>
              </tr>
              <tr>
                <td valign="top" style="width: 50%; font-size: 12pt;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 8%; font-size: 12pt; text-align: left;" rowspan="1">Its <br>
                </td>
                <td valign="top" style="width: 35%; font-size: 12pt; text-align: left;" rowspan="1">Chairman of the Board &amp; CEO <br>
                </td>
              </tr>

          </table>
          <div style="margin-top: 12pt; font-family: Arial, Helvetica, sans-serif; font-weight: bold;"> </div>
        </div>
        <div style="margin-top: 0.5pt;"><br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter">
            <div><br>
            </div>
          </div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          <div class="BRPFPageHeader"></div>
        </div>
        <div class="BRPFPageFooter">
          <div>
            <div>
              <div>
                <div class="BRPFPageFooter">
                  <div><br>
                  </div>
                </div>
              </div>
            </div>
            <div><font style="font-size: 11.5pt;">&#160;</font><br>
              <div style="line-height: normal;">
                <div>
                  <div class="BRPFPageFooter">
                    <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                    </div>
                    <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                    </div>
                    <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                    </div>
                  </div>
                  <div class="BRPFPageFooter">
                    <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                    </div>
                  </div>
                </div>
                <div>
                  <div>
                    <div>
                      <div>
                        <div>
                          <div class="BRPFPageFooter">
                            <div style="line-height: 0.65pt;">
                              <div><br>
                                <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                </div>
                                <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                </div>
                                <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                </div>
                                <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                </div>
                                <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                </div>
                                <div style="line-height: 11.4pt;">
                                  <div style="line-height: 11.4pt; text-align: center;"><font style="font-size: 48pt;">EXHIBIT E</font><br style="line-height: 11.4pt;">
                                  </div>
                                  <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                  </div>
                                </div>
                                <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                </div>
                                <div style="line-height: 11.4pt;">
                                  <div><br>
                                  </div>
                                  <font style="font-size: 11.5pt;"><br>
                                  </font><br>
                                </div>
                                <br>
                              </div>
                              <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                                <div class="BRPFPageFooter"></div>
                                <div class="BRPFPageBreak" style="page-break-after: always;">
                                  <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                              </div>
                              <div>
                                <div>
                                  <div>&#160; </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <div>
                <div><br>
                </div>
                <div style="text-align: center; margin-top: 12pt; font-size: 12pt; font-weight: bold;">SECOND AMENDMENT TO THE NOVEMBER 4, 2015<br>
                  AMENDED AND RESTATED EMPLOYMENT AGREEMENT</div>
                <div style="text-indent: 36pt; margin-top: 12pt; font-size: 12pt;">THIS SECOND AMENDMENT TO THE NOVEMBER 4, 2015 AMENDED AND RESTATED EMPLOYMENT</div>
                <div style="text-indent: 36pt; margin-top: 12pt; font-size: 12pt;">AGREEMENT (this &#8220;<font style="font-weight: bold; font-style: italic;">Amendment</font>&#8221;) is made and entered into as of January 14, 2022, by and between Masimo Corporation,
                  a Delaware corporation (the &#8220;<font style="font-weight: bold; font-style: italic;">Company</font>&#8221;), and Joe Kiani (the &#8220;<font style="font-weight: bold; font-style: italic;">Executive</font>&#8221;).</div>
                <div style="text-align: center; margin-top: 12pt; font-size: 12pt; font-weight: bold;">RECITALS</div>
                <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">A.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">The
                    Executive is the founder of the Company and has been its Chairman of the Board and Chief Executive Officer (&#8220;<font style="font-weight: bold; font-style: italic;">CEO</font>&#8221;) since its inception. The Board of Directors of the Company
                    (the &#8220;<font style="font-weight: bold; font-style: italic;">Board</font>&#8221;) recognizes that the Executive&#8217;s contributions as Chairman of the Board and CEO have been instrumental to the success of the Company. The Executive and the Company
                    entered into an amended and restated employment agreement dated November 4, 2015, which agreement was amended pursuant to an amendment dated July 27, 2017 (as amended, the &#8220;<font style="font-weight: bold; font-style: italic;">Agreement</font>&#8221;).







                    The Board and the Executive desire to further amend the Agreement pursuant to the terms hereof to assure the Company of the Executive&#8217;s continued employment in an executive capacity and to compensate him therefor.</font></div>
                <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">B.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">The
                    Company considers the establishment and maintenance of a sound management to be essential to protecting and enhancing the best interests of the Company and its stockholders.</font></div>
                <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">C.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">The
                    Board has determined that appropriate steps should be taken to retain the Executive and to reinforce and encourage his continued attention and dedication to his assigned duties.</font></div>
                <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">D.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt;">The
                    Company desires to continue to retain the services of the Executive, and the Executive desires to continue to be employed by the Company pursuant to the terms and conditions of the Agreement, as amended by this Amendment.</font></div>
                <div style="text-indent: 36pt; margin-top: 12pt; font-size: 12pt;">NOW, THEREFORE, in consideration of the premises, the mutual promises and the mutual covenants and agreements hereinafter set forth, the Company and the Executive hereby
                  agree that the Agreement is amended as follows:</div>
                <div style="text-indent: 36pt; margin-top: 12pt;"><font style="font-size: 12pt;">1.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt;">The




                    second sentence of Section 8.4(iii)(1) of the Agreement is deleted and replaced with the following:</font></div>
                <div style="margin-top: 12pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt; margin-left: 81pt;">Each RSU shall vest effective as of immediately prior to the earliest to occur of (A) the applicable Retention Vesting Date as
                  provided in Section 8.4(iii)(3) below, (B) a Qualifying Termination during the Employment Period, (C) Executive&#8217;s death during the Employment Period and (D) the termination of Executive&#8217;s employment pursuant to Section 7.2 hereof (any
                  such date or event in clause (A), (B), (C) or (D) above, the &#8220;<font style="font-weight: bold; font-style: italic;">Vesting Date</font>&#8221;; <font style="font-style: italic;">provided that</font>, in the case of clause (A) above, the
                  &#8220;Vesting Date&#8221; shall apply only with respect to the RSUs</div>
                <div><br>
                </div>
                <div><br>
                </div>
                <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                  <div class="BRPFPageFooter">
                    <div><br>
                    </div>
                  </div>
                  <div class="BRPFPageBreak" style="page-break-after: always;">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                  <div class="BRPFPageHeader"></div>
                </div>
                <div><br>
                </div>
                <div style="margin-top: 12pt;"><br>
                </div>
                <div style="margin-top: 12pt; font-family: Arial,Helvetica,sans-serif; font-size: 12pt; margin-left: 81pt;">that are deemed vested as of an applicable Retention Vesting Date as provided in Section 8.4(iii)(3) below).</div>
                <div style="margin-top: 12pt; text-indent: -45pt; margin-left: 81pt;"><font style="font-size: 12pt;">2.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt;">ENTIRE







                    AGREEMENT; REFERENCES. Other than as specifically amended, the Agreement will remain in full force and effect, provided that any section references contained in the Agreement shall be updated as necessary to reflect the provisions of
                    this Amendment. References to &#8220;this Agreement&#8221; in the Agreement shall refer to the Agreement, as amended by this Amendment.</font></div>
                <div style="margin-top: 12pt; text-indent: -45pt; margin-left: 81pt;"><font style="font-size: 12pt;">3.</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 36pt;">&#160;</font><font style="font-size: 12pt;">INTERPRETATION.







                    This Amendment shall in all respects be interpreted, construed and governed by and in accordance with the laws of the State of California, without regard to conflicts of laws principles.</font></div>
                <div style="text-align: center; text-indent: 36pt; margin-top: 12pt; font-size: 12pt;">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]</div>
                <div><br>
                </div>
                <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                  <div class="BRPFPageFooter">
                    <div><br>
                    </div>
                  </div>
                  <div class="BRPFPageBreak" style="page-break-after: always;">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                  <div class="BRPFPageHeader"></div>
                </div>
                <div><br>
                </div>
                <div style="margin-top: 12pt;"><br>
                </div>
                <div style="text-indent: 36pt; margin-top: 12pt; font-size: 12pt;">IN WITNESS WHEREOF, the Company at the direction of the Compensation Committee of the Board has caused this Amendment to be executed as of the day and year first above
                  written.</div>
                <div class="BRPFPageFooter">
                  <div><br>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: Arial, Helvetica, sans-serif; font-size: 10pt;">

              <tr>
                <td valign="top" style="width: 45%; font-size: 12pt;">&#160;</td>
                <td valign="top" style="font-weight: bold; font-size: 12pt;" colspan="2"><br>
                </td>
              </tr>
              <tr>
                <td valign="top" style="width: 45%; font-size: 12pt;" rowspan="1">&#160;</td>
                <td valign="top" style="font-size: 12pt;" rowspan="1" colspan="2"><font style="font-weight: normal;">"Company"</font> <br>
                </td>
              </tr>
              <tr>
                <td valign="top" style="width: 45%; font-size: 12pt;">&#160;</td>
                <td valign="top" style="font-size: 12pt;" rowspan="1" colspan="2">MASIMO CORPORATION&#160; <br>
                </td>
              </tr>
              <tr>
                <td valign="top" style="width: 45%; font-size: 12pt;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 3%; font-size: 12pt;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 40%; font-size: 12pt;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 45%; font-size: 12pt; padding-bottom: 2px;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 3%; font-size: 12pt; padding-bottom: 2px;" rowspan="1">By:<br>
                </td>
                <td valign="top" style="width: 40%; font-size: 12pt; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">
                  <div style="text-align: left; font-variant: small-caps;">/s/&#160; Craig Reynolds</div>
                </td>
              </tr>
              <tr>
                <td valign="top" style="width: 45%; font-size: 12pt;">&#160;</td>
                <td valign="top" style="width: 3%; font-size: 12pt;">Name: <br>
                </td>
                <td valign="bottom" nowrap="nowrap" align="left" style="width: 40%; font-size: 12pt;">Craig Reynolds<br>
                </td>
              </tr>
              <tr>
                <td valign="top" style="width: 45%; font-size: 12pt;">&#160;</td>
                <td valign="top" style="width: 3%; font-size: 12pt;">Its: <br>
                </td>
                <td valign="top" style="width: 40%; font-size: 12pt;">Chairperson of the Compensation Committee of the Board of<br>
                </td>
              </tr>
              <tr>
                <td valign="top" style="width: 45%; font-size: 12pt;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 3%; font-size: 12pt;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 40%; font-size: 12pt;" rowspan="1">Directors<br>
                </td>
              </tr>
              <tr>
                <td valign="top" style="width: 45%; font-size: 12pt;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 3%; font-size: 12pt;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 40%; font-size: 12pt;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 45%; font-size: 12pt;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 3%; font-size: 12pt;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 40%; font-size: 12pt;" rowspan="1">&#160;<br>
                </td>
              </tr>
              <tr>
                <td valign="top" style="width: 45%; font-size: 12pt;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 3%; font-size: 12pt;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 40%; font-size: 12pt;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 45%; font-size: 12pt;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 3%; font-size: 12pt;" rowspan="1">"Executive" <br>
                </td>
                <td valign="top" style="width: 40%; font-size: 12pt;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 45%; font-size: 12pt;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 3%; font-size: 12pt;" rowspan="1">&#160;</td>
                <td valign="top" style="width: 40%; font-size: 12pt;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 45%; font-size: 12pt; padding-bottom: 2px;" rowspan="1">&#160;</td>
                <td valign="top" style="font-size: 12pt; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="2">
                  <div style="text-align: left; font-variant: small-caps;">/s/&#160; Joe Kiani</div>
                </td>
              </tr>
              <tr>
                <td valign="top" style="width: 45%; font-size: 12pt;" rowspan="1">&#160;</td>
                <td valign="top" style="font-size: 12pt;" rowspan="1" colspan="2">Joe Kiani <br>
                </td>
              </tr>

          </table>
        </div>
        <div><br>
        </div>
        <div>
          <div>
            <div>
              <div>
                <div class="BRPFPageFooter">
                  <div><br>
                  </div>
                  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                    <div class="BRPFPageFooter"></div>
                    <div style="page-break-after: always;" class="BRPFPageBreak">
                      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                    <div class="BRPFPageHeader"></div>
                  </div>
                </div>
              </div>
            </div>
            <div><font style="font-size: 11.5pt;">&#160;</font><br>
              <div style="line-height: normal;">
                <div>
                  <div class="BRPFPageFooter">
                    <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                    </div>
                    <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                    </div>
                    <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                    </div>
                  </div>
                  <div class="BRPFPageFooter">
                    <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                    </div>
                  </div>
                </div>
                <div>
                  <div>
                    <div>
                      <div>
                        <div>
                          <div class="BRPFPageFooter">
                            <div style="line-height: 0.65pt;">
                              <div><br>
                                <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                </div>
                                <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                </div>
                                <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                </div>
                                <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                </div>
                                <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                </div>
                                <div style="line-height: 11.4pt;">
                                  <div style="line-height: 11.4pt; text-align: center;"><font style="font-size: 48pt;">EXHIBIT F</font><br style="line-height: 11.4pt;">
                                  </div>
                                  <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                  </div>
                                </div>
                                <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                </div>
                                <div style="line-height: 11.4pt;">
                                  <div><br>
                                  </div>
                                  <font style="font-size: 11.5pt;"><br>
                                  </font><br>
                                </div>
                                <br>
                              </div>
                              <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                                <div class="BRPFPageFooter"></div>
                                <div class="BRPFPageBreak" style="page-break-after: always;">
                                  <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                              </div>
                              <div>
                                <div>
                                  <div>&#160; </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <div>
                <div>
                  <div><br>
                  </div>
                  <div style="margin-top: 3.95pt; color: rgb(35, 31, 32); font-family: Arial,Helvetica,sans-serif; font-size: 8pt;">DocuSign Envelope ID: 0E306575-3279-4C85-B05C-9997B13CA500</div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><img width="662" height="52" src="image00003.jpg"></div>
                  <div style="margin-top: 0.5pt;"><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div style="margin-top: 0.1pt;"><br>
                  </div>
                  <div style="margin-left: 105.75pt; color: #231F20; font-size: 12pt;">October 17, 2022</div>
                  <div style="margin-top: 0.35pt;"><br>
                  </div>
                  <div style="margin-left: 105.75pt; color: #231F20; font-size: 12pt; font-weight: bold;">VIA EMAIL</div>
                  <div style="margin-top: 0.15pt;"><br>
                  </div>
                  <div style="margin-right: 378.85pt; margin-left: 105.75pt; color: #231F20; font-size: 12pt;">Eduardo Gallardo </div>
                  <div style="margin-right: 378.85pt; margin-left: 105.75pt; color: #231F20; font-size: 12pt;">Paul Hastings LLP </div>
                  <div style="margin-right: 378.85pt; margin-left: 105.75pt; color: #231F20; font-size: 12pt;">200 Park Avenue </div>
                  <div style="margin-right: 378.85pt; margin-left: 105.75pt; color: #231F20; font-size: 12pt;">New York, NY 10166</div>
                  <div style="margin-top: 0.4pt;"><br>
                  </div>
                  <table cellspacing="0" cellpadding="0" id="zc7ee433b55144b7e9074f702d8376af0" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                      <tr>
                        <td style="width: 105.75pt;"><br>
                        </td>
                        <td style="width: 34.55pt; vertical-align: top; color: #231F20; font-size: 12pt;">Re:</td>
                        <td style="width: auto; vertical-align: top;">
                          <div style="color: #231F20; font-size: 12pt;">Further Clarifications Required in Connection with Your Letter Dated September 28, 2022 Regarding Masimo Corporation</div>
                        </td>
                      </tr>

                  </table>
                  <div style="margin-top: 0.35pt;"><br>
                  </div>
                  <div style="margin-left: 105.75pt; color: #231F20; font-size: 12pt;">Dear Mr. Gallardo:</div>
                  <div style="margin-top: 0.1pt;"><br>
                  </div>
                  <div style="text-align: justify; text-indent: 34.5pt; margin-right: 41.05pt; margin-left: 105.75pt; color: #231F20; font-size: 12pt;">We are writing to supplement our response of October 9 to your September 28, 2022 letter, and request
                    two confirmations from the Board of Directors (the &#8220;Board&#8221;) of Masimo Corporation (the &#8220;Company&#8221;) described herein.</div>
                  <div style="text-align: justify; text-indent: 34.5pt; margin-right: 40.95pt; margin-left: 105.75pt; margin-top: 11.55pt; color: #231F20; font-size: 12pt;">As previously noted, the Bylaws require the disclosure of the names and addresses
                    of stockholders who are known to support a director nomination, including such stockholders&#8217; beneficial and record ownership of Company capital stock. Politan seeks confirmation from the Board that Politan would only be required to
                    disclose instances where a stockholder has given material support in the form of financial support, a voting commitment or similar arrangement.</div>
                  <div style="text-align: justify; text-indent: 34.5pt; margin-right: 40.8pt; margin-left: 105.75pt; margin-top: 11.6pt; color: #231F20; font-size: 12pt;">Politan is also concerned with the change of control provision in Mr. Kiani&#8217;s
                    employment agreement, which permits Mr. Kiani to receive hundreds of millions of dollars in value if two of the Company&#8217;s directors are voted out of office. Triggering this change of control provision would result in financially
                    disastrous consequences for the Company and its stockholders. Consequently, Politan requests that the Board confirm that it would take all actions necessary or required to waive, terminate, or amend the change of control provision in
                    this agreement, and similar provisions in other agreements that would be detrimental to stockholders, in connection with any change of control that may arise as a result of any proxy solicitation or the election of directors nominated
                    by Politan.</div>
                  <div style="margin-top: 0.2pt;"><br>
                  </div>
                  <div style="text-align: justify; text-indent: 34.5pt; margin-right: 41.05pt; margin-left: 105.75pt; color: #231F20; font-size: 12pt;">We ask you to please provide these requested confirmations and a response to our October 9 letter no
                    later than October 19, 2022.</div>
                  <div style="text-align: center; margin-left: 64.65pt; margin-top: 11.55pt;"><font style="font-size: 12pt; color: #231F20;">*</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 34.55pt">&#160;</font><font style="font-size: 12pt; color: #231F20;"><font style="color: #231F20;">*</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 34.55pt">&#160;</font>*</font></div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div style="margin-top: 0.4pt;"><br>
                  </div>
                  <div style="margin-left: 105.75pt; margin-top: 0.05pt; color: #231F20; font-size: 8pt;"><font style="font-weight: bold;">Richard Michael Brand </font>Tel +1 212 504-5757 Fax +1 212 504-6666 richard.brand@cwt.com</div>
                  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                    <div class="BRPFPageFooter">
                      <div><br>
                      </div>
                    </div>
                    <div class="BRPFPageBreak" style="page-break-after: always;">
                      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                    <div class="BRPFPageHeader"></div>
                  </div>
                  <!--PROfilePageNumberReset%Num%2%Page %%-->
                  <div><br>
                  </div>
                  <div style="margin-top: 3.95pt; color: rgb(35, 31, 32); font-family: Arial,Helvetica,sans-serif; font-size: 8pt;">DocuSign Envelope ID: 0E306575-3279-4C85-B05C-9997B13CA500</div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><img width="195" height="11" src="image1.jpg"></div>
                  <div style="margin-top: 0.25pt;"><br>
                  </div>
                  <div style="margin-right: 392.95pt; margin-left: 110.95pt; margin-top: 3.9pt; color: #231F20; font-size: 12pt;">Eduardo Gallardo October 17, 2022</div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div style="margin-top: 0.3pt;"><br>
                  </div>
                  <div style="text-indent: 34.45pt; margin-right: 58.95pt; margin-left: 110.95pt; margin-top: 4.5pt; color: #231F20; font-size: 12pt;">Politan reserves all rights, remedies, powers and defenses under Delaware law and applicable agreements,
                    and does not waive any such rights, remedies, powers, or defenses.</div>
                  <div style="margin-left: 110.95pt; color: #231F20; font-size: 12pt;"> <br>
                  </div>
                  <div style="margin-left: 110.95pt; color: #231F20; font-size: 12pt;">Very truly yours,</div>
                  <div style="margin-left: 110.95pt; color: #231F20; font-size: 12pt;"> <br>
                  </div>
                  <div style="margin-left: 110.95pt; color: #231F20; font-size: 12pt;">/s/ Richard Brand<br>
                  </div>
                  <div style="margin-left: 110.95pt; color: #231F20; font-size: 12pt;"><br>
                  </div>
                  <div style="margin-right: 367.1pt; margin-left: 110.95pt; margin-top: 1.4pt; color: #231F20; font-size: 12pt;">Richard Michael Brand RMB</div>
                  <div style="margin-top: 0.15pt;"><br>
                  </div>
                  <table cellspacing="0" cellpadding="0" id="z8c0ceb82c4eb4a5b8e042c18c18963c3" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                      <tr>
                        <td style="width: 110.95pt;"><br>
                        </td>
                        <td style="width: 34.55pt; vertical-align: top; color: #231F20; font-size: 12pt;">cc:</td>
                        <td style="width: auto; vertical-align: top;">
                          <div style="color: #231F20; font-size: 12pt;">John P. DiTomo (Morris, Nichols, Arsht &amp; Tunnell LLP) </div>
                          <div style="color: #231F20; font-size: 12pt;">Martin S. Lessner (Young Conaway Stargatt &amp; Taylor LLP) </div>
                          <div style="color: #231F20; font-size: 12pt;">Michael Swartz (Schulte Roth &amp; Zabel LLP)</div>
                          <div style="color: #231F20; font-size: 12pt;">
                            <div style="margin-top: 0.05pt; color: rgb(35, 31, 32); font-family: Arial,Helvetica,sans-serif;">Eleazer Klein (Schulte Roth &amp; Zabel LLP)</div>
                            <div style="color: rgb(35, 31, 32); font-family: Arial,Helvetica,sans-serif;">Stephen Fraidin (Cadwalader, Wickersham &amp; Taft LLP)</div>
                          </div>
                        </td>
                      </tr>

                  </table>
                  <br>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                    <div class="BRPFPageFooter">
                      <div><br>
                      </div>
                    </div>
                    <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">Page 2</font></div>
                    <div style="page-break-after: always;" class="BRPFPageBreak">
                      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                    <div class="BRPFPageHeader"></div>
                  </div>
                  <div> <br>
                    <div style="line-height: normal;">
                      <div>
                        <div class="BRPFPageFooter">
                          <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                          </div>
                          <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                          </div>
                          <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                          </div>
                        </div>
                        <div class="BRPFPageFooter">
                          <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                          </div>
                        </div>
                      </div>
                      <div>
                        <div>
                          <div>
                            <div>
                              <div>
                                <div class="BRPFPageFooter">
                                  <div style="line-height: 0.65pt;">
                                    <div><br>
                                      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                      </div>
                                      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                      </div>
                                      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                      </div>
                                      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                      </div>
                                      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                      </div>
                                      <div style="line-height: 11.4pt;">
                                        <div style="line-height: 11.4pt; text-align: center;"><font style="font-size: 48pt;">EXHIBIT G</font><br style="line-height: 11.4pt;">
                                        </div>
                                        <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                        </div>
                                      </div>
                                      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                      </div>
                                      <div style="line-height: 11.4pt;">
                                        <div><br>
                                        </div>
                                        <font style="font-size: 11.5pt;"><br>
                                        </font><br>
                                      </div>
                                      <br>
                                    </div>
                                    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                                      <div class="BRPFPageFooter"></div>
                                      <div class="BRPFPageBreak" style="page-break-after: always;">
                                        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                                    </div>
                                    <div>
                                      <div>
                                        <div>&#160; </div>
                                      </div>
                                    </div>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                  <div>
                    <div style="margin-left: 56.2pt;"><img width="183" height="53" src="image00005.jpg"></div>
                    <div><br>
                    </div>
                    <div><br>
                    </div>
                    <div style="margin-top: 0.2pt;"><br>
                    </div>
                    <div style="margin-left: 56.2pt; margin-top: 4.5pt; font-size: 12pt;">October 19, 2022</div>
                    <div style="margin-top: 0.15pt;"><br>
                    </div>
                    <div style="margin-left: 56.2pt; font-size: 12pt; font-weight: bold;">VIA EMAIL</div>
                    <div style="margin-top: 0.25pt;"><br>
                    </div>
                    <div style="margin-right: 342.85pt; margin-left: 56.2pt; font-size: 12pt;">Richard Michael Brand, Esq. </div>
                    <div style="margin-right: 342.85pt; margin-left: 56.2pt; font-size: 12pt;">Cadwalader, Wickersham &amp; Taft LLP </div>
                    <div style="margin-right: 342.85pt; margin-left: 56.2pt; font-size: 12pt;">200 Liberty Street</div>
                    <div style="margin-left: 56.2pt; font-size: 12pt;">New York, NY 10281</div>
                    <div><br>
                    </div>
                    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 193.45pt; margin-left: 56.2pt; font-size: 12pt;">Re: Politan Capital Letters of October 9 and October 17, 2022 </div>
                    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 193.45pt; margin-left: 56.2pt; font-size: 12pt;"> <br>
                    </div>
                    <div style="margin: 0px 193.45pt 0px 56.2pt; font-size: 12pt; text-align: justify;">Dear Richard:</div>
                    <div style="margin: 0px 193.45pt 0px 56.2pt; font-size: 12pt; text-align: justify;"> <br>
                    </div>
                    <div style="text-align: justify; margin-right: 62.65pt; margin-left: 56.2pt; font-size: 12pt;">We write on behalf of our client, Masimo Corporation (&#8220;Masimo&#8221; or the &#8220;Company&#8221;), in response to your letters dated October 9, 2022 and
                      October 17, 2022 on behalf of Politan Capital Management LP (&#8220;Politan&#8221;). For convenience we refer to your October 9, 2022 letter and the attached exhibits collectively as the &#8220;Draft Nomination Letter,&#8221; and to your October 17, 2022
                      letter as the &#8220;Supplemental Response.&#8221;</div>
                    <div style="margin-top: 0.5pt;"><br>
                    </div>
                    <div style="text-align: justify; margin-right: 62.6pt; margin-left: 56.2pt; font-size: 12pt;">We continue to disagree with Politan&#8217;s characterizations of the Bylaw amendments adopted last month by the Board of Directors of Masimo. As
                      previously stated, Masimo amended its Bylaws, as did many other public companies, to address the SEC&#8217;s newly adopted universal proxy rules, which went into effect on September 1, 2022, and to address well-founded concerns that Politan
                      might attempt to present matters for stockholder consideration at Masimo&#8217;s next annual meeting without providing the accurate and complete information stockholders would need to cast an informed vote. As adopted, the Bylaws enhance
                      the procedural mechanics and disclosure requirements in connection with stockholder nominations of directors and reduce potential abuse of the new universal proxy card process.</div>
                    <div style="margin-top: 0.5pt;"><br>
                    </div>
                    <div style="text-align: justify; margin-right: 62.65pt; margin-left: 56.2pt; font-size: 12pt;">Far from &#8220;thwart[ing] shareholder democracy&#8221; as claimed in your letter, the Bylaws are intended to&#8212;and in fact do&#8212;increase transparency and
                      ensure that stockholders are sufficiently informed of, among other things, potential conflicts of interest and the identity of those significantly backing (financially or otherwise) a director nomination. The Bylaws facilitate
                      information gathering for Masimo stockholders before they are asked to vote on matters of great importance to the Company; they do not, as you posit, impose insurmountable barriers to the free exercise of stockholder franchise.
                      Indeed, insofar as you are invoking &#8220;shareholder democracy,&#8221; we note that actual democracy has promoted transparency with robust disclosure of financial supporters and aligned parties for decades. There, as here, &#8220;[s]unlight is said
                      to be the best of disinfectants; electric light the most efficient policeman.&#8221; <font style="font-style: italic;">Buckley v. Valeo</font>, 424 U.S. 1, 67 (1976) (quoting L. Brandeis, &#8220;Other People&#8217;s Money&#8221; 62 (National Home Library
                      Foundation ed. 1933)).</div>
                    <div><br>
                    </div>
                    <div><br>
                    </div>
                    <div><br>
                    </div>
                    <div style="text-align: center;"><img width="288" height="25" src="image00006.jpg"></div>
                    <div><br>
                    </div>
                    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                      <div class="BRPFPageFooter">
                        <div><br>
                        </div>
                      </div>
                      <div class="BRPFPageBreak" style="page-break-after: always;">
                        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                    </div>
                    <!--PROfilePageNumberReset%Num%2%%%-->
                    <div style="margin-left: 60pt;"><img width="143" height="42" src="image00005.jpg"></div>
                    <div><br>
                    </div>
                    <div><br>
                    </div>
                    <div style="margin-top: 0.2pt;"><br>
                    </div>
                    <div style="text-align: justify; margin-right: 58.8pt; margin-left: 60pt; margin-top: 4.5pt; font-size: 12pt;">Although we appreciate that Politan has endeavored to provide some additional information for Masimo to evaluate Politan&#8217;s
                      compliance with Masimo&#8217;s Bylaws, we do have concerns about the material accuracy and completeness of certain of the information contained in the Draft Nomination Letter, as well as with the letter&#8217;s clear omissions. We welcome the
                      opportunity to further discuss these concerns with you in order to facilitate Politan&#8217;s compliance with Masimo&#8217;s Bylaws.</div>
                    <div style="margin-top: 0.15pt;"><br>
                    </div>
                    <div style="text-align: justify; margin-left: 60pt; font-size: 12pt; font-weight: bold;">Identity of Significant Limited Partners</div>
                    <div style="margin-top: 0.4pt;"><br>
                    </div>
                    <div style="text-align: justify; margin-right: 58.65pt; margin-left: 60pt; font-size: 8pt;"><font style="font-size: 12pt;">The Draft Nomination Letter continues to challenge the Masimo Bylaws&#8217; requirement that your client disclose the
                        identity of its significant (</font><font style="font-size: 12pt; font-style: italic;">i.e. </font><font style="font-size: 12pt;">5%+) limited partners and financial backers of sidecar vehicles and special purpose entities that
                        were created or raised proceeds principally to invest in Masimo. Politan&#8217;s continued lack of transparency regarding its financial entanglements and significant financial backers is contrary to the best interests of Masimo&#8217;s
                        stockholders. Masimo&#8217;s stockholders are entitled to receive clear, complete, and accurate information about these issues so that they can make a fully informed decision regarding Politan&#8217;s nominations. Indeed, by attempting to
                        nominate candidates without disclosing this information, it appears that you seek to deprive stockholders of information to which they are entitled. We therefore continue to request full compliance with the Masimo Bylaws, and
                        enumerate below some of our continued concerns.</font>1</div>
                    <div><br>
                    </div>
                    <div><br>
                    </div>
                    <div><br>
                    </div>
                    <div><br>
                    </div>
                    <div style="margin-top: 0.5pt;"><br>
                    </div>
                    <div style="margin-top: 0.35pt; margin-left: 9pt;"><br>
                    </div>
                    <div style="margin: 4.75pt 0px 0px 60pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 12pt; text-align: justify;"><font style="font-size: 8pt; font-family: Arial,Helvetica,sans-serif;"> ___________________________________<br>
                      </font></div>
                    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 58.7pt; margin-left: 60pt; margin-top: 4.75pt; font-size: 12pt;"><font style="font-size: 8pt;">1 </font>The Draft Nomination Letter states that &#8220;no
                      Delaware-incorporated public company . . . has ever demanded&#8221; disclosure of, among other things, the identity of its 5% limited partners. That carefully worded statement omits reference to the fact that your firm has advocated in
                      favor of a <font style="font-style: italic;">broader </font>nominee <font style="font-style: italic;">questionnaire </font>that required disclosure of <font style="font-style: italic;">all </font>limited partners of a hedge
                      fund, not just <font style="font-style: italic;">significant </font>investors. <font style="font-style: italic;">See, e.g., Ashford Hospitality Trust, Inc. v. Cygnus Capital, Inc., et al.</font>, 21-cv-00125 (Dkt. 1, <font style="color: #1F2023;">&#182;&#182; </font>94-97). The fact that on that occasion the activist fund actually identified <font style="font-style: italic;">all </font>of its limited partners belies your assertion that &#8220;<font style="font-style: italic;">no investment fund </font>will disclose the identities of its limited partners.&#8221;</div>
                    <div style="margin-top: 0.55pt;"><br>
                    </div>
                    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 58.75pt; margin-left: 60pt; font-size: 12pt;">We note the references in your letter to &#8220;Related Persons.&#8221; As you know, per the Bylaws, no person can be a &#8220;Related
                      Person&#8221; of Politan&#8217;s if such other person&#8217;s primary business is to serve as investment manager or adviser with respect to investing and trading in securities for a client or its own account. The action in concert must also be in
                      relation to matters &#8220;that will be material to the Nominating or Proposing Person&#8217;s solicitation of stockholders.&#8221; In light of the foregoing, we do not believe that the &#8220;Related Persons&#8221; definition should impact Politan&#8217;s potential
                      nomination process. We will be happy to discuss this further if you in fact believe that the Related Persons concept adds any significant disclosure burden to Politan and its significant limited partners.</div>
                    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                      <div class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
                      <div class="BRPFPageBreak" style="page-break-after: always;">
                        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                    </div>
                    <div style="margin-left: 60pt;"><img width="143" height="42" src="image00005.jpg"></div>
                    <div><br>
                    </div>
                    <div><br>
                    </div>
                    <div style="margin-top: 0.2pt;"><br>
                    </div>
                    <div style="text-align: justify; margin-right: 58.75pt; margin-left: 60pt; margin-top: 4.5pt; font-size: 12pt;">The claim in the Draft Nomination Letter that Politan&#8217;s investors &#8220;control billions or trillions of dollars of capital and
                      their investments in Politan represent a relatively small portion of their investment portfolios&#8221; only underscores the importance of the disclosures required by Masimo&#8217;s Bylaws. Given the size of their other investments, Politan&#8217;s
                      investors may be beholden to conflicting interests and may attempt to sway Politan or its nominated director(s) to favor the investors&#8217; competing interests with other investments or investment strategies. The fact that an investor is
                      referred to as a &#8220;limited partner&#8221; does not accurately reflect the ability of significant investors to &#8220;vote with their wallet&#8221; and use the &#8220;power of the purse&#8221; to influence Politan and its nominated director&#8217;s positions.</div>
                    <div style="margin-top: 0.5pt;"><br>
                    </div>
                    <div style="text-align: justify; margin-right: 58.75pt; margin-left: 60pt; font-size: 12pt;">Politan&#8217;s omission of this information understandably gives rise to significant concern about the completeness and accuracy of Politan&#8217;s
                      statements in its Draft Nomination Letter and its Schedule 13D and amended Schedule 13D filings. The importance of the information regarding Politan&#8217;s financial backers and its agreements with investors to Masimo stockholders&#8217; ability
                      to evaluate a director nomination is self-evident and cannot be overstated. Politan&#8217;s refusal to provide this basic information only heightens our concerns about Politan&#8217;s intentions.</div>
                    <div style="margin-top: 0.5pt;"><br>
                    </div>
                    <div style="text-align: justify; margin-right: 58.55pt; margin-left: 60pt; margin-top: 0.05pt; font-size: 12pt;">In our prior letter, we also invited Politan to explain in greater detail why Politan claims that it is unable to comply
                      with the Bylaws&#8217; disclosure obligations regarding its significant financial investors, so that we can better understand your position. We specifically requested that Politan provide an explanation as to how such disclosures would be
                      unduly burdensome and to identify any statutes or regulations that Politan believes prohibit the disclosure of this information. The Draft Nomination Letter provides no such explanation and fails to identify any statutes or
                      regulations that prohibit disclosure. Nor have you identified any contractual obligations that prevent or limit disclosure of this information. In order to better understand your position and avoid a discussion in the abstract, it
                      would be helpful for you to provide us the number of Politan 5%+ limited partners, the size of their investments, the existence and size of any side vehicles, the time of their creation, and any financial or other arrangements with
                      the financial backers of such vehicles. We believe that most of the foregoing is information that Politan should have had to already disclose under Item 6 of its Schedule 13D. In any event, providing us with the foregoing information
                      may facilitate a more productive dialogue on this subject.</div>
                    <div style="margin-top: 0.05pt;"><br>
                    </div>
                    <div style="text-align: justify; margin-left: 60pt; font-size: 12pt; font-weight: bold;">Submission of Director Nominations or Proposals Within the Past 36 Months</div>
                    <div style="margin-top: 0.3pt;"><br>
                    </div>
                    <div style="text-align: justify; margin-right: 58.65pt; margin-left: 60pt; font-size: 12pt;">Masimo&#8217;s Bylaws require disclosure of any proposals or nominations submitted on behalf of any Nominating or Proposing Person or any Related
                      Person seeking to nominate directors at any other Public Company within the past 36 months. The Draft Nomination Letter does not fully comply with that disclosure obligation. Specifically, although the Draft Nomination Letter
                      describes publicly disclosed proposals or nominations, Politan continues to refuse to disclose any non-public proposals or nominations because it &#8220;requires disclosure of investments in other companies and non-public interactions with
                      other corporations as well as trade secrets of the Politan Parties.&#8221;</div>
                    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                      <div class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">3</font></div>
                      <div class="BRPFPageBreak" style="page-break-after: always;">
                        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                    </div>
                    <div style="margin-left: 60pt;"><img width="143" height="42" src="image00005.jpg"></div>
                    <div><br>
                    </div>
                    <div><br>
                    </div>
                    <div style="margin-top: 0.2pt;"><br>
                    </div>
                    <div style="text-align: justify; margin-right: 58.65pt; margin-left: 60pt; margin-top: 4.5pt; font-size: 12pt;">Politan&#8217;s position in resisting the disclosure of this important information is not persuasive. Masimo&#8217;s Bylaws require
                      disclosure only of proposals or nominations actually &#8220;submitted&#8221; to a public corporation&#8212;the Bylaws do not require disclosure of discussions that did not lead to delivery of a formal written nomination notice or other proposal of
                      business for a stockholder meeting. Because it would have been delivered to a third party (<font style="font-style: italic;">i.e.</font>, the public corporation), any formal notice of nomination or business proposal would necessarily
                      be non-confidential. It certainly would not qualify as a &#8220;trade secret&#8221; since the receiving corporation could have publicly disclosed the submission upon receipt. Based on the foregoing, we request that your client re-consider its
                      position.</div>
                    <div style="margin-top: 0.2pt;"><br>
                    </div>
                    <div style="text-align: justify; margin-left: 60pt; font-size: 12pt; font-weight: bold;">Plans or Proposals to Nominate Directors in the Next 12 Months</div>
                    <div style="margin-top: 0.25pt;"><br>
                    </div>
                    <div style="text-align: justify; margin-right: 58.7pt; margin-left: 60pt; font-size: 12pt;">Masimo&#8217;s Bylaws require that Politan disclose &#8220;any plans or proposals . . . to nominate directors at any other Public Company within the next 12
                      months.&#8221; Politan has refused to make such disclosure because, according to the Draft Nomination Letter, such information is &#8220;highly confidential&#8221; and &#8220;proprietary strategic information . . . that is unrelated to . . . the election of
                      directors of the Corporation.&#8221; We disagree. Information regarding any impending proposals or nominations Politan is planning to make would be highly relevant to stockholders&#8217; evaluating the qualifications and candidacy of a
                      Politan-nominated director&#8212;particularly where, as here, Politan seeks to nominate its own Managing Partner&#8212;including for purposes of evaluating the director&#8217;s commitment to Masimo, investment and business strategy, and vision for the
                      Company. If, for example, Politan plans to nominate Mr. Koffey or any other representative of Politan for election at a public company that is a competitor of Masimo, then that information and the consequences thereof under Section 8
                      of the Clayton Act would be of utmost importance to Masimo&#8217;s stockholders. This is particularly important in light of the Department of Justice&#8217;s recent announcement that it intends to bring more cases against &#8220;interlocking
                      directorates&#8221; that violate Section 8 of the Clayton Act.</div>
                    <div style="margin-top: 0.4pt;"><br>
                    </div>
                    <div style="text-align: justify; margin-right: 58.75pt; margin-left: 60pt; font-size: 12pt;">We further note that the Bylaw only requires disclosure of plans or proposals that have been formed as of the time of the notice. We would not
                      expect Politan to disclose preliminary investment ideas or for Masimo to seek to disqualify a nomination on the basis of a future nomination that results from a plan or proposal that is formed after the notice is delivered. We request
                      that your client re- consider its position.</div>
                    <div style="margin-top: 0.2pt;"><br>
                    </div>
                    <div style="text-align: justify; margin-left: 60pt; font-size: 12pt; font-weight: bold;">Support of Nomination Proposal</div>
                    <div style="margin-top: 0.25pt;"><br>
                    </div>
                    <div style="text-align: justify; margin-right: 58.8pt; margin-left: 60pt; margin-top: 0.05pt; font-size: 12pt;">We appreciate that Politan has dropped its prior opposition to disclosure of other stockholders known to support a
                      nomination, a requirement recently reviewed, validated and enforced by the Delaware Court of Chancery. <font style="font-style: italic;">See Rosenbaum v. CytoDyn Inc.</font>, 2021 WL 4775140, at *9 (Del. Ch. Oct. 13, 2021). We
                      further understand and appreciate that Politan has dropped its prior opposition to certain required disclosures concerning Family Members, as defined by Art. I, &#167; 1(9)(c). As</div>
                    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                      <div class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">4</font></div>
                      <div class="BRPFPageBreak" style="page-break-after: always;">
                        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                    </div>
                    <div style="margin-left: 60pt;"><img width="143" height="42" src="image00005.jpg"></div>
                    <div><br>
                    </div>
                    <div><br>
                    </div>
                    <div style="margin-top: 0.2pt;"><br>
                    </div>
                    <div style="text-align: justify; margin-right: 58.75pt; margin-left: 60pt; margin-top: 4.5pt; font-size: 12pt;">such, we assume that your client did not find it infeasible to disclose that information, as previously claimed.</div>
                    <div style="margin-top: 0.45pt;"><br>
                    </div>
                    <div style="text-align: justify; margin-right: 58.7pt; margin-left: 60pt; margin-top: 0.05pt; font-size: 12pt;">We are concerned, however, with the Draft Nomination Letter&#8217;s statement that &#8220;the Politan Parties are unaware of any other
                      stockholders that support the Nomination Proposal.&#8221; This is inconsistent with statements made by Mr. Koffey at his September 2, 2022 meeting with Joe Kiani and other executives at Masimo, when, for example, Mr. Koffey claimed that he
                      already had the support of Masimo&#8217;s stockholders, and would win a proxy contest even without Mr. Kiani&#8217;s support. We request that Politan explain such inconsistency, including what happened during the last month to lead Politan to
                      change its views on stockholders&#8217; support of a Politan nominee. Indeed, Politan&#8217;s intention to obfuscate and conceal the full breadth and scope of its relationships and supporters from Masimo&#8217;s stockholders is underscored by the
                      &#8220;further clarification[]&#8221; you request in your Supplemental Response, where &#8220;Politan seek[s] confirmation from the Board that Politan would only be required to disclose instances where a stockholder has given material support in the
                      form of financial support, a voting commitment or similar arrangement.&#8221; The Bylaw is not so limited. It plainly requires the disclosure of any stockholders known to &#8220;support such nomination,&#8221; and does not contain a materiality
                      qualifier or limit the required disclosure to any particular &#8220;forms&#8221; of support. It appears that Politan is attempting to read the Bylaw as narrowly as possible, in order to persist in Politan&#8217;s attempts to conceal from Masimo
                      stockholders the identities of those behind the scenes with whom Politan has arrangements. This, again, is antithetical to the disclosure and transparency built into the solicitation of stockholder votes, which Masimo&#8217;s Bylaws are
                      intended to enhance. Masimo expects Politan to adhere to the plain letter of the Bylaw and disclose the identities of all stockholders known to support Politan&#8217;s proposed nomination, and for Politan to reconcile the unqualified
                      representation in the Draft Nomination Letter with Mr. Koffey&#8217;s statements at the September 2, 2022 meeting with Masimo representatives.</div>
                    <div style="margin-top: 0.1pt;"><br>
                    </div>
                    <div style="text-align: justify; margin-left: 60pt; font-size: 12pt; font-weight: bold;">Mr. Kiani&#8217;s Employment Agreement</div>
                    <div style="margin-top: 0.25pt;"><br>
                    </div>
                    <div style="text-align: justify; margin-right: 58.85pt; margin-left: 60pt; font-size: 12pt;">We note the statements and requests made in your Supplemental Response with regard to Mr. Kiani&#8217;s employment agreement. As you surely are
                      aware, the employment agreement was entered into in 2015&#8212;seven years ago&#8212;and has been clearly and repeatedly disclosed in Masimo&#8217;s filings with the U.S. Securities and Exchange Commission. The agreement was the product of extensive
                      arms-length negotiations between representatives of Masimo&#8217;s independent directors and Mr. Kiani. As a contractual right, any waiver, termination or amendment to the change of control provisions cannot be effected unilaterally by the
                      independent directors. Further, to the extent you have any concerns with any &#8220;similar provisions in other agreements,&#8221; we request that you clearly identify the provisions and agreements at issue, as well as the specific nature of your
                      concerns, so that we may respond to them.</div>
                    <div style="margin-top: 0.1pt;"><br>
                    </div>
                    <div style="text-align: center; margin-right: 30.9pt; margin-left: 31.95pt; margin-top: 4.5pt; font-size: 12pt;">* * *</div>
                    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                      <div class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">5</font></div>
                      <div class="BRPFPageBreak" style="page-break-after: always;">
                        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                    </div>
                    <div style="margin-left: 60pt;"><img width="143" height="42" src="image00005.jpg"></div>
                    <div><br>
                    </div>
                    <div><br>
                    </div>
                    <div style="margin-top: 0.2pt;"><br>
                    </div>
                    <div style="margin-right: 56.3pt; margin-left: 60pt; margin-top: 4.5pt; font-size: 12pt;">To the extent Politan has additional information in support of its concerns regarding the Bylaw disclosure requirements and/or the change in
                      control provision, we are happy to consider it.</div>
                    <div style="margin-top: 0.45pt;"><br>
                    </div>
                    <div style="margin-right: 76.4pt; margin-left: 60pt; margin-top: 0.05pt; font-size: 12pt;">The inclusion or exclusion of any position or response herein is without prejudice to Masimo, which expressly reserves all positions, rights and
                      remedies.</div>
                    <div style="margin-top: 0.5pt;"><br>
                    </div>
                    <div style="margin-left: 60pt; font-size: 12pt;">Sincerely,</div>
                    <div style="margin-top: 0.5pt;"><br>
                    </div>
                    <div style="margin-right: 426pt; margin-left: 60pt; font-size: 12pt;">/s/ Eduardo Gallardo </div>
                    <div style="margin-right: 426pt; margin-left: 60pt; font-size: 12pt;"><br>
                      Eduardo Gallardo</div>
                    <div style="margin-right: 426pt; margin-left: 60pt; font-size: 12pt;"> <br>
                    </div>
                    <table cellspacing="0" cellpadding="0" id="z9dff140495934014b20f69309acedc78" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                        <tr>
                          <td style="width: 60pt;"><br>
                          </td>
                          <td style="width: 36pt; vertical-align: top; font-size: 12pt;">cc:</td>
                          <td style="width: auto; vertical-align: top;">
                            <div style="font-size: 12pt;">Michael B. Carlinsky, Quinn Emanuel Urquhart &amp; Sullivan, LLP </div>
                            <div style="font-size: 12pt;">Sarah Heaton Concannon, Quinn Emanuel Urquhart &amp; Sullivan, LLP</div>
                            <div style="font-size: 12pt;">
                              <div style="font-family: Arial,Helvetica,sans-serif;">R. Corey Worcester, Quinn Emanuel Urquhart &amp; Sullivan, LLP </div>
                              <div style="font-family: Arial,Helvetica,sans-serif;">Avi Weitzman, Paul Hastings LLP</div>
                              <div style="font-family: Arial,Helvetica,sans-serif;">Michael A. Barlow, Abrams &amp; Bayliss LLP</div>
                            </div>
                          </td>
                        </tr>

                    </table>
                    <br>
                    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                      <div class="BRPFPageNumberArea"><font style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">6</font></div>
                      <div class="BRPFPageBreak" style="page-break-after: always;">
                        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                    </div>
                  </div>
                  <div><br>
                    <div style="line-height: normal;">
                      <div>
                        <div class="BRPFPageFooter">
                          <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                          </div>
                          <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                          </div>
                          <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                          </div>
                        </div>
                        <div class="BRPFPageFooter">
                          <div style="line-height: 0.05pt;"><br style="line-height: 0.05pt;">
                          </div>
                        </div>
                      </div>
                      <div>
                        <div>
                          <div>
                            <div>
                              <div>
                                <div class="BRPFPageFooter">
                                  <div style="line-height: 0.65pt;">
                                    <div><br>
                                      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                      </div>
                                      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                      </div>
                                      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                      </div>
                                      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                      </div>
                                      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                      </div>
                                      <div style="line-height: 11.4pt;">
                                        <div style="line-height: 11.4pt; text-align: center;"><font style="font-size: 48pt;">EXHIBIT H</font><br style="line-height: 11.4pt;">
                                        </div>
                                        <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                        </div>
                                      </div>
                                      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
                                      </div>
                                      <div style="line-height: 11.4pt;">
                                        <div><br>
                                        </div>
                                        <font style="font-size: 11.5pt;"><br>
                                        </font><br>
                                      </div>
                                      <br>
                                    </div>
                                    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                                      <div class="BRPFPageFooter"></div>
                                      <div class="BRPFPageBreak" style="page-break-after: always;">
                                        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                                    </div>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                  <div>
                    <div><br>
                    </div>
                    <div style="text-align: center; margin-right: 30.9pt; margin-left: 32pt; margin-top: 3pt; font-size: 14pt; font-weight: bold;">WAIVER BY JOE E. KIANI OF THE DIRECTOR CHANGE IN CONTROL</div>
                    <div style="text-align: center; margin-right: 30.9pt; margin-left: 32pt; margin-top: 3pt; font-size: 14pt; font-weight: bold;">PROVISION IN HIS EMPLOYMENT AGREEMENT WITH MASIMO </div>
                    <div style="text-align: center; margin-right: 30.9pt; margin-left: 31.9pt; font-size: 14pt; font-weight: bold;">CORPORATION FOR PURPOSES OF MASIMO CORPORATION&#8217;S<u></u></div>
                    <div style="text-align: center; margin-right: 30.9pt; margin-left: 31.9pt; font-size: 14pt; font-weight: bold;"><u>2023 ANNUAL MEETING</u></div>
                    <div style="margin-top: 0.25pt;"><br>
                    </div>
                    <div style="margin: 4.45pt 0px 0px; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt; text-align: justify;">Reference is made to the Amended and Restated Employment Agreement, dated November 4, 2015, as amended (the
                      &#8220;Agreement&#8221;), by and between Masimo Corporation (the &#8220;Company&#8221;) and the undersigned Joe Kiani (the &#8220;Executive&#8221;). Capitalized terms not otherwise defined herein have the meaning assigned thereto in the Agreement.</div>
                    <div style="margin-top: 0.55pt;"><br>
                    </div>
                    <div style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt; text-align: justify;">The undersigned agrees and acknowledges that the valid election to the Board at the 2023 annual meeting of stockholders of any two
                      individuals nominated by Company stockholders (the &#8220;Exception Directors&#8221;) in lieu of two of the Company&#8217;s current Directors will not be deemed to constitute a Change in Control for purposes of Section 9(iii) of the Agreement.</div>
                    <div><br>
                    </div>
                    <div style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt; text-align: justify;">For the avoidance of doubt, for purposes of determining whether a Change in Control has occurred in respect of any other or subsequent
                      event, including election of stockholder-nominated individuals at the 2024 annual meeting, the Exception Directors will not be considered directors who were members of the Board at the beginning of the 24 month period immediately
                      preceding such event.</div>
                    <div style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt; text-align: justify;"> <br>
                    </div>
                    <div style="font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt; text-align: justify;">
                      <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: Arial, Helvetica, sans-serif; font-size: 10pt;">

                          <tr>
                            <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                            <td style="width: 38%; text-align: right; vertical-align: top; font-size: 12pt;" colspan="2"><strong>Joe E. Kiani<br>
                              </strong></td>
                            <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                          </tr>
                          <tr>
                            <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                            <td valign="top" style="width: 3%; font-size: 12pt;">&#160;</td>
                            <td valign="top" style="width: 35%; font-size: 12pt;">&#160;</td>
                            <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                          </tr>
                          <tr>
                            <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;">
                              <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; font-size: 12pt;"><br>
                              </div>
                            </td>
                            <td valign="top" style="width: 3%; padding-bottom: 2px; font-size: 12pt;">
                              <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt"> </div>
                              <br>
                            </td>
                            <td valign="top" nowrap="nowrap" align="left" style="width: 35%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 12pt;"><br>
                            </td>
                            <td valign="top" style="width: 12%; padding-bottom: 2px; font-size: 12pt;">&#160;</td>
                          </tr>
                          <tr>
                            <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                            <td valign="top" style="width: 3%; font-size: 12pt;">&#160;</td>
                            <td nowrap="nowrap" style="width: 35%; text-align: right; vertical-align: top; font-size: 12pt;"><br>
                            </td>
                            <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                          </tr>
                          <tr>
                            <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                            <td valign="top" style="width: 3%; font-size: 12pt;">&#160;</td>
                            <td valign="top" style="width: 35%; font-size: 12pt; text-align: right;">Dated:&#160; ____________ 2023</td>
                            <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                          </tr>
                          <tr>
                            <td valign="top" style="width: 50%; font-size: 12pt;">&#160;</td>
                            <td valign="top" style="width: 3%; font-size: 12pt;">&#160;</td>
                            <td valign="top" style="width: 35%; font-size: 12pt;">&#160;</td>
                            <td valign="top" style="width: 12%; font-size: 12pt;">&#160;</td>
                          </tr>

                      </table>
                    </div>
                    <div><br>
                    </div>
                    <br>
                    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                      <div class="BRPFPageFooter">
                        <div><br>
                        </div>
                      </div>
                      <div class="BRPFPageBreak" style="page-break-after: always;">
                        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                      <div class="BRPFPageHeader"></div>
                    </div>
                    <div><br>
                    </div>
                    <div style="text-align: center; margin-top: 3pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt; font-weight: bold;"><u>CERTIFICATE OF SERVICE</u></div>
                    <div><br>
                    </div>
                    <div style="line-height: 31.9pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt; text-align: justify; text-indent: 90pt;">I hereby certify that on March 10, 2023, the foregoing <font style="font-family: Arial,Helvetica,sans-serif; font-style: italic;">Public Version of Exhibit A to Plaintiffs&#8217; Motion for Leave to File Second Amended and Supplemented Verified Complaint </font>was served, by File &amp; Serve<font style="font-family: Arial,Helvetica,sans-serif; font-style: italic;">Xpress</font>, on the following attorneys of record:</div>
                    <div style="line-height: 31.9pt; font-family: Arial, Helvetica, 'sans-serif'; font-size: 14pt; text-align: justify; text-indent: 90pt;"> <br>
                    </div>
                    <div style="text-align: justify; margin-right: 275.05pt; margin-left: 393pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;">Michael A. Barlow </div>
                    <div style="text-align: justify; margin-right: 275.05pt; margin-left: 393pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;">Anthony Sarna</div>
                    <div style="margin-left: 393pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;">ABRAMS &amp; BAYLISS LLP</div>
                    <div style="margin-left: 393pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;">200 Montchanin Drive, Suite 200</div>
                    <div style="margin-left: 393pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;">Wilmington, DE 19807</div>
                    <div><br>
                    </div>
                    <div><br>
                    </div>
                    <div style="margin-top: 0.55pt;"><br>
                    </div>
                    <div style="margin-left: 478.5pt;"><u><font style="font-size: 14pt; font-family: Arial,Helvetica,'sans-serif'; font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;">/s/ Alexandra M. Cumings&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></u><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 234pt"> <br>
                      </font></div>
                    <div style="margin-left: 478.5pt; font-family: Arial,Helvetica,sans-serif; font-size: 14pt;">Alexandra M. Cumings (#6146)</div>
                    <div class="BRPFPageFooter">
                      <div><br>
                      </div>
                    </div>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div>
                    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div style="margin-top: 0.25pt;"><br>
                  </div>
                  <div style="margin-top: 0.05pt; color: rgb(35, 31, 32); font-family: Arial,Helvetica,sans-serif; font-size: 12pt;"><br>
                  </div>
                </div>
              </div>
            </div>
            <div><br>
              <div><br>
              </div>
              <div><br>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
  <br>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ,  QX# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P"I)(\LC22,
M7=CEF8Y)--HHH/,"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "I8;B>V8M!-)$Q&"48@D?A45% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!9L+7[=J-M:;]GGRK'NQG;DXSBNMUOX>/I&D7%
M^FH_:#" QC\C;D9 /.X].M<UH'_(Q:9_U]1?^A"O9KN9+G59-'E_U=S9,WZ[
M3_Z%0;TH1E%W/(/#6@/XBU,V:S^0JQF1I-F[ &!TR.YJ]XI\)?\ "-16S_;O
MM/GLPQY6S;C'N?6M[PG;OH&@ZSJ,PQ,)1;+QCD'''XM^E6/BAM^SZ9N)"^8^
M2!DXP* Y%[.[W/,Z*] AUGPM:K:6>EZ -29P/,:6'=(OKU4Y/? XJ/QMX<T^
MTU?2_L:"V2]D,<BKPJ\KR!V^]^E!#IZ73.#H[UZSJ6GV6@""&T\(+J-OM^><
M*LC@]^""3Z]A7#>*SH;:FIT:.6+M-&T950?8'D>XQB@)4^7J0Z]HMEI"VYM-
M9M]1,N[<(=O[O&.N&/7/Z5BUZ%X^TZQLY=&%K96\'F.P?RHE7=]WK@<]:U/%
M(\.^'9+6ZDT.WGFDRB0JBHF!U8C&">1U!_"@J5/5]+'E-%>I:Y9>&=.T^V\0
MOI*OYBJ(K5,(CEAD;@!C@9_P/%4/$>G:3J7@J+7K&PCLI1M.V)0H(+;2"!P>
M>^*!.DU?4\\HKO\ 1]%TG1/"RZ_K-L+N27!BA/(P?NC!X)/4Y[58TZ+P_P"-
M[6YMHM+CTR^B3<C0XQ]> ,]L@COQ0"IOOJ><5N^'/"M[XCD<PLL-O&</,XXS
MZ =S6/<P/:W4MO* )(G*-CU!P:[OP'K6G)I5UHM]<?9FF9BDA?8&#  @-V/'
MZT"II.5I"W'PMN$A9K;5(Y9 .$>$H#^.3_*N*33+M]5&F>5MNS+Y6QCC#9QU
MKT9? U]I,[WGA[67CE*X"3H"&'N>A_[YK"T*_N;7QR\>M64=QJ$\J1F1PH,3
M<888&.F.F*"Y05UI8Y_7]#E\/WT=G/*DDK1"1B@.!DD8&>O2LJO1_B!>0SZA
M'HZ:;"UY,(REV2-XRQ&WIG'X]Z748?#_ ((L[:";2X]2OYERYEP1QU/(.!GH
M .U I4U=V>B/-Z*[_5M&TG7_  P^O:/;"SFAW&6%>%('48' ('(QU_DNFZ5I
M/AWPG'KFJV:WMQ<8,43\J-WW1SQTY)(H%[-W//ZZ,>%,^#3X@^V]/^6'E?[>
MW[V?QZ5?U75?"NJZ$TB:?]@U($[([>/C/N0 "#^8_GT.D:=-JWPNAL;?:))B
M0"QX \[)/X &@<8)MK?0\LHKOO%?]D>&M,BT6SL+>6^>/+W,L*LZ@]\D=3SC
MTK@:#.4>5V.K\,>"_P#A(].DN_[0^S[)3'M\G?G !SG</6ME_A6X0E-85F[!
MK; _/<:L^ [9[SP1JEK&5#S22QJ6Z F-0,TGAKP)JNCZU#>SWT"QQ_>6!F)?
MCH<@<4&\8*RTN>?:GIMSI&H2V5VFV6,\XZ,.Q'L:J5Z7=2V&L?%&WA,<-S#%
M"8I ZAU+ ,?H<9_,55\6:AHFC7-WI=KH-H]Q)'EIRJCRF8<;1CL,'@B@S=-:
MN^AS.H:+96>AVM_#K-O<W$VS?:IMW1Y7)SAB>#QT%8E=]XETZR@^'^DW,-G;
MQW$GD[Y4B4,V8R3D@9/-69K'1O!6AVDM]IL>HZA<=5EP0#C)QD$ #('3)H&Z
M>O8\XHKJ_$5]X8U'2X9].M6M-1)&Z**/"#U!Z#W!'_ZNC31+3PQHMJS>'WUG
M4)QF4"+>J=SV.,9QTYH)5.[W/,:*[WQ9H%G)X>BUVRL'T^0$">V="F,G'W>W
M/Y@YK@J"91<79A11102%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK;4;N&,=$CF91^0-5I99)I6EED>21CEG=B2?QH$ZB<;(])^(_P#K=#_ZZ/\
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M,3-@[E&W'XCD5YM/<3W4IEN)I)I#U>1BQ/XFG6]U<6<GF6UQ+!)_>B<J?S%
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M3S+JXEG?^]*Y8_F:AH(E*["BBB@D**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **TV\.ZVCLIT
MB^)!QQ;N1^>*;_PC^M?] ?4/_ 9_\*"N5]C.HK1_X1_6O^@/J'_@,_\ A1_P
MC^M?] ?4/_ 9_P#"@.5F=16C_P (_K7_ $!]0_\  9_\*/\ A']:_P"@/J'_
M (#/_A0'*S.HK1_X1_6O^@/J'_@,_P#A1_PC^M?] ?4/_ 9_\* Y69U%:/\
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M1_6O^@/J'_@,_P#A0'*S.HK1_P"$?UK_ * ^H?\ @,_^%'_"/ZU_T!]0_P#
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M^M?] ?4/_ 9_\* Y69U%:/\ PC^M?] ?4/\ P&?_  H_X1_6O^@/J'_@,_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4R.>I'0\>M$=K#H/CRVAL8EAM=2MW\R&,80.G(8#MQQ^-%@N==1112&%%%%
M!1110 4444 -DD2*-I)&"H@+,Q.  .IKRG07N-8^(>F^*+@L(M0EN8K)"/NP
M11D*?Q))_P#UUT_CR[FNX[+PM8N5N]8DV2,O6*W',C?EQ[\U+?VD-AXK\(6E
ML@2"".YCC4=E$0 J%[T_3\SL_@X>_6?_ *2G^K_)G644459QA7/^)?%">'GM
MD%HUU)*&=U5]I2->K=#FN@KSA?$.@W'BC6;G5[L+'Y?V&W3RW;]WSO/R@CD_
MC32$ST2*1)HDEC8,CJ&4CN#TI]<E\/M52]T1[$3"5K"0Q*^"-\?.PX/MD?A5
M'1[#4=>N=8\_7=1@M8;^2.)+>;:P(/\ >.3M Q@#CK18+G=T5Q.GZCJ!\*^(
MH+B\DEN-.>:&.YSM<A5X.1W]Z@32]5D\(1ZS)XBU%;R.T\]$23$> N0&7^(X
M'))ZFBP7.]HKC;O7M0N]'\/V]I,L%[JVT//M!V  %R!Z^E,U6VU#PE;1ZK!K
M-_>P)*JW4%X_F!D)P2O'RG)_SW+!<[6BN<%U.?B']F\^3[/_ &9YGE;SLW>9
MC..F<=Z;-=7 ^(UM:B>46YT\N8MYV%MYYQTS[T6"YTM%<)H]AJ.O7.L>?KNH
MP6L-_)'$EO-M8$'^\<G:!C ''6I=.U^]T_PSKCW<_P!JGTN=X(I9!R_0+N]>
M318+G;45Q\/A_7?L5OJ$/B&Z?4V"R/%-)_HQSU7:!QQW_E3?%OB'['J5GI4N
MH-IL,L?FW%S&A=P,X"I@'!)!YQ18+G945YSI_B.RL-;L(=-\0WNJ6]U*(9H;
MP,S(3PK*Q4=^W^1JQI>^*=;U-#JEY8V%C+]GC2SD\MW<?>+-CI[?Y)8+F];:
MO]H\07VE>1M^RQH_F[\[MW;&.,?6M.N-\-07=MXTUN&\N?M,B0P@3%0"Z\XS
MCOCC\*[*A@@K,\1_\BQJW_7E-_Z :TZS/$?_ "+&K?\ 7E-_Z :2&'AS_D6-
M)_Z\H?\ T 5IUF>'/^18TG_KRA_] %:=# **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ KB+_P 1:;JD(L]4B@M+BVOXTFMKEP04#?>Y !!%=O6?J.B:?JIB
M:\M8I&C<,&:-23@YVG(/![BFA,Y?PS?6>F6^OZC"7CT%)@UL,'!(&&V ^IP!
M45C>:?K]Y%JVOZKI\<4;;[33C=)B/T:3GEO;M^E=M)96LUI]EEMH7ML >2T8
M*8'3CI5/_A'-#_Z VG?^ J?X4[H+&5X@L-2UU].N-(N=.FLH6,I2=V,<K#[I
M^0<@<]^M8MY_PE'_  F>E>?_ &/]L\F7RMGF^7M_BW9YSZ8KOH((;:%8;>*.
M*)!A4C4*H^@%(UM ]PEPT$;3Q@A)"@+*#U /44KA8Y>XN8=#\>27-](L%KJ-
MJJK,YP@D0]">@X]:2.ZAU[QY;36,JS6NFV[^9-&<H7?@*#WXY_"NIN+:"[A,
M-S!'-$>J2(&4_@:+:UM[.(16L$4$8Y"1(%'Y"BX6):***0PHHHH **** "FR
M2)%&TDC!40%F8G  '4TZN.\>7<UW'9>%K&0K>:Q)LD9>L5N.9&_+CWYJ92Y5
M<VH4O:U%#;OY+J_DB+P7&^N:KJ/C"X4A;L_9M/5ARELAZ^VYAG\/>M'6O^1W
M\+?]O?\ Z+%;]G:0V%E!:6R!(((Q'&H[*!@5@:U_R._A;_M[_P#18ITX\JL&
M)J^UJ.2T6R\DMCI:***9B4=9-Z-'NO[.B\V\,96)=P')XSDD#CK^%0^'=+&C
M:#:6. '1,R<YRYY;]36I10!S<VEWMKXWAU2RAWVEU#Y5YAE&TC[K<G)[#CTJ
M;PQIUUIXU7[5%Y?GZA+-'\P.Y#C!X/'3O6]13N*QR%MHFH1Z;XIA>WQ)?3S/
M;C>OSA@<=^/QQ6HFGW0\#C3C%_I?]G^3Y>X??\O&,YQU]ZVZ*+A8Y!O#NHMX
M=T-H/+AU;3 K*DIRK<89"1GKZC_Z])>VGB#Q.L-CJ&FPZ;8+*KW#?:!*TH4Y
MPH'3)]?_ *U=A11<+'+ZO8ZM:>)8=;TJTCO1]F^S2V[2B-L;LY!/'I45CI^M
MS>-8M7U"UBA@-F8PL<H;RCGA2>I/?(&.:ZVBBX6,'PQIUUIXU7[5%Y?GZA+-
M'\P.Y#C!X/'3O5"R\.7,]GXDL[U/)34+J1X7R&^4]&P#Z]CBNMHHN%CC&3QA
M<Z;'HYM8;4@+&^J1W(^Z,<JH^8,1_D5>UC1M0CU"PU?2&26[M(C#)%.Q_?Q^
MF[^]GN?7\^EHHN%CG;6;Q-J.H0-<6D6DV<1W2IYRSR3>P(&%'ZU6>QUG0=9O
MKK2K&/4;.^?S7@,PB>*3N<G@@_Y]^KHHN%CE_#^FZQ#XDU34=4CC7[5''M,3
M J,?PCG/ QR0,UU%%%)C"LSQ'_R+&K?]>4W_ * :TZS/$?\ R+&K?]>4W_H!
MH0!X<_Y%C2?^O*'_ - %:=9GAS_D6-)_Z\H?_0!6G0P"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHZ#)H YB]\;6-
MEXHBT-H9'=V6-Y5(PCMC QWZC-=/7SPVHO<>(/[2D/SO<^<?;YLU]#U$)<US
MULTP,,(J?+NUKZH1W6-&=V"JHR23@ 5Q/@U&U_6]2\83J?+G)M-.##[MNAY;
M_@3<_G7#7GQ7;Q'H']BW$*Z==7DB03WBMF)(B?G;'4''&.>">:]DTE+&+2;6
M+3'C>RCB5(6B8,I4# Y'6HC.-26FR(K8:K@J3516E+3Y+_/\D^Y<KG_$&E:I
M=ZII6HZ4]F)['S?ENBVUMZA?X1GL:Z"BMCS#FO\ BN/^I>_\CT?\5Q_U+W_D
M>NEHIW%8YK_BN/\ J7O_ "/1_P 5Q_U+W_D>NEHHN%CFO^*X_P"I>_\ (]'_
M !7'_4O?^1ZZ6BBX6.:_XKC_ *E[_P CT?\ %<?]2]_Y'KI:*+A8YK_BN/\
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M(H55& H& !2U5*C&FM-SYG'YG6QDO>TCT7];A1116QYP4444 %%%% !1110
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MIZQI^C0";4+I($)PN[)+?0#D_A2:7K.G:S"TNGW23JIPV,@K]0>10!?HHHH
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MW5]K,\\_X7)X>_Y\]4_[]1__ !='_"Y/#W_/GJG_ 'ZC_P#BZ]#HJ^2M_/\
MA_P3G^LY=_T#O_P/_P"U///^%R>'O^?/5/\ OU'_ /%T?\+D\/?\^>J?]^H_
M_BZ]#HHY*W\_X?\ !#ZSEW_0._\ P/\ ^U///^%R>'O^?/5/^_4?_P 71_PN
M3P]_SYZI_P!^H_\ XNO0Z*.2M_/^'_!#ZSEW_0.__ __ +4\\_X7)X>_Y\]4
M_P"_4?\ \71_PN3P]_SYZI_WZC_^+KT.BCDK?S_A_P $/K.7?] [_P# _P#[
M4\\_X7)X>_Y\]4_[]1__ !='_"Y/#W_/GJG_ 'ZC_P#BZ]#HHY*W\_X?\$/K
M.7?] [_\#_\ M3SS_A<GA[_GSU3_ +]1_P#Q='_"Y/#W_/GJG_?J/_XNO0Z*
M.2M_/^'_  0^LY=_T#O_ ,#_ /M3SS_A<GA[_GSU3_OU'_\ %T?\+D\/?\^>
MJ?\ ?J/_ .+KT.BCDK?S_A_P0^LY=_T#O_P/_P"U///^%R>'O^?/5/\ OU'_
M /%T?\+D\/?\^>J?]^H__BZ]#HHY*W\_X?\ !#ZSEW_0._\ P/\ ^U///^%R
M>'O^?/5/^_4?_P 71_PN3P]_SYZI_P!^H_\ XNO0Z*.2M_/^'_!#ZSEW_0._
M_ __ +4\\_X7)X>_Y\]4_P"_4?\ \71_PN3P]_SYZI_WZC_^+KT.BCDK?S_A
M_P $/K.7?] [_P# _P#[4\\_X7)X>_Y\]4_[]1__ !='_"Y/#W_/GJG_ 'ZC
M_P#BZ]#HHY*W\_X?\$/K.7?] [_\#_\ M3SS_A<GA[_GSU3_ +]1_P#Q='_"
MY/#W_/GJG_?J/_XNO0Z*.2M_/^'_  0^LY=_T#O_ ,#_ /M3SS_A<GA[_GSU
M3_OU'_\ %T?\+D\/?\^>J?\ ?J/_ .+KT.BCDK?S_A_P0^LY=_T#O_P/_P"U
M///^%R>'O^?/5/\ OU'_ /%T?\+D\/?\^>J?]^H__BZ]#HHY*W\_X?\ !#ZS
MEW_0._\ P/\ ^U///^%R>'O^?/5/^_4?_P 71_PN3P]_SYZI_P!^H_\ XNO0
MZ*.2M_/^'_!#ZSEW_0.__ __ +4\\_X7)X>_Y\]4_P"_4?\ \71_PN3P]_SY
MZI_WZC_^+KT.BCDK?S_A_P $/K.7?] [_P# _P#[4\\_X7)X>_Y\]4_[]1__
M !='_"Y/#W_/GJG_ 'ZC_P#BZ]#HHY*W\_X?\$/K.7?] [_\#_\ M3SS_A<G
MA[_GSU3_ +]1_P#Q='_"Y/#W_/GJG_?J/_XNO0Z*.2M_/^'_  0^LY=_T#O_
M ,#_ /M3SS_A<GA[_GSU3_OU'_\ %T?\+D\/?\^>J?\ ?J/_ .+KT.BCDK?S
M_A_P0^LY=_T#O_P/_P"U///^%R>'O^?/5/\ OU'_ /%T?\+D\/?\^>J?]^H_
M_BZ]#HHY*W\_X?\ !#ZSEW_0._\ P/\ ^U///^%R>'O^?/5/^_4?_P 71_PN
M3P]_SYZI_P!^H_\ XNO0Z*.2M_/^'_!#ZSEW_0.__ __ +4\\_X7)X>_Y\]4
M_P"_4?\ \71_PN3P]_SYZI_WZC_^+KT.BCDK?S_A_P $/K.7?] [_P# _P#[
M4\\_X7)X>_Y\]4_[]1__ !='_"Y/#W_/GJG_ 'ZC_P#BZ]#HHY*W\_X?\$/K
M.7?] [_\#_\ M3SS_A<GA[_GSU3_ +]1_P#Q='_"Y/#W_/GJG_?J/_XNO0Z*
M.2M_/^'_  0^LY=_T#O_ ,#_ /M3SS_A<GA[_GSU3_OU'_\ %T?\+D\/?\^>
MJ?\ ?J/_ .+KT.BCDK?S_A_P0^LY=_T#O_P/_P"U///^%R>'O^?/5/\ OU'_
M /%T?\+D\/?\^>J?]^H__BZ]#HHY*W\_X?\ !#ZSEW_0._\ P/\ ^U//H_C#
MX<>15:VU*,$X+M$F![G#DUZ#7GGQD_Y%"T_Z_P!/_1<E>AT4I3YY1D[VL&.I
M8?ZO2KT(N/,Y)IN^UO)=PHHHK<\H**** "BBB@ HHHH **** "BBB@ HHHH
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MD '\S6%IW@JRNM*@O;R>[?5IHQ*;WSW#QL1GY><<>XHL!<\,:EJ.K:=JQFN
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MKSSXR?\ (H6G_7^G_HN2O0ZPA_&G\OU/5Q/_ "+L/ZS_ /;0HHHK<\H****
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MO).3[]*HB_\ &36XO1IFF"$C>+0R/Y^/3/W<TK!<Z:>XAM8'GN)4BB099W.
M!1!-'<V\<\+;HY%#HV,9!&17&^(M7FUOP#->Z<(5A92MU'/G>F#RJX[YQU[5
MM>$_[3_L*V_M#[)L\F/R/L^[.S:,;L]_I1;0+FY6+K?BO2= (2]G)F(R(8QN
M<C^0_$BM>:3R8))2,[%+8]<"N(\ Z;%?V]QXAOD6>^NIV*NXSL /;TY_0"A+
MJ#-#2_B%H.IW*VXDFMI'.U/M"!0Q^H) _'%=567KV@V?B#3GM;E%#X_=S;<M
M&?4?X=ZKZIJ@\,:%;A_,O;C*6\*DX:9^@R?PHT>P&Y17':AK/BS1K,ZE?66E
M2V:$&2*!W\Q 3ZGC\LU;\1^*'TKP]8ZM9QH\=S)'D2*2=C*6XP1SQZT6"YTU
M%<C<ZUXJM+-M5ETJR-@HWM;"1OM"IZD_=R.IXKI;"]AU*P@O;=MT,R!U)Z_0
M^]%AW#4-0MM+L);V[DV01#+'&?P^M4]&UQ=:61X]/O[5%"LKW4.P2 _W>3G_
M .N*P/B3]O\ ^$=?ROLWV'*^=OW>9NW#;M[8]<U)J.N:UX>\-Q7E_%I[R>>D
M86W#[?*(]R/FX^E.V@KZG845SUGJ.N01RW^MPV%MIZP&7;"S-*AX.UL\$XST
M[U2MM7\5ZM:_VAIVG:=#9O\ -%%=._FR+ZC' S[TK!<ZZBL'3_$@U+0+R]CA
M\F[M%=9K>3GRY%!.#TR*RM+U[Q1KND17NGV.G1@ AFN6<"5@3G8H/ [9)ZT6
M"YV=%<;IGB?7/$-I_P 2K3K6">$[;B2\=O+#_P!U0O)XY]LXK3\-Z]<ZI+?6
M.H6T<%_8N%E$391@<X(_+^5%F%S?HJ&[NHK*SFNIVVQ0H7<^P&:YBWU;Q9JM
MF-1TZPTR&T<;HHKEW,KKV/& ,^]%AG6T5SFF^)VU3PG>:K' (KFV20/$QRH=
M5S]<=*H:=KOBG6](BOM/L-.1=OS?:&<&5AUV '@9XY-%A7.RHKG=/\2OJ7A2
M\U1(%BNK5)1)$QW*)$7/Y=*S].UWQ3K>D17VGV&G(NWYOM#.#*PZ[ #P,\<F
MBP7.RHK!T;Q-#J/AZ;5+F/[-]F+K<)G.UEY./TK/MM7\5ZM:_P!H:=IVG0V;
M_-%%=._FR+ZC' S[T6"YUU%<_9^)A?\ AN_U"*#R;RS202V\O.R103@],BKV
M@:A+JN@V=].J++/'N8("%!]LDT6'<TJ*YC3/$=Y>Z#K5])' );&69(@JG:0B
MY&>?Y8JIIVN^*=;TB*^T^PTY%V_-]H9P96'78 >!GCDT6%<[*BL'1O$T.I>'
MYM4N8_LYMBZW"9SM*C)Q^%9D6O>*+^P;5K'3+%=/P72&9V\^5!W&.!GW_6BP
M7.QHK"'BNQ_X14:^RN("O^K_ (M^<;?S[_C5(7_C)K<7HTS3!"1O%H9'\_'I
MG[N:+!<ZJF2R"&%Y6!*HI8X]JPCXNL1X6;7=K!%^4PD_,),XV?G^G-9UUJGB
MJ'2YK^\TRP^Q&(E[>*1O/C4CJ2?E.!SBBP7.CT?58-;TN'4+9)$AESM$@ ;@
MD<X)]*O5S/P^_P"1*L/K)_Z&U=-0]QH****0'GGQD_Y%"T_Z_P!/_1<E>AUY
MY\9/^10M/^O]/_1<E>AUA#^-/Y?J>KB?^1=A_6?_ +:%%%%;GE!1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5Y#X]^3X@6[?[,)_6O7J\A^('_(^V_\ N1?S-9U-CV,D_P!Y?^%GKU%%%:'C
MA1110 4444 %%%% !1110 4444 %%%% 'GFD?\EQU_\ Z\%_]!@KT.O/-(_Y
M+CK_ /UX+_Z#!7H=88?:7J_S/5S;XZ7_ %[A_P"DH****W/*,OQ)_P BQJG_
M %ZR?^@FN0O(7B\ Z!J\(/G:;Y4W'4H<!A_+\J[ZYMXKRUEMITWPRH4=<D9!
MX(R*@&E60TG^R_('V+R_*\HL3\OIG.?UIIB:.7TZ1-4LO$NNKREPCP0$C_EF
MB$9_$YJ"TUJ;0OAA87EO&KS$"-2_W5RYY/M77VVE65II?]FP0!+/8R>6&/0Y
MSSG/<]Z2+2+"+2AI:VR&R"[1"^6&,Y[Y/6G<+'*:K97\&A37FK^+96B:(LJ6
MT:1!R5X4$<MG]:H6Q_XLQ)[(_P#Z--=99>#] T^X\^VTR(2=BY9\?0,3C\*G
MC\/:7%H\FDI:XL9"2T7F.>ISUSD<CL:+BL2:6 /#UF ,?Z*G_H KR[1M%NH?
M#L7B?3Y)'O+.X9C"3\IB'W@/S.?8FO78H8X;=((UQ$B!%7/0 8 JOIVEV6E6
M?V2R@\J#);86+<GKU)H3L-HY'QA=+KW@2WU*R\PPK*DT@7[R@9##Z@G]*LPZ
M%8SZ:-13Q;KOV0IO,IU 8 ]^.*Z+3M&T_28)8+&W\J&5BSQ[V923UX)./PK.
M;P1X;:Y\\Z5%OSG 9@O_ 'SG'Z47"QS\<%BGPSU:33?MS6\Q>0->;2['(!(V
M]N._/6NOT!E;P]II5@?]%CZ'_9%7'M;>2T-JT,9MRGEF+:-NW&,8]*IZ3H6F
MZ&DJZ=;>0LI!<;V;)'3[Q-)L+%]T$D;(W*L"#7G_ (4UF#PO-=>'=9E^S-%,
M6@ED&$=3[]O7GUKT*J&IZ+INL1A-0LXI]OW2PPP^A'(H3!F/KOC72M/T^0V=
M[!=WCJ5@C@8298],XXQ5;5M=UC3M$TB.3[/!J5^XCDFD7$<!/J/7D>W!K7T[
MPGH6E3B>STZ-)1RKL6<K]-Q./PK0O]/M-4M6MKVW2>$G.UQT/J/0T70:G"^+
MK*[L?#UP^J^)[BYD<8BMTC2$2G(ZJ.H'>D\12I%\/?#LKC=&DELS#KD!#FNH
MM?!_A^SBFC@TR("9"CEF9C@C! ))(_"L;QK96]AX>TFSMDV017\2HA8M@?-Q
MDY--,31O:MJ]A%X:N+\W$;6\D#>6P;[Y(X ]S5?P7:S6?A#3X9P1)L+X/4!F
M+#]"*?%X.\/0WWVQ-+A$V=PR25!]ESM'Y5N4AG*_$3_D3+K_ 'X__0Q4'CSG
MPO9 _P#/U#_(UT^HZ;::M9-9WL7FP.063<5S@Y'((--O]*LM3M4MKR'S(48.
MJ[F&".G(-"86*/BVVEN_"FHPP*6D,)(4=3CDC\A2>&=2L[GPK93QRQK'# J2
M_, (RHP0?3I6W6%=>#/#UY=&YFTR(RL<DJS("?< @?I1T Y[0#]JL?%VI1+B
MUNGD\D]FPK9/ZBM[P0 /!FFX'_+,_P#H1K9^QVPLC9+"B6Q0Q^6@V@*>,#'2
MDL;*WTVRBL[2/RX(AA$W$X'7J>:&P2.6^'?_ "#-3_[",G\EI_A__D>_$WUA
M_P#0:Z+3M*LM)BECLH?*260RN-Q;+'J>2?2EM],L[6_NKZ&';<76WSGW$[L<
M#@G _"BX6(M<U%])T2[OTB\UX8RRKV)]_:N;MX=5OM'CU74O%GV:TEC$C+:Q
M(@C![!^N>WUKLG1)8VCD571AAE89!'H:PX?!GAVWN_M,>EQ>8#D;F9E!_P!T
MG'Z4)@SEO"+*WP_\0E&9E+7!!<_,1Y8Y/O75>#0!X/TS Q^Y_J:N0:%IMM#>
MPPVVR.]+&X4.V')R#WXZ]L5:L[.#3[.*TM8_+@B7:BY)P/J>:&[@D</H'_(H
M>*O^OBZ_] %=%X- '@_3,#'[G^IJ[;Z)IUK9W5I#;[8+MG:==['>6&&Y)R,C
MTJS9V<&GV<5I:Q^7!$NU%R3@?4\T-@D>?Z=;2W?@CQ1# I:0WLQ"CJ<;21^0
MKK/#.I6=SX5LIXY8UCA@5)?F $948(/ITK0L-,L]+29+.'REFE,L@W%LN>IY
M)]*S;KP9X>O+HW,VF1&5CDE69 3[@$#]*=TPL<YHBM?:;XPO[=";>[:408'W
M\*W(^N16WX.O[5?!-E,UQ&L<$165BP^0@GKZ5T,,$5M"D,$21Q(,*B+@ >PK
M'_X0[P]]N^V?V7#YV=W?;G_=SM_2B]PL<QX9F6X\#^)9T^[)+<N/H8P:Z;P:
M /!^F8&/W/\ 4U=M]$TZUL[JTAM]L%VS-,F]CN+##<DY&1Z59L[.#3[.*TM8
M_+@B7:BY)P/J>:38)' Z5;S77@KQ3# I:5KR?:HZG 4X%=-X=U:Q;P?:7?GQ
MK#;VZK*2P^0J,$'\JU+#3+/2TF2SA\I9I3+(-Q;+GJ>2?2LZ?P=X>N;PW<NE
MPF8G<<%E4GW4'!_*G=,+'->)KVY\1> 8M36TDMT2Y$I17W-Y8RN[H,=<_K6A
M#H5C/IHU%/%NN_9"F\RG4!@#WXXKKQ&@B$011&%VA .,>F/2L%O!'AMKGSSI
M46_.<!F"_P#?.<?I1<+'(W=E:_\ "O\ [7I2W\EHE^+IS=[2[@?*Q&WMGU]#
M7<:CK&GKX;GU W,36KPG8V[AB1P/K[5IB&)8! L:"(+L$84;=O3&/2L6+P;X
M>@O#=1Z9$LIS_$VT9]%S@?@.*+A8K?#[_D2K#ZR?^AM7355T_3[72K*.SLHO
M*MX\[4W%L9.3R23U-6J3W&@HHHI >>?&3_D4+3_K_3_T7)7H=>>?&3_D4+3_
M *_T_P#1<E>AUA#^-/Y?J>KB?^1=A_6?_MH4445N>4%%%% !1110 4444 %%
M%% !1110 4444 %%%% !7-:GXULK&\:TM[2\OY8I%CF^S1[EC)/3/=O;\,UT
MM>?W$6H^&GDBDTY[NQEU-;M+BV(:0DL#L*=2W'6FA,Z^PUS3]1TQ]0AGQ;QY
M\TN-IC(ZAAV(K)_X3K3<"5K/4ELB<"]:U(A^N>N/PJU82:'XDTN[6"!?*G?%
MW%M\I]_??C!S[YJ+Q3J%MINB'38HA+<W<9M[6U49+9&.GH* -:^U2RT[3FU"
MYG5;4 ,''.[/3&.N:S+#Q;97M]%9R6M]933 F'[9!Y8E_P!TY-8^H6+VJ>#]
M(N&#*DRF09X+(N1^N:O^/5V^'DNEXFMKJ*2-L<AMP']:=D%S4U?7[/1C"DRS
M37$Y/E6]O'OD?'7 I-(\06>LM-%$D\%S!CS;>YCV2)GH2*R[("X^(^HR2<M;
MV4<<>3T#')Q2Z@/(^(>CRQ\-<6TT4G'WE7YA^M*P7.HHHHI#"BBB@ KR#X@_
M+X[MV/ \N(_^/&O7Z\A^(W_([6__ %QC_P#0C6=38]C(_P#>7Z,]>HHHK0\<
M**** "BBB@ HHHH **** "BBB@ HHHH \\TC_DN.O_\ 7@O_ *#!7H=>>:1_
MR7'7_P#KP7_T&"O0ZPP^TO5_F>KFWQTO^O</_24%%%%;GE!3(IHIXQ)#(DD9
M) 9&!!QP>17'Z[G5_&MIH-U<20Z>;8SM'&Y3[0V3\I/<8'3V-5?#?AZXMH-/
MU+1[CR<S2+=P22-LEC#L,@<_, /\]W85SO:*R->U:[TZ*&+3].EO;RX)6-5X
M1<=V/8<__7%87@0WIU#Q -1E$MV+A!*R],@'I[46TN%SM**X/Q;I-OKGC;2+
M"Y>1(I+>0DQ$!N,GN#Z5!J?P_P!,T73+C4;/5;ZVN((RZ2/*H&1T' !YZ=:+
M(+GH=%<=J%S=7OPMDN;T$7$EH&<D8SR,'\1@_C5+P'JUQ9>3H.IG!EA6XLG)
MX=&&=OX<_D1V%%M N=]17'>+O^1I\*_]?3?^R5V- PHJO>7UKI]LUQ>3QP0K
MU=VP/_UUEV/C'P_J-TMM;:E&TSG"JR,FX^@+  FE8#<HJ"\O;;3[9KF[GCAA
M7J[G K/TSQ/HVLSF"POTEE SL*LA/T# 9_"BP&O15+4]7T_1X!-J%U' AX7=
MR6^@')_"J4'BW0KE('AU!'$\PA0!&SO/0$8R,^IP*+,+FU151M3LTU6/3&FQ
M>21^:L>T\KZYQCMZT7NIV>G/;)=S>6US*(HAM)W.>@X''XT 6Z*P[R'2V\7:
M=+/<RKJ2PN((0/E=<')/'U[BI]4\2:/HLBQZA?)#(PR$ +-CUPH) IV U:*H
MZ9K&G:S"9=/NXYU7[VW@K]0>1^-95C+HFF7VO7L5Y*760/?!U)$1&<8PO/?I
MFBP'1T5QG@GQ1%JAN;6ZOFFOI+B1XT9#_J@!C'& /:M?PO#I<-A<KI-S+/";
MIS(T@P1)QD#@<=*&K"N;E%8-UXS\/6=T;:;4XQ*IP0JLX!]R 1^M:QOK46#7
MPG1K58S(94.X;0,DC'6E898HK!F\:>';>.%Y-3C F4,@".3@],@#(_'%;%K=
M07MLEQ:S)-"XRKH<@T6 FHI&8*I9B H&22>E8/\ PFWAO[5]G_M6+?G&=K;/
M^^L;?QS18#?HK"\5:W!I/A^>;[3Y4T\3+;,H)W/MXP1T^M8O@&'0)8%NK)FE
MU980+N1C)G+')^]\O4=1Z4[:7%?4[>BN;\>_\B5J/T3_ -#6DM_%^@6<-K9S
MZG$LXB16 #$*<#@L!@?B:+:!<Z6BJEYJ=G8Z<VH7$ZK:*H8RJ"PP2 ",9SU'
M2IQ/&;87 ;]T4W[L'[N,YI#)**I6NK6%[I@U*"Y4V9!/G."@ !().[&.AK-A
M\;>')[D6Z:K%O)P"Z,J_]]$ ?K3LPN;]%8?BJ+2Y]&"ZO<RV]KYR$/$,G=V'
M0_RJ]>ZO8:;-;0W=P(GN,B+<#@X&3DXP/QQ2 O45B6GB_0+V]%G;ZE$TY.U5
M(90Q] 2,'\#6I>7MMI]LUS=SQPPKU=S@46 GHK$T_P 7:#JER+:TU&-YFX5&
M5D+'T&X#)^E:&HZI8Z3;?:+^Y2"+. 6/)/H!U)^E%@+=%9&F>*-$UB?R+'4(
MY)>R%61C] P&?PJ?5-<TS18U?4;Q( _W0<EF^@&319@:%%9FE^(-)UK<-/O8
MYF49*8*L!Z[2 <>]:= !1110!YY\9/\ D4+3_K_3_P!%R5Z'7GGQD_Y%"T_Z
M_P!/_1<E>AUA#^-/Y?J>KB?^1=A_6?\ [:%%%%;GE!1110 4444 %%%% !11
M10 4444 %%%% !1110 5PFH:KK.FLMKJUA=WNR^26"ZMHE82(&R%(&,-V]_U
MKNZ8\4<H42(K[6#+N&<$=#]::8F<AIXU33;+6_$$FFR?;+UU:&Q0%V  VKN
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MS!?+^U^6_G[>G3[N<?\ ZZ70.IDZ-/++\+M6BDD,BVZSQ1L>Z@9'\ZZWPO\
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M\\_M?XH_]"YI?_?Q?_CU']K_ !1_Z%S2_P#OXO\ \>K3VZ_E?W,X_P"R9_\
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MZ*\\_M?XH_\ 0N:7_P!_%_\ CU']K_%'_H7-+_[^+_\ 'J/;K^5_<P_LF?\
MS]I_^!Q/0Z*\\_M?XH_]"YI?_?Q?_CU']K_%'_H7-+_[^+_\>H]NOY7]S#^R
M9_\ /VG_ .!Q/0Z*\\_M?XH_]"YI?_?Q?_CU']K_ !1_Z%S2_P#OXO\ \>H]
MNOY7]S#^R9_\_:?_ ('$]#HKSS^U_BC_ -"YI?\ W\7_ ./4?VO\4?\ H7-+
M_P"_B_\ QZCVZ_E?W,/[)G_S]I_^!Q/0Z*\\_M?XH_\ 0N:7_P!_%_\ CU']
MK_%'_H7-+_[^+_\ 'J/;K^5_<P_LF?\ S]I_^!Q/0Z*\\_M?XH_]"YI?_?Q?
M_CU']K_%'_H7-+_[^+_\>H]NOY7]S#^R9_\ /VG_ .!Q/0Z*\\_M?XH_]"YI
M?_?Q?_CU']K_ !1_Z%S2_P#OXO\ \>H]NOY7]S#^R9_\_:?_ ('$]#HKSS^U
M_BC_ -"YI?\ W\7_ ./4?VO\4?\ H7-+_P"_B_\ QZCVZ_E?W,/[)G_S]I_^
M!Q/0Z*\\_M?XH_\ 0N:7_P!_%_\ CU']K_%'_H7-+_[^+_\ 'J/;K^5_<P_L
MF?\ S]I_^!Q/0Z*\\_M?XH_]"YI?_?Q?_CU']K_%'_H7-+_[^+_\>H]NOY7]
MS#^R9_\ /VG_ .!Q/0Z*\\_M?XH_]"YI?_?Q?_CU']K_ !1_Z%S2_P#OXO\
M\>H]NOY7]S#^R9_\_:?_ ('$]#HKSS^U_BC_ -"YI?\ W\7_ ./4?VO\4?\
MH7-+_P"_B_\ QZCVZ_E?W,/[)G_S]I_^!Q/0Z*\\_M?XH_\ 0N:7_P!_%_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.<HKW8RM<Z&BBBJ.$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>7'KM!/]*\%@L)=0TS5M5D8L;8QECZM(^,_S_.LJCZ'T&0TXJ<J\NEDO5O\
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M.!<R",-Z%5!!_ D&M'XF:]#;Z:=$",T]RJR,V>%4-D?7)4U<^&4/E^$M^/\
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M[D7%Q>D2'(Y"?PC^9_&N5^&.FVM_>:BUW;0W$<<: ++&' ))YP?I7K(
M X %.";]YG+FU>G1B\'1C9*S?GH+1116IX 4444 %<'/J.O:W++<66I)I]G%
MJ"VD2I$'=R&QN;/;V[UWE<5JVBVLDB:CH>JO ]Q>QA_)=98?,W??*]-P^M-"
M9T6C2ZK]CE768HDFA<J)8R-LJ#H^,\?2N?;Q=<7_ (BTJWTZ*1-,FF9&N7CQ
MYY"GA<\X'K_DZ?AS5+ZZGU'3-3\N2ZL)%1IHUPLJL,@X['UJ#Q$ /$WAD 8
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MA\9VY )./;<:]2T/2(]#T>WTZ*0R+$#EV&"Q)))Q]37F5K_IWQ?;OMO)/_'
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M_*!^'XUZ=7S17T5H]U]MT6QNLY,L".?J5&:*<KJQ&>X-4IJNG\6Y=HHHK4\
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M@U:K0\247%VDK,****!!7A&MV]SK?C34XK1#)*9I=JCN$!Z?@O%>[,P52Q.
M!DFO(OAPIO?&=S=L.5ADES[LP']36=35I'MY1-T85JZ^ROZ_(T?A1:2";4[E
MHV"A4C#$=3DDC]!7=ZYH=GX@T_['>A]@8.K1G#*1W'YFM*BJ4;*QP8G&3K8A
MXB/NO3Y6*>EZ;;Z/IL-A:!A#",+N.2<G))]\FO$(-2N_"WB2^:SVB2-Y;<AA
MQC=C^@/X5[W6-<^$]"O+N>ZN--BDGG&)&)//N!G /N.:4HMVL=& Q\*$I^W3
MDI[G#_"G3]]W?ZDX^XHA0GU/+?R'YUU/C[2?[4\+3LBYFM?WZ?0?>'Y9_(5N
MZ;I=EI%FMI80+#""3M!)R3W)/)-6Z%&T;$8C'N>,^LPZ-6]$>7?":$F[U.;'
M"I&F?J2?Z5ZC4%M9VMDC):6T,",=Q6*,*"?7BIZ<596,<=B?K-=U4K7_ ,@H
MHHJCD"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH AN[2WOK62VNH4EAD&&1QD&N4
MTCX>V>D>(5U.*[D>*,DQ0,GW21CEL\XR>U=C12:3-Z6)K4HRA"5E+<****9@
M%%%% !6;X@L&U3P_?62 &26%@@/=AROZ@5I44%0FX24ENCQCPCKU[X9U:33;
MN,Q0RDB6.5=K(^WY3_+\#67X-E\GQAI;YQF8)_WT"/ZUO_%+3OL^NV]\HPMU
M%AC_ +2\?R*UR6BR_9]=T^;./+N8V_)A7,[IV['W%%0KX>5>*LYQU]5='T31
M1172?"A1110!X+J%A=:QXRU.VLX_,G>ZG94SC.&8X_(5W'PQT>_T_P#M*:]M
M)K<2;$02H5)QNSP>W(K#\'?O/B9._P#TTN&X_'_&O7JRA&^I])F^-G""PJ6C
MBOZ_ ****U/FPHHHH \S^+-M_P @RZ _YZ1L?R(_K7<>&[G[7X:TV?.2UL@;
MZ@8/ZBN?^)]MYWA590.8+A&S[$%?ZBK/PYN?/\&VZ9R8)'C/_?6[_P!FK-:3
M9[%7]YEE.7\LFOOU.KKR'P]_I/Q9FEZ@7-R_X8<#^E>O5Y#\/O\ 2?'=S-UQ
M'+)^; ?UHGN@RS2AB)?W;??<G^*UN$U>PN H!D@*DXZ[3_\ 94WP9X(TWQ#H
MK7MY-=)()VC"Q.H4@ 'NI]36G\68<VFF3X^Y)(F?J ?_ &6M?X:IM\'Q'^]-
M(?UQ_2ILG/4[GBJE/*H2INSO;\68_P 2M$AMM!TV:TB"1V;>1@=D(XS^(_6N
MF\#ZC_:7A*R=CF2%?(?ZKP/TP?QJYXDT[^U?#E_9A=SO$2@_VAROZ@5P/POU
MJ"UGNM+N)E3SV5X W&Y^A'U(Q^55M/U.2-\3EK6\H._R?]/[CM?&DGE^#M3;
MUBV_F0/ZUSOPHCQH]_)_>N OY*/\:U_B')Y?@J\']]HU_P#'P?Z53^%\>SPK
M(W_/2Z=O_'5']*'\9%/W<KF^\O\ ([6BBBM#QPHHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH \@T!A:?%F9&.U6NKA.??=C^E4/B%??;?%]RH.4ME6%?P&
M3^I-:7Q#LY-'\66VKVPV^?ME4^DB$9_]E/XUR&I7)U+5KZ\1&Q-,\V,9V@L3
MS^=<\M%RGW&$IJK4ABUMR6^=S0T3PS?>(;.^FLE\R:W*85F W[LYY/&>*Z30
M_AE=W,-RVL%[1PN($C=6);U;&1CVZ_2NH^'&G-8^%EED0K)=2M+R.=O0?RS^
M-=?5QIJUV>1CLXKQJSI4FDD]^NAXOX=U^]\#ZM/8:A;-Y#N//C/WE_VE['C\
M^*]<TS4[76-/BO;.3?#(.,C!![@CL:\\^(?AS4K_ ,16US86<LZ31+&QC7(5
M@3][T&".367X4\12>#M5N]-U1)!;ER)$49,<@XW#U!']*2;B[/8UQ6&IX^@L
M12_B6NTNO1Z'L=%1P3QW-O'/"X>*50Z,.X(R#4E;'S+33LRAKD_V70-1GS@Q
MVTC#Z[3BO/\ X309GU2X(^ZL: _4L3_(5UOCJ;R/!>I,.K(J?]],!_6L7X50
M;= O)^\ESM_ */\ $UF_C1[&']S+*LN[2_)G>4445H>.%%%% !1110 4444
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M$OVJ56+KNPHVMC'N7_2L_:*]CV(9-4GAX5(OWI/Y6M<F^'_[WQY</U^25O\
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M_P!],3_6I@[RN=V94%AL&Z4=G/\ "QOT445J?.!1110 4444 %%%% !1110
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MKPWI<?\ =M(@?^^!7@=_9FSEB4_=E@CE4^NY0?YY'X5]"V">5IUM'_<B5?R
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MWCRVFL95FM=-MW\R:,Y0N_ 4'OQS^% CKJ***DH**** "BBB@ HHHH ****
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ME:5% $5Q;07<)AN8(YHCU21 RG\#1;6MO9Q"*U@B@C'(2) H_(5+10 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8'C'1'U[P[-:
MPA3<(PEAR<?,.WX@D?C7A(D<1M$&.QF#%?4C./YG\Z^E:^?8]--QXK&F ?>O
M/)/L-^#^E8U5JF?49!7M3J0ELM?\_P CU?P9X4L]$M(=07S6O;BW7S-[#"9
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5RMMX(M;;Q=)KPN7;<[2K 4X5VSDYSR.2<8KJJ*329K2KU*2DH.UU9
M^@4444S(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O%_$T.?B=)
M%_?NH/U"?XU[17+:AX)M[_Q9#KK7;J4='>'9D,R8QSGCH.QJ)IM:'IY7BJ>'
MJ2E4>\6OGH=31115GF!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(592?IN S^%9OB]?M=]H.FOS;W-YNE3LX09P?:D\<1);Z3:ZE"BK<6-S$T3
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M]%_.CS8_^>B_G0 ^BF>;'_ST7\Z/-C_YZ+^= #Z*9YL?_/1?SH\V/_GHOYT
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M.A42R/UV@\X KKZ*+A8****0R$INN<LN5V=QQG-/\J/_ )YK^5/HH 9Y4?\
MSS7\J/*C_P">:_E3Z* &>5'_ ,\U_*CRH_\ GFOY4^B@"#RE^T_ZL;=GIQG-
M2>5'_P \U_*GT4 ,\J/_ )YK^5'E1_\ /-?RI]% #/*C_P">:_E1Y4?_ #S7
M\J?10 SRH_\ GFOY5'%$OS[HQ]\XR.U3T4 ,\J/_ )YK^5'E1_\ /-?RI]%
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MY&1VJ6D,**** "L'4/&&C:;=O;3W#M)'_K3%&7$?^\1T^E:[W$3N]O%<1?:
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MD7]N;*]C8F%6;(FC[%3Z^W_U\ &M?77V&QGNC%)-Y2%_+B7+-CL!7&D?9O\
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M+=?#^XN+JU@:[T6Y8NR9^>"3MD]U/ R?Y]6A,[.U1;2WM[-[EI95CP&E8%W
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MGYXL(;%M0T72?#=R94M[C[3=RPR;E*XY,C#AF:NVFABN(FBFB22-N&1U!!_
MU':V=K91F.TMH;>,G)6*,(/R%%PL+!:6]J93;P1Q&5S))L4#<QZD^]3445(P
MHHHH **** "BBB@ HHHH **** "BBB@ K#\0^)(/#LEB;F)FM[B0H\BG_5X'
M7'>MRLG4]$35-6T^ZG96M[42[H&7(D+KMY^E- S3BECGA2:%UDC<!E=3D$'N
M*YV/5[G7-=EL;.UC;2;<M%>33H<2-C&Q1[=__P!6<\BX\"W>1YD_AV9^1RS6
M;$_JO^>O7L89(IH5F@9'CD&Y60Y# ]Z-A&!HNAWV@ZM+!:3*^B2J76*1CO@?
MT7U!_P \]>CHHI#"L;Q)X@3PY9V]W+ TL,EPL4FT\J""<CUZ=*V:RM7T?^UK
MG37>0"&TN//>,KG?@''ZG^=- R_:W4%]:QW-M*LL,B[D=3P16%/K-WJ/B'^R
M=-MT>VMVQJ$\Z'9@C[@'<G_/%9US;7'@F\>^L8WFT*9MUS:KR;<_WT]O;_(Z
MVTN;>\MDNK61)(91N5UZ-1L(PM,T.]T'6V33Y$;1+C<[P2,<P/\ ['J#Z5T2
MHB9V*JY.3@8R?6G44KC"BBB@#G/&]S<6WAPFTG>&Z>>)(F0X)8L./YT[P_X@
MDO99-+U2,6VKVX_>1]I1_?3U%;EQ:P72HL\2R".19$W#[K*<@CWK*\0>'X]9
MBCFAD-MJ-N=UM<KU4^A]13TV$5]2T*\UK7(S?SJ-'M]KQV\9(,LGJ_L/\]ZN
MOH<1\2Q:TDK1R+ 89(U'$@SP3]/\/2GZ'<:C<::IU6U%O=HQ1\$$/C^(>@-:
M5%P"BBBD,B>Y@CN([=YD6:4$QQE@&8#K@=\5+7'>*](NM<\1:5;V[RVWD0S3
M"Z0?=;Y=HS]0/P-7_#_B":XN'TC5T%OJ\ Y'\,Z_WT_P_P AVT%<@\1V^G:M
MJ=OI\5T8-=C0RVTT:DF/'.&(Z ^__P"NG:16/BB273]<LOLNO6@^>2+Y'8=
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MQ[,R@@G'4$Y_SP>KNKF1=-DNK&(7<GE[XD5P!)QQ@^]1IH]BDE\_D!_MQ!N
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MOH#NMKE/O1M_A[5L44 16R31VL23RB694 >0+M#'')QVJ6BB@ HHHH ****
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5BB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image1.jpg
<TEXT>
begin 644 image1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  9 :@# 2(  A$! Q$!_\0
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M#D$>M#H)(V1MP# @[6*G\".1^%<W\/'GD^'N@M<9\S[(@&?[HX7_ ,=Q734
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M*.X.IW6QID+H/]9U ()X]Q7H/Q/OO$^GZ.L6LO;2>'[F017,NE(8Y_7!$A8
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M-,^*NG7FA[H9=6G62W=!_JYP0'/TY#'_ 'C7T'65J?\ R%]'_P"NS_\ HMJ
M///BMX'@_P"%=6;:?&3)H:#!Q\SQ8 ?/OD!B?8^M:_P@TBZM/"$6J:@[R7=^
MB!"_5+=!MB4>V,M_P*NVU3_D$WO_ %P?_P!!-+IG_(*L_P#K@G_H(H M4A(
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1>%S^%%>D7G_(XQ_A10!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image00003.jpg
<TEXT>
begin 644 image00003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "H"%@# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUO<V\5W:S6LR[XID*.I[J1@_SKX_\3:)+X<\1WVDRY_T>4JK,,%D/*M^((-
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M_DHNA_\ 7S_0T#Z'T#'\.[.*:.3^W?$+F-@P5]18J<8X(QR.*[.BB@04444
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M/:;_ -?47_H0H&?32_#J"/!A\1^)8W7[K#42<?@01W-03>!M?B&_3O'FKI*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]2!N.: .D^)1SJ_@@GOK$?\ -:D\>:;H3:_I.L>)=:BBTZS#%=.F3<)G_O
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MQD@L2I_(@UW'P$_Y'>]_[![_ /H:4#Z'T71110(**** "BBB@ HHHH ****
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M6!XVEC@\#:Z\C[5^P3+GW*$#]2*!'Q_7T[\&]2;4/AY;1R.6:SF>WR<YP#N
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M<JODW![^8O!_/@_C0-G54444""BBB@ HHHH \>_: _Y &D?]?3?^@UXCHO\
MR'M-_P"OJ+_T(5[=^T!_R -(_P"OIO\ T&O$=%_Y#VF_]?47_H0H&C[/HHHH
M$5-0@-UIMU;K@-+"\8+=,D$5\6LNUB/2OM'4Y?(TF\E_N0NW7'8GK7Q:3DYH
M&CZ)^!.HR77@^[LI,E;2Z(C)/16 ;'Y[OSKU6O(?@%:O'X=U2Z8826Z"*?7:
MO/\ Z%7KU @HHHH **** /F?XW?\E%E_Z]8OZUG?"JZAL_B/IDT\\<$($H=Y
M) J@&-NI/OBM'XW?\E%E_P"O6+^M9?PNT^UU/Q_86E[:1W5LZR;XY "OW&Y(
M[\XH'T/HK4O&_AC2K<S76MV0 !(6*99&;'HJDD]:\K\&>)/^$L^-\NJJACA:
MUDCA4_>"* !GW_QKT+5/A;X/U2!H_P"R(K5RN%EM<QLOO@<?I7FOP]\/S>%_
MC//H\[[S#;R%9 ,!T(!4_D?YT"/?J*** "BBB@ HHHH *Y7XD?\ ).]=_P"O
M4_SKJJY7XD?\D[UW_KU/\Z /DJOH_P $?$'PII?@K2+&]UF&&YA@"2(4<E3S
M[5\X5]7_  ZMK>3X>Z([V\3$VPR3&"30-C'^*/A' 6VU-KR9CA(+:!WD<^BC
M'->1^(=!\9_$?Q,^IIH-S:VY BA%S^["1@GKNP2>N<#O7JGBSX8:'K]D[V5K
M%I^I*-T-Q;*(\L!QN ZC]:\+T;Q[XI\)7K01W\LB0N4DM;DF1,@X(Y.1T[4"
M/9OA_P#"NU\)W"ZE?SK=ZI@["H(CAR,';ZG&1DUZ37,>"O%]IXTT);^!?)G1
MMEQ 7W&-OKW!ZBNGH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "L/3]"-KXEU;6II5EDO5B
MBC4+CRHT!XSWR23GZ>E;E% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >%
M?'+PD\=U'XGM8\Q2!8;S'\+=$;\1\OX#UKD_A!J?]G?$6R5B5CNT>W;GU&5S
MZ\@5],7EG;ZA:2VEW"DUO,I62-QE6'H:^??%_P +M8\):DNL^'1+=6<,HFC"
M#=+;D'(R/X@,=?S]:!GT717$^#?B/H_BFQC26YAM-350)K65@N6[[<_>%=KP
M1D<@T"%K@?B#XXN/"][HMA8"%KJ^N1O\Q"P6+(![]23^AK4\2^/M"\,P,;B\
M2XN^D=G;L'E8GH,?PY]37@&N2Z_?>/-/U/Q!9S6TUY/%) DBX"Q;QA5^GOSZ
M]: /JFBBB@ HHHH **AGGAMH&FGECBC099W8*JCZFN9\2^-M(T?PY?W]MJ-G
M<7$41\J**=&9G/"\ ],D9_&@#E[[3(?B/\1;R*:>YCTSP]&(4>WDV-]J8Y8J
M<<8VXXY!4>M;W_"L]/\ ^@_XD_\ !FW^%5OAY/I&@^$+6.ZUFP^W7)-U=%KJ
M/<9'Y.>>H&!^%=U%)'-"LL4BR1NH*NI!# ^AH XM_ACILT;12:WXADC=2K*V
MHL58$="",&OG/Q5H4GAOQ/?Z5)T@D.P_WD/*G\B*^N[O4++3T5KV\@ME8X4S
M2A03^/6O#_C=::9?M9:[IU_:7$RC[/<)#.C';R4; /U'Y4 A_P "/$0BO;WP
M]/)Q./M%N"?X@/G _#!_X":]WKXTT#5YM U^QU6#.^VF5\*<;E!^9?Q&1^-?
M6-MXIT&ZMXITUBP"R(' :Y0$ C/KUH&S:HI.M+0(**** "O OV@?^0YH_P#U
M[/\ ^A5[?=:KIMA*(KR_M;=V&X+-,J$C\37A/QTO[*_UG2'L[NWN42W<,890
MX!W=#@T C@?!?_(\:#_V$(/_ $,5]A5\>>$)$B\9Z)++(D<:7T+,[$*J@.,D
MGL*^K_\ A(]"_P"@UIO_ (%)_C0-FI7G?QFUA=-\ S6P;$U_*L" '!VYW-^&
M!C_@5:VJ?$KPCI4<C2ZU;S.F?W=J?-<D<?P\#\:\>UJ#Q=\6/$,<\&ESV^G1
MYCMS,I2.)2>26/WFXYQGI0(X'1=(N]>U>UTVRCWSW#A5'8>I/L.M?7NBZ5;Z
M'HUGIMK_ *FVB$:D]3@=3[GK7.>!/A_I_@JR8H5N=1F $UR5Q_P%?1<_G79T
M %%%% !1110 5Y5\;_#@U'PS%K,* SZ>V)#CDQ,0#^38/XFO5:K7EI!?V4]I
M<1B2">,QR*>A4C!% 'QKINH7&EZC;W]J^RXMY%DC;T(/\J^A? ,DGC#Q7J7C
M:>)X[<(++3XW .U!RQSZY_F:\(UCP]=Z5XJN-!V-+<QW'DQA1S)D_*1]01^=
M?5WAK18?#OAVQTJ$#%M$%9@,;F/+-^))- V>%_&[PT-,\2Q:S!'MMM17]YCH
M)EZ_F-I_.N8\"^,[KP9?WT\"[TN+9T*'IO /EM^#?H37T/\ $+PTOBCP=?62
M1[[J,>=;>OF*./S&5_&OG3P)X;;Q-XQLM->-S K^9<XXQ&OWL^F>%_&@#W[X
M6Z%)I'@Z&XN@3?ZBQN[AV^\=WW0?P_F:[BF@!0 !@#@"G4""BBB@ HHJG=ZE
M8V&S[;>VUMOSL\Z54W8],]>HH ;JFI0:1I5UJ-T=L%M$97]< 9P*\U\(^!3K
M^EGQ)J^HZK;:CJ[FY<6=T8E\LGY 0!Z<CZU+\1?$%AK=UH_A6SU6U,%_<"2^
ME6==J0*<D%LX!.#QWVUWUIK&B-Y5I::E8,<!(HHKA">!P  : .>_X5GI_P#T
M'_$G_@S;_"L#QC\*[6;PS>RVNI:M=WEO&98$O+LRKD<G@CJ5!'Y5ZK6=<:WI
M-I.T%SJ=G#,N-T<EPBL..X)H ^,:^K?AEXB/B/P19SR-NNK?_1I_]Y0,'\5V
MG\:^>O'NEVND>,+Z"PN(9[*5_.@>)PXVMSMX]#D?A73?!CQ3%HGB2;3[R9(K
M._C^_)(%5)%!()SZC(_$4#/I&BJ%MK.EWLODVNI6D\I!.R*=6;'T!S5^@044
M44 %%%4+K5M-L)?*N]0M+>0KN"33JA(]<$T >(_M _\ (<T?_KV?_P!"KB/A
MK_R470_^OG^AKL/CI?V5_K.D/9W=O<HENX8PRAP#NZ'!KC/A[-%;>/\ 1IIY
M8XHEN,L[L%"C!Y)- ^A];T5E_P#"1Z%_T&M-_P# I/\ &H+CQ9X=M(3+-KFG
M*B]2+I"?T- C9)"@DG ')->;_"K5I=;N?%%ZUU<30OJ3&!9)6=40DD!<]!SV
M]JYGXA?&"UNM.FTGPT[2>>ICFO"I4!3D$)GG)_O<<=/;7^ ENJ>$M0N,G=)>
ME2.P"HO_ ,4: /6:*** "BBHI98X86EED5(T4LSL0 H'<F@"6O+M?LT^('Q%
M_L-YYETO1(/-N&A;8QN'^Z <'H,?DU=;K?C/0]*T6\OUU2QF>"(NL4<ZLSMC
MA0 >YP*YOX:7>F:;X8-[J.L6 U359FO+HO<H&RQ^4'GL.<=MQH TO^%9Z?\
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M  D>A?\ 0:TW_P "D_QJ*?Q9X=MHO-FUS350'&?M*'^M C59UC0NY"JH))/
M '6O.OAEXKU'Q5JWB6XN+F273X[A/L*LH78A+\<<YP%ZYKF?B+\7;.YTR31_
M#<[2&<%)[S!4!>X3OD^OI]:O?L__ /( U?\ Z^E_]!H ]AHHHH **** "N5^
M)'_).]=_Z]3_ #KH[BZM[2!IKF:.&)<;I)&"J.>Y/2N,^(&NZ1<^ M:A@U6Q
MEE:W(5$N$9F.1Q@&@#Y:KZU^&_\ R3O0O^O4?SKY*KZE^'^NZ1;> M%AGU6Q
MBE6W 9'N$5E.3Q@F@;.ZKY'^(4*6WQ!UV./.TWCOR<\M\Q_4U]8V]U;W<"S6
MTT<T39VR1L&4\]B.M?.WQF\+76F^*I=;CA+6%_@EP#A)  "K>F<9]\F@2)_@
M1J+6_BZ[L,_)=6A..?O(01^A:OHFOEKX2ZM9Z1X^M);Z9(8I(Y(1(Y"JK$<9
M)Z XQ]37TVM]:.Z*MU"S2<( X);C/'//&30#+5%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MTJ* "BBB@ HHHH KW5K;WMK):W4,<T$JE7CD 96![$'K6)_P@7A'_H7-,_\
M 9?\*Z.B@#G/^$"\(_\ 0N:9_P" R_X5N6UO#9VT5O;QI%#$@CC1!A54#  '
MIBIZ* ,[5-$TO6XTCU.PM[M8R603QAPI]LUF_P#"!>$?^A<TS_P&7_"NCHH
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M_P !E_PH_P"$"\(_]"YIG_@,O^%='10!SG_"!>$?^A<TS_P&7_"C_A O"/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8?\ OL?XUQNO_"KPYXDUJXU:_-[]IN-N\13!5^50HP,>@%9W_"C/"'][4?\
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MQYX;\5MM2UD9K"]<C@*P)4GZ98^ORCKTJ3X71MJDVN^+IT_>:K>,D!/40H<
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%^OB9G33XT5[:U=0#$,XY]SU/->HUX_\,N?BIXW_ .N\G_HUJ /8*86"@L>
M!DT^H;B!+FWD@D&4E0HPZ<$<T >56.M^,OB+=7EWX>U*'1M%MI3#'(T8>29@
M,\@CW4]L9[XK1\*>*]=LO%[>#_%GES7Q0R6EY" %G4#/(&.P8YQU!%=%X-\+
MQ^"= DT_^T&N8%E:;S)$5 BX&1QVX)R?6N(TF1?'GQD.NVF6TG18?)2?!"S/
M\V,'ZNS?11ZT =KXH\=Z5X49H;M+J6Z\GSDBAA9@PR1][&T<@]365\)_$.I^
M)?#=[?:I<&:47SHF0!L7:I"\>F3UKO)!F-@>F#7F/P*_Y$R^_P"PC)_Z E &
MOX^\6ZCHTVFZ+H44<FLZI)LB,HRL:Y W'\_T-8&K?\+'\':<^N3ZY::Q;P8:
MZM&@"X3/)4@ _P"'X5V6L^$(]8\5Z/K[7CQ2:83MB$8*R ^_:L;XK>(5TSPS
M)H]L'EU35@;>W@CR7*D@,<#V./?- '6Z%K$&OZ'9:K; B*YC$@4G)4]U/N#D
M?A6G7.^"-$D\.^#M,TR7_7119E&<X=B68?@2:Z*@#R!Y/'/B/QKXDL=$\1QV
M5MITZH(Y8U(VL#C'RGT/>MS1/#OQ"M=9M9]4\5VUU8I(#-"L>"Z^@^0?TKG[
M+P'XJU/Q?XBGN]2N](TN[NR^^W=1+<JK-Y>"O0!3W_*DU$^(/A7K=C=-K%SJ
MOAV\F$,RWCEWB8]>>QP"01P<'([T =;X^\77FA)8Z7HL N-<U-S';*V"$ ZL
M?SX_&N>U)?B-X0T_^W[C6[?68(!NN['[.%"KW*D#)Q^''K3[QA=_M#:>LS@+
M;:<3".FXE6_/[Q_+VKTC4H8I]+NX9G"0R0NKLP! 4@YS^% $.A:S:^(-%M=5
MLR?(N4W 'JI!P0?<$$?A6%X_\8CPKH^VU FU>[S'9P ;CGNY'H/\*Y'X5>(+
M;0_A9?ZAJ,BI:65W($QU?*JV!SR2Q(%6O#FD7^MQ:KXYUY&6ZN;61-/MSG$$
M&PX('8G_ !/\7 !O?"W6M0U_P3#?ZG<M<7)FD0R%0I(!XZ#%=M7G7P3_ .2<
MP?\ 7S+_ #KT6@#DO'7BQO"VDQ?9(%N-4O95@LX#T9R1R<=AG\R/6N7O-.^)
MNE:3)K1\26]U<0(9Y=.^S H1@DJ"!DX]L>QK/^+6HW6G>//"L]K!]JFB#M!;
MGD-*6 7\<X_(5H7VC?$^TL6UF/Q)!/>QIYCZ8D \O Y*J>Y_+/K0!U^A^++?
M4O!:>(KQ#:(D+/<HW\#)G</TX]B*XO2Y?B#XYM6UJRUB#0M/DW?9+?R@[. <
M MD?K[=*K>*/&,GBCX(7.HQQ".X>:.VNU0G",'!/T!&.#V:O2O"L$5MX2T>&
M!Q)$ME"%=0 &&P<\>O6@#G/ WC#4=2U*_P##?B*".#7M/^9C&,+/'_>'YJ>/
M[PK/UGQ#XE\2^+[OPWX2N(;*"P ^VZ@Z!\.?X1D$>V/8],54U(BT_:'TMH)
M6N;!A,O!QA),#_QQ33_@K_I&G:]?RL!>7&I,9HR/F7C//?JS=?0T .B\0^)_
M _B&RT_Q7>1:EI-^_EPZ@D81HW)Z,!V_QZUN^/?%EWX?M[&PTB!+C6]3E$-K
M$W(4<98C\0.W7VK(^.$,;^ ED9MKQ7D;(./F)# CGV)/X5F"9]1^.'AYKR0+
MY6DK+$I'$CE&)(SWY;I_<]J )]1C^)7A33SKDVMVVKQP@R75EY*JJH.258 $
MX'?C'O7H7A[7+7Q'H5GJUIGRKE-VT]4(X*GW!!%7+^*.?3[F&5MD<D3([<<
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M ,<'_?1]*S])U2+X4^*-6T[6K:2/1]1N&N;2]C0LHZX0@#T./PST->PJH4
M *!@ = *CGMH+N$Q74,<T;=4D4,I_ T >/Z[K</Q0\4:'I?AZ*>2SL;@75U>
M/&550".@//8CMR1[T5Z_;6EM9Q"*UMXH(AT2) J_D** +%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9W#';H./:MGX/P10_#;39(XU1YC*TA Y9O,89_(#\J .[)"J23@#J:X$^/\
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M&002,@UH?%W'_"L=6SZ0_P#HU: .SCD2:)9(V#(RAE8=".Q%2U1T?_D!Z?\
M]>T?_H(J]0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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144 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image00005.jpg
<TEXT>
begin 644 image00005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0K!WD# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#S=^E5GJ8M
MFHFKR$C[]C%JPOW:B1:FZ"K,V57^_4@Z4Q_O4Y:I"N/6E>DZ4A.:?4TC+0>G
M2FGK2 XI:F1<6.[4B]:3-'2LV3)CSTJN?OU*&S2;<M1%'+5>AK6!P!76Z)*H
ME7FN,A?8E7K+5?)E'-:Q1Q-GNFCW*;%Y%=")E8#!%>/:3XC'RC=7:Z=K FV_
M-6\=CAK4VY7.YA8%:3^.J=C/O4<UH(N3FNA:H\^2Y63K]VFFI /EIC5I$X:@
MVGK3*<M4S*#U):8W2G"D-92.E#%ZU+3 .:?1'8;"F=Z<:2FR&**6D%+0B@HH
MHI@(>E1FI#TJ/O31G,5:)/NFEJ.9L1GZ5,RZ:.$\5.!')7@GB$YU!OK7LOC*
M\V>8,UXEJ\OF7A/O7%/<^EP7PHA'^KJ$U.H^2HG&*R/5D_=(1_KU^M?07PS<
M"Q7GM7SZO^N7ZU[7\/[WRH$7/:MJ;L>#CE<]8/,E75^Y6?:-YJAJOKTQ6\3R
M9"KUJ6F 4^M8F;"BBBF(**** "BBB@ HHHH **** "BBB@ HI*": 0R3[IKA
M_$_^HD^E=NY^4UPOBD_N9/I6538Z\-\1\]^)/^0FWUJL/]55GQ)_R$F^M4U/
M[NN29[M!:$)^_P#C7K_PS_@KR!OO5Z]\,OX*TI&.*V/;K;[@^E6*K6WW!5FN
MD\">XM%%%60%%%% !2&EI*!,04ZD%+0""BBB@852O/N'Z5<JG>_</TK.1I3^
M(\*^)GWGKRV'K7JGQ*&6>O*DX:L9:GT&&V+,G^KK7\'?\A5?K6.W^JK8\&_\
MA5?K20Z[/I+0?^/6/Z5T2]!7/Z$/]$C^E;Z]*Z(/0\+$?$.HHHJSG"BBB@ H
MHHH **** "HYO]4WTJ2HYO\ 5-]*3&CR#QS]Z2O%-2_X_#]:]H\=MAY*\6U$
M_P"E'ZUS21[F%^%#'_U5:6@_Z\?6LMC^[K3T(_OQ]:A'157NGO'@G[B5Z+']
MT5YQX(/RI7H\?05O \*O\1)1116QSA1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ^4-<'XJ_P!3)]*[QONFN#\5C]U)]*SJ;'9AOB/GOQ%_R$F^M5E/[JK/B/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M? _W4_"O2(^E><>"!A$KT>/I6\#PJ_Q$E%%%;',%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9RV-*?Q'AOQ*&6>O*%.&KU?XDGYGKR@<M6)]!AMBRW^JK8\&?\A9?]ZL5O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&E/XCP[XDGYGKR<<M^->J_$LX9Z\KBY-8O0^@PVQ.W^JK8\&?\A9?]ZLA_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(E>CQ]*\Z\$_<2O14Z5M \&O\1)1116QSA1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^M9FU;8]W\#CY$KT9>E>>>"1A$KT->E;4SP*_P 0ZBFYIU;HP"BBBF 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#XV)Q4+G-2R=*K
MYYKR4C[F;T&@?,*ZW0;3S"O%<F#\XKO_  JJL4S6L3SZK.WTO2=T(^6M(:#G
M^&MS0[56@7CM70I9IMZ5T1B>/6K-,X%M S_#0N@8_@_2N_\ L<?]VC[''_=K
M51T,?K#//V\/Y/W?TI!X?X^[7H7V*/\ NT?8H_[M'*'UAGGW_"/_ .S^E*=
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M %%%% "4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:*V.82@T&DIB;$I:2G"@E"T444BPHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!\8L>*6 X:FOTIL1YK@1]M58MTV6KK_"A_>1_
M6N-N/O"NQ\)\RQ_6KB>7B'H>^>&US9K]*WP*Q?#0_P!"7Z5N8YK='AS=VQ5%
M24@I:U,0HHHH **** "D-+10!'MYI]+BB@!M)3C3:1+"G=J;3J.H(*2BEJ@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\8RCY:9!R
MU22<BFP##5YR/LJK([OAA79>$.9(_K7'7GWA77^$3B2/ZUM$\K$,^A/#0_T)
M?I6Z16%X9/\ H2_2MXUT+8\2>X@I324&K1G<6BDHI@.HI*6D4@HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI5QY@'->$Z!JQ>51N[U[!X;N/,5>:HYIP.Q'2G4Q#D4ZK6AS,6BBBJ$%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI!=D*0*#TJPJ@4 4ZFB6Q*!3&/-/7I3L(6BBBD 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C
M</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C
M</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C
M</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C
M</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C
M</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C
M</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C
M</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C
M</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C
M</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C
M</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C
M</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C
M</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C
M</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C
M</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C
M</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C
M</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C
M</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C
M</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C
M</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C
M</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C
M</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C
M</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C
M</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C</6@!:*3</6C
M</6@!:*3</6C</6@#D?^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@
M_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$J
MB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^
M:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A
M*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC
M\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\
MA*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[
MX_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?
M/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_
M[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C
M_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$J
MG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH
M^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*H
MO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OF
MC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^
M$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_
M.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*
MI_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_
MOC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS
M_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[Y
MH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z
M/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I
M_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@
M_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$J
MB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^
M:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A
M*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC
M\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\
MA*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[
MX_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?
M/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_
M[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C
M_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$J
MG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH
M^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*H
MO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OF
MC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^
M$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_
M.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*
MI_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_
MOC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS
M_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[Y
MH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z
M/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I
M_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@
M_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$J
MB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^
M:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A
M*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC
M\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\
MA*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[
MX_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?
M/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_
M[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C
M_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$J
MG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH
M^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*H
MO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OF
MC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^
M$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_
M.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*
MI_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_
MOC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS
M_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[Y
MH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z
M/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I
M_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@
M_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$J
MB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^
M:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A
M*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC
M\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\
MA*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[
MX_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?
M/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_
M[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C
M_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$J
MG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH
M^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*H
MO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OF
MC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^
M$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_
M.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*
MI_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_
MOC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS
M_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z/^$JB_OC\Z^?/^$JG_OFC_A*I_[Y
MH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I_P"^:/\ A*I_[YH ^@_^$JB_OC\Z
M/^$JB_OC\Z^?/^$JG_OFC_A*I_[YH ^@_P#A*HO[X_.C_A*HO[X_.OGS_A*I
M_P"^:/\ A*I_[YH N_\ ")R?W*/^$3D_N5[?_8,7]S]*3^P8O[GZ4 >(_P#"
M)R?W*/\ A$Y/[E>W_P!@Q?W/TH_L&+^Y^E 'B'_")R?W#^5'_")R?W*]N_L&
M+^Y^E+_8,7]S]* /$/\ A$Y/[E'_  B<G]RO;_[!B_N?I2'08O[GZ4 >(_\
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M\(G)_</Y4?\ ")R?W*]N_L&+^Y^E+_8,7]S]* /$/^$3D_N4?\(G)_<KV_\
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M$3D_N5[?_8,7]S]*/[!B_N?I0!XA_P (G)_</Y4?\(G)_<KV[^P8O[GZ4O\
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M^P8O[GZ4AT&+^Y^E 'B/_")R?W*/^$3D_N5[=_8,7]S]*7^P8O[GZ4 >(?\
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M$3D_N5[?_8,7]S]*/[!B_N?I0!XA_P (G)_</Y4?\(G)_<KV[^P8O[GZ4O\
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M^0/2CR/:KF*,4 4_(]J/LX]*N8HQ0!3\CVH\CVJYBC% %/[./2CR/:KF*,4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BD)H!H 6BBDS0 M%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !13 U*30 ZBF@YIU !13<\THH 6BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BD)Q2 YH =1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%(:;NYH ?4;FI*C<4 *AXI],0<4^@ H
MHHH **** "BBB@ HHHH **83S3A0 M%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%,)YIPH 6BBB@ HHHH **** "BBB@ HHHH **** (W
M-*AXI'%*@XH <>E1@\U(W2H1]Z@">BD'2EH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH @7K3VZ4!>:<1
MQ0 U*>>E-48IQZ4 1$_-4J]*A/WJF7I0 M%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M12'I0 9I:C#<U(* "BBB@ HHHH **** "BBB@ HHHH ,T4QCBE4YH =1110
M4444 %%%% !1110 4444 %%%% #'I$IS#-(HQ0 ^BBB@ HHHH **** "BBB@
M HHHH ***0]* #-&:C+<TJG- $E%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "-TJ(?>J4
M]*:%YH <.E!%+10 @%+110 4444 %%%% !1110 4444 1-UIZ]*0CFG"@!:*
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH B;K3UZ4A'-.% "
MT444 %%%% !1110 4444 %%%% !1110 A% %+10 C=*A ^:ICTIH'- #ATI:
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** #-%,8XI5- #J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***:QH 7-+4:G)J2@ HHHH
M **** "BBB@ HHHH **** "BBB@!H-.J%3S4HZ4 +2'I2T4 1$?-4B]*,<TM
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4C=*6B@"(#YJD'2DQS3J "BBB@ I#2TUN
ME ";J<#FH">:D0T 2444C=* $SS3JA!^:I1TH 8XI4Z4XC- % "T444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4TFG5$QYH D%+35Z4Z@ H
MHHH *0]*6D- $)'-.04_;2@4 +32:=43'F@"04M-7I3J "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ II-.J
M)CS0!(*6FKTIU !1110 4444 %%%% !1110 4444 %%%% !1110 4A.*6F/0
M X'-+4:&I* "BBB@ HHHH **** "BBB@ HHHH **** $)Q0#FFO2(: )****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "@T4C=* $SS
M3JA!^:I1TH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@"-Q2ITIQ% H 6BBB@ HHHH *#12-TH 3/-.J$'YJE'2@!::32FHV/- $
M@I::O2G4 %%%% !1110 4444 %%%% !1110 4444 %!HI&Z4 )GFG5"#\U2C
MI0 M%%% !36Z4ZD- $:CFI::!3J "BBB@ HHHH **** "BBB@ HHHH ****
M(E7FI!4/FBCSA0!/15<S@4Y9@: )J*0'(I: "BBB@ HHHH **** "BBB@ HH
MHH **** "BBD)P* %HJ)I0*C^T#UH LT56^T#UIPG!H GHI%.12T %%%% !1
M110 4444 %%%% !1110 4444 %%%% !129HS0 UCBE4YIC<TY.E #Z1NE(S8
M%0F<9Q0 [;3U&*B\X4OG"@">D/2HA**E4Y% # O-2"DQ030 M%(#2T %%%%
M!1110 4444 %%%% !1110 4444 %%%% !129I: $8\4T'FE?I3%ZT 2U&PYI
MY.!5:2X530!97I2U1-ZH'6H6U- >M &IFC-9)U5/44W^UD]10!KYI,\UD_VL
MGJ*9_:J9ZB@#:S2UDKJB'O4JZ@I[T :-1L.:BCN _>I@<T .7I2T44 %%%%
M!1110 4444 %%%% !1129H 6D)HS4,D@% $P-+543BG^>* )Z*K_ &@>M!G%
M %BBJXG%!G% %BBH//%)]H'K0!8HJN9Q0)Q0!8HJN9Q2^>* )Z*K_:!ZT&<4
M 6*C8<U&)Q2&<4 6%Z4M0"84><* )Z*@\X4><* )Z*K_ &@9J56W"@!]%%%
M!1110 4444 %%%% !113&?% #Z8PS4?G#-!E H D48I]5UF!J96S0 ZBBB@
MHHHH **** "BBB@ HHHH ***0G% ",,TBC%-:0"F^<* )Z*KFX'K0+@>M %B
MBHUD!J2@ HHHH **** "BBB@ HHHH **** "BBDS0 M(:6F2' H 4&G54\\
MTY;@'O0!9I#TJ#SQ3EE!H <%YJ2FCFG4 %%%% !1110 4444 %%%% !1110
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MD'^*@#N5O1CK2_;1ZUPXUL#C=3SK8_O4 =K]M'K1]L'K7$C6P?XJ&UL ?>H
M[$WP\P#-:]I,'0<UYFNM RCYJZS2-2$BJ,T =:.E+4<+;HP:DH **** "BBB
M@ HHHH 0]*HW$P4=:N2G$9-<MJNH"(D9H O?;!OZTDMX .M<9)K060_-4,VO
M#'WZ .WAO03UK8M9-ZUY;;ZZ-X&^N^T&[^T0@YSQ0!NT444 %%%% !1110 4
M444 %%%% !4<IPM257NFPE %&XN-O>JGVT>M9.M:AY /-<VNO D_-0!VSWP]
M:1+X%NM<6=9!_BI(M9'F?>H ](MK@-CFM%3D5Q.FZF&Q\U=3:7'F <T 7Z*.
MU% !1110 4444 %%%% !1110 5$QYJ6HF'- #UZ5#<MM2IUZ52U%ML1- &1<
MW>PGFF07X/>N<UG4?)+<UDVFN G[U '>-?#=UJS;W6YAS7 -K0W?>K7TS4Q)
M(HW4 =_$V5J6JEF^^$&K= !1110 4444 %%%% !1110 4444 %%%% !1110
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MXZTTW[YZU1/%. XS0!>-^^.M-6_?/6J6><4I&* +KW[^M*M\^.M41\U2 8%
M%@W\F[K3SJ#[>M466HV- %]-0?/6EDU!_6LT'%#'- &G;WSF5>>]>@>')G8I
M7FEFN9E^M>H^&8/D0T >BV1S;K5FJ]H,0BK% !1110 4444 %)FFL<4*<T ,
MN3B!OI7FOB2X9';FO2KK_4-]*\N\4C!<T <+=:BXF/-4Y-1D/>JMT_\ I+#W
MJ,C(H O6U](9EY[U[1X(E:2U7/I7B5E%F5?K7MO@E-MJOTH [6BBB@ HHHH
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M?Y:CWX:E\MO2F-&WI0!-OW"I$%5X5;/(JV!0 UH\\TQFVC%7D0&,FLRX/[S
MH  WS4YWXIBQL1G%*8G/8T "28J429JJT;CL:>BOCH: )V?BH"W-.V/Z&F^4
MWI0  YI&;%2QPMZ5'/$P/2@"YI_,RGWKU7PTX$:BO+--C;S%XKTSP[D;* /2
M+4_N14]5[/\ U JQ0 4444 %%%% #'%(@IY% % $5S_J&^E>8>*>=]>GW/\
MJ&^E>9>)Q\ST >5W2?Z4WUI=G%6;E!]H/UI-O% #[/Y95^M>T^"SFV7Z5XI$
M<2K]:]G\#G-JOTH [:BBB@ HHHH **** "BBB@ J)AS4M(10 W'RUD:L,0GZ
M5LXK*U@?N#]* /'/&"%PU<;IZ^6W-=YXG4$OFN)QM8XH L2MN&*HRVQ;YL5.
MK$N*TU@5H,T 9%DY@FKT'P[J@!4;J\]N1Y;G%:&B7S)*.3UH ^@-*NO.5>:V
M:X?PK>^8BY-=LC!AQ0 ZBBB@ HHHH **** "BBB@ J)AS4M(10 B]*Q?$/\
MQZM]*W*P_$7_ !ZM]* /%?$7,C_6L&U.W-=#KX_>/]:YI#AJ 'RC=*#74^&A
MBX2N:0;F%=1X>'^E)]: /9])'^B)]*OL.*I:2/\ 0T^E7R* &(*DI *6@ HH
MHH **** "BBB@!":;NI6Z5#F@"<&D)YIJ=*:YP: ),\50OKP0(235AY@J=:Y
M#Q1J BMFPW:@# \4ZT)%90U>>373.QYHU/4WGF89/6L]&)/- #I0SG-1B,@U
M?C4%>::T8S0!%%\M6"X(J)D..!1%&['H: ),9IIBR:M):N?X35V*P<K]TT 9
M:QX%&RM)K)P?NFF-9OC[IH S\4F15I[60?PFJ[P..QH ;D4R4Y3%.V$#D5$V
M<T 4U1O,S6Q93&,CFJJQBG$[!Q0!W>BZR(2H+5Z-I&HBXC!W9KY[747BE7!/
M6O4?"&J;XDW-0!Z@C;A3JJ6DP>/.:M YH 6BBB@ HHHH **** "BBB@ HHHH
M **** &N<*36%JU\$A89K8N7"Q,?:O/_ !#?%=PS0!SNK:AF5OFKE;V8RYYI
MVH7A:9N:I1OYAYH J-E30K9-2W2XZ5#$I)'% %K^"DA&9*F6%C'TIUM;.9>A
MH +B'*=*J);G/2NA^PLR#Y::-.8?PT 8GD'TI2-HQ6V=/;;]TUFSVCAONF@#
M/!PU/)!%*]NX[&FI&V>10 Y>!6?/&S2Y%7V^4U)'"'&30!8TN4Q8R:[C1M6V
M%1NK@2?+Z5/9Z@T<O6@#W73+\3JHS6\G2O-?">H>:R@FO2(G#(,>E "L^*;Y
ME13$YJ+<: /G9FS2*<4W-** (9SEJZKPTV&2N3F^]74^'!\Z4 >R:(<VR_2M
M:LC0_P#CU7Z5KT %%%% !1110 4444 %%%% !1110 4444 %5KW_ %#59JM>
M_P"H:@#S'Q5]QZ\S/_'PWUKTSQ7]QZ\RZW#?6@!\M7=*;_24^M4IN*M:7_Q\
MI]: /=O"QS8K]*Z&N=\*_P#'BOTKHJ "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@!&'%-5<&GT4 -DXC/TKS;Q;=;"XS7H=Q)MC;Z5Y#XSN?W[#- '!W
MQWW>[WJ82YBQ5:4[GS2Q$DXH &7)S5RT?8*$MRPZ4V13"* ([N;+4_2FVW:M
M[U2DR[9JQ9OY<@H ]G\.W^Z%$S78QGY :\J\+7A:5%S7J<'-NI]J )U.:?4:
M5)0 4444 %%%% !1110 4444 %%%% !1110 5#(F:FI"* (3\D9-<9XDO]L+
MKFNOO'"0-]*\H\47_P"\=<T <'J\GFW+?6L^W_=-FK,Y\R<FH+A=BYH L//Y
ME6;>#S.U9=J#(PKL=(TXR*#B@""UTW>PXKH;/0]X'RUIV.E8(RM=5I]@J@96
M@#FX?#V!]W]*L?V#_LUW"6B!1\HI_P!E3^Z* .".A?[-0S:!E?NUZ ;5/[HI
MK6B%?NB@#RN?P]AC\M8]]I'EJ?EKURYL$.?E%<YJFF!E.%H \BN[4H3Q519O
M+.*[+4])(W?+7(7UF\<G>@"99MRU7G.X4V/*C!IS#(H U_#4GDS@Y[U[%H5Y
MO5>:\1T^;R9 ?>O2_#&H;MHS0!Z9&VY:7;S5:REWH*NXH 0=*6BB@ HHHH *
M#110!EZE'N0UY[KMCYA;BO2[I-RUS.HV6_/% 'E$^D9D^[4\>CX3[M=J^D@O
M]VIQI8\O[M ' '2_F^[4J:5C^&NR_LKY_NU*-+X^[0!Q+Z7G^&H3I>#]VN\_
MLOC[M1-I7/W: .*_LKC[M,.E9_AKNQI7R_=I@TKYONT >=W=E]G&<8J@C9-=
MEXELO)B/%<3&<.?K0!>#X0BJ!7S+BK!;Y:;:#?=@>] &O:Z;OC!Q5S^Q^/NU
MT6DV >!3BMH:8-OW: //I-'_ -FHAI1'\->A/I8_NU6;2N?NT <5_97'W:9_
M9?/W:[L:5\OW:C&E?-]V@#CDTK'\-1SZ7G^&N[&E\?=J-]*S_#0!QMG8;)%X
MKO\ 0K7 4XK.CTO$H^6NLTJUV(O% &];#$0%34R,804^@ HHHH **** "BBB
M@"*Y_P!2WTKS3Q..7->EW'^I;Z5YKXH/#T >8W+?Z2P]Z1C@4RY/^EM]:&.5
MH ?!\TJ_6O:/ XQ:K]*\8M!^]7ZU[5X)_P"/9?I0!V=%%% !1110 4444 %%
M%% !1110 5EZQ_J#]*U*S-7_ -0?I0!Y!XJ?87KBX3YC&NO\8?QUQ^G<L<T
M2%=KBM".7]SBJ<Z_-0CG&* &3Q^8326T?DN#5E ":)@%'% '>>%;_9M&:].T
MZ?S8P<UX5HE]Y+J,]Z]<\.7@EA7GM0!U-%-4Y%.H **** "BBB@ HHHH ***
M* "L3Q ,VK?2MNL77_\ CV/TH \8\1?*[US$7S&NG\2\N_UKF+?@T 3*=KBN
MH\.\W2?6N6/+BNH\-_\ 'TE 'MFD_P#'FGTJ_5#2O^/-/I5^@ HHHH ****
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M R/[.!/2G_8!C&*U-HHP* ,?^SAGI3O[/'I6MM%&T4 9/]GCTI#IP]*U\"C
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M/6+(PS-Q6/"?GQ7HGB;3-H=MM>?E/+F8>] $LGW:R)21<@^]:K-D5GS19?-
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M8N!AJZKPTN62@#V#0_\ CU7Z5KUE:(,6P^E:M !1110 4444 %%%% !1110
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M@:,5X[X;OL;!FO4M,N-\2\T :STB4O5:51B@!U%%% !1110 4444 %8NO_\
M'L?I6U6)X@.+5OI0!XSXE^^_UKF+?K73>(>9'KF8_E- $I^^*ZCPW_Q])7,H
M,L*Z?P[Q=)]: /:]*_X\T^E7ZH:3_P >:?2K] !1110 4444 %%%% !1110
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MB0UTW@V;9<+]: /?;27?&OTJU6-I,V^->>U;- !1110 4444 %%%% !1110
M4444 %%%% !3)?\ 5M]*?3)?]6WTH \L\8M^\>O,KE,SY]Z]*\8_ZYOK7GEP
M/G- %65L18J[H2[YQ]:SY_NUK>&US.,^M 'K_A6+:BUV8Z5ROAP (OTKJQTH
M **** $)I :1Z1* )*0\"EIK_=H 8'YI7Z574G?4[?=H (Z+A<Q&A*=)RAH
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M%&:\7MYC'.*] \,WV74$T >M0MN05+5"RF#Q+SVJ\#0 M%%% !1110 4444
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MW4H.:AS4B4 //2H6XYJ>HIAA: *\C!QBN0\2V>^-CBNI0DR8JEK%L)(3QVH
M\.U2/R'-58;@;<9K9\70&%VP*Y**1A0!H3N"":O^&KG9?+SWK%D<F.I-'F,=
MV#[T ?0NBW8DA09[5T Z5P'A2[\Q4&:[]?NB@!:*** "BBB@ HHHH **** $
M)JE>OB%_I5QJR]0;$+_2@#Q/QL^;\_6LBW'[C-:/C(DZ@?K6?#_QZ_A0!5D?
M+8KK_!R9F7ZUQ+$^=7>>"P/-6@#US3TVHOTJ^352TQL'TJPW6@!YY%, YIZ]
M*7% "]J*2E[4 -)I14;=:>O2@!U%%% !52_0&U?Z5;J"[&8&'M0!XIXKM_\
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M/K51GP*M:,?]/0^] 'N>@?\ 'FGTK?QE:Y[P^_\ HB#VKHU^Z* &J,4^BB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH BN?]2WTKS/Q0WWZ]+N?]0WT
MKS+Q0/OT >7W1_TIJ =PHN_^/EJ$X% %BV&)5^M>T>"?^/5?I7C-N?WJ_6O9
M?!/_ !ZK]* .THHHH **** "BBB@ HHHH **** "LO6/]0?I6I67K'^H/TH
M\>\7?QUQUD<,:[/Q8N2]<3"=C&@"VXS)72>'.+I*YQ3N85TN@#%RA]Z /7(8
M]^G*/:O.?&FG[D<XKTG3V#62CVKG?$]CYT;<=J /#XH/(D/'>M!/F2K&JVGV
M>0\8YJK"_P F* *C';/74>'KO9,O/>N8E3Y\U>TNX,4PYH ]PT>]WHHS721-
MD5YMX=O]VT9KT&SEWJ* +M%%% !1110 4444 %8GB XM6^E;=8GB'_CU;Z4
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M0WO71-H3E_NFI%T%Q_": .K\$SEI%%>JI]P5YEX/T]X)ER#7IJ?<% #J***
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M>KZ-<B1%YKPBPN?LS YQ7J7A+4O/"_-0!Z&#Q2U#$^Y:?NYH ?132>*0')H
M?1110 5BZ_\ \>S?2MJL3Q"<6K?2@#QGQ)P[US%OR:Z7Q$VZ1_K7-0_*: )2
M<.*ZCPW_ ,?25S &7%=1X<XNDH ]KTK_ (\T^E7ZH:3_ ,>:?2K] !1110 4
M444 %%%% !1110 5B:U-Y<9Y[5MUR?BN?RH6Y[4 >9>*)?-=N:Y1"5:M?5KG
MS9&YK-2/(S0 ^0_N#5OPJI?4P/>LXR9;974^$+#_ $U7QWH ]BTFWV6T9QVK
M7JM9+MMD'M5F@ IN.:=10 4444 (10!BEHH **** "BBB@ I#R*6B@""1<<T
MR(Y.*GD&144:8- %*_L!<9R*QWT1=WW1768!%0M&">E '-+H"'G:*?\ V G]
MT5TRH .E.VCTH Q[#3%MFR!BM@=*, 4M !1110 4444 ':HF/-2U&1S0 Y>E
M.I%Z4M !61JBYC;Z5KU0OH]T;?2@#Q/Q8A^T-]:Y>-L/BN\\66GSNV*\XDFV
M7>WWH T+KB'-&BW)CG'/>EE^>V_"JMF/+ES[T >W>$[P.BY-=LL@(ZUX_P"&
M]3\D*,UZ'8:@)E'- '04A%,B;<N:DH :!3J** "BBB@ HHHH #TJI(WS5;JN
MZ9:@!Z_,E,:$$U*@P*<: *P@'I3O*P*E!IQZ4 9TQ*&H?,-6YHMQJ'R/:@#Y
MU!S3L5#$<FK)'RT 4Y?O"NN\-N%9,UR4OWJW=&G\MEYH ]ITBX46X^E:/VM?
M6N,TS4,6XY[5:_M/YOO4 =0;M1WH^V+ZURTNIX7[U1)JN?XJ .N^V+ZTOVQ?
M6N/;5>?O4X:IQ]Z@#K?MB^M+]L7UKCAJOS?>I[:IQ]Z@#K?MB^M'VQ?6N135
M<_Q4C:KS]Z@#L/MB^M)]L7UKDAJG'WJ8-5^;[U '8_;%]:3[8OK7)-JG'WJ1
M-5S_ !4 ==]L7UJ"[NU,)YKEVU7G[U)+J>Z(_-0!A>*)0R/7FQ_X^&^M=KKM
MSO5N:XK_ );-]: "4UHZ2?\ 24^M9TM7=*/^DI]: /=O"_\ QXK]*Z"N=\*G
M_05^E=%0 4444 %%%% !1110 4444 %%%% !1110 4UFVC-.JO>/LA)H Y3Q
MC=#["X![5X?-(6O'SZUZEXJO=\;IFO+)EQ<,?>@"88 JLB%[U/K3]]6K"#S+
MM#CO0!ZYX/LU^QHQ':NYA 5,"N:\*P[+!>.U=*IYQ0!+10** *>H1AK5_I7B
M7BFUQ>L<=Z]RNQFW8>U>3>*K;]X[8H X#(!Q4<N,4R=]MP1[TDC96@#0TN<Q
MR+@]Z]E\)3[[=<GM7AEI)ME7ZU[#X,G_ '"\]J .]ZFI#]VHXOF&:FQQ0!&O
M6I::!S3J "BBB@ HHHH **** "BBB@!"::W*FAS30<B@#E=>@#(YQ7DFO1;)
MVXKVO5HMT3\=J\B\2PXE;B@#D8G_ 'V*UE *5AH2+G\:VHFR@H I74CQR#::
M[/PQJICC4,U<E<Q[N:AAU VC@ XH ]OLM70X^:M^#4D91S7BFG:ZV!\U=38Z
MV6 ^:@#TH7BGO4B7"MWKBX]5R!\U:=GJ ?'S4 =,) :>#FLN*Y![U?CE!7K0
M!-13-X]:7>* '44F:6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *BF^[4M,D&5H \W\<9\EOI7DA_UI^M>O>.EQ U>2 9E/UH
MG0#RCGTIFDG_ (FR?6GDXC-1:2?^)LGUH ^A/#H']G1_2MP=*Y_PZW_$OC^E
M= .E "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% $-S_ *AOI7F7
MB;[SUZ=<_P"I;Z5YKXG'WZ /,[G_ (^#]:;VI+EO]*;ZTCG"T +'_KE^M>S^
M!O\ CU7Z5XQ;?-*OUKVGP0,6J_2@#M:*** "BBB@ HHHH **** "BBB@ K+U
MC_CW/TK4K+UC_4'Z4 >2^)3@M7&CDFNP\4'!>N-C.2: &MP]='X=R;M/K7./
M]^NF\-K_ *4GUH ]LT=?]"3Z5H,,U2TG_CR3Z5>H I75JLD39':O$_&UB5NV
M*CO7N\@_=M]*\P\7Z?YCNV* /+XCL&TU+@=:@NP8;G;[U*&_=T 5[AF'W:[;
MP7?&$J&-<>D?FM6I8W/V*1<'% 'O&G70FC&#VJ]U-<=X6O\ SX5R>U=C%\PS
M0!(?NTU.M28XI .: '4444 %8/B3_CT;Z5O5A>(QFU;Z4 >*:X?WK_6N?7K7
M0^(!B5_K7/0<F@">/[PKJ/#W_'TGUKE<X<5U/ASFZ2@#VO2?^/-/I5^J&E?\
M>:?2K] !1110 4444 %%%% !1110 5PGCERL#8]*[NN \>?\>[?2@#QVYD+2
MG/K5J$#R#]*HR_ZT_6KD3?N3]* ,],F_ ]Z]2\)6Z@H<5YA N=0'UKUKPJF%
M2@#T>W&(5^E2U'!_JE^E24 %%%% !1110 4444 %%%% !1110 F:6HF/-2+T
MH ",T 4M% !28I:* "BBB@ HHHH **** "BBB@ I,4M% !1110 5!.N4/TJ>
MF2#*&@#S7Q7;@I(<5XS?Q,NI?C7O'B2'<C\5Y'JMEB\+8[T 1)S; >U5P-K9
MJRO";:A<8H TK&],3#FN\T36 %7+5Y9YI0UHVFKM"0-U 'NUIJ\9C'-74U)&
M[UX_9>(6V@;_ -:W;/7"Q'S4 >DK=J>]2B<&N/M=4W ?-6I#? ]Z -\2 T\'
M-9<5T">M7XY05ZT 344W>*7<* %I,49I: $Z"HW?BGN<"JCOS0!.C9-355A.
M35J@!I4&DV#TI]% 'S#%'@U9(^6D&*?VH H3_*:L6,^QAS4%V/2H(F*T =O:
MZMLAQNI?[9^;[U<<;IU7K4!O7W=: .X?6-P^]40U;'\5<<MY)W-*]V_K0!V!
MU;/\5+_:_&-U<<MV^.M--V^[K0!V7]J]]U*=7S_%7'F[?;UIJW;YZT =D-6Q
M_%2'5L_Q5Q[W;^M"W;XZT =C_:_&-U)_:O?=7&F[?=UIYNWV]: .P.KY_BH&
MK8_BKC5NWSUI7NW]: .P.K9_BIW]K9&-U<:MV^.M"W;^9UH Z#4+CS(R<U@1
MG=*:M2S[H>M5+;F2@"288JYI:_Z2GUJM<\5<TC'VA/K0![AX5&+%?I715S_A
M?_CQ7Z5T% !1110 4444 %%%% !1110 4444 %-)Q3JB>@"0&L_5I-EHQ]JN
MJ>*QO$$P6Q?GM0!Y3K]YON'7-<K*N6)JYJMT7U%QGO4##Y<T 9LK;6Q74>';
M3SI$;%<G=G$H^M>D^"+7S(T)% 'I>@P^79J/:M4#FJ]A'Y<(%7,4 ****,T
M1S#,3#VK@O$]ENB=L5Z PR*Y_7[8-9.<=J /GW4(MEZWUJ,+N%:>MP[;U_K5
M*W7)H K@>7(/K7I7A"]VH@S7G5VNUABND\-791T&>] 'N>GR>9$#[5=K&T*7
MS+53GM6S0 4444 %%%% !1110 4444 %%%% #'%(HIY%&* ,^_BW1-]*\O\
M$MB69CBO6YTW1FN+URQWACB@#Q2YM3%.3BGQS8XS6[K-B49B!7+/N1S0!I[]
MXK+NH"TF15JW?-6_+5N: *=H&CQ6Y:W9CQS685"GBFR2E5XH Z=-7P!\U:=E
MK@7'S5YV;IP:EBOI%[T >M6^O#CYJTX=?&/OUY'!J<@'6KT6K."/FH ]937
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MY15/[;'ZT?;8_P"]0!:8XI%;-5&NT;H:E@?=0!9HHHH **** "BBB@ HHHH
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M55D4#=6K%.'[T 6J*13FEH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH @N#A#7GGC*3]VU>@W7W#7G'C$_NVH \RE^9S4;-M0BGN?G-0R<J:
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MCL:K%&!Z5WEUH9 )VUASZ858\4 8L>:FJR]J4[5"5Q0!$1Q4/\52.<569^:
M+)QMJ(MS41FXQ3/,YH GZTW:<U) -]6A!D4 0PS&-JVK74S&!S6.\.WFJ[3%
M.] 'I&C:P78 M7>:?>!P.:\0TC4"D@YKT;1=2W[>: /1H7W"IJS=/FWH.:T1
M0 M%%% !1110 4444 %%%% !1110 4444 %%%% !44WW:EJ.496@#SCQSS"U
M>1GB4_6O7O'*X@:O),9E/UH LK_JC3-)/_$V0>].!Q&:BTD_\39/K0!]">'A
M_P 2^/Z5N#I6#X=;_B7Q_2MX=* %HHHH **** "BBB@ HHHH **** "BBB@
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MT&?=;(,UX582;+U?K7L'ANXW0H,T =RO*BEID1S&*?0 4444 %%%% !1110
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M&H])'_$W3ZT >_>'!_H$?TKH1TK"\.K_ ,2^/Z5NCI0 M%%% !1110 4444
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M5 >M/<D&HF- '1^'Q^\'UKU[P]]Q:\?\-G,P^M>QZ /D6@#I.U%%% !1110
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MI>(S2:2/^)LA]Z#]RETC_D)I]: /?O#S?\2^,>U;HZ5SWA[_ (\8_I70CI0
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M(<,*ZCP[S=)]:Y4G$@KJ/#9_TI/K0![9I/\ QYI]*OU0TK_CS3Z5?H ****
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MN:K%XV^4U75<'- '3>'$_>K]:]@\/C"+7D/AQOWJ_6O7] /R+0!TG:BCM10
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MI7D@_P!8?K7K/CDY@:O),XE/UH G;_5FHM)_Y"J?6INL9J+21_Q-D^M 'O\
MX</^@1_2NA7I6!X=7_B7Q_2M\=* %HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** (KC_4M]*\U\4#AZ]*N?\ 4M]*\S\4-]^@#S"Y/^E-]:'/RTRZ
M/^E-]:,Y% $MKS*OUKVKP2/]&7Z5XQ:C$J_6O:/!/_'JOTH [.BBB@ HHHH
M**** "BBB@ HHHH *R]8_P!0?I6I67K'^H/TH \?\6=7KC+;J:[3Q6,EZXR
M8)H 9*?WE=+X:_X^T^M<Y*,R5TGAOB[3ZT >YZ1_QY)]*T*S]'_X\4^E:% !
M1110 4444 %(WW32TAZ4 <EKEOO#<5YIK>GE69L5['?6WF \5Q&NZ=^Z8XH
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M^AC%LOTK6K*T7_CV'TK5H **** "BBB@ HHHH **** "BBB@ HHHH *K7O\
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M,BI+G_CX/UIO:@!+?Y95^M>T^"#FU7Z5XM'_ *Y?K7L_@;_CU7Z4 =O1110
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MH **** "BBB@ HHHH **** "BBB@ HHHH *K7O\ J#5FJU[_ *@T >7^+?\
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M +5O_K5^M>R^"?\ CU7Z5XQ:G,J_6O9_!/\ QZK]* .THHHH **** "BBB@
MHHHH **** "LO6/]0?I6I67K'^H/TH \A\5=6KC8?O&NQ\5G!>N,MSEC0 YQ
M\]=%X<'^EI]:YYO]8*Z;PXO^E)]: /;='_X\D^E:%4-)_P"/)/I5^@ HHHH
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M]H["5GVFO=+FU$H(Q7*Z]HJFV9MO:@#Q!(S'-@U>."M2:C:F&[;CO58,1UH
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MN10!/X<THB13MKTO3K+8J\5E:+IHCVG;786\(51Q0!+ FU:GI ,4M !1110
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M ZO2/E@ K7S\M9]A%LC K0Q\M #5/-2U$HYJ6@ HHHH **** "BBB@ HHHH
M**** "JM\,V[5:J&Y7=$10!YAXA@RS\5Q#VA:5N.]>K:OIYDW<5S:Z*3(?EH
M X:7323]VMO1;,I*O'>NB?0S_=JW9Z5Y<B_+0!UFA+MMU'M6\O2LO3(MD0&*
MU!TH 6BBB@ HHHH **** "L[4FQ;/]*T:HW\>^!A[4 >(>)07U!A[U2MK$D
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MGW:BMM**7BG;WH [31%VVR?2NAC/%9>F0;(%&*U4&!0!)1110 4444 %%%%
M!1110 4444 %%%% !1110 4QC3Z8PH AF.86^E>>>(HRS/7HKKF,BN3U>P,F
MXXH \IEM";@\4DMF2O2NM;229C\M3?V,2/NT <$MF1,O'>O8/!,>RU7Z5R_]
M@GS =G>N[\.VGV>$#&.* .AHHHH **** "BBB@ HHHH **** "J5^N8C5VJM
MY_JZ /*O&%IYBMQ7!VVGE7/RUZ[K-C]IR,9K 302#]S]* .06Q).<5O:%:E+
MI>.]:XT4C^&M'3M+*3J=M ';Z:-MFOTJVIYJ"T3;;J*G4<T 24444 %%%% !
M1110 444AH 6BFYYIU !3'7*FGT4 <]J]GOA;BO,=7TS]ZWRU['>Q[HB*XS4
M-.WNWRT >7/IQ#'Y:061':NZ;12Q^[3?["/]V@#C4LCGI6]HEL4NEX[UK#12
MO\-7]/TPI.#MH [73.+11[5?4U4LX]L %6U% $E%%% !1110 4444 %%%% !
M1110 4444 %-(S2FFYYH IW=L)5Z5@7>ECGY:ZW&:J7$(;M0!YU?Z."#\M<I
M?:5M8_+7K=S9!E/%<[?:3N).V@#RV>PV=JJ" @]*[N]TG&?EK#ET\H3Q0!D(
MNT4CL15]K?':JTD- %$R'=BE8G;FIQ;$GI4OV4D8Q0!03+&K"PD]JO6VGDMT
MK6@THMCY: ,FWLR>U;&GV&^95Q6Q::.<?=K9T[2=DRG;0!9T[01Y:MMKH;33
MQ#CBK]I"$@48J1B%H =&N!534%S;O]*MQONJ.Z3=$P]J /']?M-UVQQWKF-0
MMBL9XKU#4],,DY.WO6%?Z$7C^[0!S7A*(FZ&1WKVC2$VHOTKSW0M(-M/DKCF
MO2--&%% &I1110 4444 %%-)I0: %HHHH **** "F.N13Z* ,RYLQ(.E<_J&
MAB0'Y:[+ J&6(,.E 'DNI:$(]WR5R=]9&)C@5[/J5@) >*X_4M$+[L+0!YD[
MLK8IZ@M717.@,)"=M1+I14_=H Q=A%*"16I=61C7I5(09[4 5V)Q4!)S5\P'
MTI%LR3TH I;3C-20PESTK22Q)'2M"TTPY'RT 9L5J1VJW#IOF.#MKH(=))Q\
MM;%II'3Y: ,S2]*Y'RUVFG::$"G;3;+3]A'RUT-O"%4<4 .MX=@'%6J0# I:
M &%:3;4E% &9_9J>E1OIR =*UZBEZ4 84E@F>E6+:T5<<5/)UJ6&@"Q%&%%2
MXI$Z4Z@!,4M%% !1110 4444 %%%% !1110 4444 %(PR*6B@"A<VJN#D53C
MTY-W2M>7I4,?WJ *ITY,=*A^Q*C<"M@]*J2?>H EMT"K5BHXONU)0 4444 %
M%%% !1110 5%,NY"*EIK_=- '-7%@CW.2.]:$&GIY8XILG^OK3@^X* *+Z<A
M'2EBTY$/ K1- H 9'&$&!4F*6B@ HHHH **** "BBB@ HHHH **** "BBB@
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M.Z5?CT]".E(/]=6C%TH J#3$STJ]! (A@5**=0 4444 %%%% !1110 4444
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$0!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image00006.jpg
<TEXT>
begin 644 image00006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0F!WT# 2(  A$! Q$!_\0
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M_BH =1110 4G>EI.] !WI:3O2T (*6D%+0 44E% "#K2GI0.M!H 4=**04M
M!1110 4G>EI.] !WH-%!H !TI&ZTHH/6@ %+2"EH **** "D[TM)WH .]!H[
MT&@ ;I0O2@T"@!:*** "FC[].IH^]0 O>@T=Z0T +VIJ]Z=VIH[T .'2EI!T
MI: "BBB@ I.]+2=Z #O0:.]!H .U H[4"@!:*** $7I0.M H%  :#1WH- "-
MT%.[4UNE+0 "CUI!UI:  =*!0*!0 &CO0:.]  :%H- H 6FMTIU-/(H #]VC
MM0?NT=J %[4"CM0* %HHHH #TI%I>U(* $_BI>]'>CO0 "@4"B@!3TJ-/OFG
MYIJ_>H 4_>IB=:?WIJ\&@!R]32CK2"@=30 -0W2@T&@!>XH-)WI30 HZ4G>E
M[4G>@!G\=._BI/XJ7^*@!32+U-*:0=30 'K33]ZG4A^]0 [M0WW:.U!^[0 #
M[M H'2B@ /2FCK3J0=: %% H% H 1NU+2'M2T )WI:3O1GF@!!U-(GWS3AWI
M%^\: '=Z!1WHH 6FM3J:U "_PT#I1VH'2@!$Z4O>FI]VGT -:C^&ANE ^[0
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M%!H% "4O:D-+VH 3O2]J;3A]V@ [4=Z.U)WH 3^.E--/WZ<:  =:6FC[U/H
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M!PZ4C&G4QZ '+THI$Z4IZT +2=Z#10 44&D- "CK2'K2BB@ H-'>B@ HHHH
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M+]P4Y/NT 2T4G:@4 )WIU,[T[M0 4M-'6G4 -/6@4AZT"@!U-<X6G5%*?DH
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M4]:1>IH/6@!QZ4=J0]*7M0 F>::YP*.])-]V@!RGY,TH/%1H?W0IP^[0 XT
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M7Z4D=*W2A* ']Z#TIHZTIH 8.M*>M ZTIZT **:U+FDH 1>AI(S2]C3(CR:
M&7/*8IT0Q&/I36^;BI@,)0 J=*B;_65*OW:8.7H F%)0*#0 A/%*IXJ-C3TZ
M4 *U-3[U*U(O6@!1UI6Z4T=:5NE #32CI332]J %S3EZ5%FI(^E #Z*** (G
M'-(O I[#FF]!0 U?O4Y.]&,#-+'WH 24<4U1P*D<9I .E #FZ4+]V@]*%Z4
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MYC4PJ-14E #7H6E;I2+0 X]*::>>E,[T +VI!3NU(* $/6DI6H% "4M(:%-
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M[@/M2 9<&@!)NHI'^ZM+-U%*P_=T /ZJ*)/NTD7,8IS<\4 ,7@4Y>](>*<E
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M)YH <W2FK2GI0* ''I3/XJ?VIG>@!QZ4BTIZ4U>M  ]"T-3A0 QJ1*>PIHH
M>.E+2#I2T ,_CIQI/XJ4]: &.VU<TR%MQ)J*^D\N+-)8/OBSZT 6?^6E/[TW
M^.E[T .HHHH 0]*@,HW[:G?A36*;G_3"N: -A3D4QN*;"V33WH 0_>6F22!&
M^M2'[RUFZI/Y4D?/4T :0.8P:;WIMLV^V4U)CF@!PHI0** &&G+TIO>GCI0
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MYIPZ4G>G"@ HHHH RM9G$4:\U)82>99HWO6%XPN_L\<?/>M#PW-Y^D1OUYH
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MF\^U#5?- #:7K2&D!H <1Q0!Q2GI1VH C?I2K]VF.:=G"T 0WK;+*5O1:R-
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MI7$Z[=>7XEB3/45VI.$)KR[Q)=_\5I"F?X: /2H#FUC/M5A?NBJEG\UC$?\
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M^=?06DOOLHF_V10!?_BI^.*9_%4O:@!H'!J-1\]2]JC'#4 *_2G?P4R0T_\
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M0!X7JUR;GQ"T><_-781:./[+W[>U</8Q&\\3,W7YOZU[3'9@:,%QVH \;O\
M-C?J>G->Z>&9?.T&U;U2O&/&MH8)1(!C%>K^!)_.\/6PST04 ;=P^V.?V6O
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MC!%*OWC2MU% $3GYZ6,YIL@^<TL- #P*;)]]:D'2FN,NM &%XU'_ !2.H?\
M7$UYQ\&&S;8]S7I/C3_D4=1_ZXFO,_@K_JB/K0![2?NTR'HWUJ3M4<7 /UH
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M#4:2;@*DE^Z* &RGD5+_  BJSMEQ5G^$4 'I4,YVE:E[BJ]T>5H +WG3I_\
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M0!-U6A#S3%;C%-9]G)H G_BIK'FH4G!:GL<F@!V.:6E]*&X!H 8C?.:E[&J
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M(<@4_O0 S=^^(]J<.15>239,3[4L4P(H G;J*1>]&<D&@=30 \=*6D'2E[4
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MJOI5R)HA@YJ+5)Q"IR<4 >'^*VW>/,_]-!7M.CS9MHUS_"*\+\1SAO&F[/\
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MWJZ3X:'_ (I&#ZUR_P 83_HMO_O5TWPS_P"10@^M '7M]ZD;[E._BII^Z:
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M?!7_ (]3^- 'L8^]1_ :0?>J.:410LQ- %:"3,[#T-7B:P[&<273X/>MH]J
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MC^/L,"OHC3I/,TJ)A_=% %YCPM>/?&CF_P!&_P"NM>OM]U:\>^,Q_P!.T?\
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M_P"_7NB]?PKPOP/_ ,CQ>_[]>YKU_"@!6/RFJ,WS6$_T-7,_*:J'_CRG^AH
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M@T <MX<OO.2Y;/W'(KGO%.L".[1-W>H_!%[YEIJA)^[,PKB?%^HL=610?XJ
M/4IY_/\ A]?-GK :Y;X)G]PP^M;5FY?X;7I/_/N:PO@E_JV_&@#V7_EIBL;Q
M-=_8]+DDSC%;)_UU</\ $N\\CP]-@\\4 6/#5S]H<-G.:[%ATKSKP#*9;:%C
MW KT=ATH 3. *=_A44AQCZU(#S^% '/^,)/+\-W#5YS\)DWWVH2?]-*[KQ_)
MY?A.Y-<?\'H\Q7S^K4 8/Q"C\GQCI\OK-7LNBOYFG0OZ@5Y+\5H_*UK39/\
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MS% %U_NUY!\96VSZ-_UV%>O/7D'QI_U^B_\ 784 =]HISX2_[9G^5>4>#/\
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M5>#$_P!F^,_+''S 5[E</GP\[>L/]* /'O!5SY>GZP<_\O#?SKG[^W.H:KN
MSAJL^';CRM-UCG_EX;^=:WA.R^WW3L1G#4 =B(#;_#R\0C'[@USWP7&V GZU
MVVOV_P!F\%7R8Q^Y-<9\'QML0?<T >P-]XM[5Y-\1[W[1;R6H.23TKU>1L0.
MW^R:\&\1W1N_%:VV<@D\4 =]X!MC'909'117H3=JYCPK:^39QC'05TK_ 'A0
M V4=/K3A]_\ "B0=*0?ZW\* .+^)<FSPE<#WK&^$$.W3;EO[QJ_\5I-GAF9?
M4BE^%D.S12V/O 4 <W\7X\7&GOZ/7>>!I/,\-6_TKC_C!'^ZM']#72?#B7S/
M#5O]* +GCM-WAV3Z&N)^#TN(+E#_ ,]37?\ C!/,T*4?[)KS7X3R;+RXC]93
M_.@#V-.&;ZU3UAO+TJX?T0U=Z2#WK+\3OY?AV^?TC- 'FGPY)F\<ZA+V*UW/
MCFZ^S:.3G&:X;X3#S=9N9_[PK>^*]UY&B#G&6H \QALS?732@9YJ;4]'9;0G
M;T%='X&T_P"VV!E(SS73ZOH@_LZ0[>U '-?#2Z^SW+0DXR0*]*\6G'ANZ/\
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M,O)ZXD%>S^'XO*T>)?84 ::\-4IJ!N)!4_:@!>U1M\R$>U/;[M1J<YH I"$
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M%?B*,_$:#Z"O:-*.-.M1_P!,Q0!>:O'_ (U?Z[1O^NPKU]NAKQ_XU?ZS1O\
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M^W>*[]^NV2@#VS2[8)I<8QVKC_B':_\ $B) [UWMNFRU1?:N<\:VWG:'(,=
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M_8?B':KTW&O=[([K.,^HH M"@T#I0: $%(:.]':@#SGXK?\ ('/^[6O\-?\
MD4K3_=K'^+)QHY_W:U_AH?\ BD;3_=H [*D'2EIHZ4 /HH[44 07G_'I)]*\
M)L_^2GW/X5[M>?\ 'I)]*\'L_P#DJ5T/I0!Z+\0K?S_"QX_AKSGX17'DZA)"
M3_RT->M>*(//\.,N,_)_2O$? $_V7Q<T/3,A_G0!]&1GO7D/QLYOM%_ZZUZ[
M$<VX;VKR'XT\WNB?]=: /1?"G_(O6WTKS+XL3DZBL0/<5Z;X4_Y $'TKR+XG
M2^9XM2'W% 'H'PWM FAY(ZFNFURV#Z5,,=JH^#(/L^B1C&,@5N7R>99NOJ*
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M_A.<7UZOH:]=;J* '8^0UXEXT&/B%;C_ &:]N_AKQ/QOQ\1;8?[- 'L.E_\
M(-M_]P58D^X?I5;3?^09;_[@JQ+_ *IC[4 >$7Y_XN1.?1Q6[XRNO,7:#_#7
M/:DVWQ]=-Z-5K6)S<S!<YH Y>.-@AZ]:[WP;>[;V%":YU[':O3MFE\-79BUZ
M-,_Q4 >ZS'=&I]J\,U/YOB)(?[L@->X1G?9(W^S7AU^<^.[QO[K9H WO&MSY
MT2J#V%<'%&RR;O>NHU:8W<@7K5*2QV0[L4 =7X-OL3QQDUZA]Y4/M7A/AJ^,
M6N11Y[U[K;'?;1-[4 2MP!3EZ5'*<;:?0!Y+\8&Q /J*T/!M^L>C0@G^$5D?
M&A]EO^58GA_5?)TF,;OX10!ZNNK(&'S51U;5%-I+@_PUY^WB+$GWOUJ.\UWS
M+9QNZB@#&MLWGBOU^8?SKV_4X]OAHH/^>?\ 2O%_!D?VOQ)OZU[EJ,>[3/+_
M -C^E 'F/PNM2FK7C$?\MC7LW<5Y[X$T_P"S7ETV.LA->AF@#C_B,H;PW<'T
MC-<M\&&SI0^IKJOB(?\ BF;G_KF:Y/X+?\@K\30!C?$,?\7%@^@KV32_^/"U
M_P"N8KQWXA?\E#@^@KV/2Q_Q+K4_],Q0!<;H:\?^-7W]&_ZZBO7I#BO(OC3_
M *W1O^NHH [OP]_R)W_;,_RKRWP7_P E0?Z&O5- &/!__;,_RKRKP6?^+HO]
M#0![RO0TV/J:<G0TV/JU $=Y_P >[_2OFGQ$3_PL*[QZ5]+7?_'O)]*^:]>7
M=\1+H4 7=[X'-&]_4U?^R<#CM2?9/:@"FDCAQS6%XD9CJNFY_P">@KJOLN.<
M5S?BJ+R]0TL^L@H ^A?"/_(OP?2O*_&MLTOQ#0XXXKU3PC_R+UO]*X_Q%I_G
M>,EEQV% '=V*;-'B'^P*GMAF%P?2G0)BPC7_ &13XQMB?Z4 ?/LWR_%/C_GX
MKTOXF_\ (N?\!_I7FTXS\4<_]-Z])^)O_(MG_=_I0!1^#9!\*-Z[S7?P@_:*
M\X^#,O\ Q317_;->F1)B7- 'EGQ*L_,\2Z>X'2O0O#R[=+@'^S6%XRL/M.I6
MTF,[:Z72$\NPB'M0!XMXP;'Q!7_KJ*]PT[_CQA/^R*\*\9MCXAJ/^FHKW+3C
M_P 2Z'_=% 'G?QC_ .0"WU%;/PY_Y%V'_KF*Q?C'_P B^Q]Q6Y\.QCPY!_US
M% 'B^K1[OB;)_P!=Z^B]%3R]-B^E> WD6_XFR?\ 7>OH.R&RPB'M0!:E^:)A
M[5X-KB>3\5;<#NM>[!LDCVKP_P 5KL^+-H/5* /3_$<FSP=(W^Q7F?PBB\[7
M-2<\_/7H?BY]G@F0_P#3.N)^#,7^F:@_J: /8CP%6LOQ'&)-(F'^P?Y5I,W[
MW%5-8&_3[@?],S_*@#YW\&C9XY(_VS_.O;_&1_XH^7_<KQ+PN-GCQA_MG^=>
MU>,S_P 4;+_N4 <C\'R/.O\ ZUZD_,OXUY)\()<3WX]Z]=4;B#0!YE\3[3S%
MA8#_ ):"NR\&(4T1 ?05G>-[+[3%%QGYQ6_H$/D:<B^PH UZ*** /)?C%_QZ
M0?6NF^%__(G0?6N;^,(_T.#ZUTGPP_Y$Z#ZT =EVI::3Q0#0 -7S]XN_Y*';
M_P#7<5]!-7S]XN_Y*'!_UW% 'O5C_P >4?\ NBISTJ"P_P"/./\ W14[=* &
M3?ZNJ&H_\@J;_=K0DY7%4-5&-)F_W: /#O#DXB\;7IS_ !UZK_:BB51FO#K2
M\\CQG>G/\==;)KN+@#=0!Z=<:H@CZ]J\O\=7_G$JIZBI[SQ!A!\W:N1U6^-[
M=HN<YH ])^%-L8[>5R/O<UZ>W45QG@"S^SZ:K8QN45V;?>% #Z:.E*:!TH 7
MO0W2CO0W2@#PGQ5_R4"Q_P"NXKW&#_CW3Z"O#_%7_)0+'_KN*]QA_P!0GT%
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M'H* ,;Q=_P B9J/_ %Q->:_!3_4,?K7I7BW_ )$O4?\ KB:\W^#(VZ?(_LU
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M^S0!J#I0:!0: &'K3ATI.].[4 >:_%K_ )!!_P!VM?X9_P#(HVG^[61\6?\
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MSKQ'79_+\9WONU &W91M<W&>M=!=:?\ Z$>.U5?"MI]H*MC-=I<:?FU(QVH
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MV[O0!KZI;K<%7ZXJY9KMMXQZ"HHR)H,U-;G@#TH \&\:_P#)1%_ZZBO<]/\
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M0GYJ /,_B/*'\6P$'_ELO\Z]B^]X:'_7#^E>">+[S[3XKM^<_OE_G7T!&O\
MQ3?_ &P_I0!XI\-[</XUN&QTG;^=?0;_ .I(]*\+^%\>[Q3>-Z3M_.O<@=P<
M4 8OBW_D3-1'_3$UYI\)9!%HLI)[-7I/B\_\4CJ(_P"F)KR'X?7?V?0Y><<-
M0!F^(;LW'B3R\Y&_^M>X>$H!#I41]5%?/'G_ &KQ<!G/S_UKZ2T1?+TN$?[
MH U'IP^[33T%/'W:  =*9)]PGVI2<4V8XMW/L: /"O&K^=\0;5.O%>SZ7A=(
MMU]$%>(:[)Y_Q)MAUQ7M%E)ML85]%H C\3@2>&KP?],S7E_PD<)KUS'[&O2M
M<EWZ'>+_ -,S7E'PUF\KQ?<IGM0![I(/E8>HKPW5U^S?%JT/3*U[F>?Q%>)^
M,E\CXEVDG3Y: /9[=MUO$?:O./BU+B*TC_O'%>@Z8WF:?"W^S7F7Q:DS>Z;'
MZOB@#JO $?E>'(O]VO/=682_%%E/0 5Z9X3C\GP['_NUY3J$O_%SY&S_  T
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MO)\:WAS_ ,MF_G57QA=^=K;<]'H ]D\!VP_L2WDQU%=E)VKE_ 7_ "+-L?\
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MU%>O8X->1?&G_6Z-_P!=A0!WF@_\B?\ ]LC_ "KRKP5_R5%OH:]5T'_D3_\
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MZF/_ '17COQHMO\ 1_-QT KV*+[D8_V17F_Q=M/.T61L=!0!#\)KKS-,5,]
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MM>&:)\OQ-O\ _KO7N3\A: '@Y>O$_&__ "5ZR_ZYU[8OWZ\3\;_\E>LO^N=
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M )*';_\ 7<5] >M?/_B__DH=O_UW% 'O-A_QY1_[HJ?M4-C_ ,>4?^Z*F[4
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M]:\=^&3;?$=XOM7L,O\ J1]: 'IQ%7!_%(?\4]*?:N\/RPBN#^*9QX9F/M0
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M'3B.[7TKK_'7_(HW=<?\(./MGUH ]7'WS3\4WUJ1>E 'D7Q=X5?J*[3P)_R
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M\*@./B3-]17NMS_QY2?[M>$1_P#)2IOJ* />H3^XC_W13\U'#_J(_P#=%/H
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M_P B?!0!V(H/6@=*0]: %[5\_P#BW_DH=O\ ]=Q7T >GX5X!XL_Y*'!_UW%
M'O%C_P ><?\ NBI^U0V7_'G'_NBINU "'J*I:U_R"9O]VKK=JHZR?^)3/_NT
M >,>"N?'%[_OU[C(<(M>'>!_^1XOO]^O;Y_N+0!,/N5"6^:I5/R57;[] %EO
M]72#[@I/^65*/N"@!&^Z*D[4QONBG]J #O0W2CO0W2@#PGQ5_P E"L?^NXKW
M.'_5+]!7A?BO_DH=A_U\"O=8O]4GT%  >M/IC?>IXZ4 %!Z44AZ4 5YA\K-[
M5Y#\0=1*LT8/>O7;MMEH[>@KP'QI,UWJI13_ !4 =!X!T[SH/.*_Q5ZY;IY=
MNJ^U<9\.K(1Z)EASFNX(PO% !W6O*?BLG[RU;_IH*]6/5:\Q^+"XAMV_VZ .
MN\%/N\.Q'VK?^[&?K7,^ 7W^&8S732?ZK\: &W1Q9.?:O#_"(\SXA:B?2:O;
M-1;;IKG_ &:\5\"?O/'6IM_TUH U?C F'T]O^FHKT'P6^_P]"?:N%^,:_N+%
MO22NR\ /O\,PF@#I\<56U!MME(?:K54-8;;I\GTH \3\#C?X_P!2;_IM7O(_
MI7A7P\7?XVU1O^FU>[#^E #4ZTRZ.+27_=-/7[U1W?\ QYR_[IH \)T-\_$U
M/^NAKWOTKY_T Y^)R_\ 70U[^QP5H ;,V"*>.4%0W'5?K4J'Y!0 R7[V/:O(
M/B9=?Z2L.>HKU]_OGZ5X9\19#)XEAA!ZT ;OAS1@]C!)MZJ#7;6M@$5!CI1X
M9LE71+8D<[!6\L*A1@4 >!?$L;/%%H/^FZ_SKVB?CPPI_P"G?^E>,_%(8\76
MH_Z;K_.O9KG_ )%9?^O?^E 'DOPI&?$=X?\ INW\Z]S8_-BO#?A-_P C!>_]
M=V_G7N)^_0!C>,!CPCJ7_7$UX+\+++[3J;'&<,3^M>]^,O\ D4-2_P"N)KR#
MX*6X>\D8CUH ['XD6>[PSTZ5D?""Y_=O%GH]=IX^MA+X>D4#H*\U^%4Y@U:2
M$GK(: /=F/-._AJ/K@U)_!0 Q.IKG?&LWE:!*<]0171+UKC_ (CR^5X:8^IQ
M0!Y=X%TS[2;J7;G]Z:Z^'0P7<[>]0_"ZT#Z7<.1UD->@6]DH#G;0!Y[_ &($
MO%.WO7'>)[3[)XABDQC,@KVJ:Q7SE.WO7E_Q*@%O>P2 8_>"@#UKPQ)YFC1'
MV%<I\6(=_A^1O0BM_P $R>;X>B-9_P 3(O,\,34 0?#R;/AS']U*XB(?:?'S
M]]LU=/\ #B;.@W _NBN;\.KY_CR[/7;+0![)*O\ H3#_ &:\&N8=_P 29![5
M[[,/]'<?[->&RJ%^)K9]* /0GTH/"GR_PBF#1P%^[76PVRM;QG'\(I_V5<'B
M@#F(]."1$8ZT>)(_*\%SKZ1FMJ^V0!0>]97BPAO"%P1_SS- '/?!O_D63_UT
M:O2L9C(]Z\U^#7_(M'_KHU>F1\@T 9VN?+HLW^[7EGPA^;Q)K_\ OUZEXA_Y
M L_TKR[X-\^(]?\ ]^@"?XUC$&D_]=A7?^#.?#L/^[7!?&[_ %.E?]=A7>>"
MO^1<@^E '0+P*\Y^+K?\4K<#VKT8=*\S^+[X\.3#U% $_@<?\4(O_7&O//#U
MOYWCG4%QWKT;P.,^!4'_ $QKB/"2 ?$"^![F@#O8]+&[;M[4W^QPLN[;75QV
MR_:.G:I9K50N<4 <RFF@2+Q76V8V6Z+Z"LRY*0SQJ>XK4MSE 10!8%!Z4+0>
ME "=J#]VE[4C=* /./BP?^)*?]VM;X9_\BA:?[M9'Q8_Y I_W:U_AG_R)]G_
M +M '94G:EIO\- #^U% Z44 07?_ !ZR?2O!]-_Y*S>'V%>\7G_'I)]*\&T\
MX^*MT?I0![FGWT_W:9K$7FZ9*OJ*>O5#_LBIKA=]LR^U 'S?I8^Q^-9NW[XU
MT?Q4D\W^PV_VQ6#JZ?8O&#OTS*:TOB'+YMKH+>KB@#UC0.?!H_ZYG^5>/Z-!
MYOQ!E7'8U[!X=&?!RC_IF?Y5Y=X>4+\2I ?0T =Y_9("$[:;_8X\IOEZUUS6
MR^2#BC[,HC QUH YNUTP(B_+6Z$V::T?^S1<E+?8#WJ4X>#CH: /(-*'V?XG
MNO3*U=^(I\WQ/:1>J"JD_P"X^*A[?+5KQJ?,\=Z>GK$* /2[.+_BFH4_Z95Y
M;X,;R/'6I+ZR5ZY9)_Q)XE_V*\>T1O)^(=X/6:@!GBO][X]1?205[/8C$40_
MV!7C&L_O?B0R^CBO:K886/\ W!0!;HHHH 1ONFJ\G(3ZU._W#4#?=7ZT >4_
M&5O^)="/^F@KJ_AP<^&U_"N2^,?_ !YQ?]=!76?#3_D6U_"@#JB/W;U4UH9\
M/W _V#5YA\K55U89T6<?[% 'D'P\?9XNO$KVAQF-:\0\$MY?CJ\7WKW$_<7Z
M4 -N#M@K@/BJV/"TO^Z*[VZ.8<>]>=_%J3;X:=?510!>^&2[?#\)]4KS.\.W
MXN7'O**]3^'";?#-H?6,5Y7?\_%R;_KJ* /H>#_4I_NBH[D8LY_]P_RJ2W_U
M2?[HIMY_QY3_ .X?Y4 ?+NFV_P!H\9W:XS^_/\Z]LU6PW>%0N.D=>2^%(?-\
M=70(_P"6[?SKWJ_MP="9,?P4 >/> YO(\1RP],-7NZ_,J_2OGS0G-IXYF4\
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MW^E 'LNF\Z7!_N"K)'[L_2JVF?\ (+M_]P5;/W* /G+QUQ\1+/\ Z^%_G7T
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M7;IJ@?W:FA.+;)["@#P3XH<^+[?_ *[K_.O9)N?"H_ZX?TKQGXD.)/%\&/\
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MF@KI?AO_ ,BXM '7L.#5?45SIDR_[-6Z@O1FRD'M0!X9X8;ROB'>+_M5[O\
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MWZ-O Z*37D-K<G_A&UC)Z9H ]=^#_/A@_P"^:]&/(KSKX/<>&#_OFO11]TT
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MWKO5;G- 'E_QE;&DL/5:Z+X?'/@_31Z(*Y3XRR[K$*#U%=5\._\ D4K >B4
M>9>,C_Q<11_TU%>Z::,6$/\ NBO"?&7'Q&7_ *ZK7NUBX^PP_P"Z* /._C-_
MR+K'_:%=!\//^18@_P"N0K ^,W_(M,?]H5O?#KGPO!_UR'\J /,M/.?BC<C_
M *;U[T#E@/:O =./_%T[K_KXKWR(YEQ[4 2GTKQ#QOQ\7;+_ *YU[=_'BO$/
M'7'Q=LO^N8H ])\01^9X3*^L=>7_  [G^R^(;J/.-SXKUK4$\SPV%]4KQ309
M39^,W7IF6@#Z$3G!KGO&=UY&DR\]5(K;MY@85.>U<1\1[O;I; 'K0!X_X'^;
MQZ&]6/\ .O8/B+QX98_[->0> A_Q6B$]R:]A^(ZY\*.?]F@"/X82^9I+#T45
MZ$O"+7E_PHG!LI$)Z"O3G; 6@#BOB>?^*?(K/^"XQX7F_P"NIJ?XGR@Z*5SW
MJ/X.+M\,2_\ 70T >D4M)WI: /)?C(/]%M?]ZNH^&@_XI""N9^,G_'I:_P"]
M71_#>4+X2@&: .R ^6E%0^<N.M+YP]: )''-> >+!GXB6_\ UW%>^"0-WKP7
MQ7Q\0[<_]-Q0![Q:#%K'_NBIZJ6TP%O'S_"*E\X>M $IZ5FZP,:5<?[M7#.O
MK5+5V#:1.1_=H \;\##_ (KB^/\ MU[H.P]J\.\#?\CK??[]>XK][\* &X^:
MI3]VD(YIW:@",#Y33A]VEQQ2@<4 -/04^FGH*=0 G>D-*::: /#O%O\ R4#3
M_P#KX%>X+_JD^@KQ#Q9_R4#3_P#KX%>W+_J4^@H ?FG5'4G:@ I#TI:0T <A
MX^G\C1&&?O BN+^&%G_IC3XZDUT7Q4F\K1XAGJ<56^&<2KIBR^IH ]%D7Y:6
M,82F-*I[T"8 =: 'D<BN#^*4/G:*O'W>:[L.&Z5ROCV'SM#DXZ*: ,'X3SYT
ML19Z$UZ2:\A^%%SMF:(GH37KI;- '->.I_*\/3\_PUP/PEASJ%]+_>;-=5\2
MKD)X?F /\-8WPE@Q:SRX^\,T :_Q.B\W0\_W035/X3W&[043/1C6UXZB\WP]
M.?1#7'?":YVV7ED]&- 'K[C)%<MXZG\C1)6S_#74[L@&N!^)]R$\/S8/:@#"
M^%B?Z9=R_P!]LUZWT:O+?A?%BT$G]X9KU)NU !_'FHKG_CWE_P!PU-45S_J)
M?]PT >$>&_\ DIO_ &U->\/R:\%\-G_BYO\ VU/\Z][ R30 ]!\@IDHY%2KP
MHIKCD4 )+Q WTKP/73L^)]F_H37OD_\ J&^E> >*?W?Q M7]#0![O;'?ID9]
M5HD;R[&0^BU%I$@DTF#GJ@IFIRB+3;CGHAH \"\83?:/%L)Z_OE_G7NDG'A?
M_MA_2OGK5Y?-\40L?^>P_G7T'*P/AC_MA_2@#R;X4_\ (QWO_7=OYU[JO4UX
M5\)_^1AO?^N[?SKW1/O-0!B^,O\ D4-2_P"N)KSCX)G_ $0CZUZ/XS_Y%#4O
M^N)KS3X)']PP^M 'L,HW+(/]DUX!XGB^Q^,H[CI@U] ==WTKP[XG0?9KOSP,
M8- 'L/AZ;SM(MVSU05ILV'KF?!%QYOA^T.?^68KHI3B4?6@"63H*\C^+\_F6
M\=OG^,&O6Y.@KQ'XH3>9KZ09[B@#T#X>)LT.,>PKKI?N&N8\$)LTF,>PKIY?
MNT +%_JQ7FOQDB\S08?9J])C^Y7!_%2+S= 7V)H I_"67_B0*G^U79>)%WZ1
M*OM7GWPEF_T+R\]&->CZRN^RD7_9H \9\*S?9H=87.,R&MWX5IG6-4D_O&N2
MMI?LTFJ+TS(:[;X5I\]Y)_>H ]0/,=>&^/%\GQ@DO^T*]R',=>)_$]/+U>.7
M_;% 'KF@R^;I,)_V!5RVZO\ 6L/P?<"71(^?X16S"VWS#[T >2_$V;?J=JF>
MC5TCC'PVD'_3$_RKB_'LWG>(H$!SB2NXN5V_#N4?],3_ "H RO@U_P B\P_Z
M:-7IR\&O+_@R?^)"P_VVKU$]: *.N?\ ()F^E>6?!_\ Y&?Q!_UTKU/6_P#D
M%2_[M>6?"#_D:/$'_72@"Y\:US96!])*ZCX=R>9X9B^E<[\9DW:7:GT:M+X8
M7 ;PY&N: .YBXS7B/QLN>%CSU%>V[MH)KY\^-$^^^0 T >H_#9?^*0MO>(5Y
MWKQ^S>.R_3,@KTGX:C_BDK3_ *Y"O-?'H-OXMC?IF04 >VZ7)YUA$WL*O2?<
M/TK%\+S"71X3GM6O<.%C;Z4 >*^.[CS?%MJN>E>NZ",:-;?[@KQ'Q-*;CQM
M!S@U[AHPVZ1;C_8% &D*#2"G4 -[TPGYJ>>M1?QT >?_ !7XT1O]VM+X:'_B
MD;/_ ':R_BUQH;?[M:/PS/\ Q2%G_NT =NW2FC[M*W2D'W: ']J*** (+S_C
MTD^E> +Q\3YOJ*]_O/\ CTD^E> '_DITW^\* /?4_P"/6+_=%2Y^8#VJ./\
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MI* /?M%;=X1S_P!,C_*O)/!/_)5'^AKU3PVV[P7G_IF?Y5Y;X('_ !=%S]:
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MOV+Q?OZ?O:]^M5WZ1"/]BO"_',1M=;$@&/GS0!Z99ZR#:*=W:N2\8WOVVTV
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MO[PKRSQ:3#KLZ_WI#7KWPYBV:3&W]Y: .Z7[N*\?^*\/SI)CHXKV%>N*\O\
MBK!FRWXZ&@"_X O]^FHF>G%=;<S^3;R-FO*?AQ?G&PGHU>@>(+KRM,=@>U '
MD^KS?;O%<8SG$E>GZPGE>!)E_P"F1_E7D.A.;[QASSB6O9O%B>5X1G7_ *9'
M^5 '+_!@_P#$D8?[;5ZH?O5Y3\&>-(8?[9KU8_>H S==.-,E_P!VO+OA ?\
MBJ-?_P"NE>G>(3C39/\ =KS#X0<>)]>_ZZ4 =!\6H?-T:,XZ'-8OPSU#9IR0
MY[UU7Q(A\W0F..@->4^ [\PWBQ9_BH ]WU"?R;3?GM7@'Q0/VIO-Z[:]I\27
M7EZ,&!_A%>+^*U^U:'<3==IH ]=^&A_XI2S_ .N8KA/B;;[=9BEQ_P M*[CX
M9G_BE[0?],Q7/?%&V^:.3'\5 '0>"K[=IT4>>@K?UJ[\BV8Y_AKSKP+??,L9
M/2NE\9WODZ>2#_#0!YH%^W>,8WZX:O>--7;I\*^BUX?X-C^V>(%D/.&KW6U7
M;$%]!0!.*?313J $/6HOXZE-1X^>@#SGXN'_ (D;_P"[6E\,_P#D3[+_ ':S
M/BY_R!6_W:U/AJ,>#K'_ ': .V;I2#[M#=*5?NT .HHHH @O?^/.7_=KP$<_
M$N4_[0KWR_\ ^/*7_=KP.$9^(\I_VA0![Y'_ ,>T7^Z*>WW@:CC_ -1%_NBI
M)/N9H X_Q];^=I4AQ_#7S0X\OQ)&GI)7U7XH@\[1Y>/X:^6M3C,?BY%_Z:T
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MX*M#HE5K'_D&0?[@JS_<H \S^+<.^R@;T:D\ :ALT:.(GO6G\38/,TM3CI7
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M>-B4Z9'*!QEJ .\\47GVJSB .>*XSQ19G[#I38_CK3ANC?6\()SQ6AXGL?\
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MB'^S7'>+=-%S S[<X% 'CULC):$>U:OANT:27)%/ELO+3;BNF\*:;^Z+X[4
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M/]FJ_P 18O-TQA[5H^"(_+\-6B^@H ZANE"]*&Z4=J '4444 5K_ /X\9?\
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MZ=ZUM/@\C3Y>.B&@#R*+]Y\4XB.P->Y1<VZJ?2O#='_??$Q6],U[?$V H]J
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MTGK2FDH \WU>UW>)X7Q_RTKT6#B,?2N5U"TW:Q$^/XZZN/A?PH ?2U&#4E
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M]<=*TL#-+@4 4(+18G! I);82RG(J\V 14:?ZQJ *7V!?2C[ OI6B ,T[ H
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M/"4 +C"FFCD4X_<I(^] "J, U&QX_&I,]:B8?)^- $N/F!]J:W>G],4P_=-
M"YX6CN::?X*>>] #1RE"?<-*G^KI%^X: *.HIYNG3+ZBO!IV-EXDDQQF2OH"
M1=UO(*\&\46QBU]W _CH ](TR^W:=G/\-<3XVORVGA0>K5=T[4?+T_;GM7,>
M('-W"BCGYZ .X^%EOMM_,QU->I]0:X3X=6WDZ:O%=QN^;% %6(_O7]C5E#FJ
M\*_O9#[U.O!H DQA:2/[II2<BDC^[0 ^G4G:EH C'WS0_K1_&:'Z4 ,4\TN:
M1*,4 .'-.4<FFKTIXZT )_%3CTI#UI6Z4 12G$1I@_U6:?+S":;C]S^% #E/
MR+0G^M(I%X5:5?\ 7F@":BBB@ HHHH *0TM(>M !1110!$3\U**:?OT\=*
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M ./^KI1]VC^"E'W: $I*=24 *.E.IHZ4Z@ J-NM25&>M #!]ZGN,BFCK3^]
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MD_AJ-OOTX'Y:  =#28RPIRT+U-  ?O4UUW"G-2KR* &QC I6'.:4\4IZ4 1
M?/2R\BCO2MS0 V,4JKBE3K3B/EH :W*&G+PHI!]VG=A0 M%%% "=Z*#UI*
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MPZ&FGI3OX33?X10 T\#-.I&'R4O84 .H[4E+VH <O2EI!TI: "BBB@ HHHH
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MZT8XH 8XR*%'RTX\@T*/DH $-17',9I\?4TV7F(T */X/I0OWGH'\'TH7J]
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M $/2F <T]NE-7I0!&&^?%/[U #^^/UJ<]: %Q2CI1VI1TH 0?>H-'\5(.IH
M7TH-(>U+_%0 W%(YP*>:AEZ4 3KRM(.M$?W!1_%0 DE+_#1)0OW:  #BDIR]
M*:>M " \XH8?-FF_QT^3I0  \4D)R#2)T-);GAOK0 YN%:FGE%-.D_U9I!_J
MA0 JG(I%/441]Z1?OF@ @& ?K4U1Q\9I] $)7Y\U+2,*!T% ",.<TV,Y!J1N
ME10]Z )%ZTHXS35^\:7L: #JM*O2D7[M*O2@!KFG?P4QZ=_!0 VCK1VI%H 5
M>M2=14?>I%Z4 ,/%/'04R3@TX?=% #LT9I**  T@I>U(.M #J*!1WH ****
M%HHHH 0]*:?NT\]*:?NT (GW:!T-"_=I1TH 8.:%^\:%^\:5?OF@!&ZFHU7Y
MLT]_O4Y5XH :3SBG=%-,_CJ1ON&@!%^[3:5/NTJ]Z !>E)VIR]*;_": %/:E
MQQ2>E/[4 ,%(:?3#0!(.E+2#I2T (>E-6G'I310 'K0>E+WH[T (>E(!2FE
MH *9GFG&F-0 _/%)0.E(.M  W5:!]\TK?>%(O^L- "TG>EH-  .E+T- Z4AZ
MB@ 'WC3<_O2*/^6AI!_KS0 @.),4]^1BHF_U]2G[PH :YPR"GU%/_KHZF/6@
M %*>E(O6G'I0 SH*1/XJ<WW::G0T +VI%Z44J=: %8?+1BE[T4 )2CI24HH
M<**** "BBB@ HHHH 8W2D'W*<>E-'W* !.AH/(H'0THH 8!BG9YIQ%1]Z $F
M&:53\HI9!E:90!*.E**0=*7M0 M(U':D/6@!HZT^F=Z=0 G8TQ#EZ=ZU'%_K
M#0!-GYJ:_6E;_64/0 G:@]*7M0?NT *GW*:GWJ<GW*:GWJ !OOBG"D;[XI:
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M&D>D0_-0 DOWA4B_=%1R_>J5?NB@ HI:* $[4WO3NU-H <*.](*7O0 4444
M%%)10 M(?NT4'I0 +TI10O2@=* (T^\:4??-(GWC2C[] "$?/3UZ4G\=.[4
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M '>@]:.]'>@ ;[M(.U*>E H #33UIQI"* !>E(/O4)0O6@!#R:<*:O+&G=Z
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M0** "D-***  4'K1WHH 2E%(:44 '>D/6E[T=Z $H'6EH% "=S2*/FIU)WH
M/XJ4T#K0>M  :.U(:7M0 &@]*:>M.;I0 "EI%I: "F$<T^DH 6D[TM% !111
M0 4@ZTM)WH 6BBB@ I#0:*  =:#11WH #TIJ]33C2"@!>]'>@4=Z #O2TE+0
M 4444 (.M+24M !2=Z6D[T '>CO1WI: $/2D[TIZ4G>@!312TAH #10W2D%
M"=C3EZ44"@ [T44E "FCM110 4=Z*6@!.]'>CO1WH #TH%+3/6@!QH/2D[44
M -7K2CK0.M H 1/O&G'K2#K3C0 =J6DH% "T444 )WI:3O2T %%%% ""@=:!
M0.M "T444 (W2FG[E.;I31RIH 0?<I8^E-'3%*GWL4 24444 %%%% !1110
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M*<4_HE "_P )H/04J_=H/2@!!U--0_-3O6HXSS0!.>E"TA/%"T .I:;WI30
MA-03#YA4Q/%,D&: %7[M2+TJ/HM/3I0 ZBBB@ /2D%!H% #>].I.]+0 4444
M %%%% !0:**  4II!UH- !2-2TAZ4 +VH'6D[4M !31U-*.M'>@!W:FGK2TC
M=: #O2]Z0TO>@ '6CO0.M+0 444G:@ HHHH *0TM'>@!:3O11WH :/O4KT@^
M]2O0 J_=HH'W:04 !IK4I/-(>E #$_BI5Z-21=6I?[U #HON4^HXO]74E !1
M124 +12#I1VH 0_=H7I3CTI.BT (.M/I@IU !3'Z4^FOTH :W04X_=%-;M0W
MW10 _P#@IJ_<IP^Y31]V@!DGW*?']VDD'R41?=H DHH%%  .E+2#I2T %)2T
ME !1110 E+VI*7M0 "@T44  ZT444 '>CO0*;GF@!QH[T&B@ [T=Z*!0 M(*
M4]*04 !H/2AJ0]* %[4AZT=J.] "FD[4IH[4 -/6E/2BB@ 6G4VG=J "BDI:
M "BBB@ HHHH *3O2T=Z "BBB@!#0*#0* %I.]+2"@!:2@TF>: %'2CO1VH[T
M +1124 +1244 +1110 4G>EI.] !WI:3O0: #M2=Z7M10 M-:E-(: !NE I6
MZ4"@!:04M)0 M,-.I,4 **!2BB@ HHHH 3O1WI>]% !3/6GTWUH !]VDI1TI
M* %[T4AZTI^[0 4ZFCI2F@ - I*44 +1110 G>EH[T4 %%)10 "CO0** %HH
MHH 0]*8G\5//2HX^K4  ^\:%_P!::%^^:5?]:: )**** "BBB@ HHHH ****
M "BBB@ IC]*?3#R* !?NT@ZTB'K2C[U #Q0**2@!LOW*KP_?JR_*U!$,24 6
M#Q3#T-/:F=C0! GWJL)R*BVXJ2(T ./W32+]VE/W30OW: $6E[4"E[4 ,7K1
M_P M*1/OT_\ CH :_#"G-]VHI3AA4@Y2@!/X12$_/0*8Q_>4 2MU%*?NTC=*
M;GB@!'_U8H7_ %-*X_=BFC_54 (O^J_&IA]T5%&/W7XU(3\M "M]VD3I2$_+
M21GK0!)2'I0.M#4 (.E(W:AN$)I&Z+0!*/NU"?\ 6FIA]VH\?,30 /\ <J"+
M_65*3GBD1<'- #U^]2ORM,/!I_5: &1\5*W2HONXJ7M0 P_=HCZ&E;[M-CZT
M ,?[]/8X%(P^>DEXQ0 LG^K'UIXX44W&8Q2,<"@"0U .KU*QX%0GO[T .@ZF
MD'^NS3XA@&@#YB: ).HI&^X:;&<J?K2O]V@!L=1Q\3M4J#Y:B;Y69J "7FI6
M_P!742?.F:DZC% $B?=%'7- X%-0Y+4 (>AJ-.#4C\"FXQ0 ^E6D6GB@!.].
M:DQS2F@"-NGXTYONTC=*'^Y0 /\ =IR=*8WW:>GW: '4444 (W2A>E#=*%Z4
M )WI>])WI>] !1110 4444 %'>BCO0 =Z#1WI#0 O:D/2E[4AZ4 )_"*?VIH
M^[3J &CK0?O"B@]: %/6D;K1WI30 AI>]%%  *6DI: "D[444 %%%% !1WHH
M[T %%%% "#K0U*.M(U "C[M-%.'2@4 1MUI3TI2.::WW@* $A'+49Y84Y!C-
M1(<RL* )(O\ 5U)34&%Q3J  TWL:=2=C0 #[M)VI1]VCM0 II&Z4A/-#=* %
M'2E%)V%+WH 6F-TI],;I0 U^@H?H*5^E-?\ AH >OW:04 TF?FH <_W:;%TI
M3UQ21]#0!(****  =*6D'2B@!:2BB@ HHHH 3O2FCO0: #M0*** "DHS2T
MZ4T?>IU)CF@!:*.]% !0**!0 =J6D[49H 1J0_=I6H/2@!/X:7O0>E'>@!30
M>E!H/2@!.U ZTHZ4@ZT !ZTO:D/6G=J &]Z=3>].H **2EH **** "BBB@ H
MHHH 0T"@T=J %I!110 &FC[U*W44G>@!U'>BCO0 "DI110 E%+10 M%%% !2
M=Z6D[T '>ANE'>@T  Z4M(*6@!#UI#UI3UHH #TI:2EH 3O24O>B@!*=24M
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MZ^RWS[T 6,Y45(O2H(3NB4^U3+0 ZBBB@!&Z4BTK=*1: #O2TWO3J "BBB@
MHHHH *.]%'>@!#UH-*>M(>M "_PTG:E/2D'2@!1TH- H- !VI.]+VHH ;WIQ
MIO>G=J %HI!10 M%)10 =J2BEH **** "DI:* "@=*2E'2@ '6@TG>@T *.E
M+2#I2T --1-_K5J6F$?O : %R,D5!%_KVIB2YG9<]ZD VR,: + I::ARM.H
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M!O>G4G>EH 2EI#2T (*6D%+0 E HI10 4@I:04 (>E I>U(* %/2D[4IH[4
M!IJ]Z=2+WH 44=Z!1WH *!2T@H 6BBB@!#0*#0* %I!2T@H !10** #M0.M'
M:CO0 C_=J%>]3/\ =J(#@T /4X&:<O/-02OLCS3K5]\8- $]%%(* %HI*6@
MHHI.] "T444 %%%% !VJ!ON&ICTJ%ON&@!L1PK&EA;<YJ-CLMV:JVFS^9*XS
MTH U.]%%!H *::5CA:1C\M #0>32-*%[TA.(V:N<U+51 P&[O0!T?GJ>],<\
M9KE(]:#2 ;JZ*VE\Z$&@"Y&?EJ1ONU''TJ1ONT ,_AJ.%_WF*D ^2LQ+C;J1
MCS0!K8^:D;[XIWO2-]X4 (1FF&4*,9IY.%)KE]4U46\Q7=C% '1K,N>M.?E<
MUQT&MAG4;N]=7:R>=;!J )X>5-*!\U-A/.*<.IH %^^143_ZS%/0_O&I&'[S
M- #RX0<U&9USUK,U6]%OWQQ7/_VZ/-QOH [=7#48P361I=\)R.:V#0 Q>M,<
M\T_H::PR: &3MBV-30\PH?:L_4I?*MS5RS;=:QGVH E8\TTGYJ4\O2'[] "L
MP3K4?VA=W6L[5[T6QZXKGSK8W_>H [8,&%,?@BLS3KT3(ISUK3?D T 2#E:7
M^&DC^Y0?NT )2KP,T@Z5'._EQ$T #2@,>:02AN]<U?:J(F/S5%::P)' W4 =
M8I_>_A22#]V:BMGW@-[5.XS'0 ,<0CZ5&)EP.:AO9O*MCST%<W/K CXW4 =<
M)@<#-/;I7+:=JHGD4;N]=.3E : #HM*#Q0WI5>YE\I* )3.HXS2"0.<9KD[O
M6A'/MW=ZMZ7J8GF(W9H Z0\1T1_=)I =T0-*.(S0!'"W+_6DDF"@\U4GE\F)
MVS7/7>LA3C=0!UT<H91S4_45RFF:H)2HW5U,+;HP: #HU.'6FGK3A0 ZD%+2
M"@ ;I63J\OEV>?\ :K6/W37*^*+GR;#K_$* -^Q;?;(?:K*=36?HK^981-_L
MBM!.IH ?1110 AZ4BTII%H 3^*G4P_>IQH .U+WI** %HI*6@ '6D_BHH[T
M*>M'>D[T=Z %-(*3UI5H /XJ#1_%0>M "]J.U':CM0 VG=J:>M+VH 4=*.U
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M10 4444 %%%% !1110 4444 %%%% "4M%% "'K2T44 %%%% ""EHHH ****
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M#+>$%JX/4T:>^WC/6MGPQ,;:_.3B@#WJT;?;*:EDXC-9VAW'GV"MFKSMNC-
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M^^#?_(BP_P"\:] _BH 4=#2]J%HH 3L:;GY*7L:;_"* ']%H[BAONBD/WA0
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MHJ6ZC':@#SGQOI^+-I,?=&:/A9-YL>?3-=-XVLPVA7# <A#7%?"*7&Y#U!-
M'L;G]W0O)!ILG^JI\?W10!)1110 R0X%>4_&%?\ B5*?]L5ZK+T'UKR[XOC_
M (DZ_P"^* .L\##'ARW_ .N8KID[US?@H8\.6W_7,5TJ=* '4444 ,DZ4O\
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M/@7_ *FY^E>6ZE<-<::Y/I7J?P,&(+CZ4 >T4444 -?[M,7IFG2_<I!]S\*
M/"?B--Y_B>T@S_RTQ7K_ (6@\C0($QC KQ/Q9)YWQ%LXO^F^*][L(O)L$3T6
M@"27_4-[BO!O']O]G\0QRXQR/YU[S)_JJ\:^*T'E3QR8[B@#U?P^=VA63?\
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MN/:@#Q7P1_HWBUX>E>PZ^^S0Y&_V/Z5X]H_^C_$:2/IQ7K'BJ39X;=O]C^E
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH 9*<)FJ.IR^5ISOZ"K=R<0FL7Q+*8] E;_8H \E\=ZB)K
M!EW=C1X#U$0Z%"N[O7(>);XRP2 GL:7PS?&+28!G^*@#Z/T*X\ZT!S4>IWGD
MWR+GJ*SO!DYETU236=XLO?(UJ%<XR* .Y@;?"K>HJ8=*I:6^^PA;U6KM "&F
M?Q4\]*3O0!')UJI?S>5MYJZ_6L#Q'/Y*KSVH V(&WPJWK4X/%4M+;S--B?U%
M6\T .;E&^E>+_$>R:6Y.!7M/\-<!XNT\3W(^7/% 'C5UI;+H\C%>@KT/X*+L
M2X'M46KZ0(_#\S;>BU:^$*[)+D4 >OT444 ,E^Y2=(_PIS_=IC?<_"@#Y\UY
M=WQ/L_\ KXKZ!C.(E'M7@^M19^)%JWI/7ND9X ]J )&'[L?6O)/B\ORQ_45Z
M]CY17DGQ;Y9![B@#T+PDV?#ED/2(5@>/K<S61P.QK:\'G_B06@_Z9BE\2VOG
MVI&.U 'S^NDL6?Y:E\$0_9_&Q3&.*] BT488[>U<CHT'V?XD/'C' H ^A(_^
M/:/_ '14A^Y^%1Q?\>T?^Z*>WW3]* /GK6&\WXH6H]+BO?1\L48]A7S_ '(,
MGQ4C]KBOH"3A8_PH E4?O,^U>.?&)<SQ?[RU[*O7->/?%L;KN(?[0H ]*\,_
M\BY8C_IDM:YZBL?PW_R ;(?],A6N?O"@ Q\QKROXMKOM;<?]-17JWK7F'Q-C
M\R*W'_344 =3X(39H$?T%=&IPI-8GA1-FB1CV%;3'$1H YKX@C/@G4#_ -,Z
MYOX/\:(G^[72^/3GP3?#UCKG/A&,:*O^[0!W.N)YFG./8UX%K6F,^HM\O>OH
M>\3S;5A[5YO>Z.'O2=O>@#R+6+,VQ0$8SBOI'PG_ ,BG8?\ 7(5XEX^L?LL\
M(QC@5[;X3_Y%2Q_ZY"@#;C^Y7EWQM&=!L_\ KJ*]23[@KS/XSKNT&U]I10!K
M?#+_ )%E*[1N5KB/AFW_ !3BCWKMNIH Y#XC#_BB=0_W*YKX0<Z4OLM=/\2>
M/!E\/5*YGX/#_B5_\!H ]38\"G_PU$QXIX^Y0!E:ZVS19S[&O)/A=%YGB347
MQTF->K>*FV>'YS[5YO\ "2+=J>I/_P!-: /9,=*27F-A[4I8 TPL#D4 >=7%
MCM\6^=BN@\;G;X1D_P!VIKNR'V\38[U7\>G;X0E^E '$?"5,SW9_VZ]>D'S+
M7D_PC7FZ/^W7K3CC- $=R-UK(/\ 9KPE?W7Q/8>U>[O\UNWTKPB^_=_%)OH*
M /3O'#8\&N?]D5R'P77-MJ)]9*ZGQVV/!#'_ &17-_!=?]#OCZO0!ZG&*9>#
M=;-]*E4=:;,-T#?2@#P@'ROBE(/85ZCXSDV^%6/JH_E7E.HGROBFWX5Z9XZ?
M;X0SZJ* .5^$4>'O&]9*];'#UY?\)H\0W#>K5Z?)PZT -OANLI1ZJ:\&T_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML\$JW^RM>?>,!Y?Q*!]Q_.NY^)C[/A^C?[*T 1?"E/\ 0)&]37HTP^=:\_\
MA4O_ !)=WJ!7H;C)% "/S$P]J\%UW]U\2S]1_.O>CSD5X'XM/E_$K_@0_G0!
M[M;?\>D)_P!@584YJO:?\>$!_P"F8_E4L1SF@":BBB@!#7DWQC'_ !+E_P!\
M5ZRW2O*OC ,Z8I_VQ0!V'@K_ )%RV_ZYBNE'2N;\%?\ (NVW_7,5THZ4 %%%
M% #&X:O.?B@VS36?TQ7HDO S7G/Q8^7PY*_H!0!T'@:7S?#]N?\ 8%=/T4FN
M+^&TOF>'8>>D8KLW.(F/M0!X+\0[S;XN5<])!7L'AV3S=$A;V%>!_$6Z/_";
M$9Z.*]P\$R>=X=C/L* .E/W<^U>,W$QE\;;<])37LTG$3'V->&6,GG^/IAUV
MS&@">"8IXZ*YZR"O;!RB_2O")W\KXA@>LHKW:/E%^@H Y_QG)Y6AR'VKS'X<
M7>[Q+LSU<UZ)\1)/+\..:\@^&ES_ ,5E&F>K&@#Z'E_UBUS/CR;RM!E.>J&N
MGD^\IKB/B=-Y6@MSU0T <?:R$^!H9/<UVWPQF\WP]G/\9K@[$Y^&<,GUKK?A
M#+YGAQO^NAH ]";_ %PKQ/XQ7>S5K,9KVUOOY]J^>/C3<8UJV&>AH ]?\"R^
M;X=M3_LUT_\ RT:N+^&DGF>&[;V05V;'#/\ 2@#R+6Y\_$G9G^$5ZOI__'LG
MTKQ?5)M_Q3*Y_A%>U6(Q:Q_[HH F_CK-\2''AZ]/_3,UIMUK*\2G_BG+[_KF
M: /)O"-[M-VN?X#63>P-<SEAS\U5/#EYY=[=)G^$UUFD6'VJWWXSS0!R&J6;
M+<1G!X%>C?#6\Q"\1/>LK6=)Q\VWHM5/ -YY6L/!G^/% 'M"'!8UXKXWG,FO
MW$8/>O9V.(\^U>&:\_VCQM<Q=>: ,--.<J3@T6"-:WRN>,&O0[70@UKNV]JY
M/7+/[$ADQC#4 >Q>$Y_/TU3GH*X+X@2%/%^C#UEKI_AU<>?I).<X%<C\2#M\
M9:'[RT >LV?_ ![+]*LKPE5K+_CTC^E6#PM 'G'Q(E\JU7G^(5V7AXY\/VY]
M8A_*N!^+,GEV:G_;%=[X:Y\-6A]81_*@#Q?PG_R4[5/^OBN_^*W_ "+_ /P$
MUP/A(?\ %S=4_P"OBN]^*_\ R+__  $T <)H\W_%M[:,'_EJ:QKO37:4-@\B
MK>@2[_"-K#_TU_K7=?V"'C1MO5?2@#RZP#66LQ9XYKZ,T67S=$A/J@KP/Q5;
M?V=JL1 Q7MGA";SM MSG^ 4 ,\83>3H3\]5->&W%LUU:*PR?GKV#XC3^3HZC
M/45Q'A[3/MFE1MMS\U '+MISI$&P>!7;_#BZV3^63_%5J_T,1V+-MZ"N=\%W
M'D:X8LX^>@#V^\E\NU,GH*\%\6RF]UN0 Y^:O;-;F\OP[++Z)FO#;#_B9ZZ^
M>?FH SI-,?8#@UM>"9C:>(D4G'%=A+H \@G9VKAD/]G^)T'3F@#T?X@(;G1B
M1W45X#K5JT5];9'6OH[5;?[=H2'&<H*\7\9Z<+?4K,8QDT 7/"=HRZA ^#RP
MKT_QZQB\+P_6N;\/:9Y<=C+M^\171?$W]WX8A'O0 _X92;]%8^YKG_$-UY?Q
M,LQG^ UK_"EMV@L?<UQOC"Y\OXE6IST4T .U_-UJA Y^:L+5--?R2<'@5T]G
M#]MU0$C.6K<U'0@;:0[>@H P/AG<&*]\DGI7MZMT^E?/_A"7[+XQDM^F"*]Z
M#?+G_8H \Q^)%YF0H#VKS^SL'D@D;!YKH_'MUYNKB/-;6B:()--5MOWEH Y'
M1(6M+P$\<U<U*]\S7[5<_P#+45IZG8?87+ 8KBA>>=XIMUSTE% 'TLAQIJG_
M *9_TKQ7Q9<&?4'0'N:]FSC2<^D/]*\(N)?M?B)TZ_.10!1737*$X/--\,,;
M/Q$H/'SUZ)!H8:W4[>HK@K^+^S_$:]OWE 'T%I\OFV:M[5(O^M)K,\-3>=I$
M39[5J#N: 'H<@U5OW\NSD;VJQ$?D/UK-\02>5I4K>U 'A'BAS=ZPZCG#4S^S
MF%F#@]*FM(_[0UZ<=</7=-H@_L_.WM0!POAJ4VVKJ"<<U[S:/YB1-_LBO IA
M]AUI>WSBO==#?S=.C?\ V!_*@#C_ (B7FVW9,]J\JBL7G._!YKM/B+>9O/*S
MUJ3P_HPN+"-]O44 <7;6C6]PS$'BO8? EYYFEJF:XW6=*^RQ2OMQ@5H?#B]W
M-Y6>E 'I<QVV,W^Z:\:T2\Q=:DF?^6IKV2]^6PE_W#_*OGW2KK;K=_'GK,:
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MNAF"0>HH ^>[1C:_$J5>@+ ?K7T #_H^[_IE_2OG_5Q]F^(V_IND _6O?_\
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M?!R/_B2L_P#TT->G./WPH D[5B^)#_Q3U_\ ]<S6R>E8WB3_ )%V_P#^N9H
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M  FYTNY/^U7I#?ZJ@ A'!->+_%1,:E"__35?YU[1'_JZ\>^*R_OH&_Z:C^=
M'H.F-N\*?]L?Z5Y9\,S_ ,57?C_IX/\ .O3=$.[PF?\ KE_2O,?AGQXNOO\
MKX/\Z /=@.:R/%H_XI;4/^N+5K,=IK(\6'_BE-0_ZXM0!YQ\'1BP+?[1KUBX
M;!%>5?!__D&?\#->J7 RPH XKXKG'@:Z'J!4'PE/_$AC_P!P5)\63CP7<#V%
M1_"3_D!)_N"@#T=ONFDB^Y2M]TTV+[E $E%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% "-]VH2,+FIF^[4;_ZLT >;_%GG0A_NFK7PG./!5O\
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M^@KR+QW>[T,:GO0!S7A^T_M+7-Y&>:]UT^/R+5$] *\J^&UEOO-[#->NE=N
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MR:X/X6'/AY!Z**[QJ  5X)\0O^1\C'^VO\Z][%>">/\ GQ^@_P!M?YT >X6
MQI]L?^F:_P JM]Q56R_Y!MO_ -<U_E5L=!0 M%%% #6Z5Y1\8A_Q+D_WQ7J[
M=*\I^,7_ "#%_P!\4 =GX,_Y%NU_ZYBNC7I7.^#/^1<M?^N8KHEH =1110!%
M*?EIBCY&^E.FZ4B\(?I0!X/8CR/B3+_M3UZ'\29=OAQQ_>0UY_=+Y'Q'B/\
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MZ1Y=ZIV]ZZOP[IROX<M6QU6KD>G!;D''>@#J=&C\NQ0>U7I.M16B;+=14K4
M8GC#_D6+G_=K@_A)_P ?U]]:[SQA_P BQ=?[M<'\)?\ C^OOK0!ZW12&EH 9
M-]RHV/S(*DF^Y4)_UB4 )?MLL)CZ+7@NOWGVO6)(<YP:]PUR81:9/D_PU\^0
M[[KQ;,.HW4 >J> +'R(P^.U=U]XUC>&+40Z<IQVK:B'6@"1>E./W:8O4T\]*
M &2?Z@_2O$)?^2KR_05[>_\ J#]*\0F_Y*Q-]!0![A%_Q[1_[HIPZTV+_CVC
M_P!T4[O0!1U&3RK>1O:O!_%%W]LUSRLY^>O:O$LX@L'YZBO!%W7?BU>X\P4
M>M^!M/\ LD:MC&17=2_=K+T>U$%K'@=A6I)R* #I'3H^E-;[E.3[M $:?ZUZ
MXGQ'?^5JL<>?XQ7;#_6/7DWC2Z,?B2)<_P#+0?SH ]7C.ZVB]U%. R*BM3NL
MX#_L#^531]#0!E>(QN\/W0_V*\C^$GR>+]46O7M=YT6Z'^S7D/PM^7QIJH]Z
M /= ?E%(YXH7[@IK]* /*/BU_K(_H*[_ ,(_\BS8_P#7(5Y_\6_]9']!7?\
MA'_D6;'_ *Y"@#=/:O#OB;\WB2!?^FR_SKW ]J\/^)!SXKMQ_P!-E_G0!Z]H
M:>7I$(_V!_*KO_+45!IX"Z9;_P"X/Y58/^M6@"EK:>9I-POJM>/?#L^7XTU)
M/1Z]FU ;K"8>U>+^!>/B#J@']^@#VU&S,1[5-GC-58_^/MOI5C^"@#E/B&OF
M>#[H5QOP1XCU!?1Z[?QHN_PK<BN'^"W$FI+_ --* /6W/[T?6G[OWN*C?_6C
MZT _Z0: /%/BH<>(X?\ KHO\ZZKX@C/PO3_<7^5<E\5#GQ+ /^FB_P Z['QX
MN[X9(/\ IFO\J #X3#&AGZ"O0N]>=_"IQ_8S+Z 5Z)Z4 *OWC7A'CH;_ (A(
M/]H?SKW;HS5X9XM_>_$51[C^= '9_$@?\6Z4?[*TWX4'.BD>PJ;XC+GX?8_V
M5JK\)6SI+CTH ]#F;:Z#UJ6JUT?WT?UJR?NT >#>-!O^)2CW7^==M\35S\/$
M'LM<7XI_>?$['T_G7=_$=-W@(#V6@"/X5-G0\>@%>@.?F%>=?"=\Z2X]*]#D
M^^M "YY->"^./F^(JC_;7^=>\$X+5X-XL_>_$G [,/YT >Z6G_(-M_\ KF/Y
M5:'056M?^0? /]@?RJP.U #J*** $->4_&+_ )!:_P"^*]7KRCXQ_P#(*7_?
M% '9^"O^1<M?^N8KHQ7-^"?^1<M?^N8KI!0 M%%% $<@R*C8X./:IS5>7_6C
MZ4 >(^(U\CX@V3?WI:Z3XFOG2;)?[W%87CE?)\<:6WK)6G\1Y-UCI0_O,* .
MN\"Q>7X-C3'8UY_ /L_Q9 Z96O3/",>SPW"GM7FNICR?BU&?]B@"W\6'W>4G
MJHKT'P@FSPQ9?]<A7F_Q/;?J%I'ZH*].\-+L\-V8_P"F8H I^-4W^&[K_KF:
MXGX6/ML94]%-=[XJ7?X=NQ_TS-><_#1]AND]$:@"O9_O_BH3Z+7;?$%-WA"<
M>F*XGPY^^^)KM_LFN_\ '*;O"=R* .<^',V-!NO]D5@>"%\_Q_J;^CUH?#^7
M;H6I?[-5OAJGF>,-4?\ VJ /9';&VO$_B2NSQ;#+_M+7M,WWE^M>.?%--NKP
M2?[:_P Z .E\;R?\4 A]8UJS\,H?+T<M_>6LOQQ+GX?Q?[BUT7P^CV>'H3ZH
M* //O%B^3X[LFZ;IQ6[\6)/^*?LO]I@*Q_'Z^7XQTMO685>^*\F="TT>L@H
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MWZ%_UUH ]<TD?Z!']*O]ZHZ7_P @Z'Z5=- 'DOQG/^@H/]M:]$\,?\BI9?\
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M6^/$.G?6@#U#PK_R+]N?5:YOXJG'AQ/]ZNE\*?\ (N6O^[7,?%GCPW'_ +U
M$?PE.?#3?[QKE]<./B_IY_V:Z;X1?\BPW^\:Y?7_ /DKMA_NT >UQM^XC^E,
M08ESZTB'_1X_I4F.5- 'B_Q4Y\0V(_Z>%_G7?^*AN\'1_P#7(?RKS_XH_P#(
MR67_ %W7^=>A^)!N\'I_UR'\J .8^#[YLKH>DIKU%OF1A7D_P<?_ $:\7_IL
M:]73JPH CAX#BOG_ ,7-_P 7)0?]-5_G7T O'F5\\^*WW?$Q?^NJ_P Z /H6
MWXM(#_L#^54=7M_.[=JM!Q'I\!/]P?RIZ[;A,]: /+?$6A^8&;;7#74']EW,
M38QDU[QJ6G+) YQ7C_Q$M#:10NHZ4 >I^"[G[3HT;9SQ73K]S%<#\+;CS_#\
M1)[5WXZ4 *>A^E>'>*3L^)%A[M7N+?TKPSQM^[^(FG-VS0![/8C-K&?:K3?=
M%5M,._3H6]5JP_;ZT -QM<GVKD?B ?,\*S#WKK+IQ%$6-<=XND$_A:<CGF@#
M%^$9Q972_P"U7J!["O+/A,V([I?]NO5/XA0 T#YC7D/Q5?\ ?P)_TU'\Z]AQ
M\QKQ7XJ2?\3>!/\ IJO\Z /1=$39X8QZQ?TKR_X<\^+KX^DY_G7K&GKL\-K_
M -</Z5Y/\->?%>H_]?!_G0![9(-[#VK+\5C_ (I6_'I":V(AEC63XK'_ !2^
MH_\ 7$T <#\&Q_Q*B?\ ::O6(SE2:\J^#?\ R!F_WFKU* _NVH \^^*PW>#+
MQO2G?"3_ )%^/_<%'Q/&? NH'WI/A%_R+\?^X* /1.[4J<+2#[QIR]* '444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 (WW:C(I[?=I,<4 >;_
M !>_Y%__ (":G^#W_(C6WU-0?%__ ) '_ 34_P (/^1$M?J: /0NU,CZ&G"H
MU8#- #H^K5+4:=ZD'2@!#56^3?!BK1J.5=R8H RH;? Z5YS\38MK0GVKU=8L
M"O,_BFF!$?:@#I_"D0;PO9\?P5I?9_WH..]5O!ZY\+V7^Y6YY7S9H DC&(Q2
M]:=C"TU>E &%XP_Y%FZ_W:X7X3?\?M[]:[KQA_R+5U_NUPWPG_X_+V@#U<]:
M7O3#]ZG#K0 DGW:A7EQ[5([#=BF0\DT <UXUO/LU@5SC<*\M\,Z>;G6WGQG)
MKL_B?=^5%"@/6J_@"P\V(3$=10!Z)ID?E6*K5I!A338TV1!:D(PE  O6E/2D
M%!Z4 #_Z@_2O$)Q_Q=>7Z"O;W_U!^E>(S_\ )5I?H* /;HO^/:/_ '13A3(O
M^/:/_=%2#I0!P_Q O/L]JJYQN%>;^&; W.N+/C/S UU/Q8NO+:V0'K1\/K#S
M8TE(]Z /3;<;857T%3]14:C#8]!4B<K0 'TIZ]*C/WP*>6VT ,Q\S5XG\0I/
M+\40_P#75?YU[;UYKPOXGG9XG@/_ $V7^= 'M>G'=I]N?^F8_E5B/A6^M5-&
M;?I5N?\ IF/Y5:'W6H SM9YT>Z_W:\B^&8QXUU7ZUZYK)QH]S_NUY/\ #5?^
M*QU,^IH ]L3_ %8H(XH3_5BG8XH \D^+?WX_H*[_ ,)?\BS8_P#7(5P/Q;_U
MD?T%=]X2_P"1:L?^N0H W/2O"_B2V/%MO_UV7^=>Y]Z\)^)O'BN _P#39?YT
M >TV+9TNW/\ L#^56C_K%^E9^FONT>W/^P/Y5H?QK]* *NH-BPG/M7C/@,;O
MB!JK?[=>P:L^W3;@^QKR'X=#?XWU5O\ :H ]JC7]^Q]JF_AIJC'-&X$XH P/
M%JY\.7 ]JX'X-_+=ZF/^FE>B^*%SH4X]J\Z^$9V:EJ:_]-: /6V'[RFI_KVJ
M7')J%>'<^U 'AWQ-;?XLA7_;7^==]XOC\WX<HO\ TS7^5>>_$ ^;XVC4?WA_
M.O3?$$?F>! O_3,?RH YSX37&ZVGCS]TXKU(=17C/PBG_P!,OHR>DF*]F7DT
M -E.V.1O:O"=6?[1\1_H17NEZ=MG*W^R:\%A;[1\1V/6@#TOQ]'O\"E?]D5A
M?!Z7=9W*_P!UL5U'C./?X/9?]@?RKBO@Q+SJ"9Z28H ]7G&Z5?8U*[?NV/H*
M:PRQ/I3)FVV\A]J /$-4/G_%-AZ 5Z%\0$W>"MO^R*\[C_?_ !5D[\5Z;XX3
M=X29?]D4 <[\(Y,V4Z^C5Z6W+BO*/@_+\EXGI)7K ^^: (Y3A9#Z"O"]5'VC
MXE-WP1_.O<+HX@F/HM>(V_\ I/Q(D/7% 'N5OQ:PC_8%2@_,*BAXCC'^R*?G
M]X* )J*** "O)_C%_P @E?\ ?%>L5Y/\8O\ D$K_ +XH [/P5_R+=K_US%=(
M.E<UX+_Y%NU_ZYBNE7[HH 6BBB@!#4,@S(#4K4TC/- 'C'Q(7R_%^DM_MU-X
M]?S+;11ZN*/BFNWQ)I+?[55?%TGFIH8_Z:"@#U3PXNS1XE]J\N\2CR_BE&_^
MR*]7T5=MC&O^R*\J\9CR_B)$_L* (OB"WF^)M-B_O1BO6M%79HMHGH@KR#Q<
MWG>.]'3UB%>QV"[+&W7T6@"OXB7=H-T/^F9KRGX?/LU+4(_2)J]<UQ=VC7(_
MV#7C/@Q_*\2:JGI"U %[P4OF>/))/K7HOC)-WAFY%>?_  [7S/$TLO\ M&O2
M/%:;O#]P/:@#S#P/)MT+6O\ 9-6_A8F=>U"3U-9/A&3R]$U\>C&M[X5)_IET
M_K0!ZG*N2*\D^+,6)(9/^FB_SKV!AFO+/BW'_H<3_P#304 5/&4V[P'$,_P+
M7;^!EV^&K4^L8KSCQ1-O\&1+G^%:]+\&+M\,VG_7,4 >>_$I=OB;2&_Z;4WX
MF2>9I.EK_P!-5JQ\4%QK>D-_TUK-\>2>=9Z6O_39: /4?":;- A'L*W@.165
MX?39HT(_V16OT&: &./G%97BCCPU?'_IF:U=P+"LGQ7_ ,BQ?_\ 7(T >,_"
M>3_BK+H^HKW@#]]GVKY\^%<NSQ5<>]?0P^Z&]J 'J:\8^,C;KN"/U%>RH>#7
MBOQ:;S-<M$]: .@N6\CX8P#T@K$^%MMYDAGQUK5\0'R?AM$/^F%'PCAW:)%+
MCJ* /3%P)L>U<U\0^/"\U='_ ,O%<O\ $=\>%YJ .4^"7-GJ/_72LWXI?\C?
MH?\ UUK0^!YS9ZC_ -=*SOBKQXMT0_\ 36@#U[2C_P 2R'Z5<S^\Q5#1SG2H
M#[5=4_Z2?I0!XU\99/\ 28H_]I:]0\*'_BEK0?\ 3$?RKR/XR2YUR%/I7K7A
M/_D6;7_KB/Y4 >/>%!_Q<[5/^OBO0/BJ,^'6_P!TUP/A0?\ %S=3_P"OBN_^
M*?\ R+S?[IH C^$''@:'_?->@M]VO/OA'QX'A_WS7H/\% '+>/?^10N_I7&_
M!?IJ'UKL_'G_ "*-W]*XOX,?\Q'ZT <YXL;[5X]$77;**]FT>'RK"(8["O%;
MP^?\4[B,_P ,HKWBWC\NUC'L* +?'ED^U>#>.Y/,^)=@?05[NQQ Q]J^?/%<
MGF_$BT]C0![%<77V;0H&SCY*T]&G%Q8(^<Y%<EXFN/L_AF!LX_=UL>"KCS]"
MA;/44 ;DZ!D?Z5XQ\2['_1?-QT<5[:RY0_2O-OB7:#_A'VDQ_%0!J?#6;S-#
M4>@ KAOBPV[Q)IP_VJZOX4R;](<>AKD/BD<^*M/'^U0!ZUX6&/#EK_NURWQ:
M_P"1<C_WJZSPR/\ BG[;_=KE/BU_R+D?^]0!%\(A_P 4NW^\:Y77N?B]IX_V
M:ZSX1C_BE6_WC7*ZX,_&'3Q_LF@#V51^XB^E3XX6HU'[J/Z5.HX% 'A_Q0_Y
M&6S_ .NZ_P Z])UU=WA!?^N/]*\V^*/_ ",MG_UW7^=>FZLN[PF!_P!,?Z4
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MU.IB??:GGK0 ^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZA?"K'_:KO!7!?%9@OA1A_M4 4OA(,Z/*?\ :KEOB@G_ !56GG_:KK?A&O\
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M]J &7)Q#N]*\"\:_Z7XWC'7$B_SKWF\;%A(WHM>#W(^V^.SWPP_G0![7,/\
MB0*G_3#^E>0_##_D:K__ *[G^=>P3#_B7;/2'^E>0?#+_D;=0_Z^&_G0![HW
M45D>+?\ D5-1_P"N)K7;[PK)\6_\BKJ/_7%J /-?@L/]&;_>->NG_CYKR7X+
MC_0V/^T:];/_ !\4 <)\7O\ D2+OZ5#\)/\ D7H_]P5-\7O^1)NZA^$G_(O1
M_P"X* /04_UAIYZU&O\ K33VZT 24444 %%%% !1110 4444 %%%% !1110
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MGUH U?@I+Y<5VN>KU8^,"YN;"3^Z:QOA/-Y-S.F>KUO?%E=UK;R?W1F@#L?
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M1UE?"Z\V6T<>:U-3_P!,\#2MUQ%7%_#^\,-\D6?XL4 ?00;Y,^U>9?%:\#:
M8L_QBO1O,'V3=G^&O%?B;?&2/R<_QB@#L_A.FW0']S7*?%9MOB"P/O7:?#*/
M9X?^H%<'\7'VZY9'T- 'J/A>?_B16HSU6N;^,!_XIR/_ 'JN^%;K_B3V0SU
MJA\8#_Q347^]0 GPCY\*-_O&N:UOCXQ:=_NUTGP@Y\*-_O&N:U_CXPZ=_NT
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MZC_UQ-:[?>%9'BS_ )%74?\ KB: /._@O_QX-_O&O63_ *^O)O@O_P @]O\
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M,5R7Q+A\RYC/M77^%AMT:V'^P* -X]:XGXEV_GZ'@#FNW-<_XKMOM6G%,9H
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MO]NNVUC7T0"@#PKXCVA34_-4=ZZOX>ZB(M.(8_PU'\0M.\Q&DQTKD=%U3[!
MZYQQ0!U/CC4!-:2JIZ@UC?"*T9=5>1AV-9=[J7]H-LSG-=[\/=-^R'S,8R*
M.ZU?G2YL?W#_ "KQKX8H5\47Q_Z;G^=>QWYWZ7/]#7E/PZAV>([PX_Y;&@#V
M=NHK(\5#/A?4!_TQ-;![5D^)AGPY?CUB- 'GGP;7;8-_O&O56'[X5YE\)4V6
M;#_:->GD?O,T </\65W>"+L>U4/A,-NB1C_9%:OQ/7?X1N5]15'X8IY>DH/]
MD4 >@_Q4'K1_%0W6@"2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M09- &9XC7?H,Z^JUR_@*#RI;CCK78:NGF:5(OJ*Q/"UMY,DO'6@#JOX:B/\
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MM\5W,F.LF:Z3Q1!]HL]N,\4 5/A]%Y/AB)?]HUU+??K$\+0_9]&1.G-;C=:
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MCM5J493%*HQ'B@")#^\J8]:B4?/4A/- $E%%% !1110 4444 %%%% !1110
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MZ4 19Q.![4V4XF44K?\ 'TOTILX_?K0!8'W:KD8?/K4X^Z:C<<+0 HYD/TH
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M-]ZGTT_>H C8<T\=*0CFE[4 *.E+FD[44 +0.E)2]J (L?-2D?,*,?-3CU%
M"]ZC/^LJ3O3/XZ !OO 4TC]X*<?]8*,?.* &GEZ=_%31_K*<O^L-  _6G+]V
MFO3E^[0 =J.U+VI!TH 5:B<?-4JTA% "(*5A0*=B@!G:F;>:?WIV* &'@4T#
M]Y3GHQ\U #AUH4?,:%ZTH')H C;[U/ZK3/XC3U^[0 VAQE:&^[2CD4 ,1<5(
M.31C I%^\: %IPIIIPH :WWJ:1S3F^]1B@!?X:C/6I>U1GK0 E+VHI<<4 -Z
M4'YA2OP*(^10 @XH;D4/Q2CD4 (J_,*?2@4G>@!%^\:"/FI!]ZG'K0 W'SYI
MW:C'-)0 QERX-.)P*=BF24 -/K35;G%/_AJ!<[Z +*#!S3@>M"CBD3J: &%?
MF)IQY6G,/E)IJ_<H $ZT\TU!S3FH B>G#[HHD^[2C[@H 1?O&ANM"??-*_6@
M!A'[T?2G#[]'_+4?2C^.@"6BBB@!#3!UJ2F#K0 F*6/J:!2)U- $E%%% #7Z
M4S^,4]^E-_C% !_>J/'S T_UHQP*  GYJ:XR]#??I^/FH B<?N33Q]Q:20?N
MC3A]Q: '_P -1 ?.WTJ7M48'S&@ 0?)^-*W2A?NTIH C7K4H'-,4<U(* &/U
M%,;_ %GX5(?O4QO]90 C?ZLTZ/H*#_JS2ITH /[U,/W!3^S4W'R"@!R_=I<4
M+]VE'2@!G>LW7EW:#>+ZH:T_XJHZLN[2KI?5#0!Y?\-;7R=?N&QU%>ND?/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG*T *.*#S2GI0*  4A'S4M*10 T\B@=**6@!,4$4[%&* &KUI"/FIXZTF.:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4#I0 'I0O2CM0* #O3".:DIIZT ,9<+2Q_=I6^[21]* 'F@4II.U  :6DI:
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M 2@]:** "BE-)0 'K2TE+0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %':BCM0 VE%% H #1WHH[T +124M !1110 AI:0TM !1110 4AI:
M0T ':D%+VH6@ %+2#K0: #M11VH/2@ I#2]J.U !2TAH[4 ':CM0>E':@ %)
MWI110 M(:6B@!*;WI12T ':A>E--*O2@!U-;K2]Z#UH !TH_BHH[T %!H-%
M""G4@I: "BBB@ H/2BD-  *!0*6@ HHI* "D/2EI.HH 4=**0]*44 )3J2B@
M!:0=*7M2"@ H[T=Z3^*@ /6E[44&@!HZT[M24"@!$[TXT@X%)WH #U%/IC=1
M3J %HI#0* %I#UH/6B@ -':BCM0 =Z6D/6B@!:*** "FBG4@H !2T@H% "T4
M44 )WI>]%)WH 6F]Z444 %(:*6@!#]VE'2CM2CI0 4G>EIHZT +WI:3O1VH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 AZ4M(>E H
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M30/GS3C0 "@T=J* #M1WHHH #0*6B@ /2D%%% "GI33TIU-/2@!>] I.]**
M T"@T"@!:0]*6D/2@ %-/0TX4AZ&@!!]P4HZ4@^[3NU !VH%% H 04O:B@T
M+33TI<\4G:@!PZ44@Z4M "4&D[TIZ4 **2@=*2@!U(:6D- "44M,4_-0 HZT
MB]32_P 5)TS0 ?Q4H^]32>E*.M #OXJ7O1WH/6@!#2BD/6EH 6D'6BB@ -!Z
M4&CM0 #I2TE+0 4G>EI.] !WI:;W%+0 4&B@T -_B%.%)_%3J "BBB@ I#11
M0 G>E-%)0 4E.I,4 .HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH 0]*!0:!0 M(:.]!H !TH/2@44  I:04M !1124 +1124 +1110 4VG4E
M"T444 %(>E+2=J !>E!Z4#I0>E "=J4=*.U%  :#0:#0 =J.U':CM0 @I>U
MHH ::44$4"@!U(:6D- !2]J*2@!O>GCI3:6@ - I.]+VH .]!I!2T  H-%%
M"T444 %%%% !1124 +1110 @I:2CO0 &B@T4 -[4[^&FCI3NU  *!TH'2EH
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M[4#I0 BTM(*6@ '6EI!2T )1WH[T4 !I.]*:.]  U)BE-':@!*8.<T_M30*
M 4HH'6@=: '=J!1VH%  :6BB@ IK4ZD- "4X=*2EH 0=:.] HH !0>E**#0
ME ZFB@=:  ]*1?NTIZ4+TH 0]*7M2'I2]J "EI*6@!!0:44AH !10*6@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 3O
M2T44 %%%% !1110 4E+10 4444 %%%% !1110 4444 %)2T4 %)WI:* "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@!.]+110 E+110 4E+10 4444 %%
M%% !24M% !1110 4E+10 4G>EHH **** "BBB@ I.]+10 4444 %%%% !111
M0 E+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% "=Z6BB@ I*6B@!.U+110 E+110 4444 %%%% !2&EHH **** "BBB@
M!M***!TH 6BBB@ I.]+10 4444 %%%% !2=Z6B@ HHHH **** "BBB@ HHHH
M 0T=Z6B@!.]'>EHH 0TO:BB@ I!2T4 (*6BB@ HHHH **** "DI:* $-+110
M E)BE/6CM0 V@=:#10 _M1110 4444 %(:6B@ HHHH **** "BBB@ I*6B@
MI!TI:* $[4M%% "4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 )0.E% Z4 +1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M"&@]*#2&@ I*6B@!U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 )0.E% Z4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "'K2&E/6DH
M**.U*.E "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 E Z
M444 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% "'K2>M%% !VI1THHH 6B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
(* "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
